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ABSTRACT 
Synthesis and Reactions of New N-Heteroaryl Boronic Acids 
Kate M Clapham, University of Durham, October 2008 
New functionalized pyridazinylboronic acids/esters are reported. A comprehensive 
study of the reactivity of the C-B bond in palladium-catalyzed cross-couplings with 
aryllheteroaryl halides is presented. Aryl/heteroaryl-pyridazines have thereby been 
obtained in synthetically viable yields (typically 40-75%). 
A series of pyridazin-3(2/i)-one derivatives have been obtained from the corresponding 
3-methoxypyridazines in straightforward procedures. Further functionalization of the 
pyridazin-3(2/i)-one derivatives through C-C and C-N cross-coupling reactions yielded 
a number ofmultiheteroaryl arrays. 
The synthesis of trifluoromethyl-substituted pyridylboronic acids and pyrazolylboronic 
esters is described. An extensive study of their palladium-catalyzed cross-couplings 
with aryl/heteroaryl halides is presented. CF3-substituted aryl/heteroaryl-pyridines have 
thereby been obtained (51-98% yields). Analogous cross-couplings have yielded 
heteroaryl-3-(trifluoromethyl)pyrazoles (60-85% yields). Regioselective halogenation of 
the 4-position of selected trifluoromethylated pyrazole derivatives was successful. 
Subsequent Suzuki-Miyaura cross-couplings yielded tetra-substituted pyrazolyl 
derivatives. 
X-Ray crystal structures are reported for several aryllheteroaryl-pyridazines and derived 
pyridazin-3(2/i)-one derivatives, and selected pyridylboronic acids, pyrazolylboronic 
esters and derived trifluoromethyl-substituted heterobiaryl systems. 
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Chapter 1 - Introduction 
CHAPTER 1 -INTRODUCTION 
:Ll Boronic Acids 
In modem organic chemistry boronic acids and esters are widespread; the versatility of 
the C-B bond allows the transformation of organoboron species into new synthetic 
compounds through functional group conversion1-4 and carbon-carbon bond forming 
reactions. 5' 6 In addition they have received considerable attention in macrocyclic 
chemistry/' 8 supramolecular chemistry,9-12 materials chemistry, 13' 14 organic 
chemistry15-19 and as sensors for saccharides20' 21 due to their intrinsic affinity for the 
diol functional group. The potent biological activity of organoboron compounds has 
been shown in several areas, for example artificial lectins (boronolectins),22 
antibiotics,23 enzyme inhibitors, specifically protease inhibitors24 and boron neutron 
capture therapy (BNCT).Z5 
Functionalized biaryl and biheteroaryl templates have contemporary pharmaceutical, 
agrochemical, materials and supramolecular applications. Boronic acids have become 
valued reagents for modem organic synthesis, largely since the 1979 paper by Miyaura, 
Yamada and Suzuki,26 which established the foundations for a very important 
transformation in the construction of carbon-carbon bonds. Since the discovery of what 
is now known as the Suzuki-Miyaura reaction the synthesis of novel boron containing 
reagents and improvements to the parameters have been widely studied. It is essential 
that new heteroaryl boronic acids are developed; these systems should show widespread 
reactivity in cross-coupling with a range of halogenated partners, yielding new building 
blocks of importance for industrial applications. 
In this chapter literature methods for the synthesis of arylboronic acids and boronic 
esters are described, with N-heteroarylboronic acids as the main focus. Reactions of 
boronic acids are reviewed, specifically the palladium-catalyzed Suzuki-Miyaura cross-
coupling reaction. 
The following chapters detail the syntheses of functionalized pyridazinylboronic acids 
and esters, and new (trifluoromethyl)-substituted pyridyl- and pyrazolylboronic acids 
and esters. The importance of pyridazine derivatives and (trifluoromethyl)-substituted 
1 
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heteroarenes and their current syntheses are briefly presented. Furthermore, the 
preparation and further development of pyridazin-3(21/)-one derivatives is described in 
Chapter 3. The Suzuki-Miyaura reactions of each novel class of boronic acid or ester, 
with various (hetero )aryl cross-coupling partners, is explored in each chapter. 
1.1.1 Structure and Properties of Boronic Acids 
Boronic acids are trivalent boron-containing species; the boron has six valence 
electrons, resulting in a vacant p orbital orthogonal to the three substituents. The mild 
Lewis acidic nature ofboronic acids is a consequence of the valency. 
R 
OH OH OR' I 
I I I 0-"' 8'o R-B HO-B R-B 
\ \ \ I I OH OH OR' R-"' 8 'o-"'8'R 
boronic acid boric acid boronic ester boroxine R' = alkyl or aryl 
Figure 1.1 Organoboron compounds. 
The acidic character of boronic acids in water yields the tetrahedral hydroxyboronate 
anion (Scheme 1.1 ), hence, the most acidic boronic acids possess the most electrophilic 
boron atom that can best form and stabilise the hydroxyboronate anion. 
OH 
I R-B + 2H20 
\ 
_OH 
I R-B-OH + H30+ \ OH OH 
Scheme 1.1 Ionization equilibrium ofboronic acids in water. 
Most boronic acids are solids which are chemically stable, can be handled in air and 
show shelf-stability for long periods. They tend to exist as a mixture of the free-acid and 
oligomeric anhydrides, in particular the cyclic six-membered boroxines, as a result of 
dehydration of the boronic acid during preparation. Anhydride formation may 
complicate analysis and spectroscopic characterisation, however, most reactions of 
boronic acids, including the Suzuki-Miyaura cross-coupling, proceed regardless of the 
hydrated state?7 X-ray crystal structures have been reported of aryl28• 29 and 
heteroarylboronic acids30-32 which confirm the almost planar trigonal conformation. 
Dimeric units bound through a pair of 0-H ... 0 hydrogen bonds is a common motif in 
the crystal structures. Boroxine structures characterized by X-ray analysis33 are almost 
2 
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planar. Boroxines may possess partial aromaticity due to 1t orbital overlap of the oxygen 
lone pair into the vacant boron orbital. 
One reason for the stability of boronic acids and their esters is that ligand exchange (the 
exchange of the hydroxyl substitutents for other ligands) and disproportionation (to the 
corresponding trialkylborane and borinic or boric acid) are both thermodynamically 
unfavourable. For example, dehydration techniques are required to drive forward the 
substitution with alcohols or diols to form boronic esters. Arylboronic acids can readily 
deboronate by protolysis of the C-B bond in highly acidic or basic aqueous solutions; 
notably ortho-substituted or electron-poor arylboronic acids deboronate under basic 
conditions.34 Consequently, competitive protodeboronation can affect the Suzuki-
Miyaura reaction which is often carried out under basic aqueous conditions. Hydrolytic 
protodeboronation ofboronic species will be discussed further in section 1.3.3. 
1.1.2 Synthesis of Aryl Boronic Acids 
Figure 1.2 outlines three common methods for the synthesis of aryl/heteroaryl boronic 
acids. One of the earliest methods was the transmetalation of aryl silanes or stannanes 
with a hard boron halide (BBr3) (Figure 1.2, scheme c). The thermodynamic drive for 
this reaction is the higher stability of B-C and Si/Sn-Br bonds compared to the 
respective bonds in the substrates. Simple arylboronic acids are isolated following 
hydrolysis of the arylboron dibromide product.35 Benzene and pyridyldiboronic acids 
have been prepared through the transmetalation of organotin compounds with borane 
and subsequent hydrolysis. 36 
The classical synthesis of arylboronic acids is the reaction of an organometallic reagent 
with a trialkyl borate electrophile.37 The intermediate is hydrolyzed by the addition of 
an aqueous acid to yield the corresponding boronic acid (Figure 1.2, schemes a and b). 
This is, probably, the cheapest and most common way for preparing arylboronic acids, 
especially on a large scale. On using small trialkyl borates, such as trimethyl borate, 
products resulting from multiple addition (i.e. borinic acid and borane) were isolated. 
With triisopropylborate this is not the case and the clean formation of lithium 
alkoxyboronate salts has been observed by NMR spectroscopy, resulting in good yields 
of the arylboronic acids upon acidic quench.38• 39 
3 
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a. Electrophilic borate trapping of an arylmetal intermediate from aryl halides 
RQ-x 
X= Br, I 
1. R"M 
2. B(OR'h 
M+ 
R~~­tJ-_' B(OR'h 
b. Electrophilic borate trapping of an aryllithium intermediate from directed orlho-metalation 
DMG DMG RO-H 1. R"Li R:r{-t;)-_' B(OR'h 
u+ 2. B(OR'h 
c. Transmetalation of arylsilanes and arylstannanes 
Ro-XR'3 
X= Si, Sn 
Figure 1.2 Common methods for the synthesis of arylboronic acids. 
DMG 
~B(OH), 
Organomagnesium or organolithium reagents are typically used in arylboronic acid 
syntheses as the source of nucleophilic carbon.40 Grignard formation can be conducted 
at ambient temperature, however, these reagents do not tolerate polar functional groups 
(e.g. C=O, C=N, N02, COOR). Organolithium formation often requires low 
temperatures. A wider variety of functional groups are tolerated for organolithium 
intermediates; problems generally arise as a result of acidic protons being present. 
Organolithium reagents for boronic acid synthesis, can be generated by lithium-halogen 
exchange, lithium-hydrogen exchange, or directed ortho metalation (DoM). Although 
this section encompasses arene metalation, special consideration will be given to the 
lithiation of N-heteroarenes, specifically pyridines. Excellent reviews have been written 
on the subject of lithiation of pyridines and related heterocycles. 4144 
Lithium-hydrogen exchange (or direct lithiation) uses an organolithium reagent which 
abstracts a proton from the aromatic system; the site of deprotonation depends upon the 
acidity of the hydrogen to be removed and the stability of the anion formed. Direct 
lithiation of pyridines often shows complications not usually seen with benzene 
analogues. Benzene compounds, with pKa of ea. 38-40, can be metalated with a strong 
base such as n-, sec- or tert-butyllithium, pKa ~ 45. Alkyllithiums add to pyridines very 
quickly, even at low temperatures, due nucleophilic attack at C-2 (Scheme 1.2). 
4 
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O·•H 
1 Bu 
Li 
Scheme 1.2 Nucleophilic attack of butyllithium on pyridine. 
The pyridine ring is more sensitive to deprotonation at the C-2, -4 and -6 positions than 
benzene. The kinetically favoure9 a-deprotonation of pyridine is possible due to the 
directing ability of the pyridyl nitrogen. There is presumably some complexation of the 
lithium base prior to deprotonation. The resulting C-2 anion can migrate to the 
thermodynamically more stable C-4 position as a result of repulsion by the lone pair on 
the pyridine N. Efficient a-lithiation of pyridine occurs when the complex base 
BuLi·LiO(CH2) 2NMez (BuLi·LiDMAE) is used; trapping with electrophiles leads to 2-
substituted pyridines in good to excellent yields.45 Hindered lithium amide bases show a 
much greater selectivity for proton abstraction vs. nucleophilic addition (shown in 
Scheme 1.2), as they are less nucleophilic and weaker bases; LDA pKa 35.7, LTMP 
pKa 37.3. Thermodynamically favoured deprotonation at C-4 of pyridine generally 
occurs with lithium amides.42 Lithium-halogen exchange involves the nucleophilic 
attack of an alkyllithium, usually n-BuLi, on an aryl halide (Scheme 1.3).46 The 
equilibrium favours the aryllithium which is less basic than the butyllithium. 
~Li + V Bu-Br 
X= Br, I 
Scheme 1.3 Lithium-halogen exchange. 
With lithium-halogen exchange, selectivity is usually only an issue when more than one 
halide is present. Alkyllithiums undergo metal-halogen exchange in preference to 
deprotonation or nucleophilic attack of halopyridines. Regioselective lithium-halogen 
exchange of substituted dibromobenzenes is influenced by the electronegative 
substituent adjacent to bromine (e.g. OMe, F, CF3), with reaction occurring 
preferentially at the activated bromine.47 However, when the non-activated bromine is 
replaced with iodine, lithiation occurs at this position and not the activated bromine. 
Halopyridines yield lithiumpyridyls via lithium-halogen exchange, resulting in 
regioselective lithiation in good yields. Metal-halogen exchange reactions are highly 
5 
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exothermic; low temperatures, between --40 °C and -100 °C and slow addition of n-
BuLi are required to suppress any side reactions48• 49 (competitive deprotonation of the 
acidic halopyridines in THF), and to reduce decomposition of unstable organolithium 
intermediates. THF is the solvent often used for lithiations since it is coordinating and 
dissociates any butyl lithium aggregates.50 Temperatures below 0 °C are required to 
prevent deprotonation of THF by BuLi; the resulting intermediate is unstable towards 
reverse [2+3] cycloaddition. Selective lithiation of dihalopyridines can be achieved by 
selecting the appropriate reaction conditions.48• 51 For example, monolithiation of 2,5-
dibromopyridine favours C-5 with coordinating solvents (Et20, THF) and higher 
concentrations, while non-coordinating solvents (toluene) and lower concentration 
favour C-2 lithiation.51 Although lithium-halogen exchange is a versatile method for the 
rapid, selective lithiation of heteroarenes, drawbacks are the availability and greater 
expense of halo-substituted heteroaryls. 
Directed artha metalation (DaM) is an important protocol for selective deprotonation 
and the Snieckus group has been the forerunner in developing this strategy. 52"54 
Snieckus defined directed artha metalation as "deprotonation of a site artha to a 
heteroatom containing directed metalation group (DMG) by a strong base, leading to an 
artha-lithiated species" (Scheme 1.4).55 DaM is useful since the starting material does 
not require a halogen atom. The number of DMGs available is considerable: amides, 
carbamates, sulfonates are all very good DMGs, while amines, alkoxy, trifluoromethyl, 
chloro and fluoro groups are also good DMGs.55 DaM usually employs a powerful 
alkyllithium, for example when DMG = NHCOR, OR, CONHR clean regioselective 
metalation can occur with alkyllithiums. However, for systems where nucleophilic 
addition of alkyllithiums is an issue, lithium amide bases have been successfully 
employed; for instance, DMGs Cl, F, CONR2 can be treated with less basic lithiating 
agents such as LDA and LTMP for effective deprotonation.43 
UDMG ==R=L=i = ~oMq\ 
~H Rli 
DMG = e.g. NHCOR, OR, CONHR, 
CONR2, Br, Cl, F, 
Scheme 1.4 Directed artha metalation. 
6 
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For successful deprotonation, the DMG must provide a good coordinating site for the 
lithium reagent and be a poor electrophilic site for attack by a strong base. DMGs 
influence artha lithiation either through coordination to the lithium reagent or through 
an inductive effect making the artha hydrogens more acidic.55 There is evidence that 
inductive factors dominate in the artha deprotonation step for Br, F and CF3 groups.56 
In contrast, OMe and NMe2 groups show enhanced reactivity rates, greater than those 
expected based solely on inductive effects. Consequently, a coordination component in 
the deprotonation step has been invoked. For azine and diazine rings, kinetic and 
thermodynamic factors can rationalize the regioselective DaM effects (Figure 1.3). 
When metal amides are used the regioselectivity is a result of the stabilization by 
chelation of the metal with the DMG (a), the electron-withdrawing effect of the DMG 
(b), and destabilization by electronic repulsion between the carbanion and the lone pair 
on the nitrogen (c). When alkyllithiums are used as the base at low temperature, the 
reaction mainly proceeds under kinetic control. The course of the reaction is directed by 
the acid-base (inductive) mechanism (d) and chelation in the transition state (e). 
Coordination of the DMG to the Lewis acidic metal allows disaggregation of the 
metalating agent, reinforcing the electron-withdrawing effect of the DMG and 
increasing the proximity effect of the complexed base. 42' 43 
(d) 
'jrDMG 
Au o ..
(b) 
)CD M~ 'u I H-B 
(e) 
(c) 
Figure 1.3 DaM effects under thermodynamic control (a), (b), (c) and kinetic control (d), (e).43 
Proposing a mechanism for DaM is not always straightforward. For example, Fort et al. 
found that C-3 lithiation of 2-chloro- and 2-methoxypyridine with LDA was not a 
simple process. They proposed that precomplexation of lithium dialkylamides near the 
C-6 proton was involved in the formation of a 3,6-dilithiopyridine intermediate.57' 58 
Thinking beyond thermodynamic acidity, the concept of complex-induced proximity 
effect (CIPE) in deprotonations suggests the formation of a pre-lithiation complex, 
7 
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which brings reactive groups into proximity for directed deprotonation. 59 Do M of a 
compound bearing two potential DMGs can use a CIPE to alter the inductive and 
association effects and thus the regioselectivity of lithiation. However, it is still unclear 
whether deprotonative lithiation is a result of CIPE or "kinetically enhanced 
metalation". 59 The main distinction between the two postulations is the transition-state 
structure for proton transfer. For CIPE, the reaction proceeds via a complex 
intermediate, whereas for "kinetically enhanced metalation" this is not the case. Instead 
proton transfer is the only required step between the reactant and the lithiated product, 
and is hence the rate-determining step. Therefore, CIPE is a useful concept; however, 
the detailed mechanism must be investigated on a case by case basis. 
Directed ortho metalation combined with cross-coupling methodologies presents an 
efficient nexus for regioselective preparation of (hetero )biaryls. 60 Recently, the 
DoM!boronation of substituted pyridines, and subsequent Suzuki-Miyaura cross-
coupling has been combined in a one-pot procedure (see Section 1.2.1 ).61 
Metalation-boronation techniques are now common for large-scale preparations of 
(hetero )arylboronic acids. The relatively cheap reagents and wide availability of halo-
and DMG-substituted (hetero )arenes make these routes industrially viable. 
1.1.3 Synthesis of Aryl Boronic Esters 
Boronic esters are often preferred as synthetic intermediates due to their increased ease 
of handling, characterization and stability compared with their boronic acid derivative. 5• 
62 Figure 1.4 shows the main procedures for the preparation of aryl- and 
heteroarylboronic esters. 
The synthesis of boronic esters from boronic acids and alcohols or diols is 
straightforward (Figure 1.4, scheme a), although it is an equilibrium reaction which 
requires the removal of water to drive the reaction forward. This is conducted by either 
using Dean-Stark apparatus63• 64 or by addition of a dehydrating agent. 65 Cyclic, 
hindered boronic esters are often prepared as they hydrolyse at a slower rate compared 
to non-cyclic alkyl based boronic esters. Six-membered ring esters, such as 2,2-
dimethyl-1 ,3-propanediol (neopentylglycol) or 2-methyl-2,4-pentanediol derivatives, 
are thermodynamically more stable than their five-membered analogues, such as 2,3-
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dimethyl-2,3-butanediol (pinacol) boronic esters.66 An alternative route to boronic esters 
involves the ortho-lithiation-in situ trapping of substituted arenes. Following lithiation 
and boronation with B(Oi-Pr)3, the isopropyl boronic ester intermediate generated is 
reacted with a diol to yield the (hetero)arylboronic esters in high yield.67 Non-aqueous 
conditions have also been applied.68• 69 Using 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane as the boronating agent following lithiation and upon controlled 
acidification yields pinacol boronic ester derivatives. 
a. Boronic acid dehydration in the presence of alcohol/dial 
2R'OH Ro-B(OR')2 
or 
or 
HO) R' 
HO 
b. Palladium-catalyzed coupling between an aryl halide/triflate and diboron 
or borane reagent 
(R'0)2B-B(OR')2 
or HB(OR')2 
Pd(O), base 
X = Br, I, OTf, Cl 
c. lridium-catalyzed direct borylation by aromatic C-H functionalization 
(R'0)2B-B(OR')2 
or HB(OR')2 
lr(l) 
Figure 1.4 Common methods for the synthesis of arylboronic esters. 
Palladium-catalyzed cross-coupling reactions of B-B, or B-H reagents with aryl, vinyl, 
allyl and benzyl halides or triflates (Figure 1.4, scheme b) represents a direct method for 
the borylation of organic electrophiles, without using lithium or magnesium 
intermediates. 70 Ishiyama et al. were the pioneers for the direct preparation of 
arylboronic esters. They reported the palladium-catalyzed coupling of 
bis(pinacolato)diboron (B2pin2) with bromo- and iodoarenes,71 ' 72 and then extended this 
protocol to aryl triflates72' 73 and chlorides (Scheme 1.5).74 
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Pd(dppf)CI2, KOAc 
Ar-X Ar-B(pin) 
DMSO or dioxane, 80 °C 
X= Br, I, OTf, Cl 
Scheme 1.5 Pd-catalyzed coupling of an aryl electrophile with a diboron reagent.72• 74 
The coupling reaction occurs in the presence of base and palladium catalyst. KOAc was 
found to be critical for the reaction to occur. This suggests there is transmetalation 
between the B2pin2 and Ar-Pd-OAc intermediate, as a result of displacement of X in 
Ar-Pd-X by AcO-. The catalytic cycle is shown in Figure 1.5.72 When stronger bases 
(K3P04, KzC03) were used competitive homocoupling yielded biaryls, reducing the 
yields of arylboronic esters. For bromo- and iodoarenes Pd(dppf)Cl2 is a good catalyst.71 
Ligandless Pd(OAc )2 is also a suitable catalyst for the coupling of B2pin2 with a number 
of substituted arylbromides.75 Arylboronates prepared in this way have been used in situ 
for Suzuki-Miyaura cross-coupling reactions to prepare unsymmetrical biaryls. 
A,-B(pio) r Pd(O) ~ A,-X 
Ar-Pd-B(pin) Ar-Pd-X 
(AoO)B(piA-- N-Pd-OAc ~ KOAc 
B2pin2 KX 
Figure 1.5 Catalytic cycle for cross-coupling of diborons.72 
When less reactive chloroarene precursors are used Pd(dba)2 and PCy3 are required.74 
Buchwald et al. have demonstrated that biaryl phosphine ligands XPhos and SPhos (see 
Section 1.3 .1) and Pd(OAc )2 or Pd2( dba)3 form highly stable and efficient catalyst 
systems for the borylation of substituted aryl chlorides and heteroaryl chlorides with 
B2pin2.76 At elevated temperatures, the preparation of pinacol arylboronic esters from 
substituted aryl chlorides (including those bearing electron-donating groups) requires 
much reduced reaction times of 10 min-24 h (Scheme 1.6)/6 compared to 24-48 h as 
previously reported. 74 The room temperature cross-coupling of B2pin2 and chloroarenes 
requires a stronger base and extended reaction time to give 64-97% isolated yields of 
boronic esters (Scheme 1.6).76 In a further extention of the work pinacol boronic esters 
have been reacted in situ (without work up). After the Pd-catalyzed coupling of Bzpinz 
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with aryl chlorides, a second aryl chloride was added and extra base (no additional 
catalyst was added to the system) to yield unsymmetrial biaryls from chloroarene 
precursors in yields of 62-92%. This is notable due to the lower cost and wider 
availability of substituted aryl chlorides, and the cost of commercially available XPhos 
and SPhos ligands is comparable to other phosphine based ligands. 
Examples of other tetra(alkoxo)diborons used include bis(neopentyl glycolato)diboron77 
and bis(l ,3-diphenylpropanediol)diboron. 78 
R = e.g. Me, OMe, CF3, 
CN, C(O)Ph, C(O)NH2 
Pd2(dbah or Pd(OAch 
XPhos or SPhos 
KOAc, 1 ,4-dioxane, reflux 
or 
K3P04, 1 ,4-dioxane, RT 
reflux T 62-97% yield 
RT 64-97% yield 
PCy2 
i-Pr g PCy2 i-Pr 
i-Pr 
XPhos 
MeO OMe 
SPhos 
Scheme 1.6 Buchwald et al. Borylation of chloroarenes with B2pin2• 76 
More recently Murata et al. have found that pinacolborane (HBpin) couples to aryl and 
vinyl electrophiles in the presence of a palladium catalyst and triethylamine (Scheme 
1. 7). 79-81 Other bases (KOAc, DBU, pyridine) promoted dehalogenation, yielding Ar-H, 
due to HBpin behaving as a hydride source. Using HBpin is more atom economical than 
B2pin2. 
Ar-X + HB(pin) Ar-B(pin) 
dioxane, 80 °C, 1-6 h 
X= I, Br, OTf, Cl 
Scheme 1.7 Murata et al. Pd-catalyzed coupling of an aryl electrophile with pinacolborane.80• 81 
The exact mechanism for HBpin borylation is unknown; two processes have been 
proposed leading to the formation of an Ar-Pd-Bpin intermediate. Et3N could facilitate 
B-C bond formation through Pd(II)-X displacement with a weakly bound nucleophilic 
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boryl anion Et3NH0+·Bpin°- [Figure 1.6, (a)]. However, it is possible that HBpin may 
oxidatively add to the Pd(O) complex, followed by a-bond metathesis of the boryl-
palladium complex with aryl halides [Figure 1.6, (b)]. 80 Other catalyst systems are 
advantageous for the HBpin borylation of ortho-substituted haloarenes 
(Pd(OAc )2/biphenylphosphine ligand)82 and electron-donor substituted haloarenes 
(Pd(OAc)2/DPEphos).83 In both cases the borylation procedure was extended to a one-
pot Suzuki-Miyaura unsymmetrical biphenyl synthesis. 
A,-B(plo)( 
Ar-Pd-B(pin) 
Pd(O) 
(a) 
[ o+ o- ] Et3NH-B(pin) 
l 
H-B(pin) 
Pd(O) -~~ 
(b) 
Ar-B(pin) + X -Pd-H -
(pin)B-Pd-H 
j Ar-X 
(pin)~-~d-H 
I I 
I I 
I I Ar-X 
Figure 1.6 Plausible reaction mechanisms for the Pd-catalyzed borylation of arylhalides with 
HB . 80 pm. 
Buchwald et al. reported an improved system for the Pd-catalyzed borylation of aryl 
halides with HBpin.84 Previously Murata et al. had successfully borylated only para-
substituted electron-rich aryl chlorides.81 The active catalyst system based on 
Pd(MeCN)2Ch and SPhos was general for aryl iodides, bromides and chlorides with 
both electron-donating and electron-withdrawing substituents. Higher quantities of 
palladium catalyst and longer reaction times were required for chloroarenes; however, 
this system was effective for a range of chlorides giving pinacol boronic esters is good 
yields (51-96%). Aryl bromides still gave higher yields compared to chloro analogues.84 
Methylpentanediol borane (HBMP) has been used in Pd-catalyzed borylation of 
substituted aryl bromides and iodides.85 The scope of HBMP equals that of HBpin, 
leading to comparable yields of boronic esters. Suzuki-Miyaura cross-coupling reactions 
of methylpentanediol boronic esters with aryl iodides give good conversion to the 
coupling products. There appears to be no advantage to HBMP over HBpin, especially 
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as HBpin is reactive with aryl chlorides. However, the authors report that HBMP is 
"much less expensive than HBpin, very easily prepared and stable."85 
An extension of the above methodology was the aliphatic or aromatic C-H borylation. 
Aromatic C-H borylation is catalyzed efficiently by iridium; extensive work has 
established some key mechanistic steps in the catalytic cycle. 86' 87 An Ir(l) complex 
prepared from Y2[IrX(COD)h (X = OMe or Cl) and bpy or dtbpy exhibits excellent 
activity and selectivity for aromatic C-H borylation with B2pin288-91 or HBpin.92 
Initially borylation of (hetero )arenes with B2pin2 was conducted at 80 °C with 
[IrCl(COD)h and bpy or dtbpy, using an excess of (hetero)arene to avoid multiple 
borylations.88' 89 It was later found that [Ir(OMe)(COD)h and dtbpy was an improved 
system. The reactions are faster in non-polar solvents such as hexane or octane; more 
coordinating solvents also slow the reaction. The superiority of dtbpy compared to bpy 
can be attributed to the greater solubility of dtbpy in hexane. The high catalytic 
efficiency of [Ir(OMe)(COD)h compared to the chloro analogue can be ascribed to the 
more facile conversion into (boryl)iridium complexes (proposed intermediates in the 
catalytic cycle) meaning that C-H borylation of (hetero )arenes can be conducted at 
room temperature with stochiometric amounts of either B2pin2 or HBpin.90-92 The 
reaction is suitable for arenes possessing OMe, I, Br, Cl, C02Me, CN and CF3 
substituents (Scheme 1.8).90' 92 Regioselectivity of borylation largely depends on steric 
factors rather than on the electronics of the arene. Five-membered heteroarenes such as 
thiophene, furan and pyrrole yield mono- and di-borylated products depending on the 
amount of arene employed. 89' 91 Recently a one-pot Ir-catalyzed aromatic C-H 
borylation-Suzuki-Miyaura cross-coupling procedure was developed for the synthesis 
of unsymmetrical biaryls.93 As hydrolysis of pinacolboronates to boronic acids is 
unfavourable, in some cases lower reactivity is found in Suzuki-Miyaura cross-coupling 
reactions. Consequently, Hartwig et al. have developed a synthesis of arylboronic acids 
and aryl trifluoroborates through the treatment of crude, isolated pinacol boronic esters 
prepared from Ir-catalyzed borylation of arenes.94 This one-pot procedure alleviates the 
need to prepare boronic acids through organolithium derivatives and generates 
substitution patterns which complement those available from lithiation of haloarenes. 
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(a) B2pin2 or (b) HBpin 
[lr(OMe )(COD)b-2dtbpy 
hexane, 25 °C 
2 o-s~~ 
R =Cl, Br, I, CN, CF3 
OMe, C02Me 
Br 
(pin)B--Q-CI (p;o)B--Q 
(a) 82% yield Cl (a) 83% yield CN 
(b) 73% yield (b) 74% yield 
Cl Cl 
(p;o)B-Q (p;o)B--Q 
(a) 53% yield Cl (a) 80% yield C02Me 
(b) 22% yield (b) 70% yield 
Cl OMe 
(p;o)B--Q (p;o)B--Q 
(a) 82% yield I (a) 81% yield CF3 
(b) 67% yield (b) 73% yield 
CF3 
(p;o)B--Q 
CN 
(p;o)B--Q 
(a) 91% yield Br (a) 84% yield CF3 (b) 80% yield (b) 83% yield 
R 
J:J (pin)B S _j[J__ (pin)B S B(pin) 
(a) 91% yield (a) 83% yield 
(10 eq. arene) (1 eq. arene) 
--0 (pin)B N .JG_ (pin)B N B(pin) 
H H 
(a) 72% yield (a) 75% yield 
(10 eq. arene) (1 eq. arene) 
_j[J__ (pin)B S R _j[J__ (pin)B O R 
(a) R =Me, Br, CN (a) R = OMe, Me 
60-95% yield 85-90% yield 
.JG_ (pin)B N R 
H 
(a) R = Me, C02Me 
96-99% yield 
Scheme 1.8 Ishiyama et al. Ir-catalyzed aromatic C-H borylation with B2pin2 or HBpin.90-92 
There is mechanistic evidence for a tris(boryl)Ir(III) intermediate (Figure I. 7, 
intermediate B) in the Ir-catalyzed borylation of arenes.95 The tris(boryl) intermediate B 
can be produced by oxidative addition of B2pin2 to a mono(boryl)Ir(l) complex A, 
formed via a-bond metathesis or an oxidative addition/reductive elimination sequence 
between [Ir]-OMe and B2pin2. It is unclear whether oxidative addition of Ar-H or a-
bond metathesis occurs at the vacant site of Ir(III) intermediate C, to create an Ir(V) 
species D. Reductive elimination of ArB(pin) gives an Ir(III) hydride complex (E). 
Oxidative addition of B2pin2 to E, followed by reductive elimination of HBpin, 
regenerates C. The resulting HBpin can participate in the catalytic cycle through a 
sequence of oxidative addition to E and hydrogen reductive elimination from a Ir(V) 
intermediate F. 87 Although catalytic cycles involving Ir(III)-Ir(V) are rare, the ease of 
elimination of HBpin or H2 from an Ir(V) intermediate should promote borylation under 
mild conditions.87 Iridium-catalyzed C-H borylation of (hetero)arenes is a convenient, 
economical and environmentally benign route to boronic esters, for which some 
substitution patterns have not previously been reported. 
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1-Bu~"" 
N "N c = N 7' N 
,_I 
1-Bu 
HBpin ( N Bpin ~ Ar-H 
''lr''' N"' 1-...Bpin 
B pin Bpin C oxidative addition or 
2 2 _\ a--bond metathesis Hz \ 
HBpin H H 
C N,, ,,H \ ( N,J1.::-,,Bpin lr· ~ r· N"' 1-...Bpin N .. 1-...Bpin 
E 
Bpin F Bpin 
ArBpin 
Ar H 
C N,.~~,,Bpin N .. 1-...Bpin 
Bpin D 
Figure 1.7 Proposed catalytic cycle for Ir-catalyzed arene borylation.87• 95 
Harrity et al. have developed cycloaddition reactions of alkynylboronic esters with an 
appropriate substrate for the synthesis of (hetero )arylboronic esters.96 This will be 
discussed in more detail in Section 1.2. It should be noted that initial preparation of the 
alkynylboronic ester is required. 
The one-step synthesis of organoboronic esters from organic electrophiles has 
advantages over traditional lithiation-boronation techniques, for example, protection of 
functional groups that are sensitive to organometallic reagents is not necessary. Diboron 
reagents are relatively expensive, therefore, for large-scale syntheses the cross-coupling 
of HBpin or direct C-H borylation is recommended. If catalytic levels of Pd or Ir can be 
reduced the preparation of boronic esters through coupling reactions is more 
economical. 
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1.1.4 Boronic Acid Alternatives 
There are several arylboronic acid alternatives which are competent substrates in many 
of the same reaction processes that involve free boronic acids. Aryltrifluoroborate salts 
reported by Molander et al. are a class of air-stable arylboronic acid derivatives.97 
Trifluoroborates are easily prepared by the treatment of boronic acids or esters with 
aqueous KHF2. They are generally more robust, easily purified and easier to handle. 
Aryl- and electron-rich heteroaryltrifluoroborates partake in Suzuki-Miyuara cross-
coupling reactions, under ligandless conditions, with aryl and activated heteroaryl 
bromides.97 However, the metal-catalyzed bond-forming reactions are very slow in the 
absence of base, due to the high electronegativity of the fluorine atoms.98• 99 The strong 
B-F bonds make trifluoroborate salts resistant to electrophilic reaction with a strong 
oxidant. 
Diethanolamine adducts are stable boronic acid derivatives through tetracoordination of 
the boron moiety.66 The internal chelation of the nitrogen lone pair to the vacant orbital 
on boron, makes their hydrolysis less favourable. They are readily formed through 
dehydration of boronic acid derivatives with a diethanolamine species. 2-
Pyridylboronates are renowned for being unstable due to the boronate being a to a 
heteroatom; however, they have been stabilized as their diethanolamine adduct100 (see 
Section 1.2.1 ). 
Cammidge et al. and more recently Miyaura et al. have reported the preparation of 
trihydroxyborates 101 and cyclic triolborates, 102 respectively. These tetracoordinated 'ate' 
complexes are extremely air and water stable, and the procedure for isolation is easy 
and convenient. The nucleophilicity of organic groups attached to B is enhanced by 
quaternization with an anionic ligand. Ordinarily in metal-catalyzed coupling reactions 
of boronic acids, a nucleophile (usually from base or KF) is added and formation of an 
'ate' complex occurs. For trihydroxyborates and cyclic triolborates these discrete salts 
can be used directly in Suzuki-Miyaura rections without the need for an additional 
nucleophile or base (unlike trifluoroborate salts, as discussed previously). Good to 
excellent yields are obtained for Suzuki-Miyaura coupling reactions of substituted aryl 
trihydroxy- and cyclic triolborates with arylbromides. 101 ' 102 Miyaura et al. also found 
that 2-pyridyl- and 2-thienyl triolborates, whose boronic acid/ester derivatives generally 
undergo B-C bond cleavage in water, reacted quantitatively with bromoarenes in 
16 
Chapter 1 - Introduction 
anhydrous DMF. 102 The presence of Cui increased the coupling yield with 2-
pyridylboronate (Scheme 1.9). Cyclic triolborates were also successful in the copper-
promoted arylation ofthe N-H bond in a number of amine and amides. 102, 103 
R-Li 
1. B(OR'h 
H;}--2. HO 
HO 
(-3R'OH) 
1 a R = 2-pyridyl 82% yield 
1 b R = 2-thienyl 99% yield 
Ar-Br 
Pd(OAch/L 
for a Cui (20 mol%) 
R-Ar 
DMF, 80 °C 
2a R = 2-pyridyl; 90% yield 
Ar = 4-N02-C6H4 
L = PPh3 (for a) 2b R = 2-thienyl; 96% yield Ar = 4-(C(O)Me-C6H4) 
JohnPhos 
Scheme 1.9 Coupling reactions oftriolborates, usually sensitive to protodeboronation. 102 
1.2 N-Heteroaryl Boronic Acids 
Functionalized biheteroaryl systems are of great importance due to their widespread 
applications in many areas of contemporary interest. The metal-mediated cross-coupling 
reactions continue to be of paramount importance in their synthesis; currently, the 
Suzuki-Miyaura cross-coupling protocoe7' 104' 105 or direct acylation approach106-108 are 
favoured. Direct acylation of heteroarenes through the activation of an arene C-H 
bond109-111 (Ar-H + Ar-X) represents a recent area of research. The catalytic oxidative 
arene cross-coupling, 112-115 in which neither substrate must be pre-activated (Ar-H + 
Ar-H), whilst still in its infancy is an exciting prospect in atom-efficient cross-
couplings with reduced cost and waste. The Suzuki-Miyaura cross-coupling remains an 
established and well-practised method for the preparation of biaryls, with a wide 
commercial availability of boronic acid derivatives and halide coupling partners. The 
synthesis of heteroaryl systems, where both boronic acid moiety and coupling partner 
are heteroarenes, is generally underdeveloped in comparison to aryl analogues. The 
prevalence of heteroaryl boronic acids in the literature is mounting116 and their 
commercial availability on the increase. 
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The next section will specifically focus on the current literature (up to August 2008) 
surrounding pyridyl-, pyrimidyl-, pyridazinyl- and pyrazolylboronic acid derivatives; 
other N-heteroarylboronic acids will be briefly reviewed. The procedures for the 
synthesis of boronic acids or esters described in section 1.1 are all applied to the 
preparation of N-heteroarylboronic acid derivatives. 
1.2.1 Pyridylboronic Acids 
Of all the N-heteroarylboronic acids, pyridine derivatives are among the most abundant 
and earliest reported, reflecting the importance of the pyridine motif in organic 
chemistry. The parent 3- and 4-pyridylboronic acids 4 and 6, respectively, are relatively 
stable compounds and now commercially available in multigram quantities from 
numerous suppliers. 3- and 4-Pyridylboronic acid decompose to pyridine and boric acid 
upon UV irradiation in neutral or slightly basic conditions. 117 Original preparations were 
low yielding, with difficulties in their isolation from aqueous media, due to the 
hydrophilic nature of the compounds. The reactions of 3-pyridylmagnesium bromide 
and 4-pyridyllithium at low temperature with tributyl borate or trimethyl borate yielded 
4 and 6 in 28 and 20% yields, respectively, after acidic workup (Scheme 1.1 0). 118 These 
species were not fully characterized, instead, treated with a diol to afford the ester 
derivatives which were oxidized and reacted with picric acid to yield the corresponding 
hydroxypyridine picrates to confirm the initial preparation of 4 and 6. 
1. Mg, THF a Br _2._C_H_2_B_rC_H_2_B_r,. 
N 
3 
1. B(OBub, -60 °C 
UMgBr _2_. H_C_I __ _ 
N 
UB(OH)2 
N 
Br AcOH 
reflux 
4 28% yield 
B(OHh 
6 1. BuLi, Et20, -60 °C [ - B(OMe)Jl u+ 2.B(OMe)J 6 I ~ ---------/- 6 
N N N 
5 6 20% yield 
Scheme 1.10 Synthesis of 3- and 4-pyridylboronic acid. 118 
More recently, Cai et al. reported the preparation of the boroxine derivative 7 on a 
multigram scale by a lithiun1-halogen exchange, "in situ quench" procedure (Scheme 
1.11 ). 63• 119 They found this procedure to be superior to previous routes. The preparation 
of 4 via magnesium-halogen exchange showed poor converstion to the boronic acid due 
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to poor solubility of the 3-pyridylmagnesium chloride intermediate.49 Previous lithium-
halogen exchange procedures had identified the importance in the order of reagents and 
choice of solvent, with the best isolated yield of 4 being 87%.49 Yields of 7 from the "in 
situ procedure" at -40 °C in THF were 90-95%; at 0 °C the yield was 80%.63 
y 
a B(OH)2 __ c_ry_st_a_lli_za_t_io_n __ o"8 'o MeCN 1 1 N Nvs,o ... s~ 
4 I 0 ~ .. J N 
1. n-Buli 
2. HCI 
B(Oi-Prb ----
7 90-95% yield overall 
Scheme 1.11 "In situ quench" procedure for the preparation of3-pyridylboronic acid 4.63 
It is often difficult to quantify the purity of boronic acids due to the mixture of free 
boronic acid and anhydride species present in the sample; dehydration to their boroxine 
derivatives can improve the purity. Suzuki-Miyaura cross-coupling reactions of 
boroxine 7 are comparable to those of boronic acid 4. For 7 aqueous conditions are 
required as the boroxine undergoes initial in situ hydrolysis prior to cross-coupling.27 
In the "in situ quench" procedure, unstable aryllithiums, which may be labile or undergo 
side reactions, are quenched immediately after they are formed, resulting in improved 
yields of the boronic acid. Employing the "in situ quench" procedure with a number of 
bromoheteroarenes and substituted phenylbromides gave mixed results, compared with 
the sequential addition approach. For the heteroaryl examples (3- and 4-pyridyl-, 3-
thienyl- and 5-pyrimidylboronic acid) the yields ofboronic acids when using the "in situ 
quench" procedure were improved or comparable to literature reports. For example, 
sequential lithium-halogen exchange followed by boronation afforded 6 in 65% yield 
from 5120 and the 4-pyridylboronic ester from 4-iodopyridine in 74% yield.68 Whilst the 
"in situ quench" procedure yielded 6 in a comparable 60% yield.63 With substituted 
phenylbromides, on using the "in situ quench" protocol, yields of boronic acids were 
comparable to sequential addition procedures, or in some cases markedly reduced. In 
some cases unreacted arylbromide was isolated. This suggests that not only does the 
stability of the aryllithium species influence the suitability for the "in situ quench" 
procedure, but if the generation of the aryllithium is relatively slow, competitive 
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reaction of n-BuLi with triisopropylborate can occur, thus not consuming all of the 
aryl bromide. 
The preparation and Suzuki-Miyaura cross-coupling of 3-pyridyltrifluoroborates has 
been recently reported.97• 121 • 122 Iridium-catalyzed C-H coupling between 
bis(pinacolato )diboron and pyridine afforded a mixture of 3- and 4-pyridylboronic 
ester. 89 Substituted pyridine derivatives have been shown to regioselectively borylate, 
leading to 2- and 4-pyridylboronic esters. 123 
2-Pyridylboronic acid has remained elusive since early work showed the boronic moiety 
at the a position of the pyridine ring to be highly prone to protodeboronation. 117 The 
reaction of 2-pyridyl Grignard with tris(trimethylsilyl)borate has recently been reported 
to yield the corresponding boronic acid 9 in 70% yield (Scheme 1.12); 124 this procedure 
was applied to the preparation of 3-pyridyl- and 5-pyrimidylboronic acids, giving yields 
of 75% and 72%, respectively. 
u 
N Br 
~gBr ] 
8 9 70% yield 
Scheme 1.12 Preparation of 2-pyridylboronic acid. 124 
Diethyl 2-pyridylborane is reported to be a stable compound;62 however, its attempted 
palladium catalyzed cross-couplings yielded unreacted starting materials. 125• 126 Dialkyl 
3-pyridylboranes are commercially available or easy to prepare; 127 diethyl 3-
pyridylborane has been coupled with a pyridyl stannane reagent under palladium 
catalyzed conditions. 128 Dimethyl 2-pyridylboronic ester has been prepared and cross-
coupled under Suzuki-Miyaura conditions; however, there was no acidic work-up 
during the synthesis and therefore the active species may be the trimethyl 2-
pyridylborate complex. 129• 130 The pinacol 2-pyridylboronic ester could not be isolated 
from the palladium-catalyzed reaction of 8 with bis(pinacolato )diboron. Instead, a 
mixture of 2,2' -bipyridine, pyridine and unreacted 8 was recovered (Scheme 1.13), 131 
resulting from coupling of the boronic ester in situ with 8 or protodeboronation of the 
boronic ester in the reaction mixture. 
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u 
N Br 
8 
B2pin2, Pd(PPh3)2CI2 
KOAc, DMSO, 80 °C 
78% yield 
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0 N + u N Br 
17% yield 5% yield 
Scheme 1.13 Attempted preparation of pinacol 2-pyridylboronic ester. 131 
The instability of 2-pyridylboronates was highlighted by Molander et al., in their 
preparation of potassium 2-pyridyltrifluoroborate 10 (Scheme 1.14).97 The synthesis of 
10 was complicated by solubility issues and the product did not show an adequate 
(extended) shelf life. Attempts to cross-couple 10 were unsuccessful. 
1. n-Buli, Et20, -78 °C 
u N Br 
2. B(OMeh, -78 °C toRT 
8 
Scheme 1.14 Preparation of potassium 2-pyridyltrifluoroborate.97 
More recently the preparation and Suzuki-Miyaura cross-couplings of diethanolamine 
stabilized 2-pyridylboronates have been reported, 100' 132' 133 these being the most stable 
isolated 2-pyridyl adducts reported thus far. Buchwald et al. described an efficient 
method for the Suzuki-Miyaura coupling of 2-pyridyl nucleophiles. 134 They found 
lithium triisopropyl 2-pyridylborate lla to be markedly more reactive than 2-pyridyl-
boronic acid 9, pinacol boronic ester, N-phenyldiethanolamine adduct, and 
trifluoroborate 10. Lithium triisopropyl2-pyridylborate is stable under argon for up to a 
month and can be synthesized in quantitative yield on a multigram scale; a number of 
substituted 2-pyridyl borate derivatives have also been prepared llb-e (Scheme 1.15). 
Suzuki-Miyaura cross-coupling reactions of lla-d with substituted bromo- and 
chlorobenzenes or heteroarylbromides yielded bi(hetero )aryl systems in good yields 
(40-92%) when using phosphine oxides as the ligand; reaction conditions [Pd2(dba)3 
(1.0-1.5 mol%), Cy2P(O)H or t-Bu2P(O)H (6 mol%), KF, 1,4-dioxane, reflux, 20 h]Y4 
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~ Rit_ __ .J.__ 
N Br 2. n-Buli, -78 °C to RT 
~ R~_.A 
N B(Oi-Prbli 
11a-e 
Cl 
N B(Oi-Prbli 
n Fu 
MeO N B(Oi-Pr)Jli N B(Oi-Prbli 
11 a 99% yield 11 b 90% yield 11c 96% yield 
H NC~ w O B(Oi-Pr)JU ~--.J.__ N B(Oi-Pr)JU VO 
11d 73% yield 11 e 95% yield 
Scheme 1.15 Synthesis of lithium triisopropyl 2-pyridylborate derivatives. 134 
Pyridylboronic acid derivatives substituted with a variety of functional groups (e.g. 
halo-,30• 61 • 135-143 alkoxy-,30• 32• 139• 140• 144 cyano-,65 amido-61 ) have been prepared and 
successfully cross-coupled under Suzuki-Miyaura conditions to yield bi(hetero)aryl 
systems. Halopyridylboronic acids have been extensively studied, due to the wide 
commercial availability of halopyridines. In a series of papers Rault et al. described the 
syntheses of a range of halo-substituted pyridylboronic acids and pinacol esters - a 
summary of the compounds prepared and synthetic route are shown in Scheme 1.16. 135-
138 The reactivity of the halopyridylboronic acids in Suzuki-Miyaura cross-coupling 
reactions is highlighted in each case. 
In the synthesis of 6-halo-3-pyridylboronic acids the dihalopyridines were used. The 
different reactivities of the halogens towards lithium-halogen exchange was exploited to 
yield the expected products. 135• 145• 146 Comparable yields were obtained regardless of 
whether lithium-halogen exchange or directed ortho metalation was applied in the 
synthesis of 2-halo-3-pyridylboronic acids. 136• 147 4-Halopyridines are more challenging 
to prepare as the precursor to 4-pyridylboronic acids; as a consequence, directed ortho 
metalation is often employed. For 3-halo-4-pyridylboronic acids, DaM of 3-
halopyridines is used; the electron-withdrawing effect of the halogens increase the rate 
of metalation. 3-Halo-4-pyridylboronic acids were isolated in reasonable yields 
reflecting the selective deprotonation at C-4. 137 The C-4 position is more acidic than C-
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2, and significantly more so than C-5 and C-6, due to the inductive electron withdrawal 
by the halogen. 
~ n-Buli, Et20 or THF, 
fl '1 -78 °C 
x1 l!--. N~ x2 ---------------
Lithium-hal~gen exchange [ ~ ·] B(Oi-Prh [ ~- pi-Pr l 
L1-X2 X1l!_,_ ~ Ll ---- X111 ~~ 8,-0i-Pr + 
X1 = F, Cl or Br; X2 = Br N~ "-N '? Oi-Pr Li 
X1 0: : ------------ ~ \ p· I A OH "N LOA, Et20, -60 °C NaOH, HCI · maco • c 
. NaOH, HCI 
Directed ortho metalation 
DoM 
X1 =F,Cior8r ~ ~ 0~ fl '1 fl '1 I 
X1 l!_,_ ~ B(OH)2 X1 l!_,_ ~ B, 
N N 0 
Cl 
~B(OR)2 
t.J N 
Li-X2 R = H; 75-87% yield Li-X2 R = H; 60-66% yield Li-X2 R = H; 25% yield 
X1 = F, Cl, Br; R = pinacol; 65-78% yield X1 =Cl, Br; R = pinacol; 56-70% yield R = pinacol; 20% yield 
ref 135 
BryyB(OR)2 
t.J N 
Li-X2 R = H; 71% yield 
R = pinacol; 75% yield 
ref 136 
DoM R = H; 45-63% yield 
X1 = F, Cl, Br; R = pinacol; 53-65% yield 
ref 136 
B(ORh 
6 N x1 
Li-X2 R = H; 64-68% yield 
DoM R = H; 43% yield 
R = pinacol; 41% yield 
ref 136 
s~, 
N 
DoM R = H; 32-46% yield 
X1 =F, Cl, Br; R = pinacol; 60-66% yield 
ref 137 
X1 =F, Cl, Br; R = pinacol; 51-55% yield 
ref 137 
Cl~ 
t.A N B(ORh 
Li-X2 R = H; 45-55% yield Li-X2 R = H; 36% yield 
X1 = Cl, Br; R = pinacol; 38-56% yield 
ref 138 
R = pinacol; 47% yield 
ref 138 
Scheme 1.16 Halopyridylboronic acids and esters prepared by Rault et al. 135' 138 
5-Chloro- and 6-halo-2-pyridylboronic acids were isolated in acceptable yields 
considering the unstable nature of boronic acid moieties adjacent to heteroatoms. 138 The 
first X-ray crystal structure for a 2-pyridylboronic ester moiety was reported,148 
identifying a slight deformation of the boronic ester moiety. The C-B bond is longer 
than in the corresponding 3-pyridyl derivative (2-pyridyl- 1.578 A, c.f. 3-pyridyl- 1.557 
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A145), and may be more fragile. The X-ray structure of the corresponding N-
methyldiethanolamine 2-pyridylboronate (or N-methyldioxazaborocane) confirms the 
presence of an N~B bond (1.696 A). 149 In comparison with the 2-pyridylboronic ester 
the C-B bond is longer (boronic ester 1.578 A, c.f. dioxazaborocane 1.615 A), however, 
the boronate is stabilized by the N ~ B bond. 
Our group has an established interest in substituted pyridylboronic acids; a summary of 
the compounds prepared and synthetic routes is shown in Scheme 1.17.30, 139, 140, 144 The 
syntheses of 6-halo-3-pyridylboronic acids has also been reported by Bryce et a/.,30' 139 
with similar reaction conditions and yields to Rault et al. Bryce et al. extended the 
lithium-halogen exchange/boronation protocol to the preparation of 6-alkoxy-3-
pyridylboronic acids in good yields.30' 139 The X-ray crystal structures of 6-chloro- and 
6-bromo-3-pyridylboronic acid revealed extensive hydrogen-bonding of the boronic 
acid groups. A study into the Suzuki-Miyaura cross-couplings of these boronic acids 
with heteroaryl bromides and chlorides gave moderate to good isolated coupling 
product yields.30' 150 Good compatibility was found with a variety of functionality on the 
coupling partner (viz. trifluoromethyl, nitro, primary amine). 6-Fluoro- and 6-chloro-3-
pyridylboronic acids have been reported by other groups, with a comparable synthetic 
strategy being used. 151 ' 152 
Directed artha metalation is generally preferred in the commercial preparation of 
functionalized pyridylboronic acids. Di-substituted pyridine starting materials are not 
required, which is beneficial as they are generally more expensive than their mono-
substituted analogues. DaM reactions are also more atom efficient than lithium-halogen 
exchange procedures. Standard directing groups used in DaM are halogens and methoxy 
groups.43 Methoxy substituents are regarded as having increased chelation to the 
metalating agent, and are therefore more effective in regioselective metalation57 
However, contrary to this, Bryce et al. found that lithiation/boronation of 5-chloro-2-
methoxypyridine with LDA gave 5-chloro-2-methoxy-4-pyridylboronic acid in 48% 
yield.30 This implies that the stronger chelating ability of the methoxy group, which 
would have directed lithiation at the C-3 position, is insufficient to overcome the 
removal of the acidic C-4 proton, which is aided by the directing chloro substituent. The 
use of the methoxy substituent in DaM has the advantage that the reagent is not prone to 
metal exchange unlike halogen substituted reagents. 
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[ 
~~~~PR 
x1l!.... ~ B,-oR 
N OR 
Directed ortho metalation 
Do M 
R =Me, i-Pr 
X1 = F, Cl, OMe or OEt; 
X2 = Cl, Br or H 
nB(OHh 
x1 N 
Li-X2 
X1 = F, Cl, Br; 51-79% yield 
X1 = OMe, OEt; 61-65% yield 
ref 30, 139 
E~, 
x1 N 
Do M 
BryyB(OHh 
t.) 
N 
Li-X2 
74% yield 
ref 139 
UB(OHh 
X1 N x1 
Do M 
aB(OH)2 
N x1 
DoM 
X1 = OMe 58% yield 
= OEt 70% yield 
ref 139, 144, 150 
&~' 
N x1 
DoM 
X1 = OMe; X2 = Cl; 48% yield X1 = F, Cl, OMe; 73-82% yield X1 =Cl, OMe; 56-60% yield 
X1 = OMe; X2 = Br; 39% yield ref 140 ref 140 
X1 = OEt; X2 = Br; 23% yield 
ref 30, 139 
Scheme 1.17 Halo- and alkoxy-pyridylboronic acids prepared by Bryce et al. 30• 139• 140• 144• 150 
The DoM!boronation protocol was extended to alkoxy substituted pyridylboronic 
acids. 139• 144 Initial yields of 2-methoxy-3-pyridylboronic acid were only 13%. 139 
However, after much experimentation, this compound was prepared, following an 
optimized procedure in 58% yield on a 75 g scale. 150 2-Ethoxy-3-pyridylboronic acid 
was easily synthesized on a 70 g scale, and proved to be a versatile building block for 
the preparation of a library of functionalized heteroaryl-pyridines. 144 Do M of 5-bromo-
2-alkoxypyridine with LDA yielded the 4-pyridylboronic acid derivatives, analogous to 
the preparation of 5-chloro-2-methoxy-4-pyridylboronic acid. 139 Lower yields were 
obtained for the bromo derivatives, presumably due to the weaker directing ability of 
the bromo substituents compared to chloro. Interestingly, for 5-bromo-2-fluoropyridine, 
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Gallagher et al. found regioselective lithiation occurred ortho to fluorine and prepared 
the 3-pyridylboronic acid derivative 12 (Scheme 1.18). 142 Suzuki-Miyaura cross-
coupling of 12 initially occurred at the boronic moiety; extended reaction times lead to 
debromination of the coupling products. Further cross-coupling at the bromo substituent 
furnished 3,5-disubstituted-2-fluoropyridines in good yields. 142 
1. LDA, THF, -78 °C 
nBr 2. B(CMe)J 
F N 3. NaHCC3, HCI 
(HChB~Br Ar~Br 
)!__,) F N Na2CC3, toluene/EtCH ,)!_.,) F N 
12 80% yield 
reflux, 2 h 
71-87% yield 
(Het)ArB(CHh, Pd(PPh3)4 
Na2CC3, toluene/EtCH 
reflux, 2 h 
Aryy(Het)Ar 
,)!__) 
F N 
58-89% yield 
Scheme 1.18 Synthesis of 3,5-disubstituted-2-fluoropyridines. 142 
Dimethoxy- and dihalopyridylboronic acids have been prepared v1a DaM of the 
corresponding disubstituted pyridine precursor with LDA, followed by reaction with 
triisopropylborate or trimethylborate (Scheme 1.17). 140 The preparation of 2,3-
dimethoxy-4-pyridylboronic acid was low yielding when using LDA (12% yield); 
following literature conditions for the lithiation, n-BuLi (2.2 equiv.) in THF,153 the yield 
was improved to 60%. Suzuki-Miyaura cross-couplings of the dimethoxy- and 
dihalopyridylboronic acids with a number of heteroaryl bromides yielded new highly-
functionalized heteroarylpyridines in 42-96% yields. 140 
Snieckus et al. have combined the DoM!boronation of pyridine derivatives and 
subsequent Suzuki-Miyaura cross-coupling into a one-pot protocol (Scheme 1.19).61 
Halides or N,N-diethylamide were employed as DMG, the halide examples being 
comparable to previous work where the analogous boronic acids had been isolated and 
subsequently cross-coupled. This one-pot procedure showed good functional group 
compatibility. The coupling products offer additional synthetic potential in directed 
remote metalation (DreM) chemistry, as highlighted by cyclization to yield 
azafluorenones. 61 
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or 
(NH) o, I B-o ODMG 
N 3. pinacol or diethanolamine c.:;. J DMG N c.:;. J DMG N 
DMG = 2-, 3-, 4-CONEt2 
3-CI, 2-F, 2-0CONEt2 
0:pR 
0 
R = OMe, Cl, CN 
55-81% yield 
1. concentrate 
2. (Het)ArBr, Pd(PPh3)4, 
Na2C03, toluene, 
reflux, 12 h 
DMG = CONEt2 
LDA, THF, -78 °C 
1.5-2 h 
(Het)Ar ()oMG 
N 
30-85% yield 
Scheme 1.19 One-pot DoM-boronation-Suzuki-Miyaura cross-coupling synthesis of 
b. 1 61 aza Iary s. 
Recently Rault et al. synthesized ortho-cyanopyridylboronic acids leading to cyano-
functionalized bipyridines.65 Their procedure involved the ortho-lithiation of the 
cyanopyridines with L TMP at low temperature and quenching with triisopropylborate. 
The subsequent low yields of the cross-coupling reactions were explained by the close 
proximity of the electron-withdrawing cyano group facilitating competitive 
protodeboronation of the boronic acid. The corresponding pinacol ester derivatives were 
more stable (with respect to protodeboronation). Novel cyanobipyridines were obtained 
in 40-60% yields. 
Oxybispyridylboronic acids have been prepared from bromo-oxybispyridines, using 
standard lithium-halogen exchange with n-BuLi in THF at -78 °C, followed by 
boronation with triisopropylborate. 154 Yields of boronic acids were variable, 20-86%, in 
some cases degradation products were isolated, indicating instability of the 
oxybispyridylboronic acids. Suzuki-Miyaura cross-couplings were successful, preparing 
substituted pyridylethers which may be potential ligands for neuronal nicotinic 
cholinergic receptors (nAChRs). 
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An alternative strategy to halo-substituted pyridylboronic esters is through the [ 4+ 2] 
cycloaddition of 1,4-oxazin-2-ones with alkynylboronic esters (Scheme 1.20).I4I For 
1 ,4-oxazin-2-one when RI = H or Cl, the pericyclic reaction with alkynylboronic esters 
provides useful levels ofregiocontrol for isomer 14 (ea. 5:1, 14:15), when RI= Br the 
regioselectivity is further enhanced (ea. 10:1). Unfortunately, with terminal 
alkynylboronic esters poor selectivity was found. 
R - spl§ 'P< R1 2 \ sZ--o R2 N~o 0 0, .... o toluene 8 R,x~~(· + 0,BnMe c1~0 reflux, 48 h I ~ I ~ 
Me R1 N Cl R1 N Cl 
13 14 15 
67-83% yield 
R1 = H, Cl, Br; R2 = Ph, Bu, H 
Scheme 1.20 Harrity et al. [ 4+2] cycloaddition route to substituted pyridylboronic esters. 141 
1.2.2 Pyrimidylboronic Acids 
There is considerable interest in specifically functionalized pyrimidine derivatives as 
they are extensive in natural products and molecules with biological activity .155-I 59 
However, only a limited number of pyrimidylboronic acids have been reported.31• 63• I6o-
163 Early work was inspired by the role of organoboron reagents in BNCT, as potential 
anti-tumour agents. 2,5-Dimethoxy- and 2,5-dibenzyloxy-5-pyrimidylboronic acid were 
prepared through lithium-halogen exchange and in situ treatment with trimethylborate 
or tributylborate.I60 Gronowitz et al. found the couplings of halogenated uracils with 
boronic acids were unsuccessful; conversely the couplings of the corresponding 
pyrimidylboronic acid with n-electron deficient heterocyclic halides occurred in good to 
excellent yields.I 64 As noted in Section 1.2.1, the parent 5-pyrimidylboronic acid has 
been prepared in yields of 72-76% by either the reaction of the 5-pyrimidyl Grignard 
with tris(trimethylsilyl)borate124 or halogen-lithium exchange of 5-bromopyrimidine 
and "in situ quench" procedure outlined by Cai et al. 63 
More recently Bryce et al. synthesized 5-pyrimidylboronic acid in 1-10 g batches via 
halogen-lithium exchange of 5-bromopyrimidine with n-BuLi, and "in situ quench" 
with triisopropylborate in reproducible yields of 45% (Scheme 1.21).3I The method was 
extended to 2-methoxy-, and 2-chloro-5-pyrimidylboronic acids yielding 17b31 and 
28 
Chapter 1 - Introduction 
17c162 in 61% and 85%, respectively. X-ray diffraction studies of 17a and 17c revealed 
the structure of the hemi-hydrate of 5-pyrimidylboronic acid and the free boronic acid 
for 17c, with intermolecular 0-H .... N hydrogen bonds present in the crystals. Suzuki-
Miyaura cross-couplings of the pyrimidylboronic acids with heteroaryl halides, yield 
heteroarylpyrimidines (heteroaryl = thienyl, quinolyl and pyrimidyl) in moderate to 
good yields. 31 • 162 
N~Br 
1. n-Buli, -78 °C, B(Oi-Prb 
THF or toluene/THF N~B(OH)2 
)l_.J 
X N 2. H20, HBr (48% aq.) 
16a X= H 
16b X= OMe 
16c X= Cl 
A .. J X N 
17a X= H 45% yield 
17b X= OMe 61% yield 
17c X= Cl 85% yield 
Scheme 1.21 Synthesis of 5-pyrimidylboronic acid derivatives by Bryce et al. 31 • 162 
1.2.3 Pyridazinylboronic Acids 
At the outset of this project Harrity et al. reported the synthesis of the first 
pyridazinylboronate species. These were substituted pyridazinylboronic esters obtained 
in good yields ( 44-89%) by the inverse electron demand [ 4+ 2] cycloaddition of 
symmetrical and unsymmetrical 3,6-disubstituted-1,2,4,5-tetrazines with an 
alkynylboronic ester (Scheme 1.22). 165• 166 
Y-J( 
0, .... o 
8 
R1~R2 
~'N~R1 
R1 = C02Me, DMPY, H 
R2 = Me, n-Bu, Ph, TMS, H 
Scheme 1.22 Harrity et al. preparation of substituted pyridazinylboronic ester. 165 
They were successful in cross-coupling several of the pyridazinylboronic esters with 
iodobenzene under Suzuki-Miyaura conditions in moderate to good yields (51-72%) 
(Scheme 1.23). Considering that electron-deficient boronic acids are known to undergo 
protodeboronation, 167• 168 and the significant steric crowding around the boronate moiety 
these results are noteworthy. 
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19a R1 = C02Me, R2 =Me 57% yield 
19b R1 = DMPY, R2 =Ph 51% yield 
Scheme 1.23 (i) 19a: Phi, Pd2(dba)3 (5 mol% Phi), [t-Bu3PH]BF4 (12 mol% Phi), K3P04, 
MeCN, 50 oc, 90 min. 19b: Phi, Pd2(dba)3 (5 mol% Phi), [t-Bu3PH]BF4 (12 mol% Phi), K3P04, 
MeCN, J.!W 170 °C, 15 min.165 
Oxidation of the boronic moiety yielded pyridazin-4(1H)-ones in good yields and short 
reaction times. 165' 169 Prior to our work (Chapter 2) there were no reports of 
pyridazinylboronic acids prepared via lithiationlboronation techniques. 
1.2.4 Pyrazolylboronic Acids 
Until recently, pyrazolylboronic acids were underdeveloped which is somewhat 
surprising considering their utility as building blocks for biologically active compounds. 
A family of 1-alky 1-pyrazolylboronic acids have been prepared in 3 8-60% yields 
through lithiation ofpyrazole or bromopyrazole derivatives followed by boronation with 
trimethylborate (Scheme 1.24). 170 
X 
'CN 
N 
H 
X= Br or H 
X 1. n-Buli, THF, (H0)2B 
RBr, KOH, EtOH 
'CN 
-90 °C or 0 °C c~N 
reflux N 2. B(OMeb, -75 °C N I I R R 3. NH4CI/H20 
R =Me, i-Bu, n-Pr, 
CH2CH2CHMe2. 
CH2CH2CH(0Et)z 
From X= Br, 4-pyrazolyl- 38-51% yield 
From X= H, 5-pyrazolyl- 40-60% yield 
Scheme 1.24 1-Alkylpyrazolylboronic acid derivatives. 170 
It was observed that the 1-alkyl-4-pyrazolylboronic acids were unstable and easily 
decomposed in the presence of water yielding 1-alkylpyrazoles. Conversion of the 
boronic acids into their pinacol ester derivatives increased their stability; no 
protodeboronation products were observed after 6 months storage of the boronic esters 
at 5-10 oc_l7° 1-Alkyl-5-pyrazolylboronic acids are less prone to protodeboronation than 
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the 4-pyrazolyl analogues; to prevent decomposition the 5-pyrazolylboronic acids were 
similarly converted into their pinacol ester derivatives. In further work, introducing 
functionality at the C-7 position of (±)-vasicine, a quinazoline alkaloid, Suzuki-Miyaura 
cross-coupling reactions of (±)-7-bromovasicine (20) with 1-alkylpyrazolylboronic 
esters yielded (±)-7-pyrazolylvasicine derivatives (Scheme 1.25).171 
N~ 
I -...,t_) 
RN-....'l B(pin) 
Pd(PPh3)4, dioxane/H20, R~~r{ 
OH 
20 21 
9 examples, 72-90% yield 
Scheme 1.25 Suzuki-Miyaura cross-coupling reactions of pyrazolylboronic esters with (±)-7-
bromovasicine.171 
Protection of the pyrazole N-H increased the yields of Suzuki-Miyaura cross-couplings 
of 4- or 5-pyrazolylboronic acid derivatives. 172 Labile protecting groups such as SEM or 
THP have been employed in the preparation of N-protected 5-pyrazolylboronic acids 
and esters. 173-176 Following subsequent cross-coupling the SEM or THP protecting 
groups can be readily removed to yield 3-aryl-1 H-pyrazole derivatives. Although cross-
couplings of 1-SEM-5-pyrazolylboronic ester with iodo- or bromoarenes gave good 
yields (typically 40-93%), Rault et al. found that quite harsh conditions were required 
(excess n-Bt4NF in refluxing THF, >12 h) to remove the SEM group to yield 3-aryl-
1H-pyrazoles in 60-95% yield. The SEM group was not removed in the presence of a 
carboxylate moiety, instead, the carboxylate was converted into the carboxylic acid 
derivative. 173 THP is suitable for protection of the pyrazole N-H; namely, the presence 
of an oxygen atom to direct lithiation at C-5, stability to base and lability under acidic 
conditions. Young et al. described the preparation of 1-THP-1H-pyrazole, and then used 
this for the synthesis of 5-pyrazolylboronic acid. 174 Rault et al. applied their protocol for 
the preparation of SEM-protected pyrazolylboronic esters to THP-protected pyrazole 
and prepared 1-THP-5-pyrazolylboronic ester 22 in 90% yield (Scheme 1.26). 173 22 was 
an efficient partner for cross-coupling reactions with a variety of (hetero )aryl halides, 
giving 1-THP-5-(hetero)aryl-1H-pyrazoles. On treatment with ethanolic HCl at room 
temperature cleavage of the THP resulted in the 3-(hetero)aryl-1H-pyrazoles (Scheme 
1.26).173 Pyrazoloisoindolones were prepared through the intramolecular cyclization of 
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4- and 5-substituted-2-[1H-pyrazol-3(5)-yl]benzoic acid derivatives, synthesized from 
the coupling of22 with commercially available methyl 2-bromobenzoates. 175 
0 
eN 
0 
N 
H TFA, reflux 
(Het)Ar = CY R 
lY N 
1. n-Buli, THF, -70 °C 
eN 
2. B(Oi-Pr)J 
N 3. pinacol 
ob 4. AcOH 
96% yield 
R = COOEt, Cl, Br, OMe, CN 
~N Ny 0 ll /-N 
H s 
EtOH/HCI 
RT, 1 h 
15-93% yield 
£N ~6 ob 
22 90% yield 
(Het)ArX 
X= I, Br 
Pd(PPh3)4 
NaHC03, DME/H20 
reflux 12-24 h 
£-N 
(Het)Ar Ob 
12 examples, 30-92% yield 
Scheme 1.26 Preparation and Suzuki-Miyaura cross-couplings of 1-THP-5-pyrazolylboronic 
ester to yield 3-(hetero )aryl-1H-pyrazoles. 173• 174 
More recently, substituted pyrazoles have been prepared using N-THP as a switchable 
metal-directing group to enable sequential direct lithation at 3- and 5- positions of the 
pyrazole ring. 176 Following Suzuki-Miyaura cross-coupling of 22 with substituted 
bromoarenes, the THP group was equilibrated onto the thermodynamically most stable 
position (furthest from the aryl substituent), without the need for a 
deprotectionlreprotection sequence (Scheme 1.27). 176 The 1-THP-3-aryl-1H-pyrazoles 
were then regioselectively lithiated at C-5 and the boronic ester derivatives 23 prepared 
in good yields (72-82%). A further Suzuki-Miyaura cross-coupling yielded 3,5-
diarylated pyrazoles, isolated as their HCl salts (Scheme 1.27). Further complexity was 
introduced into one of the THP-protected diaryl-pyrazoles via bromination at C-4 ofthe 
pyrazole ring. Subsequent Suzuki-Miyaura cross-coupling at the 4-bromo site allowed 
introduction. of a third aryl substituent onto the pyrazole ring in good yield. 176 
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f:N 
Ar1 , 
THP 
0 
O ~N-THP 
TFA, toluene, 60 °C Ar1 N 
70-88% yield 
Ar1 = ~ R = H, F, Me, COzEt, CN; rr 
R N 
1. n-Buli, THF, -50 °C or 
LDA, THF, -60 °C 
Ar2 = ~ R=F,Me,CN; rr 
R N 
78-88% yield 
2. B(Oi-Pr)J 
3. pinacol 
4. AcOH 
1. Ar2X, Pd(dba)2/[PCy3H]BF4 
K3P04, 1 ,4-dioxane, 80°C, 16 h 
2. HCI/MeOH 
B(pin) 
~N-THP 
Ar1 N 
23 
6 examples, 72-82% yield 
Scheme 1.27 Synthesis of 3,5-diarylated pyrazoles. 176 
Harrity et al. expanded their cycloaddition protocol to the synthesis of substituted 
pyrazolylboronic esters. 177 After investigating the [3+2] cycloadditions of 
alkynylboronic esters with diazoalkanes and nitrile 1mmes and the 
cycloaddition/retrocycloaddition of sydnones, it was found that the reaction of 
alkynylboronic esters with sydnones 24 yielded pyrazolylboronic esters with varying 
regiocontrol (Scheme 1.28). 177 
R2 - l~ oY-r 'o ~9 R, o- xylenes, mesitylenes 's .... o 9~ orDCB R2h o---Bn I~ + I~ 
N-N reflux 4-24 h N-N N-N 
\ \ \ 
R1 R1 R1 
24 25 26 
55-83% yield 
R1 =Ph, 4-Me0-C6H4, 4-N02-C6H4; R2 =Ph, Bu, Me3Si, H 
Scheme 1.28 Cycloaddition of sydnones in the synthesis of pyrazolylboronic esters. 177 
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When employing phenyl alkynylboronate, good selectivity for the 4-pyrazolylboronic 
esters (25) was found for a variety of N-aryl sydnones. However, more modest 
regiocontrol was observed when TMS or butyl alkynylboronates were used (25:26, ea. 
2:1 ); using terminal alkynylboronate reversed the regioselectivity in favour of 26. The 
regioselectivity was found to be essentially uneffected by the sydnone. However, the 
reaction rate depended on the electronic nature, with more electron-deficient sydnones 
having faster reaction rates. This is in agreement with other kinetic and computational 
studies conducted by Harrity et al. which suggested that alkynylboronates partake as 
electron-rich components in cycloadditions. 166 More substituted pyrazolylboronic esters 
were prepared as single regioisomers 27 (Scheme 1.29), 177 providing access to tetra-
substituted pyrazole derivatives. Suzuki-Miyaura cross-coupling reactions of 1-aryl-3-
phenyl-1H-4-pyrazolylboronic ester with 1-bromo-4-chlorobenzene yielded tri-
substituted pyrazole derivatives in good yields (75-88%). Removal of the N-(4-
methoxybenzene) group from the cross-coupling product occurred by oxidation with 
eerie ammonium nitrate, revealing the 1H-pyrazole derivative in good yield. 177 
DCB, reflux 48 h 
0~ 
's-O 
R2~Ph 
N-N 
\ 
R1 
27 
59-75% yield 
R1 = Me, Ph; R2 = Ph, Me3Si 
Scheme 1.29 Tri-susbstituted 4-pyrazolylboronic esters. 177 
1.2.5 Other N-Heteroaryl Boronic Acids 
There are limited reports of other N-heteroarylboronic acids. Indolyl- and 
pyrrolylboronic acid derivatives are quite widespread, most likely due to these motifs 
being common in natural products and drug candidates. Indole derivatives are extensive 
in natural products and molecules with biological activity. 178 The synthesis of 
indolylboronic acids is well established, often requiring protection of the N-H group. 179• 
186 The choice of protecting group can effect efficiency in the synthesis of 
indolylboronic acids and their subsequent reactivity. For example, steric hindrance 
between the N-Boc group and the hydrogen at C-7 of N-Boc protected 2-indolylboronic 
acid explained the lower cross-coupling yields, compared to those from the pyrrole 
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analogue. 187 An extensive study into the Suzuki-Miyaura coupling reactions of indoles, 
using either indolylboronic acids and esters or indole halides concluded that the yields 
of coupling products depended on the assignment of the partner roles and protection of 
the indole. 184 Generally, it was found that using bromoindoles with arylboronic acids 
gave the highest yields. Protecting the indole partner with the strongly electron-
withdrawing tosyl group was advantageous. 
More recently Ir-catalyzed borylation of substituted indoles has selectively prepared 7-
indolylboronic ester derivatives (Scheme 1.30). 185' 186 One-pot Ir-catalyzed boronation-
Suzuki-Miyaura reactions were attempted and yielded 7-arylated substituted indoles in 
good yields, 185 encouraging prospects for synthetic utility. Notably, protection of the 
indole N-H was not required to give high coupling yields. 
HBpin or B2pin2 
Yz [lrCI(COD)h/bpy (3 mol%) 
R1 = Me, C02Et, Ph, CONEt2 
R2 = H, Cl, OMe 
60 °C, 1-8 h 
Scheme 1.30 Ir-catalyzed borylation of susbstituted indoles. 185 
R2W' ~ R1 ~ N 
H 
B(pin) 
64-90% yield 
Since 1991 a few articles have been published on pyrrolylboronic acids. Pyrrole can be 
lithiated directly or via halogen exchange with initial protection of the nitrogen atom. 
Schliiter et al. reported the first synthesis of 2-pyrrolylboronic acid, 188 and noted that it 
was susceptible to deboronation and self-coupling under Suzuki-Miyaura reaction 
conditions. The Suzuki-Miyaura reactions of N-phenylsulfonyl protected 2-
pyrrolylboronic acid have been reported without evidence of deboronation. 189 Varying 
yields (39-91 %) of the coupling products were obtained; as expected the higher yields 
were for aryl halides bearing electron-withdrawing groups. Pd-catalyzed borylation of 
an unprotected iodopyrrole derivative has been reported; successful Suzuki-Miyaura 
cross-coupling of the resulting 2-pyrrolylboronic ester with a number of 
dihalo(hetero)arenes yields bis(pyrrol-2-yl)arenes in good yields (69-97%). 190 Ir-
catalyzed borylation of pyrrole gave the 2-pyrrolylboronic ester and 2,4-
pyrrolyldiboronic ester in 83% and 80% yields, respectively, with high regiocontrol. 89 
The regioselectivity could be changed on using N-protected pyrrole; 1-methylpyrrole 
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showed preferential reactivity at the 2-position; however, sterically more hindered 1-
(triisopropylsilyl)pyrrole provided the 3-boryl isomer selectively.89 
There are isolated examples of imidazolyl-, 191 oxazolyl-, 192 and triazolopyridyl-193 
boronic acids, although in some cases instability of the C-B bond lessens their synthetic 
utility. 191 • 193 In the case of 4-oxazolylboronic acids Suzuki-Miyaura reactions with less 
reactive coupling partners (electron-rich or sterically hindered) gave markedly reduced 
coupling yields and increased levels of homocoupled boronic acid. 192 To our 
knowledge, thiazolyl- and pyrazinylboronic acids have not been reported. 
This review has sought to highlight the recent literature surrounding boronic acids and 
esters of N-heteroaryl motifs, many of which are commonly found in natural products, 
biologically active compounds or functional compounds for materials chemistry. On the 
whole N-heteroarylboronic acids have shown to be effective reagents in Suzuki-Miyaura 
cross-coupling reactions with a variety of (hetero )aryl coupling partners, providing 
efficient routes to functionalized bi(hetero )aryl scaffolds with good functional group 
compatibility. There are notable deficiencies in the literature for certain species. Given 
the considerable interest in azabiaryls it is clearly important to explore new N-heteroaryl 
boronic acids, which are thus far unknown or in limited supply. 
1.3 Reactions of Boronic Acids 
Boronic acids can undergo a number of different synthetic transformations. The most 
renowned is the Suzuki-Miyaura cross-coupling reaction for the preparation of biaryl 
systems. Homocoupling of boronic acids is a useful route to symmetrical biaryls. 
Competitive homocoupling can occur during cross-coupling syntheses, and is often 
undesired. Some boronic acid derivatives are unstable with respect to 
protodeboronation. This is often a challenge in Suzuki-Miyaura reactions, when 
employing electron-deficient boronic acids or those with the boronic acid group 
adjacent to a heteroatom. 
Patent literature holds an extensive number of reports of N-heteroarylboronic acids and 
a recent review by Corbet and Mignani highlighted sel~cted patented cross-coupling 
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reactions, applied in the synthesis of "significant products" (e.g. drugs, materials, 
optical devices, etc.). 194 
This review will attempt to cover the key aspects of the Suzuki-Miyaura reaction in 
aromatic bond formation. However, work relevant to the field of heterobiaryl synthesis 
has been prioritized. Homocoupling and protolytic deboronation are discussed in detail. 
Other reactions of boronic acids are highlighted. 
1.3.1 Suzuki-Miyaura cross-coupling reaction 
In recent years, transition metal catalyzed aromatic carbon-carbon bond forming 
reactions have become of great interest, especially in the development of agrochemicals, 
pharmaceuticals and other fine chemicals, where the biaryl unit is a recurrent motif. The 
general reaction is of an aryl halide (or triflate ), ArX, an electrophilic source of carbon, 
with a source of nucleophilic carbon in the form of M-Ar', where M is an 
electropositive centre [e.g. Li, MgX, SnR3, Cu, B(OR)2] bound to an aryl group. The 
reactions are catalyzed by a transition metal, usually Ni or Pd(O). Boronic acids have a 
number of advantages over other organometallic reagents; they are generally innocuous, 
air-, moisture- and temperature-stable, and can tolerate a wide range of functional 
groups during the cross-coupling reaction. 
There are a number of commonly used catalytic methods for biaryl synthesis, for 
example, Kumada, Negishi, Stille, Suzuki-Miyaura and Hiyama reactions (Figure 
1.8). 104' 107 In the mid to late seventies the Kharasch reaction was developed in which an 
aryl Grignard is reacted with an aryl halide in the presence of an appropriate catalyst. 
The main disadvantage of the Kharasch reaction is that due to the polar nature of the 
Grignard reagent, several functional groups, such as aldehydes, ketones, esters or nitro 
groups are precluded from use in the coupling partners. The reaction of 
organomagnesium reagents with alkenyl or aryl halides, catalyzed by Ni(II) complexes 
was reported by Kumada, Tamao and Corriu independently. 195 This transformation is 
economical, yet is limited to halide partners that do not react with organomagnesium 
compounds, and again cannot tolerate certain functional groups. 
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Suzuki-Miyaura reaction 
[Pd] 
Ar-X + Ar'-B(OHh Ar-Ar' 
base 
Stille reaction [Pd] 
Ar-X + Ar'-SnR3 Ar-Ar' + X-SnR3 
Negishi reaction [Pd] or [Ni] 
Ar-X + Ar'-Zn-Y Ar-Ar' + X-Zn-Y 
Kumada reaction [Ni] 
Ar-X + Ar'-Mg.Y Ar-Ar' + X-Mg-Y 
Hiyama reaction 
[Pd] 
Ar-X + Ar'-SiR3 Ar-Ar' + X-SiR3 
Figure 1.8 Carbon-carbon aromatic bond forming reactions. 
The Negishi reaction employs arylzinc reagents with aryl halides or triflates. However, 
Grignard reagents are required to synthesize the zinc compounds for the starting 
material of the Negishi reaction. Unlike the Kharasch or Kumada reactions, functional 
groups are tolerated on the coupling partner. The Negishi reaction has broad scope and 
is not restricted to the synthesis of biaryls; various aryl, vinyl, benzyl or allyl halides 
can be coupled to the organozinc reagents in the presence of the nickel or palladium 
catalyst. There are isolated examples in which aryllithiums have been used in the 
formation of biaryls; however, they are seldom used due to their highly polar and basic 
nature. The Stille reaction is a versatile carbon-carbon bond forming reaction using 
arylstannanes (ArSnR3, R = Me, Bu) and aryl halides or triflates. The reaction tolerates 
a wide range of functional groups on either coupling partner, and the neutral reaction 
conditions are an advantage. A disadvantage to the Stille reaction in that the organotin 
reagents and by-products are toxic. Although arylstannanes are stable and the Stille 
reaction conditions mild, boronic acids can undergo much of the same chemistry in the 
Suzuki-Miyaura cross-couplings, without the drawbacks of toxic tin compounds. 
The development of the Suzuki-Miyaura reaction in the early 1980s was a major 
breakthrough. It overcame the problems previously experienced of intolerance towards 
sensitive functionalities on either coupling partner, the issues of air and moisture 
sensitivity, and toxicity found with some organometallics. In the Suzuki-Miyaura 
reaction boronic acids react with aryl halides or triflates, catalyzed by a Pd(O) active 
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species. Suzuki et al. first published the cross-coupling of phenylboronic acid with a 
halobenzene to yield biphenyl in 1981. 196 The versatility of the reaction can be 
attributed to the commercial availability of the boronic acid reagents and the mild 
reaction conditions. The aforementioned advantages of organoboronic acids combined 
with regio- and stereoselectively and tolerance of a wide range of functional groups 
makes the Suzuki-Miyaura cross-coupling an extremely versatile procedure,5' 37, 197-199 
especially for industrial scale syntheses.200' 201 The inorganic boron containing by-
products are non-toxic and easy to remove from the reaction. 
The catalytic cycle for all cross-coupling reactions is generally the same, involving the 
oxidative addition of the organic halide to the catalyst, usually a palladium(O) species, 
to form an organopalladium halide; followed by transmetalation with the main-group 
organometallic or organoboronic acid, resulting in a diorganopalladium complex which 
undergoes reductive elimination, thereby forming the carbon-carbon bond and 
regenerating the catalyst. 198 The catalytic cycle for the Suzuki-Miyaura cross-coupling 
reaction has been well studied, with the mechanisms for each step investigated. More 
recently DFT studies have predicted the possible intermediates at each stage of the 
catalytic cycle.Z02-204 The catalytic cycle for the Suzuki-Miyaura cross-coupling reaction 
is represented in Figure 1.9. The active catalytic species is given as L2Pd(O) (L = 
phosphine monodentate ligand). There is evidence that the mechanism for Ar-X 
addition to zerovalent L2Pd is highly sensitive to the steric bulk and electronic 
properties of the phosphine ligand, and that some reactions proceed via a monoligated 
LPd(O) species.Z05-209 Reduction of the palladium precursors [usually Pd(II) species, for 
example Pd(0Ac)2 or Pd(PPh3)2Ch] can form anionic Pd(O) complexes i.e. L2Pd(O)CC 
L2Pd(O)OAc -. The rate of oxidative addition can be affected by the anionic ligand.Z10-212 
Early mechanistic studies by Smith et al. noted that water and base were required to 
activate the boronic acid and that the rate determining step depended on the halide of 
Ar-X.213 Arylboronic acids behave as Lewis acids under basic conditions, forming 
tetrahedral anions through addition of hydroxide (see Section 1.1.1 ). Therefore, it was 
suggested that on using water and potassium carbonate the active boronic species is 
ArB(OH)3-K+. The rate-determining step for Ar-Br was found to be the oxidative 
addition to Pd(O), however, when using Ar-1, transmetalation was the rate-determining 
step.213 
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Figure 1.9 Catalytic cycle for the Suzuki-Miyaura cross-coupling reaction. 
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The catalytic cycle for the Suzuki-Miyaura cross-coupling reaction was initially based 
on the work by Negishi on organozinc coupling reactions. 213 Aliprantis and Canary 
confirmed that oxidative addition and transmetalation were occurring during Suzuki-
Miyaura reactions. They observed the intermediates Band Din the reaction mixture of 
3-bromopyridine and a phenylboronic acid catalyzed by Pd(PPh3) 4, through electrospray 
ionization mass spectrometry.214 In their study on the mechanism of palladium-
catalyzed homocoupling of arylboronic acids Adamo et al. confirmed the observations 
made by Aliprantis and Canary, that intermediate D formed in the transmetalation step 
of the Suzuki-Miyaura reaction clearly adopts the trans configuration (see Section 
1.3.2).215 Suzuki et al. had previously reported the mechanism for the reaction of a 1-
alkenylboron compound with a 1-alkenyl halide.37' 216 Although they had not 
investigated the mechanism of the coupling between haloarenes and arylboronic acids, 
from their earlier studies, they believed that intermediate C was formed, even for aryl-
aryl coupling reactions.217 
Originally it was established that oxidative addition of the aryl halide to a palladium(O) 
complex was the rate-determining step in the majority of cases. Initially a cis-cr-
palladium(II) complex is formed which rapidly isomerizes to the more stable trans-cr-
palladium(II) intermediate B. Sicre and eo-workers reacted 4-bromo-2-phenylpyridine 
40 
Chapter 1 - Introduction 
and 2-bromo-4-phenylpyridine with 100 mol% of Pd(PPh3) 4 to isolate and characterize 
the oxidative addition products (Scheme 1.31 ). 204 
Br 
I 
Br Ph,P~Ph3 Ph 6 Pd(PPh3)4 PhB(OHh 6 50 °C toluene N Ph K2C03 N Ph N Ph 
28 29 30 
73% yield 
Ph 
A PPh3 l .. ~l 
B N Pd-sr r-.. I I 
Pd N 
I y-··11 
Ph3P 0 
Ph 
n N Br 
31 
Ph 6 fPh, + 
N rd-sr 
Ph3P 
50 °C toluene 
32 33 
30% yield 
Scheme 1.31 Stepwise Suzuki-Miyaura cross-coupling reaction ofbromopyridines 28 and 31.204 
For 28, the trans complex 29 was isolated in 73% yield; a singlet in the 31 P NMR 
spectrum (24.13 ppm, CD2Cb) confirmed the trans nature of the ligands. With 31 a 
mixture of mononuclear trans complex 32 and dinuclear complex 33 was obtained in 
30% yield (the lower yield attributable to difficulties in isolation). The 31P NMR signals 
appeared at 22.12 and 30.32 ppm, respectively?04 Based on NMR studies at 50 °C the 
oxidative addition at position 2 of the pyridine ring was much faster than that at position 
4 (10 min vs 10 h). The characterization of mononuclear species 29 and 32 is in 
agreement with previous work.205, 214 
The nature of the aryl halide can influence the reactivity in Suzuki-Miyaura cross-
coupling, both in terms of the halide and substituents on the aryl ring. In general the rate 
of reactivity decreases in the order I ( > OTf) > Br >> Cl. Electron-withdrawing groups 
can activate the aryl halide towards oxidative addition by stabilizing the intermediate. 
The reactions proceed efficiently for aryl and vinyl halides, however, for alkyl halides 
competing ~-hydride elimination can occur from the cr-organopalladium(II) complex 
resulting from oxidative addition of the alkyl halide. There has been increasing interest 
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into why some ligands can accelerate the reactivity of certain aryl halides. The active 
catalyst system is intended to activate the carbon-halide bond towards oxidative 
addition, whilst also enhancing the rate of reductive elimination so that the whole 
catalytic cycle turns over quickly. There is no universal catalyst system which satisfies 
the diverse requirements of different Suzuki-Miyaura cross-couplings.218· 219 A review 
summarizes the work up to 2006 on the nature of the active species in palladium-
catalyzed Suzuki-Miyaura coupling reactions.220 All forms of palladium were 
considered (e.g. solid-supported metal complexes, palladium nanoparticles, ligand-free 
palladium) and the homogeneity or heterogeneity of catalyst systems was evaluated. 
The active palladium complex must be in a zero oxidation state for oxidative addition to 
occur. The most common catalyst is Pd(PPh3)4 which fulfils the requirements of the 
complex being electron rich and having ligands which readily dissociate. Pd2(dba)3 or 
Pd(dba)2 are also frequently used with the addition of a phosphine ligand, as a method 
of preparing palladium(O)/phosphine complexes in which the Pd:P ratio can be adjusted 
to optimize catalytic ability. Other catalyst precursors are palladium(II) complexes such 
as Pd(0Ac)2 or PdCh/phosphine which are reduced in situ to the corresponding 
palladium(O) complexes. Various phosphine ligands are effective in stabilizing the 
palladium(O) species; the reactivity of the catalysts towards oxidative addition and 
transmetalation is dependent on the stoichiometry of phosphine to palladium, and the 
bulkiness or donating ability of the phosphine ligands.221 ' 222 Pd(PPh3)4 and other 
Pd(O)/phosphine complexes are in equilibrium with coordinatively unsaturated species. 
Bulky and highly donating ligands have an accelerating catalytic effect, accredited to 
their ability to donate electrons to the metal centre and ready dissociation of the ligand 
to generate a coordinatively unsaturated species. Several ligands for palladium are 
especially efficient, e.g. trialkylphosphines (e.g. t-Bu3P, PCy3), bisphosphines (e.g. 
dppp, dppf) and N-heterocyclic carbenes. A discussion of different ligands for Suzuki-
Miyaura cross-coupling reactions will be considered below. 
It has been suggested that the enhanced reactivity of bulky electron-rich phosphines, 
e.g. t-Bu3P, may be associated with a change in mechanism of the oxidative addition 
step, compared to PPh3 complexes. The presence of a monoligated (t-Bu3P)Pd species 
has been implicated in studies on the reductive elimination of Ar-X from palladium(II) 
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species.223 The mechanism of Ar-X addition to a zerovalent L2Pd(O) complex has been 
shown to be highly sensitive to the steric bulk of the phosphine ligand (Scheme 1.32). 
34 PR3 = Cy2P(t-Bu) 
35 PR3 = CyP(t-Buh 
36 R = Cy 
37 R = t-Bu 
38 R = ( o-tolyl) 
ArX 
Ar= Ph 
39 R = Cy; X= I 
40 R = Cy2P(t-Bu); X= I 
41 R = Cy2P(t-Bu); X = Br 
42 R = (o-tolyl); X= Br 
43 R = CyP(t-Buh; X= I 
44 R = t-Bu; X = I 
Scheme 1.32 The observed intermediates resulting from oxidative addition of ArX to Pd(O) with 
different phosphine ligands. 205 
The addition of Phi to complex 36 in THF occurs very rapidly to give the trans 
biphosphine complex 39. The reaction of PhOTf is much slower and through 
electrochemical techniques was shown to follow an associative mechanism. 1H NMR 
spectroscopy established an associative mechanism for the reaction of Phi or PhBr with 
the air-sensitive 34. The reaction of Phi with 34 was ea. 103 times slower than with 
complex 36. Product 40 showed characteristic virtual coupling in the t-Bu signal 
associated with trans-L2M. X-Ray crystallography of complex 41 confirmed the 
structure?05 In contrast, the addition of ArBr to 38 involves dissociation of one 
phosphine ligand preceding addition of the electrophile to produce the halide-bridged 
dimer 42.224 On treating 35 with PhBr generation of a monophosphine palladium 
complex and an equivalent of free phosphine was observed. On addition of Phi to 35, 
the 31 P NMR spectrum of the resultant 43 indicated a temperature-dependent 
equilibrium. In a parallel experiment after 4 days at RT the mixture of complex 37 and 
Phi showed one equivalent of free phosphine and one equivalent of dimer 44?05 
Overall, less bulky ligands Cy2P(t-Bu) and PCy3 initiate oxidative addition through the 
initial formation of trans-[Pd(X)L2Ar], whilst bulkier ligands CyP(t-Bu)2 and t-Bu3P 
generate dimeric [(Pd(X)LR)2] species from monoligand reactants. The effectiveness of 
these two ligands in palladium-catalyzed cross-coupling reactions is associated with a 
propensity to form monophosphine complexes, either as or en route to the true catalytic 
species?05 QPhos-tol is a sterically hindered ferrocenyl monodentate phosphine ligand. 
The oxidative addition of chloro-, bromo- and iodoarenes to the bisphosphine 
palladium(O) complex Pd(QPhos-tol)2 occurs via three different mechanisms (Figure 
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1.10), producing [Pd(QPhos-tol)(Ar)(X)].206 Addition of Phi occurs by the associative 
displacement of a phosphine (Path A), PhBr by rate-limiting dissociation of a phosphine 
(Path B) and PhCl by a reversible dissociation of a phosphine, followed by rate-limiting 
oxidative addition (Path C). Iodo and bromoarenes yield monomeric complexes H, 
whereas the chloride complex Ill is dimeric in the solid state and solution phase?06 
ArX 
Path A ;--- L -Pd-(ArX) 
X=l; + L 
L-~d-L~ 
L L-Pd + L 
Path B 
X= Br 
Ar 
I 
L-Pd-X 
11 
_j 
ArX 
L = QPhos-tol 
Ar 
I 
L-Pd-X 
Ill 
I I 
X-Pd-L 
I Ar 
for X= Cl 
o-P(t-Buh 
I 
ArA_Ar 
Ar~--Ar 
Ar 
Figure 1.10 Distinct mechanisms for the oxidative addtion of ArX to Pd(QPhos-tol)2?06 
Theoretical studies into the role of monoligated palladium complexes in cross-coupling 
reactions have attempted to evaluate why in some cases LPd(O) can out-perform 
L2Pd(O) in oxidative addition?07-209 DFT calculations indicated that monophosphine 
PR3Pd was catalytically more active than bisphosphine (PR3)2Pd for oxidative 
addition?07 Among the different PR3 ligands (R =Me, Et, i-Pr, t-Bu, Ph) the free-energy 
barriers to oxidative addition did not change significantly. In practice, t-Bu3P was the 
only catalytically active ligand towards aryl chlorides?07· 221 Through calculations it was 
proposed that the dissociation energy of t-Bu3P from (t-Bu3P)2Pd is significantly lower 
than that of (PR3)2Pd (where R = Me, Et, i-Pr, Ph). Hence, the difference in dissociation 
energies from L2Pd to LPd and L, between various PR3 ligands could account for their 
different reactivities in oxidative addition.207 DFT studies have also demonstrated how 
the electronic properties of different aryl halides affect the reaction pathways for their 
oxidative addition to L2Pd complexes. 208 The results showed that electron-donating 
groups or electron-withdrawing groups on aryl bromides and aryl chlorides do not 
quantitatively alter the preferred dissociative LPd pathway. Consequently, bulky or 
hemilabile ligands promote the oxidative addition of ArCl or ArBr, because such 
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ligands promote the monoligated pathway. For aryl iodides, electron-withdrawing 
groups favour the L2Pd pathway, whereas electron-donating groups further enhance the 
LPd dissociative mechanism for oxidative addition.208 
To summarize, there is evidence for both L2Pd and LPd active species. Generally it is 
thought that biphosphine complexes L2Pd(O) occur when using chelating bidentate 
phosphine ligands or monodentate trialkylphosphines with small or moderate steric 
bulk. It has been shown that biphosphine palladium complexes undergo associative 
oxidative addition of aryl halides to prepare monoligated [LPd(Ar)(X)] complexes. 
Monophosphine complexes LPd(O) are a result of (in some cases rate-limiting) 
dissociation of a phosphine ligand prior to oxidative addition of the aryl halide. This 
usually occurs for bulky trialkylphosphines. The stability of either mono- or 
biphosphine palladium(O) complexes is enhanced by electron rich alkylphosphines, 
through donation of electrons to the palladium. 
The role of the base in Suzuki-Miyaura cross-coupling reactions has been widely 
investigated. It is clear that addition of a base has an accelerating effect on the cross-
coupling of boronic acids, which is quite different from the related reactions of other 
organometallics. The mechanism of transmetalation involves base, and there are two 
general opinions: (i) the base is required to quatemize the boron prior to transmetalation 
(Figure 1.9, transmetalation I), or (ii) ligand exchange between Ar-Pd(II)-X and a base 
(OR-), with subsequent transmetalation to an alkoxopalladium(II) complex C (Figure 
1.9, transmetalation 11). Owing to the low nucleophilicity of organic groups in 
organoboron compounds, the transmetalation between organopalladium(II) halides and 
organoboronic acids does not readily occur. Quatemization of the boron with a 
negatively charged base increases the nucleophilicity of the organic groups on the boron 
forming an 'ate' complex. It is known that 'ate' complexes such as [ArB(R)(OR)2]Li 
readily couple with organic electrophiles in the presence of a palladium or nickel 
catalyst.225 Similarly the hydroxyboronate anion [ArB(OH)3 -], which exists in 
equilibrium with the free organoboronic acid, could effect the transmetalation. It has 
been assumed that the addition of base activates the boronic acid by donating an 
electron pair into the vacant p orbital on the boron, increasing the nucleophilicity of the 
adjacent carbon and its reactivity towards attack at the palladium(II) centre. 225 
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The choice of base plays an important role; smooth transmetalation is critical for such 
metalloid compounds with low nucleophilicity. Transmetalation to Ar-Pd-X follows 
the reactivity order Cl > Br > I, i.e. the opposite to oxidative addition. It is highly 
dependent on the counter cation of the base used as MX is produced in the process. The 
effectiveness of the base can be related to its affinity for MX formation. The reaction 
can be fast for counter ions which have a high stability constant for halide ions, 
additionally, increasing the base strength (Oir > MP04- > MC03- > HC03 -) can 
increase the concentration of hydroxyboronate anion [Ar'B(OH)3]M present.225· 226 For 
sterically bulky arylboronic acids when using NaOH or Na2C03 no coupling reaction 
was observed; the strong base KOt-Bu was essential for good coupling yields and short 
reaction times?27 The counter cation may also affect the solubility of [Ar'B(OH)3]M in 
organic solvents. Fluoride ions have a high affinity for boron and are suitable for 
forming a boronate anion, ArB(OH)2F- capable of effecting boron: to palladium 
transmetalation. Fluoride salts (E~NF, KF, CsF) allow the cross-coupling reactions of 
aryl- and vinylboronic acids in essentially non-basic conditions, rapidly and in good 
yields?28 
Transmetalation to Ar-Pd-OR, where OR = alkoxo-, hydroxo-, acetoxo- or 
acetylacetoxo-, generated in situ by ligand exchange, may involve the rate-determining 
coordination of OR- ligand to the boron atom via the transition state (Figure 1.9 C-+D). 
The transfer of an activated organic group from boron to palladium then takes place as a 
result of complex formation. The high basicity of the Pd-OR species and high 
oxophilicity of the boron centre are both attributed to the high reactivity of the 
alkoxopalladium(II) complexes. Ar-Pd-OR can undergo transmetalation with boronic 
acids without base being present.225 Ag20 has been used to promote Suzuki-Miyaura 
reactions?29 The reaction of Ag20 with trans-Pd(C6Fs)I(PEt3)2 generated trans-
Pd(C6F5)(0H)(PEt3)2 with concomitant generation of Agi.230 It was suggested that 
Ag20 promotes replacement of the iodo ligand with a hydroxyl group of H20, to 
prepare the hydroxopalladium(II) intermediate of transmetalation. 
DFT studies suggested that base binds initially to organoboronic acids rather than 
palladium species?03 From DFT calculations it was concluded that the transmetalation 
reaction takes place via a multistep mechanism, where the boronic acid is activated by 
an external base and attacks the palladium centre as an organoboronate anion?04 From 
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the comparison of relative energies, DFT studies have shown that transmetalation can 
proceed smoothly with a palladium species with one or two phosphine ligands, and 
either the cis or trans arrangement.202 
It is not obvious in many cross-coupling reactions of organoboron compounds in 
alkaline solution, which of the two possible transmetalation processes is predominant. 
Results depend on the organoboron reagents, bases and organic electrophiles. Matos and 
Sonderquist proposed that depending on the base affinity for the organoborane species it 
can either replace the halide on the palladium complex or bind to the organoborane 
species.Z31 Electron-deficient heteroarylboronic acids undergo transmetalation at a 
relatively slow rate, consequently these reagents often rapidly decompose by a 
protodeboronation pathway (see Section 1.3.3). 
Formation of the trans-diarylpalladium(II) intermediate (Figure 1.9, intermediate D) has 
been confirmed. The cis-configuration is required for reductive elimination to occur, 
forming the biaryl and regenerating the active palladium(O) complex. The trans-
diarylpalladium(II) complex undergoes a form of cis-trans isomerism to enable 
elimination of the biaryl unit from intermediate E. Diaryl complexes are the most 
reactive in undergoing reductive elimination [diaryl- > (alkyl)aryl- > dipropyl- > 
dimethylpalladium(II)] suggesting n-orbital participation during bond formation. DFT 
studies into the mechanism of the isomerization of D to E: via (i) a four-coordinate 
tetrahedral transition state, (ii) a three-coordinate rearrangement with initial loss of 
phosphine ligand then re-addition or (iii) a five-coordinate rearrangement, through 
coordination of a phosphine ligand or solvent molecule,202 have found that the energy 
barrier to isomerism was fairly high. It is feasible that the reaction takes place through 
the necessary loss of one of the phosphine ligands, after which the energy barrier for 
complex isomerism becomes quite low.202 
Aryl bromides and iodides are often used in the Suzuki-Miyaura reaction. Milder 
reaction conditions have been developed for the cross-coupling reactions of aryl 
triflates; due to their base sensitive and thermally labile nature, more efficient catalysts 
such as PdClz( dppf), and weakly basic, non-aqueous conditions have been employed. 
The addition of an alkali metal halide promotes the cross-coupling of aryl triflates and 
also prevents premature catalyst decomposition. Aryl chlorides require a much higher 
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energy for insertion of Pd(O) into the C-Cl bond in the oxidative addition step, resulting 
in their decreased reactivity.232 Nevertheless, aryl chlorides are highly desirable 
coupling partners as they are readily available and inexpensive. An electron 
withdrawing group on the aryl chloride is advantageous; those at the ortho or para 
position being more activating.Z32 The reactivity difference between electron-poor and 
electron-rich aryl chlorides in cross-coupling reactions has been attributed to the higher 
ligating ability of the electron-deficient aryl chlorides. Electron-poor aryl chlorides 
allow for more d ---+ n* back-donation from the palladium in the pre-reactive complex 
(Figure 1.11 )?09 Suzuki-Miyaura reactions of fluoroarenes have been reported.Z33• 234 
Aryl fluorides are not often employed in cross-coupling reactions due to the strength of 
the C-F bond. Successful cross-coupling reactions with phenylboronic acid derivatives 
occurred on fluoroarenes activated by an adjacent nitro substituent233 and perfluorinated 
arenes para to a CF 3 or C6F 5 substituent. 234 Qdl2 
EWG 
Figure 1.11 Activation of aryl chlorides towards oxidative addition. 
New catalytic systems have been developed for the cross-coupling of unreactive 
chloroarenes. Fu et al. investigated the effects of adding a variety of phosphines to the 
Suzuki-Miyaura cross-coupling of aryl chlorides and arylboronic acids.221 They 
established that t-Bu3P was the most effective phosphine, and that the optimal 
phosphine:Pd ratio is between 1 and 1.5. The steric bulk and electron-richness oft-
Bu3P is critical for the unprecedented reactivity, with only PCy3 being nearly as 
effective. A further study demonstrated that this catalytic system gave excellent yields 
of coupling products at room temperature, when aryl bromides and iodides were used.222 
A mechanistic study of the Pd2(dba)3/t-Bu3P catalyzed cross-couplings showed that a 
monophosphine complex was the active species. Fu et al. concluded that they had a 
methodology for which electronically and sterically diverse reactants could be cross-
coupled, without the need for substrate specific optimization of the reaction 
conditions.Z22 Recently Fu et al. have reported the cross-coupling of aryl- and heteroaryl 
chlorides with a wide range of heterocyclic boronic acids in good to excellent yields. 172 
This wide-ranging study includes the coupling of unprotected amine- and hydroxy-
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substituted pyridines, and utilizes the following reaction parameters; Pd2dba3, PCy3, 
K3P04, dioxane/water. Air-stable phosphonium salts (e.g. [t-Bu3PH]BF4, [Cy3PH]BF4) 
serve as direct replacements for the corresponding phosphines in Suzuki-Miyaura and 
other palladium-catalyzed cross-coupling reactions?35 
Buchwald et al. have reported a number of different ortho-phosphine-substituted 
biphenyl ligands (Figure 1.12)?36'241 Early work found that ligands 45 and 46 were 
suitable for Suzuki-Miyaura cross-couplings of aryl bromides and chlorides at room 
temperature and with low catalyst loadings.236 Ligand 49 was effective for the coupling 
of ortho-substituted aryl halides with ortho-substituted arylboronic acids.236 
Mechanistic studies indicated that increasing the steric bulk on the non-phosphine 
containing phenyl ring was important for catalyst activity and lifetime. Thus ligand 47 
SPhos was developed, and found to be incredibly efficient for the cross-coupling of 
unactivated aryl chlorides, hindered substrates and heteroaryl halides?37 Ligand 47 
confers unprecedented activity, allowing room temperature cross-couplings of aryl 
chlorides with low catalyst loadings (0.25-0.5 mol% Pd) to be performed. Cross-
coupling reactions of 3-pyridylboronic acid were reported with a range of aryl halides in 
isolated yields of 81-96%?38 Incorporation of a water-solubilizing sulfonate group onto 
47 gave 51239 which proved to be a highly active catalyst system for the Suzuki-Miyaura 
cross-coupling of a variety of aryl and heteroaryl bromides and chlorides in aqueous 
media. 
45 
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Of all the Buchwald ligands 47 SPhos and 48 XPhos show universal activity and 
efficiency in the Suzuki-Miyaura cross-couplings of aryl and heteroaryl bromides and 
chlorides. Recently, ligand 48 and to some extent 47, have shown to provide highly 
stable and active catalysts for the Suzuki-Miyuara cross-coupling of pyridyl-, pyrrolyl-, 
indolyl-, thienyl- and furylboronic acids with substituted heteroaryl bromides and 
chlorides.240· 241 
Other reports of specific catalyst and ligand systems for Suzuki-Miyuara cross-
couplings of aryl chlorides are plentiful. For example, under aerobic conditions,242 new 
air-stable catalysts PdCh[R2P(p-R'-Ph)h (where R = t-Bu, Cy and R' = CF3, H, OMe, 
NMe2)/43· 244 ferrocenyl monophosphine ligands,245· 246 a bowl-shaped phosphine ligand 
(the depth of the bowl dramatically effecting the catalytic abilityi47 and a PEG(300)-
PdCh system which promotes the cross-coupling of aryl chlorides with various 
phenylboronic acids have been studied. 248 
New ligands, catalyst systems, and reaction conditions for Suzuki-Miyaura cross-
coupling reactions of (hetero )aryl halides and (hetero )arylboronic acids is a vast topic. 
However, phosphine based catalyst systems show broad activity and efficiency and are 
widely commercially available. Microwave conditions have become extensively 
popular, as have aqueous conditions, in attempts to make the reaction 'greener'. 
The applications of heterobiaryl systems in many areas of contemporary chemistry have 
inspired the use of heteroaryl halides or triflates as the coupling partners in the Suzuki-
Miyaura reaction, thus generating a versatile route to bi(hetero )aryls. The activating 
effect of some nitrogen-containing heterocycles assists the cross-coupling reaction. The 
electron deficient nature of pyridines aids the oxidative addition of the Pd(O) species. 
The potential for the synthesis of a wide variety of novel heterobiaryls is fuelled by the 
Suzuki-Miyaura cross-coupling reaction tolerating many functional groups on either 
coupling partner. Indeed, Bryce et al. have reported the cross-coupling of halo- and 
alkoxy-substituted pyridylboronic acids with a variety of substituted electron-rich and 
electron-deficient heteroaryl coupling partners.30• 139• 140• 144• 150 Rault et al. have coupled 
novel halopyridylboronic acids efficiently with sterically hindered, electron-rich and 
electron-deficient halides. Under standard Suzuki-Miyaura-type conditions, no products 
resulting from coupling of the halide substitutent on the pyridylboronic acid with 
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another halopyridylboronic acid unit were observed. 135' 138 The coupling of a 
halopyridylboronic acid with itself should not occur under the basic Suzuki-Miyaura 
conditions as the boronic acid would most likely be a boronate anion, exerting a 
deactivating effect on the halogen. After the cross-coupling has taken place the 
remaining halogen should be available for further coupling. Nevertheless, it is 
interesting to note that this is not generally the case for Rault et al., who report 4 7-78% 
yields of the singly coupled products of the halopyridylboronic acids with an array of 
substituted halogenated aryls. This may be due to their use of more reactive halo-
coupling partners than are obtained from the coupling reaction. Scheme 1.33 shows the 
absence of a secondary coupling of 52, due to the inherent lower reactivity of chloro-
coupling partners. The iodinated species is very reactive towards oxidative addition and 
is preferred in the cross-coupling with the 5-chloro-2-pyridylboronic acid, resulting in 
the singly-coupled product. 138 
Cl~ 
~ .. A + 
N/- B(OHh 
Cl 
/-
N 
52 65% yield 
Scheme 1.33 Example of the Suzuki-Miyaura cross-couplings undertaken by Rault et al. 138 
Traditionally it was thought that compounds bearing labile protons were unsuitable 
coupling partners; however, couplings have now been reported in the presence of 
primary amines, 150• 240• 249 carboxylic acids250 and alcohols?51 The work done in our 
laboratory established Suzuki-Miyaura cross-couplings in the presence of an amine 
group on the halide coupling partner, with no need for protectionldeprotection steps in 
the synthesis. 150 An extensive library of (hetero )arylpyridines was reported from the 
cross-coupling of 2-methoxy-5- and 2-methoxy-3-pyridylboronic acid with amino-
substituted bromo/chloro-(hetero )aryl coupling partners in good yields (bromo-coupling 
partners 69-84%, chloro-coupling partners 40-69%). The presence of the primary amine 
group on the highly substituted pyridine coupling products offers scope for further 
synthetic transformations, as well as applications in supramolecular and coordination 
chemistry. 
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Polyhalogenated heterocycles can be regioselectively cross-coupled.252-256 In cases 
where the halogens are different the selectivity is related to the relative bond 
dissociation energies, and the reactivity of the halide towards oxidative addition 
(following the trend I > Br > Cl > F). Sicre et al. highlighted that the oxidative addition 
of 2-bromo-4-phenylpyridine to Pd(PPh3)4 occurred much faster than that of 4-bromo-2-
phenylpyridine?04 This reactivity was exploited for the cross-coupling of 2,4-
dibromopyridine with a number of phenylboronic acids to prepare 2-aryl-4-
bromopyridine derivatives regioselectively.257 The origin of regioselectivity in 
palladium-catalyzed cross-coupling reactions of heterocycles bearing multiple identical 
halogens is a combination of both the strength of the carbon-halogen bond (which is 
related to the bond dissociation energy) and the LUMO of the heterocycle (which is 
related to frontier molecular orbital interactions)?53· 258 Handy and Zhang have 
developed a guide for predicting the most likely oxidative addition reaction, and hence 
the reactive site, in polyhaloheteroaromatics, based upon the chemical shift values of the 
parent non-halogenated heteroaromatic species.259 NMR chemical shift values are very 
sensitive to the electronic environment. The initial site for coupling in 
polyhaloheteroaromatics is always the more electron-deficient centre, i.e. the carbon 
bearing the proton with the more downfield chemical shift. For example, 2,5-
dibromopyridine undergoes selective Suzuki-Miyaura cross-coupling at C-2; the 
chemical shift of the parent pyridine is 8 8.59 and 7.38 ppm for the C-2 and C-5 
protons, respectively; the predictive and experimental data are consistent (Figure 
1.13)?59 With mixed halogenated heteroaromatics the 1H NMR chemical shift 
prediction method can be overcome by the intrinsic reactivities of the different 
halogens; 2-bromo-4-iodopyridine reacts selectivly at the iodo C-4 position, even 
though in the parent pyridine the C-2 proton has the higher chemical shift value. 
I 7.75 (1 
N Br 8.59 
7.38 Br~ 
~-·~ N Br 8.59 
Figure 1.13 1H NMR chemical shift method for prediciting regioselectivity in the coupling of 
polyhaloheteroaromatics.259 The 1H NMR chemical shift values of the parent pyridine are given 
and the site of first coupling identified by the bold bond. 
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1.3.2 Homocoupling of boronic acids 
Self-coupling or homocoupling of the boronic acid can occur as a side reaction when the 
cross-coupling reaction is very slow or as a result of oxygen being present. This 
homocoupling has been developed into a useful synthetic method for the preparation of 
symmetrical biaryls.260"263 Proposed mechanisms for the homocoupling of boronic acids 
are somewhat ambiguous. Nevertheless, there is agreement that the presence of oxygen 
accelerates the reaction,260 and the reaction can proceed via a catalytic reaction between 
Pd(II) and a boronic acid?62' 264 Moreno-'Mafias et al. established that addition of a base 
was unnecessary to promote homocoupling and that oxygen accelerated the reaction. 
They proposed that oxidative addition/transmetalation of a boronic acid entity onto a Pd 
species occurs twice, followed by reductive elimination to yield the biaryl product 
(Figure 1.14). Elimination of a tetrahydroxydiborane [(H0)2B-B(OH)2] was considered 
to be thermodynamically improbable. An oxidation step was assumed to release the 
boron as a boric acid derivative. It was concluded that the oxidative self-coupling of 
arylboronic acids induced by Pd(II) involved acid-base reactions between the Pd(II) 
species and arylboronic acid, followed by 1 ,2-rearrangements of aryl groups to the 
electron-deficient positive palladium species, (Figure 1.14)_260, 265 
PdL4 !\. 2L ArB(OHh ) 
(~--""""--------· PdL2 \.. • Ar-B(OH)2 '-~dl 
+ 2 
L 
I 
H-Pd-H 
I 
L 
O=B(OH)l 
2L 
L ~ 
O=B(OH) (HOhB-~d-B(OH)2 ~ Ar-~d-B(OH) 
I I 2 
L B(OH)2 
Ar-Ar 
L 
I 
Ar-~d-B(OHh 
L 
L ~Ml(OH), 
Ar-B(OH)2 A~~q:-B(OH)2 
L 
Figure 1.14 Mechanism for oxidative homocoupling of boronic acids proposed by Moreno-
Mafias et al. 260' 265 
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Y oshida et al. acknowledged that molecular oxygen was indispensable for the 
homocoupling of arylboronic esters and proposed the catalytic cycle in Figure 1.15, as it 
is known that oxygen reacts readily with Pd(O) to afford Pd(II) peroxide.266 Initially a 
three-membered Pd(II) peroxide complex (intermediate A) is formed by oxidative 
cyclization of molecular oxygen with the Pd(O) complex. Subsequently a double 
transmetalation occurs yielding a diorganopalladium species and boron peroxide, then 
reductive elimination of the homocoupling product follows with regeneration of the 
Pd(O) species. 
CP, A<-/ p'Pd(O) '<' 
CP, Ar (P, ,0 A Pd' Pd I p' 'Ar p' 'o 
(RO),B-00-B;?.:; A (ORb}" (P, ,Ar ArB(ORb 
Pd, 
ArB(OR)2 p' OOB(ORh 
B 
Figure 1.15 Catalytic cycle for the homocoupling of boronic acids proposed by Yoshida et al. 266 
A further kinetic and mechanistic study of boronic acid oxidative homocoupling by 
Adamo et al. is consistent with the involvement of a palladium peroxo complex (Figure 
1.16).215 They prepared the (tl-02)-Pd(PPh3) 2 species and used this directly as the 
catalyst for the homocoupling of arylboronic acids. Intermediate trans-C and trans-D 
were characterized after long reaction times; the cis-intermediates were not observed 
under the reaction conditions. However, reductive elimination must occur from the cis-
D intermediate. In some cases intermediate trans-D was not observed, suggesting that 
reductive elimination from trans-D via cis-D was fast. It could also be possible that cis-
Citrans-C isomerization IS slower than transmetalation, and consequently 
transmetalation of cis-C generates cis-D which is prone to reductive elimination. 
Adamo and eo-workers do not rule out that intermediate 8 could be trapped by 
ArB(OH)2, as proposed by Y oshida et al., yielding a boron peroxide species and 
intermediate cis-D. 
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Ac-A'Y 
cis-D 
B 
HOOB(OHh 
trans-C cis-C 
Figure 1.16 Mechanism of oxidative boronic acid homocoupling proposed by Adamo et al., 
based on the observed A, trans-C and trans-D complexes.215 
Adamo et al. concluded that since the oxidative homocoupling and Suzuki-Miyaura 
cross-coupling reactions have the common intermediate L2Pd(O), the palladium-
catalyzed homocoupling reaction may compete with the Suzuki-Miyuara cross-coupling 
if the reaction is not conducted under an inert atmosphere.215 However, Miller et al. 
proposed that the oxygen present in the system is not reacting with palladium to create a 
palladium peroxo complex. Instead, oxygen is acting as an oxidant, increasing the levels 
of Pd(II) in the system, which promotes the homocoupling?64 It has been reported that 
Pd(OAc)2 can catalyze the room temperature homocoupling of arylboronic acids in air 
without ligands present.262 Miller et al. were also using Pd(OAc)2, palladium on carbon 
or palladium black as the heterogeneous catalyst in Suzuki-Miyaura cross-coupling 
reactions. They proposed that the addition of a mild oxidant would minimize the 
concentration of free Pd(II) in the reaction without causing significant reduction of the 
product resulting from oxidative addition of the aryl halide to Pd(O). Consequently, the 
homocoupling would be suppressed whilst still maintaining the cross-coupling reaction 
(Figure 1.17) 
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Figure 1.17 Catalytic cycle of Pd(II)-catalyzed homocoupling and Pd(O)-catalyzed Suzuki-
M. l' 264 tyaura cross-coup mg. 
In their system, Miller et al. found addition of potassium formate reduced levels of 
homocoupled dimer 54 from ea. 4% to ea. 0.07% (Scheme 1.34). A slight excess of aryl 
halide was used during the reaction as, not surprisingly, 55 was observed as a result of 
reductive dehalogenation in ea. 10% (HPLC analysis), and chiral dimer 56 was 
observed in ea. 0.5% yield. 
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Scheme 1.34 Preparation of L Y 451395, with addition of potassium formate to suppress 
homocoupling?64 
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1.3.3 Hydrolytic Protodeboronation of boronic acids 
Arylboronic acids can be susceptible to protodeboronation. This problem is accentuated 
for heteroarylboronic acids which are electron-deficient167• 168 or when the boronic 
moiety is a to a heteroatom.74 Protodeboronation can affect the stability of the boronic 
acid under ambient storage conditions, and the reactivity of boronic acids in Suzuki-
Miyaura reactions. Examples of heteroarylboronic acids or esters, reported as being 
unstable towards protodeboronation, have been noted previously, viz. pyridyl-,65 2-
pyridyl-, 117• 131 pyrazolyl-, 170 5-tetrazolyl-,267 2-oxazolyl-,268 triazolopyridyl-. 193 
Early work reported protodeboronation of phenylboronic acid as a result of pyrolysis; 
refluxing phenylboronic acid in water269 or heating directly at 200 °C for 25 h270 yielded 
benzene and boric acid. NaOH, HCl and Zn2+ or Cd2+ ions were found to catalyze the 
pyrolysis in water.269 Kuivila and eo-workers investigated the mechanism of 
protodeboronation promoted by acids,271 -273 bases34 and metal ions?74 After 
investigating the kinetics of protodeboronation and the effects of different acids, bases, 
metal ions, concentrations and substituents on the phenylboronic acids they inferred 
three possible mechanisms (Figure 1.18). 
a. Acid-catalyzed protodeboronation 
H 6H),+ H,o• OH B(OHh+ 6 + H+ + B(OHh 
b. Base-catalyzed protodeboronation 
' 
' 
6H),+ H,O OH),+ 
c. Metal-ion catalyzed protodeboronation 
6H),+ CdX, 6 + B(OHh + HX --- H 6 
. 1 d h . J: d b . f b . 'd 34 272 274 Ftgure .18 Propose rnec amsms tOr proto e oronatton o oromc act s. ' ' 
+ OW + B(OHh 
+ CdXOH 
Protodeboronation promoted by acid was found to be subject to general acid catalysis 
and to proceed via an A-SE2 mechanism.271 -273• 275 Proton transfer to the arene ring is the 
rate-determining step, followed by rapid ionic cleavage of the B-C bond. Stronger acid 
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resulted in more rapid protodeboronation. Base-promoted protodeboronation of 
phenylboronic acids was not subject to general base catalysis; consequently, the 
mechanism was not an SE 1 type. 34 The rate-determining step was the proton transfer to 
the boronate anion, with little disturbance of the 7t-electron system in the transition state. 
An increase in the concentration of base leads only to an increase in the rate of 
protodeboronation when this promotes an increase in the concentration of boronate 
anion, through an increase in pH. The mechanism for the metal-ion catalyzed 
protodeboronation is thought to be approaching an S*E2 reaction, with localization of 1t-
electrons occurring in the passage to the transition state. Initially Cd2+ ions were found 
to promote protodeboronation: a number of other metal ions also have the same effect, 
N ·2+ M 2+ C 2+ z 2+ Pb2+ C 2+ 274 e.g. 1 , g , o , n , , u . 
Fisher and Havinga reported the photoinduced deboronations of 3- and 4-pyridylboronic 
acids 4 and 6. 117 Although 4 and 6 are thermally stable, on UV irradiation they were 
"split into pyridine and boric acid", in neutral and slightly basic solution. It was 
reasoned that photoinduced protodeboronation represented an electrophilic aromatic 
substitution, considering photoprotodeboronation to be analogous to 
photodecarboxylation of pyridine carboxylic acids. An SEl mechanism was suggested 
on the following grounds. Calculations and UV spectra of aqueous solutions of 4 and 6 
show that the neutral forms have the zwitterion structure (a "pyridinium-boronate" 
structure); pyridine and pyridinium Ions undergo SE1 substitutions (e.g. 
decarboxylation) and the leaving group in the protodeboronation, boric acid, is very 
weakly electrophilic like the leaving group in decarboxylation, C02. Although the 
photoreactions of 3- and 4-pyridylboronic acids are considered as SEl-
protodeboronations of the pyridinium boronate form, it is now regarded that boronic 
acids are not comparable to carboxylic acids in terms of Bmnsted acidity (see section 
1.1.1). Therefore, it is unlikely that pyridylboronic acids exist as the pyridinium 
boronate zwitterion and the mechanism for the UV irradiation promoted 
protodeboronation may not be SE1 type. 
Protodeboronation is partially base promoted and is a common competitive reaction 
when conducting a Suzuki-Miyaura cross-coupling with a boronic acid derivative which 
may be prone to C-B bond cleavage. Often alternative catalysts or reaction conditions 
are used in attempts to suppress protodeboronation. For example, Payack et al. found 
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dicyclohexylamine to be an excellent base for the Suzuki-Miyaura cross-coupling of a 
2-boronic acid derivative of indole, at the same time preventing protodeboronation 
previously found when using the usual basic aqueous conditions.Z76 
Selective protodeboronation has been a useful tool in the synthesis of 4-methyl-2-
thiopheneboronic acid.Z77 Regioselective lithiation of 3-methylthiophene followed by 
treatment with triisopropylborate and hydrolysis provides the regioisomers 4-methyl-2-
thiopheneboronic acid and 2-methyl-3-thiopheneboronic acid in a 92:8 ratio. Treatment 
of the mixture with concentrated acid selectively protodeboronated the undesired 
regioisomer (2-methyl-3-thiopheneboronic acid), providing only the desired 4-methyl-2-
thiopheneboronic acid after crystallization. 
1.3.4 Other reactions of boronic acids 
In addition to the Suzuki-Miyaura C-C bond forming reaction, arylboronic acids can 
take part in a number of other reactions, including addition reactions, the replacement of 
boron and C-heteroatom bond formation. 
The boronic acid moiety can be converted into several different substituents. Treatment 
of arylboronic acids and esters with alkaline hydrogen peroxide yields the 
corresponding phenols269• 278 although this is not a popular or economical approach for 
preparing phenols. Conversely, a one-pot C-H activation-borylation-oxidation 
procedure successfully prepared a number of meta-substituted phenols bearing ortho-
and para- directing groups, that would be difficult to prepare by other means [Scheme 
1.35, (a)].279 Aryl azides can be accessed indirectly from arylboronic acids, via an in situ 
generated aryl lead intermediate [Scheme 1.35, (b )].280 Halodeboronation of arylboronic 
acids occurs by action of aqueous chlorine or bromine and aqueous iodine containing KI 
[Scheme 1.35, (c)]. 269 N-Bromo- and N-iodosuccinimides also convert arylboronic acids 
into their corresponding aryl halides.281 This is not generally used as often aryl halides 
are the precursors to boronic acids, and there are more economical methods for 
preparing aryl halides. 
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(a) 
cb 
M eO 
1. HBpin, [(lnd)lr(COD)], 
dmpe, 150 °C, 18 h 
2. aq. oxone, 25 °C, 7 min 
1. Pb(OAc)4 , Hg(OAc)z, 
Cl P-OH 
M eO 
79% yield 
o- CHCI3, 40 °C, 12 h (b) R%: /; B(OH)z 2. NaN3, DMSO, 25 °C, 3 h 
59-73% yield 
(c) o-B(OH)z Q-sr 
Scheme 1.35 (a) One-pot C-H activation-borylation-oxidation procedure.279 (b) Aryl azide via 
an in situ aryllead.280 (c) Halogenation of a boronic acid in aqueous bromine?69 
More usefully, arylboronic acids undergo copper-catalyzed C-0, C-N and C-S 
coupling reactions282 with phenols/83· 284 amines, amides and imines,284· 285 N-
heteroaromatics286 and thiols,287 to give the corresponding diary} ethers, arylamines or 
N-arylheterocycles and thioethers (Scheme 1.36). The reaction is mediated by copper(II) 
acetate and a mechanism was suggested based on transmetalation of the boronic acid 
with copper(II) acetate followed by ligand exchange with the nucleophilic substrate and 
reductive elimination to give the coupling product.284 N-Heteroarylboronic acids have 
been applied to the C-N cross-coupling between two heteroarenes;64 an alternative to 
the routine copper- or palladium-catalyzed N-arylation of heteroarenes with aryl 
halides.288, 289 
Ar-B(OH)z + R-XH 
Cu(OAc)z, Et3N 
DCM, RT 
R = aryl, heteroaryl, alkenyl 
X= 0, NR', S 
Ar-X-R 
Scheme 1.36 General reaction for the copper-catalyzed coupling of boronic acids with 
nucleophilic oxygen-, nitrogen- and sulfur-containing compounds. 
60 
Chapter 1 - Introduction 
Rhodium-catalyzed addition of arylboronic acids to carbonyl compounds and electron-
deficient alkenes has emerged as a useful system for the formation of such carbon-
carbon bonds. Functional group protection is not required, and the reaction shows good 
chemoselectivity. Initially Miyaura et al. reported the conjugate addition of arylboronic 
acids to a,p-unsaturated ketones, to give good yields of saturated ketones.290 The 
reaction was catalyzed by a complex generated from [Rh(acac)(C0)2] and dppb. 
Asymmetric conjugate addition of arylboronic acids has been established, using chiral 
bisphosphines, such as (S)-binap, and an Rh precursor?91 The rhodium-catalyzed 
conjugate addition of arylboronic acids is tolerant of a wide variety of substrates, 
including, a,p-oosaturated esters,292• 293 amides,294 vinyl-substituted N-heteroarenes295 
and aldehydes296-298 (Scheme 1.37). More recently palladium-catalyzed additions of 
aryl- and heteroarylboronic acids to aldehydes has been reported?99 There are other 
reports of palladium-catalyzed systems for the efficient addition of arylboronic acids, 300-
302 in some cases higher reactivity is observed, in comparison to using the rhodium 
catalysts. 
PhB(OHh 
~Me 
0 
[Rh(acac)(C0)2], dppb 
MeOH/H20, 50 °C, 16 h 
~CONHPh 
[Rh(acac)(C2H4)2], ( S)-binap 
dioxane/H20, K2C03, 
100 °C, 16 h 
~ ~N 
[RhCI(COD)]2, TPPDS 
H20, SOS, Na2C03 
80°C,16h 
Ph~Me 
0 
99% yield 
Ph 
~CONHPh 
88% yield, 90% ee 
Ph~ LN 
80% yield 
Scheme 1.37 Examples of rhodium-catalyzed conjugate addition of phenylboronic acid to 
alkenes_290, 294, 295 
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The palladium-catalyzed direct arylation of electron-rich (hetero )arenes with 
arylboronic acids has been reported.303 This is an efficient procedure for formation of 
aryl carbon-carbon bonds, without the requirement of aryl halides, like the traditional 
Suzuki-Miyaura coupling. Previous work on the cross-couplings of C-H bonds with 
boronic acids was generally low yielding and required directing groups. 304 The 
palladium(II) catalyzed electrophilic aromatic C-H functionalization with arylboronic 
acids is promoted by acidic conditions. Homocoupling of arylboronic acids is known to 
proceed readily in the presence of Pd(II)262· 264 (see Section 1.3.2). Consequently, it was 
noted that fast electrophilic attack of the aromatic ring was required, compared to 
transmetalation of the arylboronic acid onto the Pd(II) species. It was considered that as 
base is required for transmetalation of boronic acids under Suzuki-Miyaura conditions, 
and acidic conditions were being applied for direct acylation, this may reduce the rate of 
transmetalation and thus suppress homocoupling of the boronic acid. Unfortunately, 
high levels of homocoupled boronic acid were initially observed during the direct 
acylation reactions. Optimization of the reaction conditions found Pd(OAc)2 to be the 
best catalyst and 02 the most efficient terminal oxidant, with Cu(0Ac)2 as a cooxidant. 
A variety of electron-rich arenes and heteroarenes (including pyrroles, indoles, 
benzothiophene and benzofuran) were successful partners for the Pd(II)-catalyzed direct 
coupling with phenylboronic acid. Electron-rich substituents were beneficial on the 
arylboronic acids to promote the coupling reaction, and chloro- and fluoro-substituted 
boronic acids were tolerated (Scheme 1.38).303 The proposed mechanism involves 
electrophilic activation of the aromatic C-H bond by Pd(II), followed by 
transmetalation of the aryl-palladium species with arylboronic acid and reductive 
elimination producing the desired product. Pd(O) is reoxidized by 02 or a Cu(II) species 
to complete the catalytic cycle.303 
0) + 
R 
R'~B(OH)2 
V 
R' = Me, OMe, F, 
Cl, N02, CF3 
Pd(OAc)z, AcOH, RT 0)--QR' 
R 
R = H 50-83% yield 
R = Me 50-87% yield 
Scheme 1.38 Palladium(U)-catalyzed direct arylation of indole and N-methylindole with various 
arylboronic acids.303 
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Recently, a copper-mediated C-H bond arylation of arenes with arylboronic acids was 
reported; multiple C-H bond arylation of nitrogen heterocycles was successful, 
highlighting the potential for further development and applications. 305 Although still in 
its infancy, the direct arylation of arenes with arylboronic acids offers scope for biaryl 
preparation. Clearly, oxidative coupling where neither substrate needs pre-activatation 
is an elegant and economical procedure for biaryl synthesis, as noted earlier (see Section 
1.2). Nevertheless, much effort is needed to enhance the scope of these C-H activated 
direct arylation reactions, especially for electron-deficient heteroaryl derivatives. For 
now, the Suzuki-Miyaura cross-coupling still remains superior on account of its 
widespread utility for a variety of aryl and heteroaryl derivatives. 
1.4 Conclusions 
The prevalence of N-heteroarylboronic acids has escalated in the last few decades. 
Syntheses of a wide variety of substituted N-heteroarylboronic acids and esters have 
been reported, employing lithiationlboronation techniques, transition metal catalyzed 
protocols or cycloaddition reactions. Furthermore, N-heteroarylboronic acids are 
increasingly available commercially. Their cross-coupling reactions with a range of 
halide and triflate coupling partners, under non-toxic and comparatively mild 
conditions, yield novel (hetero )biaryl systems which otherwise are challenging to 
synthesize. 
The Suzuki-Miyaura reaction has proved to be a highly useful and versatile synthetic 
tool for the modern organic chemist; nevertheless many challenges remain. The 
versatility and scope of application for this essential carbon-carbon bond forming 
reaction has resulted in unabated research in this area of chemistry. Each aspect of the 
palladium catalyzed cross-coupling appears to be under review in efforts to improve and 
broaden the application of the reaction. There is scope for development in, e.g. 
microwave conditions, lower catalyst loadings, novel palladium catalysts and catalyst 
precursors, and the industrial, large-scale application of the Suzuki-Miyaura reaction. 
The application of N-heteroarylboronic acids in other reactions has also gained 
significance. The conjugate addition of arylboronic acids to alkenes and derivatives 
shows increasing potential. The use of arylboronic acids in the palladium-catalyzed 
63 
Chapter 1 - Introduction 
direct arylation of electron-rich (hetero )arenes is an exciting procedure, where further 
investigation may demonstrate more universal applicability. Although direct cross-
coupling reactions of unactivated arenes is an emerging area of chemistry, aryl- and 
heteroarylboronic acids and their subsequent Suzuki-Miyaura cross-coupling reactions, 
currently exhibit widespread utility and functional group tolerance, making them 
valuable reagents for the synthetic organic chemist. 
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CHAPTER 2- PYRIDAZINYLBORONIC ACIDS AND ESTERS 
2.1 Introduction 
The pyridazine nucleus is a versatile pharrnacophore in many biologically active 
molecules. It is considered a bioisotere of benzene and other heterocycles, whilst having 
the attractive physicochemical property of high water solubility as a result of its 
hydrogen bond acceptor abilities.306 The discovery of the antidepressant 
aminopyridazine Minaprene307' 308 stimulated research into pyridazine derivatives, 
highlighting their potential as bioactive compounds for several different therapeutic 
areas.
309 For example, aryl-/heteroarylpyridazine derivatives have been used in the 
treatment of dementia, and other selective GABAA antagonists? 10' 311 Piperazinyl-
pyridazine derivatives show analgesic activity involving both opiate and serotonergic 
pathways312 and exhibit antibacterial in vivo potency against staphylococcus aureus, 
comparable to that of the morpholine derivative linezolid.313 Trisubstituted pyridazine 
derivatives have been identified as p38 inhibitors, presenting a useful therapeutic 
strategy as an anti-inflammatory agent.314 The pyridazine motif is also found in several 
areas of materials chemistry, e.g. in the preparation of self-assembled supramolecular 
molecular architectures315' 316 and n-conjugated organic materials with desirable 
electronic properties. 317 
Me~ 
~-N~Nl F 
~N~ 
UJ( 
N 0 
L.(_NHAc 
Antibacterial activity313 
R 
N 
f ''N 
OMe Supramolecular self-assembly316 
Analgesic activity312 Garbazine 
Selective GABAA antagonist310 
Figure 2.1 Examples of pyridazine motifs in medicinal and materials chemistry. 
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The methods for preparing substituted pyridazine derivatives are limited which can be 
attributed to the electron-deficient nature of the pyridazine nucleus making classical 
methods for direct C-functionalization less available. The standard protocol for 
pyridazine ring formation is through the addition of hydrazine to a 1 ,4-dicarbonyl 
compound, with functionality set up prior to ring closure. There are numerous reports of 
organometallic pyridazine derivatives,42• 44 mainly organolithium species, which are 
reacted with a variety of electrophiles.318-322 The pyridazinyl-lithium intermediates are 
generally stable only at low temperatures(< -50 °C), whereas the analogous pyridazinyl 
Grignard reagents have greater stability (> 0 °C) and comparable reactivity with 
electrophiles. 323 Pyridazinylzincate species have been prepared;324• 325 their in situ 
Negishi cross-couplings yield heteroarylpyridazine derivatives in good yields.324 As 
previously noted (see section 1.2.3), reports of pyridazinylboronic acids and their cross-
couplings are limited, although halopyridazines are widely employed in palladium-
catalyzed cross-coupling reactions.310• 326-331 Chloropyridazines are readily available, 
I h · s zuk" M. · ll d 307 310 328 332 consequent y t eu u 1- 1yaura reactiOns are we reporte . ' · · 
Chloroarenes are regarded as being more difficult to cross-couple as a result of their 
lower reactivity towards oxidative addition, compared to bromo- or iodoarenes. 
However, the decreased 1t-electron density of the pyridazine ring promotes the reactivity 
of chloropyridazines. 3-Amino-6-halopyridazine provided Suzuki-Miyaura coupling 
products with a range of arylboronic acids in comparable yields whether the iodo- or 
chloro- derivative was employed.310 Regioselective Suzuki-Miyaura cross-couplings of 
di-halopyridazines are reported, in these cases reaction occurs at the other halogen, not 
the chloro substituent (Scheme 2.1 ). 329• 333• 334 
70-96% yield 
Ar =Ph, 4-Me0-C6H4, 4-CI-C6H4 
2-furan, 2-thiophene 
Scheme 2.1 Regioselective cross-coupling of 4-bromo-6-chloro-3-phenylpyridazine.329 
In 2003 our group noted the scarcity of literature surrounding pyridazinylboronic acids. 
Our approach to their preparation has been to use conventional lithiation, boronation 
and acidic workup. We identified 3,6-dimethoxypyridazine as a suitable reagent for 
DoM and subsequently 3,6-dimethoxy-4-pyridazinylboronic acid 59 was prepared.335 In 
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2005 an initial investigation into the Suzuki-Miyaura cross-coupling of 59 was 
conducted.336 The present chapter incorporates the previous work surrounding 59, 
details the scale-up of 59 and a systematic study into its Suzuki-Miyaura cross-coupling 
reactions. We have extended the chemistry to a series of 3-methoxy-6-(hetero)aryl-4-
pyridazinylboronic acids and investigated the reactivity of the C-B bond under cross-
coupling conditions. 
2.2 3,6-Dimethoxy-4-pyridazinylboronic acid 
2.2.1 Synthesis and Scale-up 
3,6-Dimethoxypyridazine 58 is prepared in good yields (86-93%) via a nucleophilic di-
substitution on the commercially available 3,6-dichloropyridazine 57. It is well 
documented in the literature that the metalation of diazines is particularly difficult due 
to their higher reactivity towards nucleophiles than other aromatic compounds. Their 
affinity for nucleophilic addition is a result of the electron withdrawing effect of the two 
sp2 nitrogen atoms which lowers the energy level of their LUM0. 318' 321 ' 337' 338 Mattson 
was the first to report the clean ortho-lithation of methoxypyridazines and incorporation 
of electrophiles in high yields.319 Subsequently there were several investigations into the 
metalation of pyridazines using lithium alkylamides, which are less prone to 
nucleophilic addition than alkyl- or aryllithium. The electron-withdrawing effect of the 
two nitrogen atoms of pyridazines makes the ring hydrogens more acidic, thus allowing 
less efficient-metalating agents such as LDA or L TMP to be used. As previously noted, 
the lithiation of 58 at C-4 using n-BuLi in THF at -70 oc is documented in the 
preparation of an organozinc derivative?24 
Directed ortho-lithiation of 58 with LDA322 in THF at -78 oc followed by addition of 
triisopropylborate and aqueous workup afforded the boronic acid derivative 59 as an air-
stable solid in 88% yield. 
Cl~ (i) 
~'N~CI 
57 
MeO~ (ii) 
r~LNAOMe 
58 93% yield 
MeOyYB(OHh 
r!LNAOMe 
59 88% yield 
Scheme 2.2 (i) Na, MeOH, reflux, 19 h. (ii) n-BuLi, HNi-Pr2, THF, -78 oc; B(Oi-Pr)3; H20, 
HBr (48% aq.). 
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The feasibility of scaling-up the synthesis of 59 was established; on a 40 g scale a 
marked decrease in yield was observed when using n-BuLi for the LDA preparation; 
however, when using HxLi, on a 40 g scale, the decrease in yield was not as 
appreciable. HxLi is used industrially on a large scale due to its ease in handling and 
greater stability compared to n-BuLi. Maintaining low temperatures for a large-scale 
synthesis is more difficult and requires specialist cooling. Hence, the preparation of 59 
was attempted at -20 °C; the yields were poor regardless of the choice of alkyllithium, 
indicating a lower reaction temperature is beneficial. 
MeO~ _(_i)- MeOyYB(OHh 
~,NAOMe N,NAOMe 
58 59 
Proce<:ilJrew. Reaction· scaiE~--"'Fiir ···· Temp ~(~·vieid(o/;f .. 
~"--•~-·"--m-.»--~----·~~ ··--~·•"-'-- ••-·-~···-----M~ m•--····--------- ----~••••·-'-'-------• •- -••••• 
A 7 g n-Buli -78 88 
B 40 g n-Buli -78 45 
C 1 g n-Buli -20 14 
D 40 g Hxli -78 62 
E 5 g Hxli -20 30 
Scheme 2.3 (i) RLi, HNi-Pr2, THF, -78 oc or -20 °C; B(Oi-Pr)3; HzO, HBr (48% aq.) or 
A eO H. 
2.2.2 Suzuki-Miyaura cross-coupling reactions 
Suzuki-Miyaura cross-coupling reactions of 59 were carried out with a variety of 
heteroaryl halides 60-66 to yield products 67-73, respectively. The results are collated in 
Table 2.1. Initial reactions with conditions C, [Pd(PPh3)2Ch (5 mol% 59), 1,4-dioxane, 
Na2C03 (1 M), reflux, 65 h] generally gave poor yields. We varied the reaction time 
(entry 7) and found that after 24 h reflux we obtained 38% yield of73 and after 4.5 days 
reflux, 60% yield of 73. For the reactions to be close to completion, 65 h at reflux was 
sufficient; low yields were a result of decreased reactivity of boronic acid 59. 
Protodeboronation of 59 was not observed, and in one case homocoupled boronic acid 
was isolated, in ea. 10% yield (entry 5, conditions C). An excess of 59 was used in one 
reaction (entry 2, conditions C) to assess whether the boronic acid would react with 
itself more readily than with a coupling partner. An improved yield of 53% of 68 
(compared to 30% when using 1.1 equiv. of 59) indicated that the boronic acid does not 
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degrade under the reaction conditions and since there was an excess of boronic acid, 
there was a greater possibility for the cross-coupling to occur, resulting in an 
improvement in the yield. 
Stabilizing the Pd(O) active catalytic species can Improve reactivity in the cross-
coupling reaction, and the addition of bulky and electron-rich phosphines can promote 
the formation of a monophosphine palladium complex LPd, which is regarded as being 
the active species.205' 208· 221 · 222 On addition of t-Bu3P (Conditions D: [Pd(PPh3)Ch (5 
mol% 59)/t-Bu3P (5 mol% 59), 1,4-dioxane, Na2C03 (1 M), reflux, 65 ]) little 
improvement was found in the cross-coupling yields (entries 2 and 5). On using a 
different Pd source and t-Bu3P ligand, good cross-coupling yields were obtained in 
some cases, for example, entries 2 and 3 conditions B: [Pd(PhCNhCh (5 mol% 59)/t-
Bu3P (5 mol% 59), 1,4-dioxane, Na2C03 (1 M), reflux, 65 h], and entry 7 conditions E: 
[Pd(OAc)2 (5 mol% 59)/t-Bu3P (5 mol% 59), 1,4-dioxane, Na2C03 (1 M), reflux, 65 h]. 
The effect was not universal, with no marked improvement in other yields, c.f. entries 1, 
4 and 6 for both conditions B and E. 
For coupling partners 60 and 64 we expected the coupling yields to be higher, as the 
bromine a to the ring nitrogen should be activated towards oxidative addition. The 
reactions in the presence of a primary amine substituent are notable as new examples of 
Suzuki-Miyaura reactions where protection of the amine group is not necessary. 150· 249 
We considered that the amine and nitro substituents may be chelating to the Pd species 
and thus could disrupt the catalytic cycle. Itoh et al. proposed that employing a 
chelating bis-(phosphine) ligand may inhibit the formation of any bis-( amine) 
complexes resulting from chelation of amino-substituted pyridines or pyrimidines to Pd 
(Scheme 2.4)?49 They found that using the sterically hindered and electron rich alkyl 
bidentate phosphine ligand 1,1 '-bis( di-t-butylphosphino )-ferrocene (D-t-BPF), with 
Pd(OAc )2, to be superior to other bidentate phosphine ligands for the coupling of 
aminochloropyrimidines/pyridines with phenylboronic acid. 
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MeOnB(OH)z Het-Br MeoUHet 
N,Nh OMe Conditions A-E N h 
'N OMe 
59 67-73 
Entry Het-Br Product Conditions Isolated yield(%) 
DN02 ~No, 
"" 
M eO A 90 
1 Br N B 37 
60 N OMe E 17 
67 
E·", n?""' A 69 (67t B 60 2 N MeO c 30 (53)b Br 61 
'N OMe 
D 33 
68 E 41 
N ~" D MeO N A 74 3 N B 78 Br 62 N OMe E 75 
69 
£YNH2 
Ni(NH2 OC' A 65(63t MeO N 4 Br N B 19 63 N OMe E 40 
70 
JNJNH2 
N NH2 A 38 MoOd r B 48 
5 Br N I N c se 64 N,N"" OMe D 11 71 E 44 
,JjN02 ~o, A 77 
6 M eO B 17 Br c 25 65 N OMe E 19 
72 
j)) M eO A 95 
7 Br I c 72 (60)d 66 N "" E 92 'N OMe 
73 
Table 2.1 Conditions: A: Pd(0Ac)2 (5 mol% 59)/D-t-BPF (5 mol% 59), 1,4-dioxane, Na2C03 (1 
M), reflux, 65 h. B: Pd(PhCN)2Cb (5 mol% 59)/t-BuJP (5 mol% 59), 1,4-dioxane, Na2C03 (1 
M), reflux, 65 h. C: Pd(PPh3)2Cl2 (5 mol% 59), 1,4-dioxane, Na2C03 (1 M), reflux, 65 h. D: 
Pd(PPh3)Cb (5 mol% 59)/t-Bu3P (5 mol% 59), 1 ,4-dioxane, Na2C03 (1 M), reflux, 65 h. E: 
Pd(OAc )2 (5 mol% 59)/t-Bu3P (5 mol% 59), 1 ,4-dioxane, Na2C03 (1 M), reflux, 65 h. a Carbon 
treated instead of silica column chromatography. h2.3 equiv. 59. c ea. 10% homocoupled boronic 
acid isolated. d4.5 days reflux. 
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With standard conditions A [Pd(OAc)2 (5 mol% 59)/D-t-BPF (5 mol% 59), 1,4-dioxane, 
Na2C03 (1 M), reflux, 65 h] the reactions of 59 with 60-66 proceeded in moderate to 
high yields (38-95%). In several cases there were noticeable improvements in coupling 
yields compared to other conditions attempted, for example entries 1, 4 and 6. We 
considered that the polar nature and amine substituents of 68 and 70 were making 
purification by silica column chromatography difficult and hence lowering the isolated 
yield. However, alternative purification using carbon treatment followed by 
recrystallization did not improve the yields. Suzuki-Miyaura reactions of 59 provided 
expedient access to highly functionalized heteroarylpyridazine derivatives, which would 
be very difficult to obtain by alternative methodology. 
bidentate 
li~ 
02N~N 
H2N)\_NA_CI~ 
monodentate 
ligand 
(i) 
R HN \~N 2 \~ J~ or [~Ph 
H2N N Ph N 
68-93% yield 
----------
slow 
Scheme 2.4 (i) PhB(OH)z, Pd(OAc)2 (5 mol%), D-t-BPF (5 mol%), K3P04, 1,4-dioxane, 
retlux?49 
When 59 was dissolved in refluxing ethanol, protodeboronation rapidly occurred and X-
ray analysis showed that the crystals obtained were a 1:1 molecular complex of 58 and 
boric acid, 58· B(OH)3 stabilized by hydrogen bonding. This is interesting as 
protodeboronation was not observed in Suzuki-Miyaura cross-couplings of 59. The 
crystal structure of 58·B(OH)3 comprises discrete neutral molecules of 58 and 
orthoboric acid (both planar and forming a dihedral angle of 7°), hydrogen-bonded into 
a centrosymmetric [58·B(OH)3h unit. The 0(4) and 0(5) act as donor of hydrogen 
bonds, whereas 0(3) is both donor and acceptor; the B-0(3) bond is longer (1.378(2) A) 
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than B-0(4) and B-0(5) (1.359(2) and 1.361(2) A). In boric acid, B(OH)3, every 
oxygen atom in two independent molecules is both donor and acceptor; all B-0 
distances are equivalent within experimental error, but the average (1.368(1) at 105 
K)339 is essentially the same as in 58·B(OH)J. 
Figure 2.2 X-ray crystal structure of 58·B(OH)3, the hashed lines are hydrogen bonds, (50% 
thermal ellipsoids). (CCDC 665174). 
2.3 3-Methoxy-6-(hetero)aryl-4-pyridazinylboronic acids and esters 
2.3.1 Synthesis and initial reactions 
In a further development that has led to more highly functionalized systems, an 
alternative cross-coupling protocol was explored. Reaction of commercial 3-chloro-6-
methoxypyridazine 74 with the readily available benzene-, 4-methoxybenzene-, 2-
methoxy-5-pyridyl-30 and 2-fluoro-5-pyridylboronic acids139 under standard conditions 
[Pd(PPh3)2Cb, 1,4-dioxane, Na2C03 (1 M), reflux, 65 h] gave products 75a-d, 
respectively, in high yields. This protocol had previously been used in our group to 
cross-couple 74 with 2-methoxy-3-pyridylboronic acid139 in 69% yield and provide the 
first example of the 3-(3-pyridyl)pyridazine system.340 Treatment of 75a-d with the 
standard lithiation-boronation seuqence used for the preparation of boronic acid 59 
yielded boronic acids 76a-d in 61-96% yields (Scheme 2.5). 
Electron-deficient boronic acids are known to be susceptible to protodeboronation both 
during their synthesis (where careful neutralization is required) and during their 
subsequent reactions.61 ' 165' 167' 168 During the synthesis of 76c instability of the C-B 
bond was highlighted; prior to acidification, on leaving the reaction mixture at room 
temperature overnight (in basic pH) formation of 75c was observed by TLC. The 
workup and isolation of 76c was subsequently conducted in a shorter time to minimize 
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protodeboronation. The boronic species may also be unstable at low temperatures which 
could account for the lower isolated yield of 76c compared to the other boronic acids. 
CIY) (i) 
N.:-N)l__OMe 
74 
ArY) (ii), (iii) Ar~B(OH)2 
N.:-N)l__OMe N.:-N)l__OMe 
75a 95% yield 
75b 87% yield 
75c 85% yield 
75d 87% yield 
76a 96% yield 
76b 88% yield 
76c 61% yield 
76d 75% yield 
(iv) Ary,/~ 
N.:-N)l__OMe 
77a 80% yield 
77b 85% yield 
77c 90% yield 
77d 73% yield 
a Ar= 
Me On cAr= 1 ~ 
N ~ 
M eO~ 
bAr= 
d Ar= 
Scheme 2.5 (i) ArB(OH)2, Pd(PPh3) 2Cb, I ,4-dioxane, Na2C03 (I M), reflux, 65 h. (ii) n-BuLi, 
HNi-Pr2, -78 °C, THF or Et20. (iii) B(Oi-Pr)3, -78 oc then H20/HBr (48% aq.) or AcOH. (iv) 
pinacol, MgS04, toluene, RT, 17 h. 
Initial reactions of 76a with 2-bromopyridine 78, and 5-bromopyrimidine 62, using 
conditions [Pd(OAc)2 (5 mol% 76a)/t-Bu3P (5 mol% 76a), 1,4-dioxane, Na2C03 (1 M), 
reflux, 65 h], gave low cross-coupling yields of ea. 10% (79) and 23% (80), 
respectively; the major product isolated was 75a resulting from hydrolytic 
protodeboronation of 76a. On reacting 76a and 3-bromoquinoline under the same 
conditions, the isolated crystals were confirmed by X-ray analysis to be homocoupled 
boronic acid, 81 (Figure 2.3). No cross-coupling was observed in this reaction. 
Electron-poor boronic acids are more difficult to cross-couple as they are less 
nucleophilic and undergo transmetalation at a slower rate than electron-rich boronic 
acids. Undesired homocoupling of boronic acids can compete with slow Suzuki-
Miyaura reactions,260 furthermore, electron-deficient boronic acids are prone to 
homocoupling261 and are more susceptible to metal-catalyzed protodeboronation.274 
In some cases boronic ester derivatives are regarded as being more stable than boronic 
acids and hence more reactive in Suzuki-Miyaura cross-couplings.65· 17° Consequently, 
we converted 76a-d into their pinacol ester derivatives 77a-d in good yields by stirring 
with pinacol and magnesium sulfate in toluene (Scheme 2.5). The direct synthesis of 
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pinacol esters 77c and 77d through trapping of the lithiated species from 75c,d with 2-
isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane in either THF or Et20 was less 
efficient than the two-step route via 76c,d. The lithio intermediates of 75c,d were 
treated with triisopropylborate, followed by attempts at in situ trapping with pinacol67 to 
yield 77c,d; however, this too was unsuccessful, giving unreacted starting material after 
work-up. 
Figure 2.3 X-ray crystal structure of81,the homocoupled boronic acid 76a. 
The substitution pattern in the boronated products was confirmed for 77b and 77d 
unequivocally by X-ray crystal structure determinations (Figures 2.4 and 2.5, 
respectively). For 77c comparison of the 1H NMR signals confirmed lithiation (and 
subsequent boronation) occurred on the pyridazine ring (Figure 2.6). It was pleasing to 
note that despite the presence of a second directed metalation group (DMG) in 75b-d, 
lithiation occurred regioselectively on the more electron-deficient pyridazine ring. To 
our knowledge there are no literature reports which compare the effect of the same 
DMG on different rings in a biaryl/heteroaryl system, making compounds 75b and 75c 
of particular interest. Qm!guiner et al. concluded that the regioselectivity of DMGs on 3-
and 3,6-disubstituted pyridazines,320' 322 was highly dependent on the nature of the 
metalating agent. They also found that the relative artha-directing power of a wide 
range of DMGs in the DaM reactions of the diazine series (pyridazines, pyrazines and 
pyrimidines),44' 341 was F > OMe > Cl. The methoxy group undergoes greater 
complexation with the metalating agent than the chlorine atom, and regioselectivity 
favours the methoxy group with increasing bulkiness of the lithium alkylamide. The 
very strong electron-withdrawing ability of the fluorine atom makes the artha 
hydrogens much more acidic, so there is no need for complexation to achieve the 
metalation. For DMG substituted pyridines there are no comprehensive reports on the 
regioselectivity of DaM. Differing reaction conditions can be employed to selectively 
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lithiate ortho to one substituent, for example 2-chloro-6-methoxypyridine can be 
lithiated to form 2-chloro-3-lithio-6-methoxypyridine usmg PhLi and 5% 
diisopropylamine,342 whereas with t-BuLi the 2-chloro-5-lithio-6-methoxy isomer is 
obtained. 343 
Figure 2.4 X-ray crystal structure of77b, (50% thermal ellipsoids). The dihedral angle between 
rings i and ii is 22.0°, between ring i and the boron atom plane is 28.0°; torsion angles C(7)-
0(l)-C(3)-N(2) 8.5(2)0 , C(8)-0(2)-C(24)-C(23) 15.6(2)0 • Ring iii adopts twisted conformation 
(ea. C2 symmetry). (CCDC 665168). 
(b) 
Figure 2.5 X-ray crystal structure of 77d. (a) major conformation; (b) disorder of the 
tetramethyl-dioxaborolan moiety. The tetramethyldioxaborolan moiety is disordered between 
two different conformations with equal probability. The pyridazine ring forms dihedral angles 
of 21.8° with the pyridine ring and 21.7° with the B atom plane. The methoxy group has an in-
plane conformation (torsion angle N(12)-C(13)-0(3)-C(7) 4.6(2)0 ). (CCDC 665169). 
The observed regioselective lithiation of 75d may be rationalized as follows. The 
electron-withdrawing effect of the fluoro substituent, making the pyridine protons 
acidic, was overshadowed by the combined effect of the methoxy-substituent 
complexing with LDA and higher acidity of pyridazinyl protons (due to the electron 
deficient nature of the pyridazine ring). 
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Hd 
r~ Ha 
OMe He OMe 
75c 77c 
B (ppm), B (ppm), 
75c multiplet J (Hz) 77c multiplet J (Hz) 
_ __in CDq!:t__ -·-~·····----~-··· _Lrl .. gQ_gl;t_ ···-~-·--·-·· 
7.73, d 9.6 
Hb 7.04, d 9.6 Hb 8.03, 5 
He 8.31, dd 9.0, 2.4 He 8.29, d 9.0, 2.4 
Hd 6.86, d 9.0 Hd 6.83, dd 9.0, 0.4 
He 8.70, d 2.4 He 8.77, dd 2.4, 0.4 
•~---~~--»,A·~»~ 
Figure 2.6 1H NMR chemical shifts for the aromatic protons in compounds 75c and 77c (400 
MHz,CDCh). 
Table 2.2 summarizes the Suzuki-Miyaura conditions screened in attempts to increase 
cross-coupling yields; protodeboronated boronic species was isolated alongside the 
coupling product in all cases. The yield of 79 was improved when using boronic ester 
77a and the Pd(OAc)2/t-Bu3P conditions, whereas changing reaction conditions to 
[Pd(PPh3)2Cb (5 mol% 76a)/t-Bu3P (5 mol% 76a), 1,4-dioxane, Na2C03 (1 M), reflux, 
65 h] with either boronic acid or ester did not dramatically improve the yield of 79. The 
conditions reported by Fu et al. for the cross-coupling of nitrogen heterocycles, 172 
[Pd2(dba)3 (1 mol% Het-Br)/PCy3 (2.4 mol% Het-Br), 1,4-dioxane, K3P04 1.27 M, 
reflux 24 h] generally gave good yields for our system; using the pinacol ester 
derivative also improved yields. Attempts to suppress the protodeboronation of 77a by 
using an anhydrous base (solid K3P04) were unsuccessful, leading to decreased yields 
of the coupling products. As previously discussed in section 1.3.3, protodeboronation is 
strongly base dependent, however, we did not investigate different bases in this case as 
the thermal instability of boronic acid 76a had been established; when 76a was heated 
in 1 ,4-dioxane (in the absence of base and palladium catalyst), protodeboronation was 
observed by TLC monitoring at> 50 °C. As this qualitative assessment was made in 
neutral conditions we must assume that it is either the temperature or adventitious water 
in the 1 ,4-dioxane which caused protodeboronation to occur.270 
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Entry 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Boronic 
species 
76a 
76a 
76a 
76a 
77a 
77a 
77a 
76a 
76a 
77a 
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HetBr Cue Het n _,__ BR ~ ~xoMe N OMe 
76a R = (OHh 
77a R =(pin) 79 Het=~ 
HetBr 
2-bromo-
pyridine 
78 
78 
78 
78 
78 
78 
78 
5-bromo-
pyrimidine 
62 
62 
62 
N 
80 Het= f'"1 ~N 
Reaction conditions 
Pd(OAch (5 mol% 76a)/t-Bu3P (5 mol% 76a), 
1 ,4-dioxane, Na2C03 (1 M), reflux, 65 h 
Pd(PPh3)2CI2 (5 mol% 76a)/t-Bu3P (5 mol% 
76a), 1 ,4-dioxane, Na2C03 (1 M), reflux, 65 h 
Pd(PPh3)2CI2 (5 mol% 76a)/t-Bu3P (5 mol% 
76a), 1 ,4-dioxane, Na2C03 (1 M), 55 °C, 5 
days 
Pd2(dba)3 (1 mol% 78)/PCy3 (2.4 mol% 78), 
1 ,4-dioxane, K3P04 (1.27 M), reflux, 24 h 
Pd(OAch (5 mol% 77a)/t-Bu3P (5 mol% 77a), 
1 ,4-dioxane, Na2C03 (1 M), reflux, 65 h 
Pd(PPh3)2CI2 (5 mol% 77a)/t-Bu3P (5 mol% 
77a), 1 ,4-dioxane, Na2C03 (1 M), reflux, 65 h 
Pd2(dba)3 (1 mol% 78)/PCy3 (2.4 mol% 78), 
1 ,4-dioxane, K3P04 (1.27 M), reflux, 24 h 
Pd(OAch (5 mol% 76a)/t-Bu3P (5 mol% 76a), 
1 ,4-dioxane, Na2C03 (1 M), reflux, 65 h 
Pd2(dba)3 (1 mol% 62)/PCy3 (2.4 mol% 62), 
1 ,4-dioxane, K3P04 1.27 M, reflux 24 h 
Pd2(dba)3 (1 mol% 62)/PCy3 (2.4 mol% 62), 
1 ,4-dioxane, K3P04 1.27 M, reflux 24 h 
Product 
79 
79 
79 
79 
79 
79 
79 
80 
80 
80 
Yield 
(%) 
-10 
55 
40 
67 
40 
44 
76 
(47)* 
23 
34 
47 
(46)* 
Table 2.2 Catalyst screening for the cross-couplings of 76a and 77a. *Using K 3P04 (s)· 
Itwas decided to use [Pd2(dba)3 (1 mol%)/PCy3 (2.4 mol%), 1,4-dioxane, K3P04 1.27 
M, reflux 24 h] as standard conditions for the Suzuki-Miyaura cross-couplings of 
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boronic esters 77a-d and accept that these electron-deficient boronic derivatives would 
remain prone to hydrolytic protodeboronation under these conditions. 
2.3.2 Suzuki-Miyaura cross-coupling reactions 
Suzuki-Miyaura cross-coupling reactions of 76a,b and 77a-d were carried out with 
heteroaryl bromides 78, 62 and 61 under standard conditions [Pd2(dba)3 (1 mol% Het-
Br)/PCy3 (2.4 mol% Het-Br), 1 ,4-dioxane, K3P04 1.27 M, reflux 24 h] to yield products 
79, 80, 82-91. The results are collated in Table 2.3. In every case competing 
protodeboronation occurred yielding pyridazines 75a-d as by-products, or in some cases 
as the major isolated product. 
Entry 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Ar~8(pin) 
N.:-N)(OMe 
77a-d 
8oronic acid 
or ester 
77a 
76a 
77a 
76a 
77a 
76a 
77b 
76b 
77b 
76b 
77b 
76b 
Het-8r 
Br J:1 
62 
D Br N 
78 
__ H_et_-s_r _ ArJHet 
Conditions A-F N .:-N OMe 
Product 
M eO 
M eO 
78 
79, 80, 82-91 
Conditions 
A 
8 
c 
A 
A 
8 
A 
A 
A 
A 
A 
A 
A 
D 
E 
A 
A 
Isolated 
yield(%) 
76 
47 
73 
67 
47 
46 
34 
59 
40 
77 
62 
28 
27 
43 
14 
46 
39 
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Entry Boronic acid Het-Br Product Conditions Isolated 
or ester yield(%) 
13 77c 
J) 
Br N A 58 
78 
N MeO ,;;--D 14 77c Br N A 37 
62 
N02 
hNH2 
15 77c Br A 42 
61 
16 77d 
J) 
Br N A 67 
78 
N D 17 77d Br N A 29 
62 
N02 
hNH2 A 18 18 77d 
Br F 52 
61 
Table 2.3 Conditions A: Pd2(dba)3 (1 mol% Het-Br)/PCy3 (2.4 mol% Het-Br), 1,4-dioxane, 
K3P04 (1.27 M), reflux, 24 h. B: Pd2(dba)3 (1 mol% Het-Br)/PCy3 (2.4 mol% Het-Br), 1,4-
dioxane, K3P04 (s)• reflux, 24 h. C: Pd2(dba)3 (5 mol% Het-Br)/[t-Bu3PH]BF4 (12 mol% Het-Br), 
MeCN, K3P04 (s)• 85 °C, 1 h. D: Pd2(dba)3 (1 mol% Het-Br)/PCy3 (2.4 mol% Het-Br), 1,4-
dioxane, K3P04 (1.27 M), J.l.W 120 °C, 1 h. E: Pd2(dba)J (1 mol% Het-Br)/PCy3(2.4 mol% Het-
Br), DMF, K3P04.2H20, J.l.W 160 °C, 5 min. F: Pd(OAc)2 (5 mol% Het-Br)/0-t-BPF (5 mol% 
Het-Br), 1,4-dioxane, Na2C03 (1 M), reflux, 5 h. 
As previously established, anhydrous conditions did not suppress the competitive 
protodeboronation. The catalyst system was changed to [Pd2(dba)3 (5 mol% Het-Br)/[t-
Bu3PH]BF4 (12 mol% Het-Br), MeCN, K3P04 (s), 85 °C, 1 h] (entry 1, conditions C) 
which had been used by Harrity et al. for reactions of their pyridazinylboronic esters. 165 
However this gave no improvement compared to our standard conditions. Microwave 
assisted Suzuki-Miyaura reactions are a routine synthetic procedure.344 It was hoped that 
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applying microwave conditions would promote cross-coupling of our boronic esters 
over protodeboronation. The yield of cross-coupling product 84 did improve to 43% 
(entry 10, conditions D) compared to the 27% yield from the standard conditions, 
however, protodeboronation was again observed and microwave conditions were not 
further investigated. The yield of coupling product 91 was improved when using the 
conditions previously used for the cross-coupling of boronic acid 59 (entry 18, 
conditions F). 
In general the overall yields of the cross-coupled products from the two-step protocol 
via the pyridazinylboronic esters are comparable to the one-step procedure from the 
boronic acid derivatives. X-Ray diffraction studies confirmed the structures of 
compounds 80 and 83 (Figures 2.7 and 2.8, respectively). 
Figure 2.7 X-ray crystal structure of80, dihedral angles i/ii 8.2°, i/iii 37.2°. The methoxy group 
is coplanar with the adjacent rings, the torsion angle N(2)-C(3)-0(1)-C(7) and C(23)-C(24)-
0(2)-C(8) equals 3.5(2)0 • (CCDC 665170). 
Figure 2.8 X-ray crystal structure of 83, dihedral angles ilii 7.8°, iliii 31.8°. The methoxy group 
is nearly coplanar with the adjacent rings, the torsion angle N(2)-C(3)-0(1 )-C(7) and C(23)-
C(24)-0(2)-C(8) equals 2.0(2)0 • (CCDC 665171). 
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In some cases the reactivity of organotrifluoroborates in Suzuki-Miyaura coupling 
reactions is superior to that of the corresponding boronic acid; trifluoroborates are in 
general more robust, easily purified and easier to handle.97 Accordingly, 76a was 
converted to the potassium trifluoroborate derivative 92 in 97% yield by using the 
established protocol with KHF2 in aqueous methanol. In cross-coupling reactions, under 
a number of different reaction conditions, 92 was less efficient than 76a (Scheme 2.6). 
92 was found to be highly insoluble at reflux temperature and no cross-coupling was 
observed by TLC analysis; on the addition of water to make the reaction mixture 
homogeneous protodeboronation occurred yielding 75a as the major product. This may 
be anticipated as the formation of such an "ate" complex and higher electron-
withdrawing strength of the trifluoroborate group (factors that usually contribute to the 
higher reactivity of trifluoroborates) assist in polarizing the C-B bond, leading to facile 
protodeboronation in some a-heteroaryltrifluoroborates.97 
PhYyB(OHh __ (i_) -
N~N~OMe Ph ~I f.:') ~xo: 
A 
8 
c 
D 
76a 92 97% yield 79 
Yield of79 
Conditions (%) 
" -~"""""""~-"--"""_"_"""""~~--""" ___ " ______ """"""""""-- --" 97_" ____ """"-"""""""-"""""""""""" " 
Pd(dppf)CI2·DCM (1 mol% 78), EhN, EtOH, reflux, 24 h 47 
Pd(dppf)CI2·DCM (1 mol% 78), EhN. MeCN, reflux, 18 h 
Pd2(dbah (1 mol% 78)/PCy3 (2.4 mol% 78), EhN, 1,4-
dioxane, reflux, 24 h 
Pd2(dba)3 (1 mol% 78)/PCy3 (2.4 mol% 78}, ~P04(s). DMF, 
100 °C, 3.5 h 
X* 
33 
26 
(LCMS yield) 
Scheme 2.6 (i) KHF2, H20/MeOH, RT, I h ~ 0 ·c, I h. (ii) 2-bromopyridine 78, conditions A-
D. *Mainly deboronated species 75a isolated. 
As shown in Table 2.3 we have successfully prepared novel highly functionalized 
(hetero )arylpyridazine derivatives in synthetically useful yields. Protodeboronation of 
these pyridazinylboronic species dominates Suzuki-Miyaura cross-coupling especially 
when less reactive coupling partners are employed. 
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2.3.3 Optimization of cross-coupling yields 
As previously described, organometallic pyridazine derivatives other than 
organolithiums are reported. As an alternative route to heteroarylpyridazines we 
explored the formation and reactions of organozincate derivatives. Adapting the 
procedure outlined by Turck et al.,324 using LDA as the lithiating agent instead of n-
BuLi, we prepared and cross-coupled the organozinc derivatives of 75a and 75c using 
the in situ Negishi protocol (Scheme 2. 7). 
Ar~ (i), (ii) 
~,NAOMe 
75a for 79, 80 
75c for 86 
r Ar~ZnCI l l N,NAOMe (iii) Ar~Het N,NAOMe 
79 77% yield 
80 44% yield 
86 73% yield 
Scheme 2.7 (i) n-BuLi, HNi-Pr2, -78 °C, THF. (ii) ZnCh, ~78 oc - RT, 1 h. (iii) 2-
bromopyridine 78 or 5-bromopyrimidine 62, Pd(PPh3) 4, reflux/sonicate, 3 h. 
The overall yields of the cross-coupling products 79, 80 and 86 (based on the starting 
pyridazines 75a and 75c) were improved to 77%, 44% and 73%, respectively, compared 
to 64%, 33% and 32% via the boronic acid 76a or ester 77c. Nevertheless, the boronic 
acid/ester route may be more practical due to the isolation and stability of boronic 
acids/esters compared to organozincate derivatives. 
2.4 Conclusions 
Through the lithiationlboronation of pyridazines we have successfully provided an 
efficient entry into a series of new pyridazinylboronic acid/ester derivatives, which are 
stable to storage under ambient conditions. A systematic study into the reactivity of 59 
under Suzuki-Miyaura cross-coupling conditions, with a range of palladium 
catalyst/phosphine ligand systems, shows that consistently good yields are obtained 
when using Pd(OAc)2/D-t-BPF as the catalytic species, although other catalyst systems 
provide high coupling yields in some cases. 
Boronic esters 77a-d, and their boronic acid derivatives, undergo palladium-catalyzed 
cross-coupling reactions to provide aryllheteroarylpyridazines in synthetically viable 
yields, although competing protodeboronation is observed. Efforts to promote Suzuki-
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Miyaura cross-coupling, and minimize protodeboronation by-products, through 
alternative catalyst systems, microwave assisted conditions, anhydrous base conditions 
and trifluoroborate salts had little effect on improving coupling yields. An alternative 
cross-coupling protocol, via organozinc pyridazine derivatives, highlights that overall 
coupling yields may be improved by this in situ method; however, zincates do not have 
the versatility of boronic acids in terms of handling. 
Good functional group tolerance has been shown throughout the preparation and 
reaction of these pyridazinylboronic species. They provide expedient access to highly 
functionalized heteroarylpyridazine derivatives, which would be very difficult to obtain 
by alternative methodology and are attractive as new pharmacophores. Moreover, they 
offer scope for further synthetic transformations, some examples of which are detailed 
in Chapter 3. 
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CHAPTER 3- PYRIDAZIN-3(2H)-ONES 
3.1 Introduction 
Of the pyridazine derivatives, pyridazin-3(2H)-ones are an important class of 
compounds with a broad array of biological activities?06' 345-352 Substituted 
pyridazinones show herbicidal activity,353 for example the insecticides Chloridazon, 
used for weed control in sugar beet cultivation, a recent synthesis of which utilized 
palladium-catalyzed cross-coupling.354 Norflurazon inhibits carotenoid synthesis 
causing chlorophyll depletion and inhibition of photosynthesis in plants.355 
Pyridazinone derivatives were identified as selective cyclooxygenase-2 inhibitors, 
thereby acting as anti-inflammatory drugs.346' 347' 356 New analgesic agents without the 
side-effects typical of opioid agonists, or gastro-intestinal problems associated with 
non-steroidal anti-inflammatory drugs have attracted considerable attention. In this 
regard a number of pyridazin-3(2H)-one derivatives are of particular interest; 
Emorfazone displays good analgesic activity357' 358 and preliminary studies have shown 
4-carbamoyl-5-aryl- and 4-amino-5-vinyl-pyridazin-3(2H)-one analogues show potent 
antinociceptive activity. 359 Arylpiperazine-pyridazinone-containing compounds show 
strong affinity for a 1-adrenergic receptors.345' 348' 360 Several 6-arylpyridazin-3(2H)-ones 
are active cardiotonic agents and platelet aggregation inhibitors, notably 6-(3,4-
dialkoxyphenyl)-pyridazin-3(2H)-ones, such as Zardaverine.361 -363 Selected structures 
are shown in Figure 3.1. 
~ X:~ 
N-N, 
Me 
Emorfazone357 
Analgesic 
Norflurazon355 
Herbicide 
Me p 
0~· 
N-N 
o-F 
ABT-963356 F 
COX-2 inhibitor 
F2HCO 
MeoR ~o ~~-~ 
Zadaverine362 
Cadiotonic PDE Ill inhibitor 
Figure 3.1 Examples of biologically active pyridazin-3(2H)-one derivatives. 
Most syntheses of pyridazin-3(2H)-one derivatives proceed via traditional methods 
(Scheme 3.1). Early literature described the condensation of y-ketonic acids with 
hydrazine hydrate, to form a 6-substituted-4,5-dihydropyridazin-3(2H)-one which can 
be dehydrogenated with bromine in acetic acid. 364-366 In order to prepare pyridazin-
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3(2H)-one analogues with differing substitution patterns alternative 1 ,4-dicarbonyl 
species were required, usually hydroxy y-lactone derivatives; their 
hydrazine hydrate, followed by oxidation, yielded pyridazinones.367 
x-
o 
N2H4 X 0 .N. Br2, AcOH 
R OH 
-------- ~0~ 
R 0 
1. Cu(CNh 
2. PhMgBr 
3. Zn-BrCH2C02Et 
Ph--(10 
1. N2H4 , AcOH/H20 
reflux 1 day 
2. KOH, EtOH 
reaction with 
0 
r-N,~H 
PhAAO 
4. HBr, AcOH 
15% yield 74% yield 
Scheme 3.1 Preparation of substituted pyridazin-3(2H)-one derivatives through classical 
methods?65' 367 
With the demand for pyridazin-3(2H)-ones increasing, including large-scale syntheses, 
more efficient synthetic protocols were developed, including several one-pot syntheses. 
Commercially available anilines can be converted, in a two step, one-pot procedure, to 
the corresponding pyridazinones in good to excellent yields. 368 The "self-catalyzed 
glyoxylic acid process" involves the reaction of glyoxylic acid hydrate with a three-fold 
excess of methyl ketone at 100 °C to give the aldol intermediate, treatment of which 
with aqueous ammonia and heating with hydrazine leads to cyclization and dehydration, 
with isolation of the pyridazinone [Scheme 3.2, (a)].369 Another alternative strategy to 
6-substituted pyridazin-3(2H)-ones is based on the [3+2] dipolar cycloaddition of 
readily available nitrile oxides with an alkyl acrylate to produce 4,5-
dihydroisoxazolines, which in turn are ring opened to give a-hydroxy y-keto ester and 
subsequently undergo ring closure with hydrazine hydrate to form the pyridazinone 
[Scheme 3.2, (b)].370 Harrity et al. developed a novel route to 3,6-dichloropyridazinones 
through the oxidation of pyridazinylboronic esters (prepared via cycloaddition protocol 
oftetrazines with alkynylboronic esters, see Section 1.2.3) with hydrogen peroxide. 169 
All of the above methods are useful for preparing substituted pyridazinone derivatives, 
offering fair structural diversity. However, the major drawback of these routes is the 
necessity to prepare the specific dicarbonyl components required for each pyridazinone 
synthesis. 
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~ OHCC02H/H20 
X~O ==~=T=, s=o=lv=e=n=t= 
Me 
OH 
4-78% yield 
0 
OH 
1. Ph-NCO, Ph-H, Et3N 
R2 2. NCS, py, Et3N ~C02R1 
R~;R2 
~Nil / C02R1 
-o 
65-80% yield 
Mo(C0)6 , MeCN/H20 j 
or H2, Raney Ni 
R~R2 
N,NAO 
H 
75-89% yield 
EtOH, reflux 
R R2 
rrC02R1 
O HO 
77-90% yield 
Scheme 3.2 More modern strategies to 6-substituted pyridazin-3(2.H)-ones: (a) One-pot 
preparation from ketones.369 (b) Nitrile oxide [3+2] cycloaddition, followed by ring-opening of 
4,5-dihydroisoxazolines. 370 
Methoxy-substituted pyridazines can be converted into their pyridazin-3(2H)-one 
derivatives under acidic conditions.334• 35° Conditions must be tailored to the substrate as 
too mild conditions may not result in demethylation, whereas too harsh conditions lead 
to degradation. For example, the conversion of 93 into the pyridazin-3(2H)-one 
derivative 94 was unsuccessful with boron tribromide in DCM, and hydroiodic acid in 
water; however, hydroiodic acid in methanol gave good yields of 94 (Scheme 3.3).334 
Chloropyridazines can be readily hydrolyzed to their pyridazin-3(2H)-one derivatives 
under acidic conditions.366 
86 
HI, MeOH 
80 °C, 1-3 h 
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Ar1 Me Ar2~o 
~'N~O 
H 
94 77-95% yield 
Ar1, Ar2 =Ph, p-CI-C6H4 
Scheme 3.3 Conversion of methoxy-pyridazines to pyridazin-3(2H)-ones. 334 
Substituted pyridazin-3(2H)-ones can undergo further synthetic transformations 
including N-alkylation usually to afford the 2-N-substituted derivatives, nucleophilic 
substitution of halopyridazin-3(2H)-ones with N-, S- and 0-nucleophiles, electrophilic 
substitution at the 4-position with a variety of electrophiles (viz. nitration, formylation, 
diazotization) and cycloadditions (in Diels-Alder and 1,3-dipolar addition reactions).349· 
350 
Pyridazinone nng formation or functionalizing pyridazinones through differing 
substitution reactions, offer reasonable routes to substituted pyridazinones, although 
there are some drawbacks. The palladium-catalyzed cross-coupling of halopyridazin-
3(2H)-ones is attractive since it adds the functionality towards the end of the synthesis. 
This allows one to take advantage of the wide selection of reactive partners (e. g. boronic 
acids, amines, organotin derivatives, acetylenes), thus enhancing the access to libraries 
of pyridazin-3(2H)-one analogues.326· 371 The solid-phase synthesis of 6-aryl-pyridazin-
3(2H)-ones through Suzuki-Miyaura cross-coupling of a grafted pyridazinone derivative 
is effective?72• 373 Chloropyridazin-3(2H)-ones are commercially available (or easily 
accessible) and undergo palladium-catalyzed Suzuki-Miyaura reactions in high yields 
when N-2 is protected with either an alkyl group or a labile (removable) protecting 
group.326, 374 
From commercially available 4,5- or 5,6-dichloropyridazin-3(2H)-one, N-alkylated aryl-
and amino-aryl-pyridazin-3(2H)-one derivatives have been prepared in high yields using 
Suzuki-Miyaura cross-coupling.354· 375"377 Selective arylation of N-alkyl-4,5-
dichloropyridazin-3(2H)-one was unsuccessful, giving a mixture of monoaryl-
substituted isomers and the diarylated product.354· 375 For mono-substitution one chlorine 
must be replaced with a methoxy group, which can be done selectively with sodium 
methoxide, depending on the choice of solvent.375 The electron-donating nature of the 
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methoxy group does not effect the cross-coupling at the chlorine, yielding monoarylated 
derivatives in excellent yields (Scheme 3.4).354• 375• 376 The remaining methoxy group 
can be easily converted into the corresponding triflate which is subsequently used in a 
second Suzuki-Miyaura cross-coupling to yield unsymmetrically substituted 4,5-diaryl 
pyridazin-3(2H)-ones.378 One can achieve selective Suzuki-Miyaura cross-couplings on 
dihalopyridazinones with different halogens; for example, 2-methyl-5-chloro-4-
iodopyridazin-3(21/)-one reacts with phenylboronic acids to yield only one mono-
substituted product resulting from reaction at the iodo position, although disubstitution 
was not completely suppressed?53 
Cl Ar 
NaOMe 
~OMe ___ A_r_-B_(_O_H_h __ _ 
~'N~O Pd(PPh3)4, Na2C03 
~OMe 
~'N~O 
I 
Cl 
~Cl R-Br, K2C03 
Bu4NBr, MeCN 
reflux 1 h 
7 R toluene, reflux R 97 85-100% yield 
~'N~O 
H 
95 
OMe 
~Ar 
~'N~O 
I 
R 
90-100% yield 
Scheme 3.4 Suzuki-Miyaura reactions of 2-alkyl-4-/5-chloro-4-/5-methoxypyridazin-3(2/i)-
one.354, 375 
Pyridazino-fused ring systems, not easily accessible by other routes, have been prepared 
using a sequential or one-pot strategy combining palladium-catalyzed C-C bond 
forming reactions with a C-X (X= N, 0) or another C-C bond forming reaction, such 
as a condensation, lactonization, Buchwald-Hartwig amination or Pschorr reaction.379 
For example, the previously undescribed pyridazino[4,5-c]isoquiniolinone, 
dibenzo[f,h ]-phthalazin-1 (2H)-one and -cinnolin-3(2H)-one polycyclic pyridazinone 
systems were prepared by Maes et al. through the cyclization of the biaryl Suzuki-
Miyaura coupling products from the reaction of 97 or 98 with ortho-substituted 
phenylboronic acids.375• 376 As the yields for the intramolecular cyclizations, affording 
dibenzoff,h ]-phthalazin-1 (2H)-one and -cinnolin-3(2H)-one, were relatively low an 
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alternative strategy utilizing an in situ Pschorr type thermal cyclization was developed, 
giving good yields and a new route to phenanthrene units.376 
B(OHh 
Cl &CHO (:cOMe 0 CHO NH40H AICI3 
OMe 
N N 0 Pd(PPh3)4 I Me OH I toluene I 
I Na2C03, DME/H20 N,N 0 N,N 0 N,N Bn 0 I I H Bn Bn 
84% yield 93% yield 93% yield 
Scheme 3.5 Synthesis of pyridazino[ 4,5-c ]isoquiniolinone via Suzuki-Miyaura-cyclization.375 
For the preparation of N-2 unsubstituted arylated pyridazin-3(2H)-ones, temporary 
protection of the lactam moiety with a hydroxymethyl group can be employed. It is 
assumed that initially cross-coupling occurs followed by loss of the protecting group as 
formaldehyde following a retro-ene fragmentation. 380· 381 This retro-ene assisted Suzuki-
Miyaura methodology has been applied to chloro-, bromo- and iodo-pyridazin-3(2H)-
ones.363, 380-382 
On the whole chloropyridazin-3(2H)-ones are chosen for Suzuki-Miyaura cross-
couplings due to their lower cost and greater availability, although bromo- and 
iodopyridazin-3(2H)-ones have been utilized. 326· 353· 371 • 383 There appears to be no major 
advantage to using bromo- or iodopyridazinones as yields with chloropyridazinones are 
comparable and the bromo- or iodo- derivatives are usually prepared from the 
commercially available chloro analogues. In all cases palladium-catalyzed cross-
couplings (Suzuki-Miyaura, Stille or Sonogashira) occur in higher yields with 2-
substituted pyridazinones, indicating that to ensure successful coupling it is critical to 
block the enolizable carbonyl group. 
Palladium-catalyzed cross-coupling reactions of halopyridazin-3(2H)-ones is a highly 
effective method for introducing different substituents on to the pyridazinone core, and 
is frequently more efficient than the traditional methodology. The remainder of this 
chapter outlines the conversion of several of our heteroaryl-pyridazine coupling 
p:r:oducts into, their pyridazin-J(2H)-one derivatives and further functionalization 
reactions. 
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3.2 Preparation of functionalized pyridazin-3(2H)-ones 
Previously in our group, Greenwood investigated the di-chlorination of 75c in attempts 
to increase the structural diversity of heteroarylpyridazines.340 The conversion of 2-
alkoxypyridines to 2-chloropyridines under Vilsmeier-Haack conditions (POCh/DMF) 
is reported. 384' 385 Studies in our group also found that different chlorinating agents 
(POCh, PCh) were successful in converting a 2-methoxypyridine moiety to the 2-
chloropyridine derivative, however, in lower yields than when using POCh/DMF?40 
Interestingly the reaction of 75c with POCh in DMF did not give the 
dichlorobiheteroaryl product; instead 99 was obtained in 60% yield,335 representing a 
new route to the 6-substituted-pyridazin-3(2H)-one motif (Scheme 3.6). 
(i) 
I -....::::::: 
N .... N 0 
I 
H 
OMe 
75c 99 60% yield 
Scheme 3.6 (i) POCh, DMF, 110 °C, 19 h.335 
While the standard methoxy to chloro transformation occurred at the pyridine ring of 
75c, this was not the case at the pyridazine ring, where demethylation occurred instead. 
There is no literature precedent for the methoxypyridazine to pyridazin-3(2H)-one 
conversion under Vilsmeier-Haack conditions; ordinarily, this transformation occurs 
under acidic conditions as discussed in Section 3.1. Treatment of 3-methoxypyridazines 
with HBr or HI, to yield the pyridazin-3(2H)-one derivatives, followed by reaction with 
POBr3 or POCh/PC15 has been applied to prepare the 3-bromo- or 3-chloropyridazines, 
respectively.365 ' 386' 387 Dimethylchloromethleneammonium chloride 
([Me2N+=CHCl]Cl-) has been used as a chlorinating agent in the conversion of 4,5,6-
trichloropyridazin-3(2H)-one to 3,4,5,6-tetrachloropyridazine. 388 In the reverse 
procedure, the reaction of 3-(N,N-dimethylamino )-4,5,6-trichloropyridazine with glacial 
acetic acid gave 6-(N,N-dimethylamino )-4,5-dichloropyridazin-3(2H)-one in 30% 
yield.389 Formylation at C-4 of a 2-alkyl-5-hydroxypyridazin-3(2H)-one derivative 
under Vilsmeier-Haack conditions has been reported.350 None of the above literature 
sheds light on the conversion of 75c into 99 under Vilsmeier-Haack conditions. 1H and 
13C NMR and MS spectra confirmed structure 99. Figure 3.2 shows the 1H NMR 
spectrum of99, the pyridazin-3(2H)-one N-H signal can be clearly seen at o 13.4 ppm. 
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f I 
0 
Ha 
I 
A 
I 
14.0 13.5 13.0 12.5 12.0 11.5 11.0 10.56 (ppm) !O.Q. 9.5 9.0 8.5 8.0 7.5 7.0 
Figure 3.2 1H NMR spectrum of99 (400 MHz, DMSO-~). 
The proposed mechanism for the transformation of 2-alkoxypyridine to 2-
chloropyridine involves initial attack of the Vilsmeier-Haack reagent on the oxygen of 
the alkoxy group, followed by attack of chloride ion at C-2 and cleavage of the ether 
(Scheme 3.7).384 
~ 
RO)l_N_J 
POCI~DMF 
R+ (; 
'o)lNJ 
Me,Nj,__O 
I I 
Me /~O 
Cl Cl 
100 
aq. NaOAc 
~ 
Cl.)l_N-:J 
Scheme 3.7 Proposed mechanism for the 2-alkoxy- to 2-chloropyridine conversion under 
Vilsmeier-Haack conditions (as illustrated in reference 384). 
There is some evidence supporting intermediate 100, however, the active Vilsmeier-
Haack reagent is generally regarded as being species 101 (Scheme 3.8). Even so, 
applying the mechanism proposed in Scheme 3.7 results in a similar outcome, where the 
product from nucleophilic attack of the chloride ion may be resonance stabilized by the 
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pyridine N (Scheme 3.8, intermediate 102). If the mechanism in Scheme 3.8 were 
correct, comparable formation of a resonance stabilized pyridazine-Vilsmeier reagent 
intermediate (Scheme 3.8, 102a) would be unfavourable due to repulsion of the 
negative charge from the adjacent N-1. This could explain why the 3-
methoxypyridazine ring does not convert to 3-chloropyridazine, and pyridazin-3(2H)-
one is isolated instead. 
POCI3 + DMF 
I 
Me,~.D 
+I RO N 
-
Me 
101 
102a 
comparable pyridazine intermediate 
~ 
CI,J!__N) 
Scheme 3.8 Proposed mechanism for 2-alkoxy- to 2-chloropyridine conversiOn under 
Vilsmeier-Haack conditions. 
We propose that the Vilsmeier-Haack reagent is acting as an acylating agent, to give the 
intermediate 102, but instead of nucleophilic attack at the arene ring, chloride ions 
attack the methyl of the methoxy substituent, and subsequently the Vilsmeier reagent is 
reformed along with pyridin-2(1H)-one (Scheme 3.9). As the pyridine-pyridinol 
tautomerization occurs rapidly in solution, nucleophilic attack of chloride ions on the 
pyridinol tautomer would yield 2-chloropyridine. However, for the 3-
methoxypyridazine ring of 75c the above mechanism would form the pyridazin-3(2H)-
one which is more stable than the pyridazinol tautomer390-394 and consequently is less 
susceptible to nucleophilic attack from chloride ions. Alternatively, the 3-
chloropyridazine derivative may be formed and hydrolyzed to 99 during aqueous 
workup. The 2-chloropyridine function would be relatively more hydrolytically stable. 
However, as we later found more efficient routes to pyridazin-3(2H)-ones from 3-
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methoxypyridazines we did not further investigate the reaction mechanism for the 
transformation under POCh/DMF. 
POCI3 + DMF 
J 
Me,~~.D 
+ I RO N 
Me 
1.) 
0 N 
H 
cl-~ 
HO~ 
~ ~9.J --
Me,NY'--...CI 
I 
Me 
~ 
CIANjJ 
Scheme 3.9 Proposed mechanism for 2-alkoxy- to 2-chloropyridine conversion under 
Vilsmeier-Haack conditions; the Vilsmeier reagent acting as an acylating agent. 
We were interested to see if other methoxy-substituted pyridazines would react with 
POCh/DMF to give pyridazin-3(2H)-one derivatives. Indeed, compound 79 when 
treated with POCh/DMF gave pyridazinone derivative 103 in 55% yield (Scheme 3.10). 
This transformation has also been repeated under acidic conditions, as highlighted in 
Section 3.1, although the reaction of 79 with HI (57% aq. soln), heated at reflux, did not 
yield 103. No starting material 79 or any other organic species were recovered from the 
reaction; it is possible that the acid protonated the pyridine ring and formed a salt which 
was inextractable from the aqueous phase. Consequently, Lewis acidic conditions were 
considered. On treating 79 with BBr3 in DCM at reflux an improved yield of 103, 84%, 
was obtained. The attempted conversion of 80 to 104 using BBr3 in DCM was 
unsuccessful; however, using HBr (48% aq. soln) in acetic acid at 80 °C gave 104 in 
77% yield. 
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n "" Ar ~ l;to 
H 
79 Ar= J) J) 55% yield from (i) 103 Ar= h- 84% yield from (ii) 
N )) D 80 Ar= N 104 Ar= ~ 77% yield from (iii) 
Scheme 3.10 (i) POCb, DMF, 110 °C, 19 h. (ii) BBr3, DCM, reflux, 4 h. (iii) HBr (48% aq. 
soln), AcOH, 80 °C, 3.5 h. 
We were interested in the structural conformation of 103, anticipating that the pyridyl N 
would face in the opposite direction to the pyridazinone carbonyl group to minimize 
electronic interactions. Compound 103 is not crystalline, so the N-benzylated derivative 
105 was prepared in 93% yield (Scheme 3.11). Alkylation usually affords N-2 
substituted derivatives, some N-1 or 0-alkylated pyridazinone derivatives have been 
reported.395 IR studies of 105 showed a band at 1646 cm-1 characteristic of the 
pyridazinone carbonyl u(C=O) stretch. X-ray diffraction studies of crystals of 105 
confirmed that benzylation had occurred at N-2, and comparison of the C(4)-C(12)-
N(11) and C(4)-C(12)-C(13) angles, 115.08(15) and 123.69(16)0 , respectively, 
indicates a pyridyl...O repulsion in 105, presumably to minimize any electrostatic 
effects (Figure 3 .3). Rings i - iii are nearly coplanar and there is a weak intramolecular 
C-H ... O hydrogen bond of 105 [C-H 0.94(2), H ... O 2.15(2), C(3)-0 1.238(2) A]. This 
is also consistent with the conformation of the pyridine ring in the crystal structure of 
compound 86 (Chapter 2, Figure 2. 7). 
-;:?" 
~ + I (ii) (i) 
~ BF4- ---
OH 
106 
Scheme 3.11 (i) BnBr, K2C03, Bu4NCI, MeCN, reflux, 1 h. (ii) HBF4, MeOH. 
I~ 
N,N 
I 
Bn 
105 93% yield 
Compound 103 was converted into its pyridinium salt 106 with tetrafluoroboric acid.396 
A downfield shift in the 1H NMR signals of the aromatic protons indicated that the 
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pyridyl N was protonated. X-Ray diffraction studies of 106 (Figure 3.3) revealed a 
strong N-H ... O hydrogen bond in 106, [N-H 0.95(2), H ... O 1.80(2), C(3)-0 1.2474(13) 
A], resulting in the co-planarization of rings i - iii; the orientation of ring iii in 106 
differs from 105 by ea. 180° rotation. Pyridyl. .. O attraction in 106 was indicated by the 
comparison of the C(4)-C(12)-N(11) and C(4)-C(12)-C(13) angles in 106, 117.92(9) 
and 124.12(9)0 , respectively. The change in conformation (from the neutral 
pyridazinone) was also observed by a shift in the carbonyl stretching signal to 1669 cm-
1 in the IR spectrum, due to hydrogen-bonding. 
106 
Figure 3.3 X-ray molecular structures of 105 and 106 (50% thermal ellipsoids). Angles between 
ring planes (0 ): i/ii 5.2, i/iii 1.3, i/iv 75.8 in 105, i/ii 12.7, i/iii 2.6 in 106. Note the much smaller 
atomic displacements in 106 at the same temperature (120 K). (CCDC 105 665172, 106 
665173). Dashed lines represent hydrogen bonds. 
3.3 Further functionalization of pyridazin-3(2H)-ones 
N-Alkylation of pyridazin-3(2/i)-one derivatives is well reported,351 • 361· 395 this 
motivated us to investigate whether our pyridazinone systems could be further 
functionalized through N-(hetero )arylation at N-2. Initially nucleophilic substitution at 
N-2 of pyridazinone 103 was attempted with 2-chloropyridine (K2C03, DMF, reflux), 
however, no reaction occurred. There are few reports in the literature ofpyridazinone N-
(hetero )arylation; several examples of copper-catalyzed C-N bond forming reactions of 
pyridazinones with aryl halides are detailed,397400 although in most cases they are 
isolated examples rather than a comprehensive study. There are a number of other 
strategies for C-N coupling of pyridazinones, for example, low yields (19-33%) are 
obtained in the Cu(0Ac)2 promoted N-arylation with phenylboronic acids, according to 
the procedure of Chan and Lam.286· 401· 402 N-Arylation of substituted pyridazin-3(2/i)-
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ones, through the coupling of a C-H bond of benzene or benzene derivative and the N-
H bond of pyridazin-3(2H)-one, in the presence of lead tetraacetate/zinc chloride, yields 
pyridazinone derivatives in 24-71%.403 To the best of our knowledge there are no 
reports of Pd-catalyzed Buchwald-Hartwig type amidations of pyridazinones with aryl 
halides. As copper is significantly less expensive than palladium and the removal of 
copper from polar products may be easier than trace amounts of palladium, we chose to 
investigate the copper-catalyzed N-(hetero)arylation of our pyridazin-3(211)-one 
derivatives with aryl halides (preferably bromides). 
3.3.1 Copper catalyzed N-(Hetero )arylation 
Copper-catalyzed C-N coupling reactions have come a long way since the traditional 
Ullmann systems. Ligand-assisted protocols accelerate reaction rates for the amination 
or ami dation of a variety of (hetero )aryl iodides, bromides and in some cases 
chlorides.288• 404 Ligands increase the catalyst solubility and stability and may prevent 
aggregation of the copper. The scope of the N-containing substrate is also wide; 
. l d' . 'd 400 405 l (p l . 'd l 406-408 1 . d l me u mg ammes, ami es, · azo es yrazo es, 1m1 azo es, pyrro es, m o es, 
triazoles)/99• 409 and pyridones.398• 410 Plausible mechanisms for the copper-catalyzed N-
arylation reactions which have been postulated include radical intermediates or that the 
mechanism involves oxidative additionlreductive elimination processes. The case for 
radicals or radical anions has been contested as reactions conducted in the presence of 
radical scavengers were not inhibited/99 however, practical and theoretical 
investigations into the copper complexes proposed as intermediates in copper-catalyzed 
amidations of aryl halides have shown the potential for the reaction pathway to proceed 
through radical intermediates.411 
It is generally regarded that copper-catalyzed C-N bond forming reactions go via an 
oxidative addition process; this is reflected in the reactivity of aryl halides, with aryl 
iodides being more reactive than aryl bromides, and aryl chlorides showing very poor 
reactivity (which parallels the leaving group ability of the halide ). As Cu(II) cannot 
oxidatively insert into a C-X bond it is more likely that the active copper species is 
Cu(I), regardless of the copper source used. It is still unclear whether the oxidative 
addition occurs prior to nucleophilic substitution of the N-H species (Figure 3.4, 
catalytic cycle A), or whether the amino-derivative coordinates to the copper before 
oxidative addition of the aryl halide (Figure 3.4, catalytic cycle B). In either case the 
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addition of the amine may occur through a nucleophilic coordination to the copper, 
followed by deprotonation. The binding of the nucleophile enhances the acidity of the 
amine proton, or the amine may be deprotonated prior to attacking the copper centre. 
Reductive elimination of the coupling product regenerates the active catalyst. A Cu(I)-
catalyzed nucleophilic substitution mechanism would parallel that of the corresponding 
Pd(O) and Ni(O) species. As Cu(I) is a d10 transition metal and isoelectronic with the 
aforementioned species, this would not be unsurprising. The formation of an arylcopper 
(Ill) intermediate is still a contentious issue, as the existence of higher order cuprates is 
debatable. Recent theoretical studies on the copper-catalyzed cross-coupling of aryl 
halides with amides, suggest that Cu(III) intermediates would be higher in energy than 
the Cu(I) complexes and the free aryl halide; however, the Cu(III) species lie at energies 
that are accessible under mild conditions.411 Oxidative addition was identified as the 
rate-limiting step and the Cu(I)~Cu(III) transformation yields a pentacoordinated 
complex.412 
~df!cti~e oxidative 
Ar-NR2 :;y LCuiX ~ArX 
eltmmatton addition 
X A X 
1111 1111 
L -su-NR2 L -su-X 
Ar Ar 
x-
nucleophilic 
substitution 
HNR2 +base 
~ 111 X base X 
Ar-NR2 LCuiX ~HNR2 +base 
. nucleophilic 
reducttve substitution 
elimination x-
x B 
1 111 L -Cu1-NR2 L-su-NR2 
Ar 
ArX 
X 
1 base 
L-su-X + HNR2 === L-yu:::NR ---
Ar 1 2 
1111 
L-su-NR2 LCu1X + HNR2 === L -yu
1 L -Cu1-NR2 
R2N, Ar 
coordination H deprotonation 
Ar 
coordination H deprotonation 
Figure 3.4 Proposed mechanism for the copper-catalyzed N-arylation of aryl halides. Based on 
the work by Taillefer et al.399 
As the oxidative addition of an aryl halide to Cu(I) is a reversible process, the role of 
the additional ligands may be to shift the equilibrium towards the Cu(III) complex 
through stabilization. Hard donor ligands (such as Lewis bases with N or 0 binding 
sites) display a higher affinity towards hard Cu(III) than soft Cu(I).399 More electron 
rich ligands stabilize the presumed Cu(III) intermediate, lowering the oxidation 
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potential for the Cu(I)-Cu(III) redox pair, and as a result, accelerate the rate limiting 
aryl halide activation.407 
The most comprehensive investigation into the N-arylation of pyridazin-3(2/:l)-one was 
reported while our work was in progress by Pu et al.397 They found that the palladium-
catalyzed N-arylation of pyridazin-3(2/:l)-one with aryl bromides "did not succeed under 
the typical palladium-catalyzed amination or amidation conditions, presumably due to 
the poor nucleophilicity of this substrate" (no further details were given). Consequently, 
they investigated copper-catalyzed N-arylation and concluded that the optimal reaction 
conditions for the reaction of pyridazin-3(2/:l)-one (1.5 equiv.) with 4-bromoanisole (1 
equiv.) were [CuCl (5 mol%), 8-hydroxyquinoline (10 mol%), K2C03 (1.5 equiv.), 
DMF, 140 °C, 20 h]. The precatalyst structure was elucidated using the more soluble 7-
n-propyl-8-hydroxyquinoline ligand. Electrospray ionization mass spectrometry and 
single crystal X-ray confirmed the structure to be the copper(ll)hydroxyquinolate 
complex 108 (Scheme 3.12). 
~ 
I /. N R 
Cu(I)CI 1 \ /0 ~ 
K2C03, DMF R N ~ 
10 
RUX 
X= I or Br 
107 R = H 99% 
108 R = n-Bu 95% 
108 (5 mol%) 
K2C03, DMF 
100-140 °C, 20 h 
R = Me, OMe, CN, Br 
6 examples 
70-94% yield 
Scheme 3.12 Pyridazin-3(2H)-one N-arylation using a copper(II) hydroxyquinoline complex.397 
Pu reported 70-94% isolated yields of 2-arylpyridazin-3(2/:l)-one products, including 
only one heteroaryl derivative from the reaction of pyridazin-3(2/:l)-one with 6-bromo-
2-methylquinoline.397 A similar catalyst system has been used recently for the N-
arylation of pyridin-2(1/:l)-ones with aryl bromides and iodides in moderate yields 11-
59%, [Cui (15 mol%), 8-hydroxyquinoline (15 mol%), K 2C03 (1.1 equiv.), DMSO, 130 
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°C, 19 h]. Alternative ligands, typically used for ami dation of aryl halides, gave much 
lower yields.398 Under these conditions one example of N-arylation of 6-
methylpyridazin-3(2H)-one was given. 
It is known that the choice of base plays an important role in the reactivity of amidation 
of aryl halides. The rate of deprotonation of the amide must match the rate of amidation, 
as an excess of deprotonated amide impedes the amidation reaction presumably through 
the formation of an unreactive cuprate complex; consequently, the pKHA of the base 
used should be lower than the pKHA of the amide.405 2-Hydroxypyridine, pKHA ~17, is 
more acidic than indoles and amides, pKHA ~ 21-26, pKHA of imidazole~ 19, is similar 
to that of 2-hydroxypyridine. Consequently, catalyst/ligand systems and bases used for 
the N-arylation of imidazole have been applied to 2-hydroxypyridines.41° For 2-
hydroxypyridine, copper-catalyzed arylation favours N-arylation instead of 0-arylation. 
It has been suggested that the Cu-N binding affinity is significantly stronger than Cu-0 
binding and isomerization from Cu-N to Cu-0 may be slower than Ar-X activation 
accounting for the selectivity.410 The pKA for tautomerisation of pyridazin-3(2H)-one 
and 3-hydroxypyridazine is -1.80, indicating that the tautomeric compound exists in the 
oxo form to the extent ea. 1 04·6: 1.392 The pKHA for pyridazin-3(2H)-one is 1 0.46, which 
is more acidic than 2-hydroxypyridine, consequently, we assumed that copper-catalyzed 
arylation would be selective for N-arylation. On applying the conditions outlined by Pu 
et al.397 [107 (5 mol% Ar-X), DMF, Cs2C03 (1.5 equiv.), 140 °C, 24 h] for the reaction 
of compound 103 with 4-bromoanisole 109 and 5-bromo-2-methoxypyridine 110, the 
C-N coupling products 112 and 113 were isolated in 41% and 21%, respectively (Table 
3.1), along with a by-product (ea. 50% yield of by-product alongside 113). The 1H 
NMR spectrum of the by-product suggested that N- or 0-methylation had occurred to 
give 3-methoxypyridazine 79, or the 2-methylpyridazin-3(2H)-one isomer 117 (Figure 
3.5). 
79 
,~ 
N,N 
I 
Me 
117 
Figure 3.5 Possible structures of the by-product isolated in the copper-catalyzed N-arylation of 
103 with DMF as solvent. 
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1 H NMR chemical shifts of this by-product were slightly different from 79 (isolated 
previously from the cross-coupling of boronic ester 77a with 2-bromopyridine). 
MS(ES+) showed a molecular ion of m/z 264.2 (M+Ht, consistent with either structure 
proposed and elemental analysis was correct. The IR spectrum of the by-product 
showed a signal at 1646 cm-1 indicative of a carbonyl u(C=O) stretch. Comparison of 
the pyridazinyl C-5 proton signal in the 1H NMR spectra of 79, 103 and 105, showed a 
downfield shift in 103 and 105 compared to 79, from() 8.54 ppm in 79 to~() 8.8 ppm in 
103 and 105 (400 MHz, CDCh). The by-product showed the C-5 pyridazine proton at() 
8.73 ppm (Figure 3.6 shows the superimposed 1H NMR spectra of79, 103, 105 and the 
by-product). From all the above data we concluded that the by-product was in fact the 
N-methylated derivative 117. The methyl substituent may originate from the DMF 
solvent. It is also possible that the methoxy group ofthe aryl halide (e.g. X-C6!4-0Me) 
provides the methyl group (analogous to deprotonation of phenol). As aryl halides 
without a methoxy substituent were not employed with DMF as the solvent, the source 
of methylation can only be speculated. 
N"" 
_1_1_7 ___ o~ ___ L 5873 
i 
I 3 
f 
_____ jt ..~ ___ )\ __ >t.l__ ----
! 
I 
()8.75 14 
105 / 11i •. I ------>~__j~-~-------l 
9.5 9.3 9.1 8.9 8.7 8.5 8.3 8.1 7.9 7.7 7.5 7.3 7.1 6.9 6.7 6.5 
o(wm) 
Figure 3.6 1H NMR spectra of 117 (spectrum 1) 79 (spectrum 2), 103 (spectrum 3) and 105 
(spectrum 4), (400 MHz, CDCh). 
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On changing the reaction solvent to 1,4-dioxane, for the reaction of 103 with 110, no 
by-product was isolated, only the C-N coupling product 113 in 74% yield. All 
pyridazinone N-arylation results are collated in Table 3.1. The reaction rates of copper-
catalyzed N-arylations can be increased by addition of a solid-liquid phase-transfer 
agent, such as polyethylene glycol (PEG) with Cs2C03 as base.407 We investigated the 
effect of using the copper source (Cui) and ligand (8-hydroxyquinoline) separately 
instead of as the pre-formed copper complex 107, and with added PEG. This procedure 
slightly improved the yield of 113 (entry 2, conditions C) and, therefore, subsequently 
the standard conditions used for the N-arylation of 103 were [Cui (5 mol% Ar-Br)/8-
hydroxyquinoline (10 mol% Ar-Br), 1,4-dioxane, Cs2C03 (1.5 equiv.), PEG, reflux, 41-
51 h]. The C-N coupling yields were good (63-81%) with a number of 
bromoheterocycles (entries 2, 3 and 5) and different functional groups (methoxy, 
trifluoromethyl, nitro). The low yield of N-pyrimidyl derivative 115 (35%, entry 4) was 
unexpected; unreacted 103 was isolated in 50% yield. 
The N-(hetero)arylation of pyridazin-3(2H)-one 103 detailed herein is complementary 
to the work of Pu et al.397 and extends the protocol to bromo-heteroaryl coupling 
partners with a selection of functionality (methoxy, trifluoromethyl, nitro). Another 
system which may be suitable for the N-(hetero )arylation of pyridazin-3(2H)-one 
derivatives is Cui, 4,7-dimethoxy-1,10-phenanthroline, K2C03, DMSO, 110 oc;410 these 
conditions have been used for the N-(hetero )arylation of pyridin-2(1H)-ones with 
bromo- and iodo(hetero)arenes. As the acidity of the amide N-H of pyridin-2(1H)-one 
and pyridazin-3(2H)-one is similar, these conditions could be compatable with 
pyridazin-3(2H)-ones. However, 4,7-dimethoxy-1,10-phenanthroline 1s not 
commercially available and requires a multi-step synthesis so it was not investigated as 
a ligand in the copper-catalyzed N-(hetero )arylation of 103. 
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Ar-Br ~ I 
Conditions A-C N,N 
I 
Ar 
103 112-116 
Entry Ar-Br Product Conditions Isolated yield(%) 
OOMe 
I"' 
N,N 0 
1 h Q A 41* Br 109 
OMe 
112 
nO Me 
I"' A 21 * 
N,N 
2 N 9 B 74 Br 110 c 80 N 
OMe 
113 
I"' 
nCF3 N,N 
3 h 9 c 81 Br N ""'I 111 
CF3 
114 
N~ 
I"' 
::;,... 
N 
4 D N,N 0 c 35 Br N A 62 
N'0-N 
115 
-;?" N~ 
N02 ::;,... I"' 
::;,... 
;j N,N 0 5 Br ~ c 63 65 
02N 
116 
Table 3.1 Conditions A: 107 (5 mol% Ar-Br), DMF, for 112 K2C03 (s); for 113 Cs2C03 (s) (1.5 
equiv.), 140 °C; 24-48 h. B: 107 (5 mol% Ar-Br), 1 ,4-dioxane, Cs2C03 (s) (1.5 equiv.), reflux, 48 
h. C: Cui (5 mol% Ar-Br)/8-hydroxyquinoline (10 mol% Ar-Br), 1,4-dioxane, Cs2C03 (s) (1.5 
equiv.), PEG, reflux, 41-51 h. *By-product 117 isolated. 
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3.3.2 C-C/C-N Cross-couplings of 99 
Compound 99 is equipped for both N-(hetero)arylation at the pyridazinone and Suzuki-
Miyaura reaction at the pyridine ring. As discussed in Section 3.1, palladium-catalyzed 
cross-couplings of halopyridazin-3(2H)-one generally require N-2 protection for high 
yielding reactions. The protection of 99 with a hydroxymethyl group, following the 
procedure outlined by Coelho et al/80 was unsuccessful, yielding a multicomponent 
mixture that was not further investigated. N-Benzylation of 99 was successful, and 
subsequent Suzuki-Miyaura cross-coupling with 2-methoxy-3-pyridylboronic acid 
produced the extended pyridazinone structure 119 in 74% yield (Scheme 3.13). 
Cl 
Cl 
(i) I~ (ii) 0 I~ N .... N 0 N .... N 
0 d 0 d 99 118 75% yield 
119 74% yield 
Scheme 3.13 (i) BnBr, K2C03, Bu4NCI, MeCN, reflux, 1 h. (ii) 2-Methoxy-3-pyridylboronic 
acid, Pd(PPh3)4 (5 mol% 118), 1,4-dioxane, Na2C03 (1 M), reflux, 3 h. 
The Suzuki-Miyaura cross-coupling of 99 with 2-methoxy-3-pyridylboronic acid, 
without protection of the pyridazin-3(2H)-one, effectively prepared 120 in 44% isolated 
yield (Scheme 3.14), 1H, 13C NMR and HRMS confirmed the structure of 120. 120 was 
subjected to N-heteroarylation under the standard copper-catalyzed reaction conditions 
previously used with 103. Pyridazinone derivative 121 was isolated in a poor yield of 
26% as a result of difficult purification. The structure was confirmed through 2D NMR 
(see Appendix A2) and HRMS. The 1H and 13C NMR spectra in CDCh at room 
temperature showed broadening of several of the proton and carbon signals as a result of 
incomplete averaging of the signals. This may be a result of incomplete averaging of 
rotamers, however the 1H and 13C NMR spectra at 90 oc in 1,1,2,2-tetrachloroethane-d2 
gave no further definition to the proton or carbon signals, which would be expected for 
restricted rotation. Protonation/deprotonation of the pyridine rings may also be 
occurring and consequently causing incomplete averaging and downfield shifting of the 
signals. 121 is a yellow solid and TLC shows fluorescence under 365 nm light. 
Conjugation between the pyridazinone ring and the N-pyridyl ring may be accountable 
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for these observations. These reactions highlight the potential for the further 
derivatization of pyridazin-3(211)-one 99, although further optimization of reaction 
conditions is required. From a sequential strategy we have successfully prepared 
extended pyridazin-3(211)-one structures which are notable as multiheteroaryl arrays. 
Cl 
(i) 
0 
99 
120 44% yield 
(ii) 
0 
1-....:::::: 
~0 
OMe 
121 26% yield 
Scheme 3.14 (i) 2-Methoxy-3-pyridylboronic acid, Pd(PPh3) 2Cl2 (5 mol% 99), 1,4-dioxane, 
Na2C03 (I M), reflux, 21 h. (ii) 5-Bromo-2-methoxypyridine, Cui (5 mol% Ar-Br), 8-
hydroxyquinoline (I 0 mol% Ar-Br), Cs2C03 (s), PEG, I ,4-dioxane, reflux, 45 h. 
3.4 Conclusions 
Substituted 3-methoxypyridazines have been converted into the corresponding 
pyridazin-3(211)-ones with good functional group tolerance via a number of different 
routes. The pyridazin-3(211)-one derivatives offer scope for further synthetic 
transformations; primarily the copper-catalyzed N-(hetero )arylation of these pyridazin-
3(211)-ones has been demonstrated. This work builds on current literature on the N-
arylation of pyridazin-3(211)-ones, expanding the variety of heteroaryl bromides 
employed and functionality introduced. 
Pyridazinone 99 has shown to be an attractive reagent, compatible with Suzuki-Miyaura 
cross-couplings and N-functionalization. This systematic approach to derivatizing the 
core pyridazin-3-(211)-one structure has prepared a number of multiheteroaryl motifs. 
These functionalized heterocycles are attractive candidates as new pharmacophores and 
scaffolds for drug discovery. 
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CHAPTER 4 - (TRIFLUOROMETHYL)-SUBSTITUTED PYRIDYL-
AND PYRAZOLYLBORONIC ACIDS AND ESTERS 
4.1 Introduction 
The presence of a trifluoromethyl moiety can dramatically modify the physical and 
chemical properties of a compound making it a privileged motif in medicinal and 
materials chemistry when attempting to tailor a specific activity profile.413 For example, 
the replacement of a substituent, or addition of a trifluoromethyl group to a lead 
compound can alter (a) the shape and size of a compound,414 (b) the acidity,415 (c) 
dipole moments,416 and (d) lipophilicity.417 Trifluoromethyl-substituted heteroaryls, e.g. 
pyridines and pyrazoles, are found in several biologically active compounds, for 
example, the insecticide Chlorfluazuron is a chitin synthesis inhibitor418 and Aptivus® 
(Tipranavir) is a commercial HIV protease inhibitor and manufactured by Boehringer 
Ingelheim.419• 420 Structures are shown in Figure 4.1. 
F 
~0 0 Cl ~"yCF, F N-i___n_oy 
~Cl 
Cl 
Chlorfluazuron 
Insecticide, chitin synthesis inhibitor418 
Mo-er?QNCF3 
?"I 
:::,.... 
O=S=O 
I 
NH2 
Celecoxib (Celexbrex®) 
Non-steroidal anti-inflammatory 
COX-2 inhibitor422 
SC-560 
Anti-tumour activity 
COX-1 inhibitor423 
Tipranavir (Aptivus~ 
HIV protease inhibitor419 
Razaxaban 
Treatment of thrombotic diseases 
factor Xa inhibitor425 
Figure 4.1 Examples of biologically active (trifluoromethyl)-substituted pyridines and 
pyrazoles. 
Pyrazoles bearing a trifluoromethyl group constitute the core structure of 
pharmaceuticals across a number of therapeutic areas:421 Celexqr~_x® (Celeco~ib) is a 
COX-2 inhibitor and non-steroidal anti-inflammatory manufactured by Pfizer,422 
whereas SC-560 is a COX-1 inhibitor and shows anti-tumour activity (Figure 4.1 ).423• 424 
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Razaxaban and derivatives are factor Xa inhibitors used in the treatment of thrombotic 
diseases.425 
Organofluorine compounds are scarce in nature; any fluorine-containing compounds for 
pharmaceuticals, agrochemicals and advanced materials must therefore be synthesized. 
In synthetic organic chemistry fluorine generally comes from an inorganic source. The 
traditional methods for the incorporation of a trifluoromethyl group into organic 
compounds from an inorganic fluorine source have been supplemented by more 
convenient procedures. Previous methods include the halogen exchange of a 
trichloromethyl group using anhydrous hydrogen fluoride or antimony trifluoride (in the 
presence or absence of antimony pentachloridet26-428 or the treatment of a carboxylic 
acid with sulfur tetrafluoride in a pressurized vessel.429· 430 More recently the copper-
promoted reductive coupling of aryl iodides with trifluoromethyl iodide,431 • 432 and the 
m situ generation of trifluoromethylcopper species from 
(trifluoromethyl)trimethylsilane ("Ruppert-Prakash reagent"433' 434) in the presence of 
copper(!) iodide and potassium fluoride have been used for the preparation of CF 3-
substituted benzene435 and pyridine derivatives.436 
(Trifluoromethyl)-substituted arylboronic acids are valuable building blocks in the 
synthesis of biaryl systems for pharmaceutical and agrochemical research, and are 
widely used in combinatorial chemistry. (Trifluoromethyl)phenylboronic acids are 
extensive commercial availability; there are a handful of accounts of their preparation in 
the literature, several of those being in patents.437-444 With the increased availability of 
CF3-substituted aryl/heteroaryl halides and phenylboronic acid derivatives bearing CF3 
groups, the Suzuki-Miyaura cross-coupling is being utilized in the preparation of 
specific aryl/heteroaryl scaffolds or libraries of compounds with trifluoromethyl 
functionalities.445453 On account of the widespread interest m 
(trifluoromethyl)phenylboronic acids one would anticipate investigation into 
heteroarylboronic acids containing a (trifluoromethyl)-moiety. Therefore, it is somewhat 
surprising to observe the distinct lack of literature surrounding trifluoromethylated 
heteroarylboronic acids, as they are very attractive reagents for the preparation of 
functionalized heterobiaryl systems. The majority of reports of CF3-substituted 
heteroarylboronic acids are in patent literature.454465 The preparations of 
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(trifluoromethyl)pyridylboronic acids are vague with little analytical data given to 
confirm their purity (Scheme 4.1 ). 454• 456• 459• 460• 465 
1. LOA, THF, -78 °C, 4 h 
2. B(OMe)J, H20, W (HOhB~ 
~ .. A Cl N CF3 
33% yield 
F3C~B(pin) 
)_ .. J 
EtO N 
F3C~Br )_ .. J ________ ..,. 
EtO N DMSO, KOAc, 80 °C, 19 h. 
97% yield 
Scheme 4.1 Example syntheses of (trifluoromethyl)-substituted pyridylboronic acids.454• 459 
Schlosser and eo-workers have been innovative in developing the area of 
trifluoromethyl chemistry.466 Starting from arenes and heteroarenes functionalized with 
a CF 3 group they have utilized "regioexhaustive substitution" to prepare a variety of 
organometallic intermediates; on trapping with electrophiles these yield new fluorinated 
building blocks.467472 They highlight the potential for lithiation of (trifluoromethyl)-
(hetero )aromatic compounds. In their work they use carbon dioxide to trap the 
organometallic intermediates, resulting in extensive libraries of structurally isomeric 
(hetero)aryl carboxylic acids. The syntheses of (trifluoromethyl)pyridine carboxylic 
acids involves halogen-lithium exchange or DoM on unsubstituted and halo-substituted 
(trifluoromethyl)pyridines.467• 468• 473 In cases where the starting pyridines are not 
commercially available they are prepared using copper-mediated iodine/trifluoromethyl 
displacement. For example, Scheme 4.2 shows the preparation of 123 from the iodo-
precursor and then, via different routes, yields the two carboxylic 125 [54%, step (iii)] 
and 127 [73%, steps (iv) and (v)]. 
Carboxylic acids 125 and 127 can alternatively be prepared usmg 4-
(trifluoromethyl)pyridine as the substrate, with the choice of base determining 
regioselective lithiation. 467 LDA and L TMP abstract protons exclusively from the 3-
position, thus generating 127 on carboxylation and neutralization. Caubere's base, 
lithium 2-( dimethylamino )ethoxide-activated butyllithium, is specific for the 2-position, 
as demonstrated by the formation of acid 125 (Scheme 4.3). The choice of lithiating 
agent and conditions can favour the lithiation of a particular available site, balancing 
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any directing effects attributable to the trifluoromethyl group and other substituents on 
the pyridine ring, and steric hindrance resulting from the trifluoromethyl group.467' 468, 
473
' 
474 Related work has also been conducted in the regioselective metalation of 
halo(trifluoromethyl)benzenes, and on the steric and electronic effects of the 
trifluoromethyl group on the site selectivity.471 , 475, 476 
CF3 CF3 
Cl (iii) Cl / I & N Br N~ COOH n (i) 124 65% yield 125 54% yield N Cl ~ N Cl 122 123 CF3 CF3 a CO OH (v) 6COOH 
~ 
N Cl ~ N 
126 127 73% yield 
Scheme 4.2 An example preparation of (trifluoromethyl)pyridine carboxylic acids.473 (i) 
Me3SiCF3, Cui, KF, 25 cc (ii) BrSiMe3 in C2H5CN, 100 cc (iii) n-BuLi, toluene/THF, -75 cc, 
C02, W (iv) LOA, THF, -75 cc, C02, H+ (v) HCOONH4, Pd/C in MeOH, 25 cc. 
CF3 6 N 
128 ~("") (" ") 11' Ill 
& N~ COOH 
125 41% yield 
CF3 
6COOH 
N 
127 80-84% yield 
Scheme 4.3 Alternative preparation of 125 and 127.467 (i) n-BuLi in the presence of lithium 2-
(dimethylamino)ethoxide, Et20, -75 °C, 2 h (ii) LOA or LTMP, THF, -75 °C, 2 h (iii) C02, W. 
The lithiation of (trifluoromethyl)pyridines is now a well known route to new 
(trifluoromethyl)-bearing heteroaroinatic building blocks. The inductive electron-
withdrawing nature of the trifluoromethyl group increases substrate acidities and in 
108 
(b) 
Chapter 4 - (Trifluoromethyl)-substituted Pyridyl-
and Pyrazolylboronic acids and esters 
some cases can stabilize anionic intermediates. However, this does not always facilitate 
kinetic deprotonation, due to CF3 being a relatively bulky substitutent. We recognized 
that these protocols could be adapted for the preparation of 
(trifluoromethyl)pyridylboronic acids, paving the way for novel pyridylboronates for 
use in the synthesis of functionalized heterobiaryls. 
Trifluoromethylated pyrazoles have been prepared via a number of protocols. In all 
cases the trifluoromethyl moiety is present on an alkene or carbonyl containing 
substrate which is used to construct the pyrazole ring via a condensation or [3+ 2] 
cycloaddition. For example, the 1,3-dipolar cycloaddition of 2-bromotrifluoropropene 
and diazomethane occurs regioselectively yielding 3-(trifluoromethyl)pyrazole 129 in 
quantitative yield [Scheme 4.4, (a)]. 
(c) 
(a) 
70 °C, 1 h 
0 
H3CH2CO~CF3 
131 
+ 
dCF~r N 
N 
H H 
Me2N¥'NMe2 
CF3 
130 
attack by 1 o N 
CF3 0 
N 
H 
129 
quantitative yield 
1. RNHNH2, RT, 1 h 
MeCN F3Ch 1 \ 
N/N 
I 2. AcOH or TFA 
70 °C, 1h R 
R = H 74-78% yield 
R= Me 77% yield 
R =Ph 81% yield 
F3c~N 
I 
Me 
132 
CF3 
-H20 0 
spo~aneous N.N 
I 
Me 
133 
Scheme 4.4 Procedures for the preparation of 3-(trifluoromethyl)pyrazole derivatives. (a) 1,3-
dipolar cycloaddition of 2-bromotrifluoropropene and diazomethane.477 (b) Reaction of a P-
trifluoromethyl vinamidinium salt with a hydrazine.478 (c) Condensation of methylhydrazine 
with 4-ethoxy;.I, I, l-trifluoro-3-btiten-2-one.479• 480 
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A ~-trifluoromethyl vinamidinium salt was reported as a novel trifluoromethylating 
agent. Following preparation from the reaction of 3,3,3-trifluoropropanoic acid with 
phosphorus oxychloride in DMF, the vinamidinium salt reacts with bifunctional 
nitrogen nucleophiles, leading to trifluoromethylated azaheterocycles [Scheme 4.4, (b)]. 
The reaction of 130 with hydrazine derivatives gave 4-(trifluoromethyl)pyrazole and !-
methyl- or 1-phenyl-4-(trifluoromethyl)pyrazole in good yields (74-81%).478 
4-Ethoxy-1, 1, 1-trifluoro-3-buten-2-one 131 has been used in a number of procedures to 
prepare 3- and 5-(trifluoromethyl)pyrazoles.480' 481 Treating 131 with methylhydrazine 
affords a regioisomeric mixture of 1-methyl-3-(trifluoromethyl)pyrazole 133 and 1-
methyl-5-(trifluoromethyl)pyrazole 132 in ea. 2.5:1 ratio (133:132). This is a result of 
initial competitive Michael attack by the primary and secondary nitrogen atoms of 
methylhydrazine [Scheme 4.4, (c)]. The mixture can be easily separated as the 
dihydroxypyrazol-5-ol intermediate to isomer 132 is sufficiently stable to allow 
isolation, whereas the precursor to 133 undergoes spontaneous dehydration. Reaction of 
131 with phenylhydrazine or 2-bromophenylhydrazine yields the !-phenyl- and 1-(2-
bromophenyl)-5-(trifluoromethyl)pyrazole derivatives in good yields (both 78% yield); 
no comment was made on whether the 3-(trifluoromethyl)pyrazole isomer was 
observed.481 
There are numerous methods for the preparation of trifluoromethylated heteroaryls and 
only a few have been highlighted here. More recently, (trifluoromethyl)-substituted 
heteroarenes, especially pyridines, have gained wider commercial availability, and at 
reasonable cost. With the trifluoromethylated heteroaryl building blocks in hand, and 
the importance of these motifs within pharmaceuticals and agrochemicals, there are 
incentives for further functionalizations to create new heteroaryl scaffolds. 
The present chapter outlines the preparation of CF 3-substituted pyridylboronic acids and 
pyrazolylboronic esters via lithiationlboronation of commercial CF3-substituted starting 
materials. The Suzuki-Miyaura cross-couplings of these boronic acids and esters with 
functionalized halo-benzene and halo-heteroarene partners provide new 
trifluoromethylated heterobiaryl systems, including tetra-functionalized pyrazoles. 
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4.2 (Trifluoromethyl)-substituted pyridyRboronic acids 
4.2.1 Synthesis and reactions of 2- and 3-(trifluoromethyl)-5-pyridylboronic acid 
Prior to our work the preparation of 137 had been reported in a patent although the only 
analytical data given was the mass spectrum of its hydrochloride salt.482 One example of 
a Suzuki-Miyaura cross-coupling reaction of 137 with 3-bromo-l-methyl-1H-
pyrazolo[3,4-d]pyrimidin-6-ylamine was detailed. Lithium-halogen exchange of 5-
bromo-2-(trifluoromethyl)pyridine 134 and 5-bromo-3-(trifluoromethyl)pyridine 135 
with n-BuLi in THF at -78 °C, then addition oftriisopropylborate followed by aqueous 
workup yielded boronic acid derivatives 136 and 137 as air-stable solids in 95% and 
94% yields, respectively, on a ea. 10 g scale (Scheme 4.5). The X-ray crystal structure 
of 136 was obtained (Figure 4.2). Here and in the X-ray crystallography figures below 
atomic displacement ellipsoids are drawn at the 50% probability level. 
Bryyz 
~ .. A N y 
(i), (ii) 
134 Y = CF3, Z = H 136 X= CF3, Z = H 95% yield 
135 Y=H, Z=CF3 137 X=H, Z=CF3 94%yield 
Scheme 4.5 (i) n-BuLi, B(Oi-Pr)3, THF, -78 °C, 3 h. (ii) H20, AcOH. 
Figure 4.2 X-ray molecular structure of 136. The rotational disorder of the CF3 group was 
modelled as two orientations with the probabilities of 85% (solid) and 15% (dashed). (CCDC-
699539). 
Suzuki-Miyaura cross-coupling reactions of 136 and 137 were carried out with a variety 
of (hetero)aryl bromides and chlorides 61, 66, 138-142 under standard conditions 
[Pd(PPh3) 2Clz, (t-Bu3P was added in some cases), 1 ,4-dioxane, NazC03, reflux] to yield 
products 143-153, respectively. The results presented in Table 1 show that reactions 
generally proceed in high yields for both electron-rich (entries 5, 6 anq9) and electron~ 
deficient coupling partners (entries 1-4, 7, 8, 1 0-12). The efficient reactions of 
heteroaryl chlorides (entries 3, 4, 10-12) are notable due to their wider availability and 
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lower cost than bromide derivatives. Primary amine, nitro and methoxy functionalities 
on the coupling partners were tolerated. 
(H0h8~Z Ar-X Aryyz 
~ .. A ~ .. A N y Conditions A or 8 N y 
136 Y = CF3, Z = H 143-153 
137 Y=H, Z=CF3 Y, Z = CF3 or H 
Entry 8oronic Ar-X Product Conditions Time Isolated 
acid (h) yield(%) 
~ ~ 1 136 ""'::: A 22 94 Br /-66 N CF3 
143 
N02 H,N% 
H2Ntl 2 136 N"' ""'::: A 17 75 
N o Br I " 61 N CF3 
144 
F3CUCI F,c% 
I " "' I 3 136° N Cl N I ""'::: A 4 92 
138 /-N CF3 
145 
N~N N~N 
4 136b CI~CI ~ 8 21d 81 139 /-F3C N N CF3 
146 
F3C 
5 136b 
Br:X::COMe 
10 
MeO Br A 1 77 
140 
CF3 
147 
s On 6 136 Q-sr A 3 93 141 /-N CF3 
148 
~ mu I 7 137 CF3 A 22 98 Br 66 /-N 
149 
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Entry Boronic Ar-X Product Conditions Time Isolated 
acid (h) yield(%) 
N02 
"'"% H2Nn 8 137 N" I "': CF3 A 17 78 N h- Br 61 I .--< N 
150 
s ~s [ }-sr ~CF3 9 137 N N I "': A 20.5" 51 
142 .--< N 
151 
F3CnCI F~vca 10 I ""' " I CF A 3 75 137c N "': 3 N Cl I .--< 11 138 N A 28.5 83 
152 
F3CnCI 
137b I ""' F3C ssr 12 N Cl B sse 
138 CF3 
Table 4.1 Conditions A: Pd(PPh3) 2Ch (5 mol% Ar-X), I,4-dioxane, Na2C03 I M, reflux. B: 
Pd(PPh3) 2Ch (5 mol% Ar-Br)/t-Bu3P (5 mol% Ar-X), I,4-dioxane, Na2C03 I M, reflux. a 2 
equiv. boronic acid. h 2.1 equiv. boronic acid. c 1 equiv. boronic acid. "TLC indicated reaction 
was complete in 2 h. e After 28 h reflux a further 5 mol% Pd(PPh3) 2Cl2 was added and the 
reaction was left at reflux for a further 27 h. 1 36% of 152 was isolated as the minor product. 
Initial attempts to cross-couple 2,3-dichloro-5-(trifluoromethyl)pyridine 138 with two 
equivalents of boronic acid 136 resulted in high yields of the mono-substituted product 
145 (entry 3). It was expected that 138 would react initially at the more activated 2-
chloro position (see Section 1.3.1), the 2D NMR spectra (Figure 4.3, 1H COSY, 1H-13C 
HSQC, 1H-13C HMBC) were consistent with the structure 152. In the HMBC spectrum 
a 3-bond correlation is observed between C-6 (for numbering identification of 152 see 
Figure 4.3) and all protons except Ha. C-7 correlates to Hd ( 4-bond correlation) and He 
(2-bond correlation). Both observations are consistent with cross-coupling at the 2-
chloro position of 138. If cross-coupling had occurred at C-3 of 138 one would expect 
to.observe a nOe interacti<m. No nOe was observed for any protons in compound 145 
indicating that the protons on each pyridine ring were not interacting between the rings, 
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which is the case when 138 is substituted at the C-2 position. An extended reaction time 
and additional t-Bu3P ligand were required to promote the his-coupling reaction (entry 
12) yielding 153 as the major product (58% yield) alongside 152 (36% yield). The 1H 
COSY, HSQC and HMBC NMR spectra which validate the structure of 153 can be 
found in Appendix 2. 
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Figure 4.3 (a) 1H COSY NMR spectra of 152 (500 MHz, CDCb), (b) HSQC 1H NMR (500 
MHz, CDCb), 13C NMR (125 MHz, CDCb), (c) HMBC 1H NMR (500 MHz, CDCb), 13C NMR 
(125 MHz, CDCh). 
The chloro-bipyridyl derivative 152 was further cross-coupled with 2-methoxy-5-
pyridylboronic acid 154, yielding the tripyridyl derivative 155 in 75% yield (Scheme 
4.6). These reactions demonstrate the versatility of (trifluoromethyl)-substituted 
pyridylboronic acids 136 and 137 for the synthesis of functionalized bi- and tri-
(hetero )arenes. 
OMe 
(HOhBn 
CF3 + I 
~ 
N OMe 
(i) 
152 154 155 75% yield 
Scheme 4.6 (i) Pd(PPh3) 2Cb (5 mol% 152)/t-Bu3P (5 mol% 152), 1,4-dioxane, Na2C0 3 (1 M), 
reflux, 2.5 h. 
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4.2.2 Synthesis of 2-chioro-5-( trifluoromethyl)-3- and 4-pyridylboronic acid 
2-Chloro-5-trifluoromethylpyridine 156 is readily available from commercial suppliers 
and a patent outlines the preparation of 2-chloro-5-(trifluoromethyl)-3-pyridylboronic 
acid 157 in 25% yield (Scheme 4.7).456 
(i), (ii), (iii) 
157 25% yield 
Scheme 4.7 Preparation of 2-chloro-5-(trifluoromethyl)-3-pyridylboronic acid 157: (i) n-BuLi, 
HN{i-Pr)2, THF, -78 °C, 2 h. (ii) B(OMe)3, -78 °C, 0.5 h. (iii) H20, RT, AcOH.456 
Adapting the patent by using triisopropylborate instead of trimethylborate the directed 
ortho-lithiation and boronation of 156 yielded a product whose 1H NMR spectrum 
seemed consistent with the data assigned to 157 in the patent. The authors described the 
solid product to be a mixture of boronic acid and boroxine structures. Quoting the 1H 
NMR data of the mixture to be 'dH NMR (D20, NaOD, MeOD) o 8.45-8.51 (m, 1H), 
8.39, 8.36, 8.29 (each of these peaks is d, J = 2.5 Hz, and the number of the proton is 
totally 1H)".456 Our 1H NMR spectra, recorded in DMSO-d6, DCl, showed four proton 
signals (Figure 4.4). However, the 19F NMR spectrum showed our product to have two 
distinct fluorine signals, oF --61.2 and -58.9 ppm: ea. 1:1.4 ratio; the 13C NMR of the 
mixture also showed two CF3 carbon signals. 
We speculated that our compound was a mixture of two boronic acid species. From the 
1H NMR spectrum (Figure 4.4), we assigned two pairs of protons; Ha and Hb have 
similar integrals and show fine coupling, resulting from 157 where the protons would 
interact through a 4J (H,H). In compound 158 the two protons would not show an 
observable interaction; consequently, the remaining protons are assigned to 158 (He and 
Hd), their integrals also matched. Subsequently the two isomers 157 and 158 were 
separated by column chromatography and isolated in 25% and 42% yields, respectively 
(Scheme 4.8). The 1H NMR spectra of the separated 157 and 158 were consistent with 
our earlier deductions. X-Ray analysis further confirmed structure 158 (Figure 4.5). 
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157 25% yield 
B(OHh 
F3C~ 
l .. ~ N Cl 
158 42% yield 
Scheme 4.8 (i) n-BuLi, HN(i-Pr)2, THF, -78 °C, 2 h. (ii) B(Oi-Pr)3, -78 °C, 0.5 h. (iii) H20, 
RT,AcOH. 
HC 
rr T T ...; -i 0 
8.7 8.6 8.5 8.4 8.3 8.2 8.1 8.0 7.9 7.8 7.7 7.6 7.5 7.4 7.3 
0 (ppm) 
Figure 4.4 1H NMR spectrum of the mixture of157 and 158 (400 MHz, DMSO-d6, DCI). 
Figure·4;5·X::fay crystal structUre of l58, and hydrogen bonding in the crystai (the dashed lines 
are hydrogen bonds). (CCDC-699843). 
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It is possible that both isomers 157 and 158 were also obtained in the patent reference 
where the 1H NMR data was wrongly assigned solely to isomer 157. Methods for the 
regioselective lithiation of 156 are known.468 However, the regioselective boronic acid 
preparation was not investigated after finding that these highly electron-deficient 
boronic acids did not undergo Suzuki-Miyaura cross-couplings. From the reactions of 
both 157 and 158 with 2-bromopyridine using conditions [Pd(PPh3)2Ch, 1 ,4-dioxane, 
Na2C03], cross-coupling was not observed. 2-Chloro-5-(trifluoromethyl)pyridine 156, 
as a result of protodeboronation of the boronic acids, and unreacted 2-bromopyridine 
were isolated. On subjecting 157 and 158 to the Suzuki-Miyaura conditions 
[Pd(PPh3)2Ch, 1 ,4-dioxane, Na2C03], without a coupling partner present, after only 30 
min protodeboronated species 156 was observed by TLC, highlighting the instability of 
these boronic acids and their facile protodeboronation. Even when using the more 
reactive 2-iodopyridine and conditions previously used for the cross-coupling of our 
pyridazinylboronic esters (which we had found to be highly prone to protodeboronation, 
see Section 2.3 .2), [Pd2( dba)3/PCy3, 1 ,4-dioxane, K3P04, reflux] no cross-coupling 
occurred, only 156 was observed instantaneously and unreacted 2-iodopyridine via 
TLC. Attempts to oxidize boronic acid 158 with H20 21 to see if these boronic species 
had some synthetic use for the preparation of pyridinols were unsuccessful. The 1 H 
NMR spectrum of the crude product showed a multi-component mixture, and the 11B 
NMR indicated boronic acid was still present. We concluded that although isomeric 
boronic acids 157 and 158 seemed relatively stable on storage at ambient temperature, 
they were both highly susceptible to protodeboronation under Suzuki-Miyaura reaction 
conditions. This is not surprising considering the electron-deficient nature ofthe pyridyl 
ring, combined with two highly electron-withdrawing substituents. It is interesting that 
changing the electronics of the system dramatically affects the stability of the boronic 
acid. Without the chloro substituent, analogous boronic acids 136 and 137 were both 
resistant to protodeboronation and underwent Suzuki-Miyaura cross-coupling reactions 
readily giving coupling products in high yields. 
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4.3 ('frifluoromethyl)-substituted pyrazolylboronic esters 
4.3.1 Synthesis of 1-(hetero )aryl-3-(trifluoromethyi)-1H-4-pyrazolylboronic 
esters 
When employing pyrazolylboronic acids in Suzuki-Miyaura cross-coupling, usmg 
Pdz(dba)3/PCy3 as the catalyst system, low coupling yields were obtained when the 
pyrazole NH group is unprotected. 172 To circumvent this sensitivity N-protected 
pyrazolylboronic acids were applied and good coupling yields observed. N-aryl 
pyrazolylboronic esters have been prepared by Harrity and co-workers. 177 As the 
copper-catalyzed N-arylation of 3-(trifluoromethyl)pyrazole with iodobenzene is 
outlined483 we followed these conditions for the preparation of several 1-(hetero )aryl-3-
(trifluoromethy 1)-1 H-pyrazoles. From the commercially available 3-
(trifluoromethyl)pyrazole 129, N-(hetero)arylated pyrazole derivatives 159a-c were 
obtained in high yields (94-98%) with conditions [Cu20, salicylaldoxime, MeCN, 
CszC03, reflux] (Scheme 4.9). 
CF3 CF3 CF3 aAr= ~ 0 (i) 0 (ii}, (iii) 1-'--fi flOMe N/N N B N/ bAr= H I I I Ar 0 Ar 
129 159a 94% yield 160a 92% yield 
cAr= J) 159b 98% yield 160b 98% yield 
159c 94% yield 160c 84% yield 
Scheme 4.9 (i) Ar-1, Cu20 (5 mol% 129), salicylaldoxime (20 mol% 129), Cs2C03, MeCN, 
reflux, 18 h.483 (ii) n-BuLi, THF, -78 °C, 0.5 h; (iii) 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane, -78 °C, 1.5 h; warm toRT over 1 h, AcOH. 
It is known that regioselective acylation of pyrazole occurs when a trifluoromethyl 
substituent IS at C-3;483 I.e. there IS no tautomerization of the 3-
(trifluoromethyl)pyrazole, unlike other 3-substituted pyrazoles which undergo 3-/5-
tautomerization. The structures of 159a-c were confirmed by the coupling constants of 
the hydrogen atoms on the pyrazole ring. 1-Aryl-3-substituted pyrazoles exhibit 3 JH,H = 
2.4 - 2.9 Hz, while 1-aryl-5-substituted pyrazoles exhibit 3 JH.H = 1.5 - 1.9 Hz. 
Lithiation of }-substituted pyrazoles with n-BuLi occurs at the C-5 position when this is 
free.484 C-5 lithiation of 3-(trifluoromethyl)pyrazole is well known.477· 481 · 485 
Accordingly, treating 159a-c with n-BuLi followed by 2-isopropoxy-4,4,5,5-
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tetramethyl-1,3,2-dioxaborolane and acidic workup yielded the pinacol ester derivatives 
160a-c in 92%, 98% and 84% yields, respectively. The X-ray crystal structure of 160b 
was obtained, further confirming the boronic ester connectivity at the C-5 position of 
the pyrazole (Figure 4.6). 
Figure 4.6 X-Ray molecular structure ofpyrazolylboronic ester 160b. (CCDC-699540). 
Boronic ester 160c showed signs of instability during purification. The boronic ester is 
an oil, so to remove small amounts of unreacted starting material 159c from the crude 
product silica column chromatography was attempted. Unfortunately, the boronic ester 
readily protodeboronated whilst on the acidic silica, yielding more of 159c alongside the 
boronic ester. We found that distillation of the unreacted starting material was suitable 
for purifying 160c without any degradation of the boronic ester. 
4.3.2 Suzuki-Miyaura cross-coupling reactions 
Initial Suzuki-Miyaura cross-couplings of 160a, usmg the conditions reported by 
Harrity et al. for the coupling of pyrazolylboronic ester derivatives [Pd( dppf)Cb·DCM, 
1 ,4-dioxane, K3P04, 85 °C] 177 yielded the desired cross-coupled products alongside 
products resulting from homocoupling of the boronic ester and hydrolytic 
protodeboronation (Table 4.3, entries 2 and 4). On cross-coupling boronic ester 160b 
and changing the base to KOAc no homocoupling was observed; however, 
protodeboronation still occurred (Table 4.3, entries 10 and 13). A range of conditions 
for the cross-coupling of 160b with 3-bromo-5-methoxypyridine 161 were screened and 
the ratios of cross-coupled product 170, homocoupled boronic ester 176 and 
protodeboronation product 159b were assessed either from isolated yields or 
quantitatively by GCMS (Table 4.2). 
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MeO~Br 
t.J N 
161 
Conditions 
CF3 
I "N 
N '-': N' 
\0 h 
OMe ~ 
OMe 
170 
CF3 
eN 
N q 
OMe 
159b 
Results (Isolated yields or 
GCMS) 
-~·"-'"""w~~-->~~,~~''""""' -~~~"~~'"'"'"' ·~·~--~~··--'·'"-'''~~~ 
Pd(dppf}CI2·DCM, 1 ,4-dioxane, KOAc, 80 oc 
Pd( dppf}CI2· DCM, 1,4-dioxane, KOAc, 80 oc, with 
slow addition of 160b 
Pd(dppf}CI2·DCM, 1 ,4-dioxane, K3P04 , RT to 50 oc 
Pd(dppf}CI2·DCM, toluene, K3P04, RT to 50 oc 
Isolated yields; 170 42%, 
159b 43%. 
Isolated yields; 170 45%, 
159b 54%. 
GCMS; 170:176 ea. 1:10. 
GCMS; 170:176 ea. 4:1. 
Isolated yields; 170 31%, 
159b 50%. 
GCMS; 170:176:159b 
1:4:2. 
GCMS; 161 and Cy2NH 
observed, no coupling 
reaction observed. 
Table 4.2 Screening of reaction conditions for the cross-coupling of 160b with 161. 
Attempts to suppress levels of protodeboronation by slow addition of the boronic ester 
to the reaction mixture (Table 4.2, entry 2) or using Cy2NH as base276 (entry 7) were 
unsuccessful. It is thought that addition of water to a system can promote the cross-
coupling of N-heteroaryl derivatives by suppressing the coordination of the heteroaryl N 
to Pd through the formation of hydrogen bonds between the heteroaryl Nand water.486 
In our case this had no effect on reducing levels of homocoupling or protodeboronation 
(entry 6). The stability of boronic ester 160b was investigated; when 160b was 
subjected to the Suzuki-Miyaura conditions [Pd(dppt)Ch·DCM, 1,4-dioxane, 80 °C] in 
the absence of a coupling partner in the presence ·of K3P04 homocoupled boronic ester 
was detected: however, with KOAc only protodeboronated product 159b was observed 
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by GCMS. Protodeboronation of 160b occurred in 1,4-dioxane only in the presence of 
base at elevated temperatures (no catalyst or coupling partner present). The boronic 
ester 160b was stable to storage at ambient temperature and also stable at room 
temperature in the presence of base and stable to prolonged heating at 80 °C in 1 ,4-
dioxane. 
To improve the yields of the cross-coupled products we suppressed the homocoupling 
by addition of potassium formate?64 However, protodeboronation could not be 
completely eliminated. The conditions [Pd(dppf)Clz·DCM, 1,4-dioxane, K3P04, 
HCOOK, 80 °C] resulted in the highest conversions to the coupling product. The results 
for the Suzuki-Miyaura cross-coupling reactions of boronic esters 160a-c with 
heteroaryl bromides 61-63, 78, 143 and 161 are collated in Table 4.3. For 160a and 
160b the reactions proceeded in moderate to high yields (60-82%) with a variety of 
heteroaryl bromides as coupling partners, including those bearing nitro and primary 
amine substituents, yielding compounds 162-173. The X-ray structure of 163 was 
obtained (Figure 4.7). The presence of the mild reductant potassium formate may 
promote reductive dehalogenation of the heteroaryl halide-palladium intermediate (see 
Section 1.3.2, Figure 1.17). No Het-H was observed or isolated in any cross-couplings 
of 160a-c with Het-Br, if the reductive dehalogenation was occurring it was only in 
negligible amounts, consequently a slight excess of Het-Br was not applied. 
Figure 4.7 X-Ray molecular structure of compound 163. (CCDC-699541). 
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CF3 CF3 1-'n + (i) _o Het-Br B N' Het N N I I I 0 Ar Ar 
160a-c 162-175 
Boronic Time Isolated 
ester Het-Br Product (h) yield (%) 
Cl (If 4.5 77 160a N Br b 78 43 59 
162 
N02 ;ff 4 82 "'"6 160a b N .& Br 26.5 66 H2N 61 N02 
163 
Meonsr ~f 160a I /- N OMo b 4 80 N 161 
164 
N yf 160a ~~ 
tN b 3 74 N .& Br 62 
165 
H2N~~~ yf 160a N .& Br ~ b 5 67 63 HzN N ,.._ 
166 
aBr lff 160a s b 5 81 143 
167 
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Boronic Time Isolated Entry 
ester Het-Br Product (h) yield (%) 
Cl cif 9 5.5 63 160b N Br q 10b 78 17.5 49 
OMe 
168 
N02 
rif 11 160b H2Nn q 5 79 N h- Br 61 H2N N02 
OMe 
169 
MeOUBr Y1' 12 I /-
N OMe q 5 82 160b N 13b 161 17.5 42 
OMe 
170 
N yf ~~ 14 160b N .,-:; Br 
tN q 3 60 62 
OMe 
171 
H2N~~~ yf 15 160b N .,-:; Br l q 5 72 63 H2N N 
:--.... 
OMe 
172 
eR' crBr 16 160b s q 5 85 143 
OMe 
173 
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Boronic Time Isolated Entry 
ester Het-Br Product (h) yield (%) 
CF3 
u ~N 17 160c N' 4.5 16 N Br 
Nb 78 
174 
N yf ~~ 18 160c N .& Br N 4.5 30 
lN Nb 62 
175 
Table 4.3 (i) Pd(dppf)Ch·DCM (10 mol% Het-Br), 1,4-dioxane, K3P04, HCOOK, 80 oc. a 
Without HCOOK. b Without HCOOK and using KOAc as base. 
For 160c the coupling reactions were less successful (Table 4.3, entries 17 and 18), the 
major product was the protodeboronated product 159c: yields of coupling products 174 
and 175 were 16% and 30%, respectively. These results are consistent with the 
combined electron withdrawing effects of the N-pyridyl and trifluoromethyl substituents 
increasing the instability of the C-B bond and thus making it prone to hydrolytic 
deboronation under basic conditions. Protodeboronation is known to occur with 
heteroarylboronic acids, especially electron-deficient derivatives (see Section 1.3.3 for 
further discussion). Pyrazolylboronic acids and esters are also known to be prone to 
protodeboronation. 170• 176 On checking 160c by 1H NMR, after its storage under ambient 
conditions for 15 days, we found that the boronic ester had started to protodeboronate, 
the ratio of 160c:159c from the proton integrals was ea. 5:1. The 11B NMR of the 
sample also showed a second signal resulting from the product of protodeboronation, 
presumably (pin)B(OH). The stability of 160c was investigated at elevated 
temperatures; at 80 °C the sample which had started to protodeboronate on storage, 
showed no further signs of degradation after heating for 1 h. However, on adding K3P04 
rapid protodeboronation occurred and the boronic ester was fully converted into 159c. 
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4.3.3 Bromination of 3-(trifluoromethyl)pyrazole derivatives 
Pyrazole can undergo electrophilic attack at the C-4 position. To further increase the 
structural diversity of the 3-(trifluoromethyl)pyrazole core we looked to introduce a 
halogen at the C-4 position for use as a handle to prepare a 4-pyrazolylboronic ester 
analogue. The N-phenyl and N-( 4-methoxyphenyl) derivatives 159a, b were the main 
focus. As we had found the 5-pyrazolylboronic ester 160c to be unstable we did not 
expect the 4-pyrazolylboronic ester analogue to have improved stability, especially as 4-
pyrazolylboronic acids are known to be more unstable, with respect to 
protodeboronation, than their 5-pyrazolyl derivatives. 170 There are a number of methods 
reported for the halogenation of pyrazole derivatives.481 • 487-491 We recognized that 159a 
and b may be more activated towards electrophilic halogenation of theN-phenyl or N-
( 4-methoxyphenyl) substituents, particularly as the trifluoromethyl group adjacent to the 
pyrazole C-4 may deactivate this site towards electrophilic reaction. A number of 
conditions were screened for the bromination of 159a (Table 4.4). Using highly 
activated conditions [Br2, {Fe}, 100 °C, 1 h], reported for the bromination of 1-methyl 
3-(trifluoromethyl)pyrazole,481 we found that both the pyrazole and phenyl rings of 
159a were activated to bromination and the dibrominated species 179 was isolated. 
Although in this case it was an undesired product, 179 may be an interesting substrate 
for cross-coupling reactions. Reviewing the literature, regioselective pyrazole C-4 
bromination of 1-phenylpyrazole is known; for example, by reaction with bromine in 
sulfuric acid at 0 °C487 or the microwave reaction with NBS in acetic acid.490 NBS is 
also used for the preparation of 4-bromo-3,5-dimethyl-1-phenylpyrazole in good yields 
from 3,5-dimethyl-1-phenylpyrazole using ultrasound irradiation.489 Our attempts to 
apply some of these conditions were unsuccessful in preparing 177, either the phenyl 
group was brominated (Table 4.4, conditions B), or no reaction occurred (conditions C). 
It has been stated that when using bromine for the bromination of 1-phenylpyrazole 
"bromination can be expected to occur preferentially in the 4-position in both 1-
phenylpyrazole and the protonated molecule".487 Consequently, we treated 159a with 
bromine in acetic acid at 100 oc and obtained 4-bromo-3-(trifluoromethyl)-1-
phenylpyrazole 177 in 51% yield. We also recovered some unreacted 159a, we assumed 
that the reaction had not gone to completion, presumably as a result of some bromine 
evaporation. When using 1.5 equiv. of bromine we were pleased to isolate 177 in 92% 
yield, without any bromination of the N-phenyl substituent. 
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CF3 Brlr CF3 BrtdF' eN 
eN 
I ",N 
Conditions A-F I ",N N N 
N N q q b b 
Br Br 
159a 177 178 179 
'"<'»'A''",O»>.~~-'·'>O'"'c'-'"'.,"""'"',-.,"""''"'''"'''"''""""cc<"""""""''""'-"«=--- ,'O'w-"""''-k" 'b > -'-'--'' 
Yield of 177 Yield of 178 Yield of 179 
Conditions (%) (%) (%) 
.. ·············-·-·-··-~······---~····· .. 
Br2, {Fe}, 100 oc, 1 h481 
evidence 
0 73 
by NMRa 
Br2, H2S04, 0 oC487 
evidence 
0 0 
by NMRa 
NBS, EtOAc, sonicate, 1 h489 no reaction occurred 
Br2 (1.0 equiv.), AcOH, 100 oc, 39.5 h 51b 0 0 
NBS (1.1 equiv. ), AcOH, 50 oc, 7 h 3Qc 0 0 
Br2 (1.5 equiv.), AcOH, 100 oc, 17 h 92 0 0 
Table 4.4 Bromination of 159a a Mixture with unreacted starting material 159a. b ea. 10% 
unreacted 159a recovered. c Reaction not to completion. 
With 177 in hand we looked to the preparation of the 4-pyrazolylboronic ester. The first 
question to consider was, on treating 177 with an alkyllithium would lithium-halogen 
exchange at C-4 occur more rapidly than deprotonation at C-5? Also, would the initial 
lithium intermediates be stable or would they rearrange to the thermodynamically most 
stable position? Literature precedent reported the selective C-5 lithiation-halogen 
exchange of 4-bromo-3-(trifluoromethyl)-1-methylpyrazole with t-BuLi.481 When using 
LDA, deprotonation of 4-bromo-3-(trifluoromethyl)-1-methylpyrazole occurred at the 
C-5 position. Analysis of the 1H NMR from treating 177 with n-BuLi and D20 showed 
both C-4 and C-5 protons present. The major signal was from the C-5 proton, indicating 
that the lithium-halogen exchange had occurred preferentially (Scheme 4.1 0). 
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CF3 CF3 
D'CN £N + N D ~ I 
Ph Ph 
major product minor product 
Scheme 4.10 Investigation into the lithiation of 177. (i) n-BuLi, THF, -78 °C, 10 min; (ii) D20. 
177 was treated with t-BuLi, as in the literature, and then quenched with 2-isopropoxy-
4,4,5,5-tetramethyl-1 ,3,2-dioxaborolane; unfortunately, boronic ester was not observed 
by TLC and the 1H NMR spectrum of the product indicated lithiation had occurred but 
not boronation, as the C-4 proton was present. An alternative route was explored, using 
177 to prepare a Grignard reagent, which could then be transmetalated with a boron 
reagent to prepare the boronic ester derivative (Scheme 4.11 ). Initially the Grignard and 
the boronate were stirred at room temperature for 1 0 min before an acid quench. The 1 H 
NMR spectrum of the resulting product showed the C-4 proton signal, indicating that 
the Grigard had been prepared, however, the transmetalation to the boronate had been 
unsuccessful. In further attempts, leaving the reaction mixture for 2 h at room 
temperature did not improve transmetalation of the Grignard to the boronate- the 1H 
NMR spectrum of the isolated product again showed the C-4 proton. Further 
investigation into both the lithiation and Grignard reaction of 177 may prove fruitful in 
isolating boronic ester 180, however, we decided to move on to the functionalization of 
the pyrazole cross-coupling products. 
Br~F3 (i) 
lL.~;N --
N 
(ii), (iii) 
I 
Ph 
177 
CF3 
(pin)By-{ 
lL.~;N N' 
I 
Ph 
180 
Scheme 4.11 Attempted synthesis of 180. (i) Mg, THF; (ii) 2-isopropoxy-4,4,5,5-tetramethyl-
1 ,3,2-dioxaborolane; (iii) AcOH. 
The pyrazolyl coupling products 162 and 163 were further elaborated by preparing their 
4-bromo derivatives and subsequent cross-coupling with another het~roarylboronic acid 
. ,. .. - - ... . ·-
to yield 1 ,4,5-[tri(hetero )aryl]-3-(trifluoromethyl)pyrazole derivatives (Scheme 4.12). 
The reaction of 162 and 163 with bromine in acetic acid at lOO oc resulted in 
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regioselective electrophilic bromination at C-4 of the pyrazole ring yielding 181 and 
182 in 66% and 86% yields, respectively (Scheme 4.12). In a further Suzuki-Miyaura 
cross-coupling reaction, 181 and 182 gave the fully functionalized pyrazole derivatives 
183 and 184 in 80% and 30% yields, respectively. Unfortunately, in the reaction of 182 
with boronic acid 136, homocoupled boronic acid and debrominated starting material 
163, (which coeluted during column chromatography), and 16% unreacted starting 
material182 were recovered alongside the coupling product 184. The X-ray structure of 
183 was obtained (Figure 4.8). 
(i) Bri~' 
R N 
b 
181 R=)) 
66% yield 
N NH2 
182 R=D N02 
86% yield 
(ii) 
R'~F3 
_)_~N 
R N 
b 
~~ R' = IIN}OMe 
183 R=~ ~ 
80% yield 
N NH2 R' =JJN __, CF3 
184 R= f'Y // ~N02 
30% yield 
Scheme 4.12 (i) Br2, AcOH, 100 °C, 19 h. (ii) for 181, 2-methoxy-5-pyridylboronic acid; for 
182, 136; Pd(PPh3) 4 (5 mol% Ar-Br), 1,4-dioxane, Na2C03 (1 M), reflux, 3.5-6 h. 
Figure 4.8 X"Ray crystal structure of compound 183. (CCDC-699542). 
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Although the boronic ester preparation from 177 had been unsuccessful in our hands we 
were interested whether the N-( 4-methoxyphenyl)pyrazole derivatives could be 
regioselectively brominated at the pyrazole ring, or whether the 4-methoxyphenyl 
substituent would be too activated towards electrophilic reaction. We then hoped to use 
this protocol for the bromination of several of the N-( 4-methoxyphenyl)pyrazole 
coupling products (analogous to Scheme 4.12). The reaction of 159b with bromine (1.5 
equiv.) in acetic acid at 100 oc gave a multicomponent mixture. Following silica 
column chromatography the major product isolated was identified as the dibrominated 
species 185 (Scheme 4.13), as had been expected. A mixture of two monobrominated 
isomers 186 and 187 was obtained in 11% yield. Separation was not attempted as the 
undesired 186 was the major isomer eH NMR spectra indicated a ratio of 186:187, 4:1 
from the integrals). 
CF3 
eN (i) 
N q 
OMe 
159b 
Brtd,F' CF3 
eN 
Brtd,F' 
I ",N I ",N 
N N N 
Q-Br Q-Br q 
OMe OMe OMe 
185 186 187 
43% yield major product minor product 
Brtd,:' 
N 
Q-Br 
OH 
188 
observed by NMR 
11% yield 
Brtd,:' 
N Q-Br 
Br OH 
189 
3% yield 
Scheme 4.13 Bromination of159b. (i) Br2 (1.5 equiv.), AcOH, 100 °C, 17 h. 
Two further minor products were isolated, both of which showed no OMe signals in the 
1H NMR spectra. Based on the 1H NMR and MS data we conclude their structures are 
188 and 189. The MS spectra for 188 and 189 were consistent with two and three 
bromines, respectively, and a hydroxyl substituent and not a methoxy (in agreement 
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with the 1H NMR spectra). It appears that the methoxyphenyl substituent prevents clean 
electrophilic bromination on the pyrazole ring. Consequently alternative bromination 
conditions were not explored, and the N-methoxyphenyl substituted pyrazolyl coupling 
products were not further derivatized. The brominated derivatives of 159b are new 
interesting species, that could be used to further expand the diversity of the 3-
(trifluoromethyl)pyrazole structure. 
4.4 Conclusions 
The preparation of new CF 3-substituted pyridylboronic acids which are stable to storage 
under ambient conditions has been described. These species readily undergo Suzuki-
Miyaura cross-coupling reactions to yield aryl/heteroaryl-(trifluoromethyl)pyridines in 
good to excellent yields. However, if further electron-withdrawing substituents are 
introduced on the pyridyl ring, as is the case for 2-chloro-5-(trifluoromethyl)pyridine, 
the boronic acid derivatives are unstable to protolytic deboronation. 
3-(Trifluoromethyl)-pyrazolylboronic esters have been synthesized through an 
expedient procedure. These species undergo palladium-catalyzed cross-coupling 
reactions to provide heteroaryl-(trifluoromethyl)pyrazoles in synthetically viable yields, 
although in some cases competing protodeboronation was observed. Regioselective C-4 
bromination of 3-(trifluoromethyl)-1-phenylpyrazole derivatives has been established, 
offering scope for further synthetic transformations, as highlighted by the Suzuki-
Miyaura cross-coupling reactions of 4-bromo-5-(heteroaryl)-3-(trifluoromethyl)-1-
phenylpyrazoles to prepare highly functionalized tri-substituted trifluoromethylated 
pyrazole structures. 
The fragile stability of electron-deficient N-heteroarylboronic acids has been exposed. 
The successful preparation and storage under ambient conditions is notable, on account 
of the highly electron-deficient trifluoromethyl group and adjacent pyrazole N. With the 
trifluoromethyl-substituent having the appeal of tailoring activity profiles, these 
functionalized CF 3-substituted heterocycles are of potential utility as new 
pharmacophores and scaffolds for drug discovery. 
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CHAPTER 5 -EXPERIMENTAL PROCEDURIES 
5.1 General Considerations 
All reactions that required inert or dry atmosphere were carried out under a blanket of 
argon, which was dried by passage through a column of phosphorus pentoxide. 
Glassware was either flame dried or dried in the oven prior to use. All reagents 
employed were of standard reagent grade and purchased from Aldrich, Alfa Aesar, 
Apollo, Frontier Scientific, Fluorochem or supplied by Vertellus Specialties UK Ltd., 
and were used as supplied unless otherwise stated. Pd(PPh)3Ch and Pd(PPh3)4 were 
prepared in house,492494 Pd(OAc)2 was purchased from Aldrich, Pd2(dba)3 was 
purchased from Alfa Aesar. t-Bu3P and D-t-BPF were purchased from Strem, PCy3 was 
purchased from Molekula. Anhydrous THF, diethyl ether (EhO), DMF, DCM and 
methanol were dried through a HPLC column on an Innovative Technology Inc. solvent 
purification system. All other solvents in this work were used without prior purification. 
All reactions were set up outside of a glovebox, including the weighing of solid 
substrates. Column chromatography was carried out using 40-60 ~m mesh silica. Thin-
layer chromatography (TLC) were performed on 20 mm precoated plates of silica gel 
(Merck, silica gel60F254), visualisation was made using ultraviolet light (254 nm). 
NMR spectra were recorded on; Bruker Avance-400 (1H NMR (400 MHz), 13C NMR 
(100 MHz), 11 B NMR (128 MHz)), Varian 500 eH NMR (500 MHz), 13C NMR (125 
MHz)), Varian 400 e 9F NMR (372 MHz)), Varian 200 (19F NMR (188 MHz)), Varian 
VNMRS 700 (13C NMR (175 MHz), using deuterated solvent as a lock. Chemical shifts 
are quoted in ppm, relative to tetramethylsilane (TMS), using TMS or the residual 
solvent as internal reference for 1H and 13C, and CFCh for 19F NMR. The following 
abbreviations are used in listing NMR spectra: s = singlet, d = doublet, t = triplet, m = 
multiplet. Melting points were determined on a Stuart Scientific SMP3 melting point 
apparatus and are uncorrected. Electron Impact (El) mass spectra were recorded on a 
Thermo-Finnigan Trace or Thermo-Finnigan DSQ with positive ionisation mode. 
Electro Spray (ES+) mass spectra were recorded on a Waters Micromass LCT mass 
spectrometer. HRMS (ES+) mass spectra were recorded on a Thermo-Finnigan L TQ FT 
mass spectrometer. All measured mass for bromine containing compounds corresponds 
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to 79Br, which displays expected isotope profile for bromine. Elemental analyses were 
obtained on an Exeter analytical Inc. CE-440 elemental analyser. 
X-Ray Crystallographic Data 
Single-crystal diffraction experiments were carried out on Bruker 3-circle 
diffractometers with SMART lK CCD area detector, using graphite-monochromated 
Mo-Ka radiation (/...=0.71073 A) and Cryostream (Oxford Cryosystems) open-flow N2 
cryostats. The structures were solved by direct methods and refined by full-matrix least 
squares against F of all data, using SHELXTL software.495 Non-hydrogen atoms were 
refined in anisotropic, H atoms is isotropic approximation or (in 77b and 77d) in 
"riding" model. Full structural data (excluding structure factors) have been deposited at 
the Cambridge Crystallographic Data Centre, deposition numbers are given with the X-
ray crystal structures. Thermal ellipsoids are drawn at the 50% probability level. Primed 
atoms are generated by the crystallographic inversion center. 
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3,6-Dimethoxypyridazine (58)496 
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MeO~ To a solution of sodium methoxide from sodium (6.50 g, 0.28 mol) 
~'N~OMe in dry methanol (130 mL), was added a solution of 3,6-
dichloropyridazine 57 (9.70 g, 0.065 mol) in anhydrous methanol (50 mL). The reaction 
mixture was heated at reflux for 19 h, cooled to room temperature then carefully 
neutralized with 37% HCl aq and evaporated in vacuo to dryness. The solid was 
extracted with EtOAc (200 mL) and washed twice with deionised water (2 x 100 mL). 
EtOAc was removed to leave 58 as a white crystalline solid (8.47 g, 93%) which was 
not further purified: mp 103.6-104.8 oc, lit. mp496 108 °C; 1H NMR (400 MHz, DMSO-
d6) 8 7.22 (lH, s), 3.97 (3H, s); Be NMR (100 MHz, DMSO-d6), 8 162.7, 122.4, 55.0; 
MS (El) m/z 140.1 (M+, 100%). Anal. Calcd. for C6H8N20 2: C, 51.42; H, 5.75; N, 
19.19. Found: C, 51.30; H, 5.78; N, 19.48%. 
3,6-Dimethoxy-4-pyridazinylboronic acid (59) 
MeO~B(OH)2 Procedure A: Diisopropylamine (13.4 mL, 0.10 mol) was added 
~'N~OMe to n-butyllithium (2.5 M in hexane, 41.0 mL, 0.10 mol) in 
anhydrous THF (400 mL) at -78 oc under argon. The mixture warmed to 0 oc and left 
to stir for 0.5 h. The reaction was then cooled to -78 °C and a solution of 3,6-
dimethoxypyridazine, 58 (6.73g, 0.048 mol) in anhydrous THF (100 mL) was added 
over 1 h. The reaction was stirred for a further 0.5 h. Triisopropylborate (33.2 mL, 0.14 
mol) was added at -78 °C and the mixture was stirred for 1.5 h. The mixture was 
warmed to -10 °C and quenched with deionised water (100 mL) and left to stir at room 
temperature overnight. The organic solvent and most of the water were removed in 
vacuo. The resulting slurry was then dissolved in water and filtered. The filtrate was 
washed with Et20 (2 x 150 mL) and acidified to pH 4 using HBr (48% aq. solution) to 
precipitate 59 as a white solid (7.78 g, 88%): mp 152.1-153.2 oc; 1H NMR (400 MHz, 
d6-DMSO) 8 8.50 (2H, s), 7.13 (1H, s), 3.95 (6H, s); Be NMR (100 MHz, d6-DMSO) 8 
163.99, 162.46, 125.35, 54.96, 54.84. 11 B NMR (128 MHz, DMSO-d6) 8 28.9; Anal. 
Calcd. for C6H9BN204: C, 39.17; H, 4.93; N, 15.23. Found: C, 39.00; H, 4.93; N, 
15.11%. 
134 
Chapter 5 - Experimental Procedures 
Procedure B: Diisopropylamine (83 mL, 0.59 mol) was added to n-butyllithium (2.5 M 
in hexane, 236 mL, 0.59 mol) in THF (500 mL) at -78 °C under nitrogen. The mixture 
warmed to 0 oc and left to stir for 0.5 h. The reaction was then cooled to -78 oc and a 
solution of 3,6-dimethoxypyridazine, 58 (40 g, 0.29 mol) in THF (500 mL) was added 
over 2 h. The reaction was stirred for a further 0.5 h. Triisopropylborate (198 mL, 0.86 
mol) was added at -78 oc and the mixture was stirred for 1 h. The mixture was warmed 
to -25 °C and quenched with water (500 mL) and left to stir at room temperature 
overnight. The mixture was filtered, the organic phase was separated and washed with 
water (250 mL), the aqueous phases were combined and washed with MTBE (3 x 250 
mL). The resulting aqueous phase basified to pH 12 using NaOH (50 mL, 10% aq.), 
then slowly acidified to pH 4 using AcOH to precipitate 59 as a white solid (23.5 g, 
45%) spectroscopically identical with the sample from Procedure A. 
Procedure C: Diisopropylamine (2.1 mL, 15 mmol) was added to n-butyllithium (2.5 M 
in hexane, 5.9 mL, 15 mmol) in anhydrous THF (60 mL) at -78 °C under argon. The 
mixture warmed to 0 oc and left to stir for 0.5 h. The reaction was then cooled to -20 
oc and a solution of 3,6-dimethoxypyridazine, 58 (1.0 g, 7.1 mmol) in anhydrous THF 
(40 mL) was added over 1 h. The reaction was stirred for a further 0.5 h. 
Triisopropylborate (4.9 mL, 21 mmol) was added at -20 °C and the mixture was stirred 
for 1.5 h. The mixture was warmed to -10 oc and quenched with deionised water (50 
mL) and left to stir at room temperature overnight. The organic solvent and most of the 
water were removed in vacuo. The resulting slurry was then dissolved in water (50 mL) 
and filtered. The filtrate was washed with Ei20 (2 x 50 mL) and acidified to pH 4 using 
HBr (48% aq. solution) to precipitate 59 as a beige solid (0.184 g, 14%) 
spectroscopically identical with the sample from Procedure A. 
Procedure D: Diisopropylamine (83 mL, 0.59 mol) was added to hexyllithium (2.5 M 
in hexane, 236 mL, 0.59 mol) in THF (1 L) at -78 oc under nitrogen. The mixture 
warmed to 0 oc and left to stir for 0.5 h. The reaction was then cooled to -78 °C and a 
solution of 3,6-dimethoxypyridazine, 58 (40 g, 0.29 mol) in THF (500 mL) was added 
over 1.25 h. The reaction was stirred for a further 0.5 h. Triisopropylborate (198 mL, 
0.86 mol) was added at -78 °C and the mixture was stirred for 1 h. The mixture was 
warmed to room temperature and quenched with water (500 mL) and left to stir at room 
temperature overnight. The mixture was filtered, the organic phase was separated, the 
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aqueous phase was washed with MTBE (2 x 250 mL ). The resulting aqueous phase was 
slowly acidified to pH 4 using AcOH to precipitate 59 as a white solid (32.8 g, 62%) 
spectroscopically identical with the sample from Procedure A. 
Procedure E: Diisopropylamine (1 0.4 mL, 0.074 mol) was added to hexyllithium (2.3 
M in hexane, 32 mL, 0.074 mol) in THF (100 mL) at -78 oc under nitrogen. The 
mixture warmed to 0 oc and left to stir for 0.5 h. The reaction was then cooled to -20 
oc and a solution of 3,6-dimethoxypyridazine, 58 (5.1 g, 0.036 mol) in THF (120 mL) 
was added over 1.25 h. The reaction was stirred for a further 1.25 h. Triisopropylborate 
(24. 7 mL, 0.11 mol) was added at -20 ac and the mixture was stirred for 1 h. The 
mixture was warmed to room temperature and quenched with water (150 mL) and left to 
stir at room temperature overnight. The organic phase was separated, and the resulting 
aqueous phase was washed with MTBE (4 x 200 mL). The resulting aqueous phase was 
slowly acidified to pH 4 using AcOH to precipitate 59 as a white solid (2.0 g, 30%) 
spectroscopically identical with the sample from Procedure A. 
Typical Procedure for the Suzuki-Miyaura Cross-Coupling Reactions in Table 2.1 
The boronic acid 59 (1.0 equiv.) the aryl halide (0.9 equiv.) and catalyst (ea. 5 mol% 
59) were sequentially added to degassed 1,4-dioxane (10 mL) and the mixture was 
stirred at 20 oc for 30 min. Degassed aqueous Na2C03 solution (1 M, 3.0 equiv.) was 
added and the reaction mixture was heated under argon at reflux for 65 h. Solvent was 
removed in vacuo, then EtOAc was added and the organic layer was washed with brine, 
separated, and dried over MgS04. The mixture was purified by chromatography on a 
silica gel column followed if needed by recrystallization. 
Conditions A: Pd(OAc)z (5 mol% 59)/D-t-BPF (5 mol% 59), 1,4-dioxane, Na2C03 (1 
M), reflux, 65 h. 
Conditions B: Pd(PhCN)zCh (5 mol% 59)/t-BuJP (5 mol% 59), 1,4-dioxane, NazC03 (1 
M), reflux, 65 h. 
Conditions C: Pd(PPh3)zC}z (5 mol% 59), 1,4-dioxane, Na2C03 (1 M), reflux, 65 h. 
Conditions D: Pd(PPh3)C}z (5 mol% 59)/t-BuJP (5 mol% 59), 1 ,4-dioxane, NazC03 (1 
M), reflux, 65 h. 
Conditions E: Pd(OAc)z (5 mol% 59)/t-Bu3P (5 mol% 59), 1 ,4-dioxane, Na2C03 (1 M), 
reflux, 65 h. 
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2-(3,6-Dimethoxypyridazin-4-yl)-5-nitropyridine (67) 
N02 Compound 59 (313 mg, 1. 7 mmol), 2-bromo-5-nitropyridine 
60 (305 mg, 1.5 mmol), Pd(OAc)2 (19.0 mg, 0.085 mmol), 
D-t-BPF (38.0 mg, 0.080 mmol), 1,4-dioxane (10 mL) and 
NazC03 (1 M, 4 mL); reaction time 65 h; eluent EtOAc 
gave 67 as a light brown crystalline solid (353 mg, 90%): mp 144.4-145.9 °C; 1H NMR 
(400 MHz, CDCh) o 9.51 (lH, d, J = 2.4 Hz), 8.57 (lH, dd, J = 11.2 Hz, J = 2.8 Hz), 
8.37 (lH, d, J = 8.8 Hz), 7.74 (lH, s), 4.21 (3H, s), 4.12 (3H, s); 13C NMR (100 MHz, 
CDCh), o 163.4, 158.8, 156.1, 145.1, 143.9, 131.7, 129.4, 125.0, 121.0, 55.3, 55.0; MS 
(ES+) m/z 263.1 ([M+Ht, 100%). Anal. Calcd. for CIIHwN404: C, 50.38; H, 3.84; N, 
21.37. Found: C, 50.36; H, 3.84; N, 21.27%. 
2-Amino-3-nitro-5-(3,6-dimethoxypyridazin-4-yl)-pyridine (68) 
Compound 59 (313 mg, 1.7 mmol), 2-amino-5-bromo-3-
nitropyridine 61 (327 mg, 1.5 mmol), Pd(OAc)2 (19.0 mg, 
0.085 mmol), D-t-BPF (38.0 mg, 0.080 mmol), 1 ,4-dioxane 
(10 mL) and Na2C03 (1 M, 4 mL); reaction time 65 h; 
eluent EtOAc gave 68 as a yellow crystalline solid (288 mg, 69%): mp 235.0-236.2 oc; 
1H NMR (400 MHz, DMSO-d6) o 8.75 (2H, s), 8.23 (2H, s), 7.45 (1H, s), 4.02 (3H, s), 
3.98 (3H, s); 13C NMR (100 MHz, DMSO-d6) o 162.3, 158.6, 156.1, 153.5, 135.1, 
128.6, 126.1, 117.7, 117.0, 54.6, 54.2; MS (ES+) mlz 278.0 ([M+Ht, 100%). Anal. 
Calcd. for C11H11N504: C, 47.66; H, 4.00; N, 25.26. Found: C, 47.47; H, 3.91; N, 
24.90%. 
5-(3,6-Dimethoxypyridazin-4-yl)-pyrimidine (69) 
Nil Compound 59 (313 mg, 1.7 mmol), 5-bromopyrimidine 62 (238 
MeO N mg, 1.5 mmol), Pd(PhCN)zCh (33.0 mg, 0.085 mmol), t-Bu3P 
'-':: 
N OMe 
(0.02 mL, 0.080 mmol), 1,4-dioxane (10 mL) and NazC03 (1 M, 
4 mL); reaction time 65 h; eluent EtOAc gave 69 as a yellow 
solid (258 mg, 78%): mp 168.8-169.5 °C; 1H NMR (400 MHz, CDCh) o 9.26 (1H, s), 
8.99 (2H, s), 7.01 (1H, s), 4.11 (3H, s), 4.09 (3H, s); 13C NMR (100 MHz, CDCh) o 
162.6, 159.0, 158.9, 156.7, 127.9, 127.6, 119.4, 55.3, 55.0; MS (ES+) mlz 219.4 
([M+Ht, 100%); HRMS (El) calcd for CwHwN40z 218.0804, found: 218.0806. Anal. 
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Calcd. for CwH10N402: C, 55.04; H, 4.62; N, 25.68. Found: C, 54.72; H, 4.61; N, 
25.24%. 
2-Amino-5-(3,6-dimethoxypyridazin-4-yl)-pyrimidine (70) 
:,.NI(NH2 Compound 59 (313 mg, 1.7 mmol), 2-amino-5-MeO~~ bromopyrimidine 63 (261 mg, 1.5 mmol), Pd(OAc)2 (19.0 I~ 
N _..-_; mg, 0.085 mmol), D-t-BPF (38.0 mg, 0.080 mmol), 1,4-
'N OMe 
dioxane (10 mL) and Na2C03 (1 M, 4 mL); reaction time 65 
h; eluent EtOAc gave 70 as a beige solid (234 mg, 65%): mp 253.2-254.2 °C; 1H NMR 
(400 MHz, CDCh) 8 8.61 (2H, s), 6.92 (1H, s), 5.46 (2H, s), 4.10 (3H, s), 7.08 (3H, s); 
13C NMR (lOO MHz, CDCh) 8 163.0, 162.7, 159.2, 158.5, 128.7, 117.6, 117.2, 55.1, 
54.8; MS (ES+) mlz 234.1 ([M+Ht, 100%). Anal. Calcd. for C10H11Ns02: C, 51.50; H, 
4.75; N, 30.03. Found: C, 51.41; H, 4.75; N, 29.97%. 
2-Amino-5-(3,6-dimethoxypyridazin-4-yl)-pyrazine (71) 
N NH2 Compound 59 (313 mg, 1.7 mmol), 2-amino-5-
MeOxx:= r bromopyrazine 64 (281 mg, 1.5 mmol), Pd(PhCN)2Cb (33.0 
I N 
N,N/: OMe mg, 0.085 mmol), t-Bu3P (0.02 mL, 0.080 mmol), 1,4-
dioxane (10 mL) and Na2C03 (4 mL, 1 M); reaction time 65 
h; recrystallized from toluene to give 71 as a yellow/orange solid (168 mg, 48%): mp 
233.3-235.4 °C; 1HNMR (400 MHz, DMSO-d6) 8 8.72 (1H, d,J= 1.2 Hz), 8.03 (IH, d, 
J = 1.2 Hz), 7.48 (lH, s), 7.04 (2H, s), 4.07 (3H, s), 3.97 (3H, s); 13C NMR (100 MHz, 
DMSO-d6), 8 162.6, 158.4, 155.8, 143.5, 132.7, 132.1, 129.6, 115.4, 54.5, 54.2; MS 
(ES+) mlz 234.1 ([M+Ht, 100%). Anal. Calcd. for CwH11Ns02: C, 51.50; H, 4.75; N, 
30.03. Found: C, 51.21; H, 4.74; N, 29.73%. 
2-Nitro-5-(3,6-dimethoxypyridazin-4-yl)-thiophene (72) 
N02 Compound 59 (313 mg, 1.7 mmol), 2-bromo-5-nitrothiophene 
65 (312 mg, 1.5 mmol), Pd(0Ac)2 (19.0 mg, 0.085 mmol), 0-t-
MeO 
BPF (38.0 mg, 0.080 mmol), 1,4-dioxane (10 mL) and Na2C03 
_..-_; 
'N OMe (1 M, 4 mL); reaction time 65 h; eluent EtOAc gave 72 as a 
browp. powqerno9 mg, 77%): mp 185.1-186.9 °C; 1H NMR (400 MHz, CDCh) 8 7,94 
(1H, d, J= 4.0 Hz), 7.64 (1H, d, J= 4.0 Hz), 7.24 (1H, s), 4.26 (3H, s), 4.12 (3H, s); 13C 
NMR (100 MHz, CDCh) 8 162.7, 157.2, 140.6, 128.1, 127.1, 124.6, 115.9, 55.4, 55.1; 
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MS (ES+) mlz 268.1 ([M+Ht, 1 00%). HRMS (ES+) calcd for CwH10N304S 268.0392, 
found 268.0387. Anal. Calcd. for C10H9N304S: C, 44.94; H, 3.39; N, 15.72. Found: C, 
44.79; H, 3.47; N, 15.01%. 
3-(3,6-Dimethoxypyridazin-4-yl)-quinoline (73) 
Compound 59 (313 mg, 1. 7 mmol), 3-bromoquinoline 66 
(0.2 mL, 1.5 mmol), Pd(OAc)2 (19.0 mg, 0.085 mmol), D-t-
BPF (38.0 mg, 0.080 mmol), 1,4-dioxane (10 mL), Na2C03 
(1 M, 4 mL); reaction time 65 h; eluent EtOAc gave 73 as a 
white solid (381 mg, 95%): mp 146.6-147.1 oc; 1H NMR (400 MHz, acetone-d6) o 9.22 
(1H, d, J= 2.0 Hz), 8.69 (1H, d, J= 2.8 Hz), 8.14 (lH, d, J= 9.2 Hz), 8.08 (lH, d, J= 
9.6 Hz), 7.81 -7.88 (1H, m), 7.67-7.71 (1H, m), 7.34 (lH, s), 4.13 (3H, s), 4.10 (3H, 
s); 13C NMR (100 MHz, acetone-d6), o 163.5, 160.2, 150.9, 148.8, 137.1, 131.5, 131.0, 
129.9, 129.3, 128.2, 127.9, 127.7, 120.0, 54.9, 54.6; MS (ES+) mlz 268.2 ([M+Ht, 
100%). Calcd for C15H13N302: C, 67.40; H, 4.90; N, 15.72. Found: C, 67.37; H, 4.85; 
N, 15.55%. 
58·B(OH)3 Complex 
M eO~ 
~'N~OMe 
OH 
I 
HO ... B'OH 
3,6-Dimethoxy-4-pyridazinylboronic acid 59 was refluxed in the 
minimal amount of ethanol, upon cooling and evaporation of the 
solvent crystals grew which X-ray structural analysis confirmed to 
be complex 58·B(OH)J. 
General Procedure for the preparation of 75a-d. 
Boronic acid (1.0 equiv.), 3-chloro-6-methoxypyridazine 74 (0.9 equiv.) and 
Pd(PPh3)2Ch (ea. 5 mol% boronic acid) were sequentially added to degassed 1,4-
dioxane (100 mL) and the mixture was stirred at 20 oc for 30 min. Degassed aqueous 
Na2C03 solution (1 M, 56 mL) was added and the reaction mixture was heated under 
argon at reflux for 65 h. Solvent was removed in vacuo then EtOAc (50 mL) was added 
and the organic layer was washed with brine (50 mL), separated, and dried over 
MgS04. The mixture was purified by chromatography on a silica gel column, followed 
by recrystallization in some cases. 
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3-Methoxy-6-phenylpyridazine (75a )328• 331 
Benzeneboronic acid (2.86 g, 0.024 mol), 3~chloro-6-n~ ~ l~OMe 1.2 mmol); eluent petroleum ether (bp 40-60 °C):Et0Ac 1:4 v/v, methoxypyridazine 74 (3.0 g, 0.021 mol), Pd(PPh3)2Ch (0.82 g, 
yielded 75a as a white solid (3 .68 g, 95%): mp 119.8-121.4 °C, lit. mp328 116 oc; I H 
NMR (400 MHz, CDCh) 3 7.97 (2H, d, J = 8.0 Hz), 7.73 (1H, d, J = 9.2 Hz), 7.42-
7.47 (3H, m), 7.00 (lH, d, J = 9.2 Hz), 4.15 (3H, s); 13C NMR (100 MHz, CDCb) 3 
164.3, 155.2, 136.2, 129.4, 128.9, 127.2, 126.5, 117.7, 54.9; MS (ES+) mlz 187.1 
([M+Ht, 100%). Anal. Calcd. for C11HION20: C, 70.95; H, 5.41; N, 15.04. Found: C, 
70.88; H, 5.37; N, 15.14%. 
3-Methoxy-6-( 4-methoxyphenyl)pyridazine (75b )328 
MeO ?" 4-Methoxyphenylboronic acid (2.38 g, 0.016 mol), 3-
~ I chloro-6-methoxypyridazine 74 (2.0 g, 0.014 mol), I~ 
N,N...-:; Pd(PPh3)2Ch (0.55 g, 0.78 mmol). Recrystallization from 
OMe 
toluene yielded 75b as a white solid (2.59 g, 87%): mp 
137.4-139.0 oc, lit. mp328 134 °C; 1H NMR (400 MHz, CDCb) 3 7.95 (2H, d, J = 8.8 
Hz), 7.71 (1H, d, J= 9.2 Hz), 7.01-6.98 (3H, m), 4.16 (3H, s), 3.85 (3H, s); 13C NMR 
(100 MHz, CDCh) 3 164.1, 160.9, 155.0, 128.9, 127.9, 126.7, 117.8, 114.5, 55.5, 54.9; 
MS (ES+) mlz 217.1 ([M+Ht, 100%). Anal. Calcd. for C12H12N20z: C, 66.65; H, 5.59; 
N, 12.96. Found: C, 66.75; H, 5.62; N, 13.10%. 
3-Methoxy-6-(2-metboxypyridin-5-yl)-pyridazine (75c) 
2-Methoxy-5-pyridylboronic acid (3.6 g, 0.024 mol), 3-
chloro-6-methoxypyridazine 74 (3.0 g, 0.021 mol), 
I~ 
N ...-:; Pd(PPh3)2Ch (0.82 g, 1.17 mmol); eluent EtOAc, yielded 
'N OMe 
75c as a white solid (3.85 g, 85%): mp 146.8-148.5 °C; 1H 
NMR (400 MHz, CDCb) 3 8.70 (lH, d, J= 2.4 Hz), 8.31 (1H, dd, J= 9.0 Hz, J= 2.4 
Hz), 7.73 (1H, d, J= 9.6 Hz), 7.04 (1H, d, J= 9.6 Hz), 6.86 (lH, d, J= 9.0 Hz ), 4.17 
(3H, s), 3.99 (3H, s); 13C NMR (100 MHz, CDCb) 3 165.1, 164.4, 153.1, 145.1, 137.0, 
126.4, 125.7, 118.0, 111.4, 55.0, 53.91; MS (ES+) m/z 218.1 ([M+Ht, 100%). Anal. 
Calcd. for C 11 HuN302: C, 60.82; H, 5.10; N, 19.34. Found: C, 60.73; H, 5.15; N, 
19.29%. 
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3-Methoxy-6-(2-fluoropyridin-5-yl)-pyridazine (75d) 
2-Fluoro-5-pyridylboronic acid (2.2 g, 0.016 mol), 3-chloro-6-
methoxypyridazine 74 (2.0 g, 0.014 mol), Pd(PPh3)2Ch (0.55 
g, 0. 78 mmol); eluent petroleum ether (bp 40--60 °C):Et0Ac 
1:4 v/v, yielded 75d as a pink solid (2.48 g, 87%): mp 147.7-
149.3 oc; 1H NMR (400 MHz, CDCh) 8 8.75 (1H, d, J= 2.4 Hz), 8.52 (lH, td, J= 8.2 
Hz, J = 2.4 Hz), 7.78 (1H, d, J = 8.8 Hz), 7.09 (1H, d, J = 9.2 Hz), 7.06 (1H, d, J = 3.2 
Hz), 4.19 (3H, s); 13C NMR (100 MHz, CDCh) 8 164.4 (lC, d, J = 241 Hz), 164.8, 
152.0, 145.8 (lC, d, J= 15Hz), 139.6 (lC, d, J= 9Hz), 130.4 (lC, d, J= 5Hz), 126.7, 
118.2, 110.1 (1C, d, J = 38 Hz), 55.2; MS (ES+) m/z 206.1 ([M+Ht, 100%). Anal. 
Calcd. for C10HsFN30: C, 58.53; H, 3.93; N, 20.48. Found: C, 58.25; H, 3.94; N, 
20.97%. 
3-Methoxy-6-phenyl-4-pyridazinylboronic acid (76a) 
Diisopropylamine (3.13 mL, 0.022 mol) was added to n-
B(OHh butyllithium (2.5 M in hexane, 8.9 mL, 0.022 mol) in 
N OMe anhydrous THF (50 mL) at -78 oc under argon. The mixture 
warmed to 0 °C and left to stir for 0.5 h. The reaction was then cooled to -78 oc and a 
solution of 3-methoxy-6-phenylpyridazine 75a (2.1 g, 0.011 mol) in anhydrous THF (20 
mL) was added over 1.5 h. The reaction was stirred for a further 0.5 h. 
Triisopropylborate (7.4 mL, 0.032 mol) was added at -78 oc and the mixture was 
stirred for 1.5 h before warming gradually to -10 °C when it was quenched with 
deionised water (1 00 mL) and left to stir at room temperature overnight. The organic 
solvent was removed in vacuo. The resulting aqueous phase was then washed with EhO 
(3 x 50 mL) and treated with NaOH to obtain pH 10, then acidified to pH 6 using HBr 
(48% aq. solution) to precipitate 76a as a white solid (2.38 g, 96%): mp 155.6-156.4 oc; 
1H NMR (400 MHz, DMSO-d6) 8 8.55 (2H, s), 8.11 (1H, s), 8.06 (2H, d, J = 6.8 Hz), 
7.46 - 7.54 (3H, m), 4.07 (3H, s); 13C NMR (100 MHz, DMSO-d6) 8 165.5, 154.0, 
136.3, 131.1, 129.2, 128.9, 126.2, 54.3; "B NMR (128 MHz, DMSO-d6) 8 29.8; Anal. 
Calcd. for CIIHIIBN203: C, 57.44; H, 4.82; N, 12.18. Found: C, 57.00; H, 4.78; N, 
11.82%. 
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3-Methoxy-6-( 4-methoxyphenyl)-4-pyridazinylboronic acid (76b) 
MeO -:?" Diisopropylamine (0.65 mL, 4.6 mmol) was added to n-
~ I B(OHh butyllithium (2.5 M in hexane, 1.8 mL, 4.6 mmol) in I~ 
N, ~ anhydrous ether (20 mL) at -78 oc under argon. The 
N OMe 
mixture warmed to 0 °C and left to stir for 0.5 h. The 
reaction was then cooled to -78 °C and a solution of 3-methoxy-6-( 4-
methoxyphenyl)pyridazine 75b (0.5 g, 2.3 mmol) in anhydrous ether (40 mL) was 
added over 1 h (the solid was not entirely dissolved in ether at room temperature). The 
reaction was stirred for a further 1 h. Triisopropylborate (1.6 mL, 6.9 mmol) was added 
at -78 oc and the mixture was stirred for 1.5 h. The mixture was warmed to room 
temperature and stirred for 0.5 h before quenching with deionised water (50 mL) and 
then left to stir at room temperature for 1 h. The organic solvent was removed in vacuo. 
The resulting aqueous phase was then washed with Ei20 (3 x 50 mL) and treated with 
NaOH to obtain pH 10, then acidified to pH 6 using HBr (48% aq. solution) to 
precipitate a white solid. The mixture was stirred overnight at pH 6. On further 
acidification to pH 2 more precipitate formed; after filtration and drying 76b was 
obtained as a white solid (0.53 g, 88%): mp 170.4-171.3 oc; 1H NMR (400 MHz, 
DMSO-d6) <> 8.51 (2H, s), 8.05 (IH, s), 8.01 (2H, d, J = 8.4 Hz), 7.07 (2H, d, J = 8.4 
Hz), 4.04 (3H, s), 3.82 (3H, s); 13C NMR (100 MHz, DMSO-d6) () 164.7, 160.2, 153.6, 
130.5, 128.6, 127.5, 114.3, 55.2, 54.2; 11 B NMR (128 MHz, DMSO-d6) () 28.9; Anal. 
Calcd. for C12H13BN204: C, 55.42; H, 5.04; N, 10.77. Found: C, 55.39; H, 5.03; N, 
10.56%. 
3-Methoxy-6-(2-methoxypyridin-5-yl)-4-pyridazinylboronic acid (76c) 
Diisopropylamine (1.3 mL, 9.2 mmol) was added to n-
B(OHh butyllithium (2.5 M in hexane, 3.7 mL, 9.2 mmol) in I~ 
N,N~ OMe anhydrous ether (70 mL) at -10 °C under argon. The 
mixture warmed to 0 oc and left to stir for 0.5 h. The 
reaction was then cooled to -78 oc and a solution of 3-methoxy-6-(2-methoxypyridin-5-
yl)-pyridazine 75c (1.0 g, 4.6 mmol) in anhydrous ether (80 mL) was added over 1.25 h. 
The reaction was stirred for a further 1 h. Triisopropylborate (3.2 mL, 13.8 mmol) was 
added at -78 °C and the mixture was stirred for 1.5 h before warming gradually to room 
temperature, before quenching with deionised water (70 mL ). After stirring for a further 
15 min the organic solvent was removed in vacuo. The resulting aqueous phase was 
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then washed with EtzO (1 x 150 mL) to remove any remaining starting material. The 
aqueous phase was cooled in an ice bath and acidified with glacial acetic acid to pH 5, 
where a precipitate formed. The solid was filtered and dried to yield 76c as a pale 
orange solid (379 mg). TLC analysis of the aqueous phase still showed a baseline spot. 
The aqueous phase was further acidified to pH 3 and then extracted with EtOAc until a 
TLC of the aqueous phase no longer showed boronic acid. The organic extracts were 
combined, dried over MgS04, filtered and evaporated to dryness in vacuo, yielding an 
orange solid which NMR confirmed to be 76c (352 mg). Total yield ofboronic acid 76c 
(731 mg, 61%): mp 144.4-145.9 °C; 1H NMR (400 MHz, DMSO-d6) & 8.84 (1H, d, J= 
2.4 Hz), 8.56 (2H, s), 8.38 (1H, dd, J= 11.6 Hz, J= 2.4 Hz), 8.12 (1H, s), 6.97 (lH, d, J 
= 8.8 Hz), 4.05 (3H, s), 3.92 (3H, s); 13C NMR (100 MHz, DMSO-d6) & 165.9, 164.7, 
152.4, 145.4, 137.4, 131.0, 126.2, 111.2, 54.8, 53.9; 11 B NMR (128 MHz, DMSO-d6) & 
29.3; Anal. Calcd. for C1 1H12BN304: C, 50.61; H, 4.63; N, 16.10. Found: C, 50.32; H, 
4.60; N, 16.12%. 
3-Methoxy-6-(2-fluoropyridin-5-yl)-4-pyridazinylboronic acid (76d) 
F ?"' Diisopropylamine (1.4 mL, 9.8 mmol) was added to n-
N ::-.... I B(OH)z butyllithium (2.5 M in hexane, 3.9 mL, 9.8 mmol) m 
OMe 
anhydrous THF (50 mL) at -78 oc under argon. The 
mixture warmed to 0 °C and left to stir for 0.5 h. The 
reaction was then cooled to -78 oc and a solution of 3-methoxy-6-(2-fluoropyridin-5-
yl)-pyridazine 75d (1.0 g, 4.9 mmol) in anhydrous THF (35 mL) was added over 1.5 h. 
The reaction was stirred for a further 0.5 h. Triisopropylborate (3.4 mL, 14.6 mmol) was 
added at -78 °C and the mixture was stirred for 1.5 h before warming gradually to -10 
oc when it was quenched with deionised water (100 mL) and left to stir at room 
temperature overnight. The organic solvent was removed in vacuo. The resulting 
aqueous phase was then washed with EtzO (4 x 50 mL) and treated with NaOH to 
obtain pH 10. The aqueous phase was acidified to pH 4 using HBr (48% aq. solution), 
and then extracted with EtOAc (4 x 50 mL). The organic layer was reduced in vacuo 
and the product 76d was isolated as a light orange solid (0.91 g, 75%) Recrystallizations 
were unsuccessful and the product was not further purified: mp ea. 149 oc (decomp.); 
1H NMR (400 MHz, DMSO-d6) & 8.90 (1H, d, J= 2.8 Hz), 8.65 (1H, td, J= 8.6 Hz, J= 
2.0 Hz), 8.60 (2H, s), 8.21 (1H, s), 7.36 (1H, dd, J = 8.6 Hz, J = 2.8 Hz), 4.07 (3H, s); 
13C NMR (100 MHz, DMSO-d6) & 166.0 (1C, d, J= 263Hz), 165.7, 151.1, 145.5, (1C, 
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d, J= 16Hz), 139.9 (1C, d, J= 9Hz), 131.0, 130.6 (1C, d, J= 4Hz), 109.8 (1C, d, J= 
38 Hz), 54.5; Anal. Calcd. for C10H9BFN30 3: C, 48.23; H, 3.64; N, 16.88. Found: C, 
45.05; H, 3.63; N, 14.60%. Characterization indicated that 76d is a mixture of boronic 
acid and anhydride, resulting in the C, H, N analysis being incorrect for pure boronic 
acid. 
General Procedure for the preparation of 77a-d. 
A solution of the boronic acid 76a-d (1.0 equiv.), pinacol (1.0 equiv.) and MgS04 (2 g) 
in toluene (25 mL) was stirred for 17 h at room temperature (TLC monitoring). The 
suspension was filtered and the resulting solution washed with brine (3 x 15 mL). The 
aqueous phase was washed with DCM (1 x 25 mL ). The combined organic layers were 
dried over MgS04 and reduced in vacuo to yield pinacol esters 77a-d. 
3-Methoxy-6-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridazine 
(77a) 
3-Methoxy-6-phenyl-4-pyridazinylboronic acid 76a (0.350 g, 
1.5 mmol), pinacol (0.18 g, 1.5 mmol), MgS04 (2 g), toluene 
(25 mL ); 12 h at room temperature (TLC monitoring); 
evaporation of the organic layer gave the product 77a as a 
white solid (0.378 g, 80%): mp 151.6-152.8 oc; 1H NMR (400 MHz, CDCh) () 8.10 
(1H, s), 8.06 (2H, dd, J= 9.6 Hz, J= 2.0 Hz), 7.44-7.51 (3H, m), 4.22 (3H, s), 1.39 
(12H, s); 13C NMR (100 MHz, CDCh) () 166.2, 154.9, 136.5, 133.8, 129.4, 129.0, 
126.7, 85.0, 55.4, 31.0, 25.0; 11B NMR (128 MHz, DMSO-d6) () 30.1; MS (ES+) m/z 
313.2 ([M+Ht, 100%). Anal. Calcd. for C17H21BN203: C, 65.41; H, 6.78; N, 8.97. 
Found: C, 65.09; H, 6.68; N, 8.69%. 
3-Methoxy-6-(4-metboxyphenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pyridazine (77b) 
mmol), MgS04 (2.0 g) in toluene (25 mL); 20 hat room 
temperature (TLC monitoring); evaporation of the 
organic phase gave the product 77b as a white solid (1.1 g, 85%): mp 176.4-177.5 OC; 
1H NMR (400 MHz, CDCh) () 8.03 (lH, s), 7.98 (2H, d, J = 8.8 Hz), 6.97 (2H, d, J = 
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8.8 Hz), 4.17 (3H, s), 3.82 (3H, s), 1.35 (12H, s); 13C NMR (100 MHz, CDCh) 8 165.8, 
160.7, 154.4, 133.2, 128.9, 127.8, 114.3, 84.8, 55.4, 55.2, 24.8; 11 B NMR (128 MHz, 
CDCh) 8 30.2; MS (ES+) mlz 343.4 ([M+Ht, 100%). Anal. Calcd. for C18H23BN20 4 : C, 
63.18; H, 6.77; N, 8.19. Found: C, 63.10; H, 6.82; N, 8.21%. Crystals for X-ray 
diffraction analysis were grown from hexane. 
3-Methoxy-6-(2-methoxypyridin-5-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pyridazine (77c) 
3-Methoxy-6-(2-methoxypyridin-5-y 1)-4-
9 pyridazinylboronic acid 76c (0.290 g, 1.1 mmol), 
s .... o 
pinacol (0.13 g, 1.1 mmol), MgS04 (2 g), toluene (1 0 
OMe 
mL); 17 h at room temperature (TLC monitoring); 
evaporation of the combined organic phase gave the product 77c as a white solid (0.337 
g, 90%): mp 146.8-148.2 °C; 1H NMR (400 MHz, CDCh) 8 8.77 (1H, dd, J= 2.4 Hz, J 
= 0.4 Hz), 8.29 (lH, dd, J = 9.0 Hz, J = 2.4 Hz), 8.03 (lH, s), 6.83 (IH, dd, J = 9.0 Hz, 
J = 0.4 Hz), 4.19 (3H, s), 3.98 (3H, s), 1.36 (12H, s); 13C NMR (100 MHz, CDCh) 8 
166.1, 165.0, 152.7, 145.3, 136.9, 133.1, 125.8, 111.2, 85.0, 55.4, 53.8, 24.9; 11 B NMR 
(128 MHz, CDCh) 8 29.97; MS (ES+) mlz 344.3 ([M+Ht, 100%). Anal. Calcd. for 
C17H22BN304 : C, 59.50; H, 6.46; N, 12.24. Found: C, 58.82; H, 6.47; N, 11.86%. 
3-Methoxy-6-(2-fluoropyridin-5-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pyridazine (77d) 
y. 3-Methoxy-6-(2-fluoropyridin-5-yl)-4-pyridazinyl boronic 
9 )L- acid 76d (0.600 g, 2.4 mmol), pinacol (0.28 g, 2.4 mmol), 
s .... o 
MgS04 (2 g), toluene (25 mL ); 12 h at room temperature 
OMe (TLC monitoring). evaporation of the combined organic 
layers yielded 77d as a white solid (0.583 g, 73%): mp 198.2-199.7 oc; 1H NMR (400 
MHz, CDCh) 8 8.78 (IH, d, J= 2.4 Hz), 8.49 (IH, td, J= 8.0 Hz, J= 2.4 Hz), 8.04 (1H, 
s), 7.02 (1H, dd, J = 8.6 Hz, J = 3.0 Hz), 4.18 (3H, s), 1.35 (12H, s); 13C NMR (100 
MHz, CDCh) 8 166.4, 164.2 (1C, d, J= 242Hz), 151.5, 145.8 (1C, d, J= 16Hz), 139.4 
(1C, d, J= 8Hz), 133.2, 130.4 (1C, d, J= 4Hz), 109.8 (1C, d, J= 38Hz), 85.1, 55.4, 
24.8, 24.6; 11B NMR (128 MHz, DMSO-d6) 8 29.9; MS (ES+) m/z 332.2 ([M+Ht, 
100%). HRMS (ES+) calcd for C16H2oBFN303 332.1576, found 332.1573. Anal. Calcd. 
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for C16H19BFN303: C, 58.03; H, 5.78; N, 12.69. Formd: C, 56.46; H, 5.76; N, 12.21%. 
Crystals for X-ray diffraction analysis were grown from toluene/hexane. 
Typical Procedure for the Suzuki-Miyaura Cross-Coupling Catalyst Screening in 
Table 2.2 
The boronic acid 76a or ester 77a (1.1 equiv.) the aryl halide (1.0 equiv.) and Pd source 
and phosphine ligand were sequentially added to degassed 1,4-dioxane (10 mL) and the 
mixture was stirred at 20 °C for 30 min. Degassed aqueous base or solid K3P04 was 
added and the reaction mixture was heated under argon at reflux or the temperature 
stated for the time stated. Solvent was removed in vacuo then EtOAc was added and the 
organic layer was washed with brine, separated, and dried over MgS04. The mixture 
was purified by chromatography on a silica gel column. 
Typical Procedure for the Suzuki-Miyaura Cross-Coupling Reactions in Table 2.3 
The boronic ester 77a-d or acid 76a, b (1.1 equiv.) the aryl halide (1.0 equiv.) and 
Pd2(dba)3 (ea. 1 mol% ArX), PCy3 (ea. 2.4 mol% ArX) were sequentially added to 
degassed 1,4-dioxane (2.7 mL) and the mixture was stirred at 20 oc for 30 min. 
Degassed aqueous K3P04 solution (1.27 M, 1.7 equiv.) was added and the reaction 
mixture was heated under argon at reflux for 24 h. Solvent was removed in vacuo then 
EtOAc was added and the organic layer was washed with brine, separated, and dried 
over MgS04. The mixture was purified by chromatography on a silica gel column 
followed if needed by recrystallization. 
Conditions A: Pd2( dba)3 (1 mol% ArX)/PCy3 (2.4 mol% ArX), 1 ,4-dioxane, K3P04 
(1.27 M), reflux, 24 h. 
Conditions 8: Pd2(dba)3 (1 mol% ArX)/PCy3 (2.4 mol% ArX), 1,4-dioxane, K3P04 (s), 
reflux, 24 h. 
Conditions C: Pd2(dba)3 (5 mol% ArX)/[t-Bu3PH]BF4 (12 mol% ArX), MeCN, K3P04 
(s), 85 °C, 1 h. 
Conditions D: Pd2(dba)3 (1 mol% ArX)/PCy3 (2.4 mol% ArX), 1,4-dioxane, K3P04 
(1.27 M), J.1W 120 °C, 1 h. 
Conditions E: Pd2(dba)3 (1 mol% ArX)/PCy3(2.4 mol% ArX), DMF, K3P04.2H20, 1.1W 
160 °C, 5 min. 
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Conditions F: Pd(OAc)2 (5 mol% ArX)ID-t-BPF (5 mol% ArX), 1,4-dioxane, Na2C03 
(1 M), reflux, 5 h. 
3-Methoxy-6-phenyl-4-(pyridin-2-yl)pyridazine (79) 
N :;.--- I Table 2.2, entry 7: Compound 77a (343 mg, 1.1 mmol), 2-
~ ~ bromopyridine 78 (0.095 mL, 1.0 mmol), Pd2(dba)3 (9.2 mg, I 
N,N.--: OMe 0.010 mmol), PCy3 (6.7 mg, 0.024 mmol), 1,4-dioxane (2.67 
mL) and K3P04 (1.27 M, 1.33 mL); reaction time 24 h; eluent EtOAc:hexane, 2:3 v/v 
gave 79 as a yellow oil, which solidified on standing (200 mg, 76%): mp 68.0-70.6 oc; 
1H NMR (400 MHz, CDCh) () 8.75 (1H, d, J= 4.8 Hz), 8.54 (1H, s), 8.15 (1H, d, J= 
8.4 Hz), 8.12, (2H, d, J= 8.0 Hz), 7.78 (lH, td, J= 7.6 Hz, J= 2.0 Hz), 7.41 -7.50 (3H, 
m), 7.33 (IH, t, J= 6.2 Hz), 4.29 (3H, s); 13C NMR (100 MHz, CDCh) () 161.5, 156.3, 
151.1, 150.1, 136.5, 136.4, 129.4, 128.9, 127.8, 126.7, 126.2, 125.3, 124.1, 55.3; 
MS(ES+) m/z 264.2 ([M+Ht, 100%). HRMS (ES+) calcd for C16H14N30 264.1137, 
found 264.1131. Anal. Calcd. for C16HnN30: C, 72.99; H, 4.98; N, 15.96. Found: C, 
72.60; H, 5.06; N, 15.58%. 
Synthesis via the organozincate:324 A solution of n-butyllithium (2.5M in hexane, 0.92 
mL, 2.3 mmol), was added to cold (-30 °C) anhydrous THF (20 mL) under an argon 
atmosphere. Diisopropylamine (0.34 mL, 2.4 mmol) was added and the solution was 
then allowed to stir at 0 °C for 15 min. The solution was then cooled to -78 °C and 3-
methoxy-6-phenylpyridazine 75a (186 mg, 1.0 mmol) dissolved in 5 mL of anhydrous 
THF was added dropwise and the mixture was stirred for 1.5 h at -78 °C. A solution of 
zinc chloride (previously dried under vacuum with a heat gun, 272 mg, 2.0 mmol) 
dissolved in 5 mL of anhydrous THF was added to the lithiated pyridazine at -78 °C, 
the mixture was allowed to warm to room temperature over 1 h. To the 
pyridazinylzincate solution, at room temperature, was added Pd(PPh3)4 ( 4 mol%, 46.2 
mg, 0.04 mmol) and 2-bromopyridine (0.11 mL, 1.2 mmol), the mixture was fitted with 
a reflux condenser and heated whilst placed in a sonication bath for 3 h (the reaction 
mixture gradually reached reflux whilst under sonication). The reaction mixture was 
then hydrolysed with a solution of ethylenediamine tetraacetic acid (584 mg, 2.0 mmol) 
in 1 0 mL de ionized water and made slightly basic with a saturated aqueous solution of 
potassium carbonate. The aqueous layer was extracted with DCM (3 x 25 mL) and the 
resulting organic layer dried over MgS04 and reduced in vacuo. The resulting crude 
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product was purified by column chromatography, eluent EtOAc: petroleum ether (bp 
40-60 °C), 1:4 v/v, yielding 79 was an off-white solid (202 mg, 77%). 
Spectroscopically identical with the sample previously described. 
Table 2.2, entry 1: Compound 76a (391 mg, 1.7 mmol), 2-bromopyridine 78 (0.14 mL, 
1.5 mmol), Pd(OAc )2 ( 19.0 mg, 0.085 mmol), t-Bu3P (0.02 mL, 0.080 mmol), 1,4-
dioxane (10 mL) and Na2C03 (1 M, 4 mL); reaction time 65 h; eluent petroleum ether 
(bp 40-60 °C): EtOAc 1:4 v/v gave 79 as a opaque oil which solidified to an off-white 
solid on standing (39 mg, 10%). Spectroscopically identical with the sample previously 
described. 
Table 2.2, entry 2: Compound 76a (391 mg, 1.7 mmol), 2-bromopyridine 78 (0.14 mL, 
1.5 mmol), Pd(PPh3)2Ch (60.0 mg, 0.085 mmol), t-Bu3P (0.02 mL, 0.080 mmol), 1,4-
dioxane (10 mL) and Na2C03 (1 M, 4 mL); reaction time 65 h; eluent EtOAc:hexane 
1 :4 v/v gave 79 as a pale yellow solid (216 mg, 55%). Spectroscopically identical with 
the sample previously described. 
Table 2.2, entry 3: Compound 76a (391 mg, 1.7 mmol), 2-bromopyridine 78 (0.14 mL, 
1.5 mmol), Pd(PPh3)2Ch (60.0 mg, 0.085 mmol), t-Bu3P (0.02 mL, 0.080 mmol), 1,4-
dioxane (10 mL) and Na2C03 (1 M, 4 mL); reaction time 5 days at 55 °C, reaction 
monitored by TLC. Eluent EtOAc:hexane 1:1 v/v gave 79 as a pale yellow solid (157 
mg, 40%). Spectroscopically identical with the sample previously described. 
Table 2. 2, entry 4: Compound 76a (253 mg, 1.1 mmol), 2-bromopyridine 78 (0.1 0 mL, 
1.0 mmol), Pd2(dba)3 (9.2 mg, 0.010 mmol), PCy3 (6.7 mg, 0.024 mmol), 1,4-dioxane 
(2.67 mL) and K3P04 (1.27 M, 1.33 mL); reaction time 24 h; eluent EtOAc:hexane, 2:3 
v/v gave 79 as a yellow oil (176 mg, 67%). Spectroscopically identical with the sample 
previously described. 
Table 2.2, entry 5: Compound 77a (530 mg, 1.7 mmol), 2-bromopyridine 78 (0.14 mL, 
1.5 mmol), Pd(OAc)2 (19.0 mg, 0.085 mmol), t-Bu3P (0.02 mL, 0.080 mmol), 1,4-
dioxane (1 0 mL) and Na2C03 (1 M, 4 mL); reaction time 65 h; eluent EtOAc:hexane 
1:1 v/v gave 79 as an off-white solid (157 mg, 40%). Spectroscopically identical with 
the sample previously described. 
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Table 2.2, entry 6: Compound 77a (530 mg, 1.7 mmol), 2-bromopyridine 78 (0.14 mL, 
1.5 mmol), Pd(PPh3)2Cb (60.0 mg, 0.085 mmol), t-Bu3P (0.02 mL, 0.080 mmol), 1,4-
dioxane (10 mL) and Na2C03 (1 M, 4 mL); reaction time 24 h; eluent EtOAc:hexane 
2:3 v/v gave 79 as an oil which solidified on standing (173 mg, 44%). Spectroscopically 
identical with the sample previously described. 
Table 2.2, entry 7 with K3P04 (s)." Compound 77a (343 mg, 1.1 mmol), 2-bromopyridine 
78 (0.10 mL, 1.0 mmol), Pdz(dba)3 (9.2 mg, 0.010 mmol), PCy3 (6.7 mg, 0.024 mmol), 
1,4-dioxane (2.67 mL) and K3P04 (s) (425 mg, 2.0 mmol); reaction time 24 h; eluent 
EtOAc:hexane, 2:3 v/v gave 79 as a yellow oil, which solidified on standing (124 mg, 
4 7% ). Spectroscopically identical with the sample previously described. 
3-Methoxy-6-phenyl-4-(pyrimidin-5-yl)pyridazine (80) 
;rNIJ Table 2.2, entry 10: Compound 77a (343 mg, 1.1 mmol), 5-
:::::,... ~ bromopyrimidine 62 (159 mg, 1.0 mmol), Pd2(dba)3 (9.2 mg, 
OMe 
0.010 mmol), PCy3 (6.7 mg, 0.024 mmol), 1,4-dioxane (2.67 
mL) and K3P04 (1.27 M, 1.33 mL); reaction time 24 h; eluent 
EtOAc gave 80 as an off-white solid (126 mg, 47%): mp 165.7-166.3 oc; 1H NMR (400 
MHz, CDCh) 8 9.30 (1H, s), 9.08 (2H, s), 8.04 (2H, dd, J= 10Hz, J= 2Hz), 7.83 (IH, 
s), 7.47- 7.54 (3H, m), 4.26 (3H, s); 13C NMR (100 MHz, CDCh) 8 161.2, 159.0, 
156.8, 156.2, 135.8, 130.0, 129.2, 128.2, 126.7, 125.5, 123.9, 55.7; MS (El) mlz 264.0 
(~, 100%). Anal. Calcd. for C15H12N40: C, 68.17; H, 4.58; N, 21.20. Found: C, 67.92; 
H, 4.53; N, 21.23%. Crystals for X-ray diffraction analysis were grown from EtOAc. 
Synthesis via the organozincate: Procedure followed as for the preparation of 79 via this 
protocol. n-Butyllithium (2.5M in hexane, 0.92 mL, 2.3 mmol), diisopropylamine (0.34 
mL, 2.4 mmol), 3-methoxy-6-phenylpyridazine 75a (186 mg, 1.0 mmol), ZnCb (272 
mg, 2.0 mmol), Pd(PPh3)4 (4 mol%, 46.2 mg, 0.04 mmol), 5-bromopyrimidine (191 mg, 
1.2 mmol). Heated and sonicated for 3 h, unsure if reaction was complete (from TLC 
monitoring), reaction mixture left to stand at room temperature overnight, then heated 
and sonicated for a further 3 h; eluent EtOAc: petroleum ether (bp 40-60 °C), 2:3 v/v, 
gave 80 as a pale yellow solid (117 mg, 44%). Spectroscopically identical with the 
sample previously described. 
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Table 2.2, entry 8: Compound 76a (391 mg, 1.7 mmol), 5-bromopyrimidine 62 (238 
mg, 1.5 mmol), Pd(OAch (19.0 mg, 0.085 mmol), t-Bu3P (0.02 mL, 0.080 rnrnol), 1,4-
dioxane (10 mL) and Na2C03 (1 M, 4 mL); reaction time 65 h; eluent EtOAc gave 80 as 
an orange solid (92 mg, 23%). Spectroscopically identical with the sample previously 
described. 
Table 2.2, entry 9: Compound 76a (253 mg, 1.1 rnrnol), 5-bromopyrimidine 62 (159 
mg, 1.0 rnmol), Pd2(dba)3 (9.2 mg, 0.010 rnmol), PCy3 (6.7 mg, 0.024 rnrnol), 1,4-
dioxane (2.67 mL) and K3P04 (1.27 M, 1.33 mL); reaction time 24 h; eluent EtOAc 
gave 80 as a pale yellow solid (89 mg, 34%). Spectroscopically identical with the 
sample previously described. 
Table 2.2, entry 10 with K3P04 (s): Compound 77a (343 mg, 1.1 mmol), 5-
bromopyrimidine 62 (159 mg, 1.0 rnmol), Pd2(dba)3 (9.2 mg, 0.010 rnrnol), PCy3 (6.7 
mg, 0.024 rnmol), 1 ,4-dioxane (2.67 mL) and K3P04 (s) ( 425 mg, 2.0 rnrnol); reaction 
time 24 h; eluent EtOAc gave 80 as a white solid (122 mg, 46%). Spectroscopically 
identical with the sample previously described. 
2-Amino-3-nitro-5-(3-methoxy-6-phenylpyridazin-4-yl)-pyridine (82) 
Compound 77a (343 mg, 1.1 rnmol), 2-amino-5-bromo-3-
nitropyridine 61 (218 mg, 1.0 mmol), Pd2(dba)3 (9.2 mg, 
0.010 mmol), PCy3 (6.7 mg, 0.024 mmol), 1,4-dioxane 
OMe (2.67 mL) and K3P04 (1.27 M, 1.33 mL); reaction time 24 
h; eluent EtOAc:petroleum ether (bp 40-60 °C) 2:3 v/v, gave 82 as a yellow solid (190 
mg, 59%): mp 214.6-216.9 oc; 1H NMR (400 MHz, DMSO-d6) 8 8.90 (2H, dd, J= 6.8 
Hz, J = 2.0 Hz), 8.33 (lH, s), 8.25 (2H, s), 8.17 (2H, d, J = 8.4 Hz), 7.48 - 7.56 (3H, 
m), 4.16 (3H, s); 13C NMR (100 MHz, DMSO-d6) 8 160.8, 156.4, 155.3, 153.5, 136.0, 
135.3, 129.4, 128.8, 126.6, 126.2, 124.9, 124.8, 117.3, 55.0; MS (ES+) m/z 324.2 
([M+Ht, 100%). Anal. Calcd. for C16HnNs03: C, 59.44; H, 4.05; N, 21.66. Found: C, 
59.58; H, 4.04; N, 21.50%. 
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3-Methoxy-6-( 4-methoxyphenyl)-4-(pyridin-2-yl)pyridazine (83) 
Compound 77b (376 mg, 1.1 mmol), 2-bromopyridine 78 
(0.095 mL, 1.0 mmol), Pd2(dba)3 (9.2 mg, 0.010 mmol), 
PCy3 (6.7 mg, 0.024 mmol), 1,4-dioxane (10 mL) and 
K3P04 (1.27 M, 1.33 mL); reaction time 24 h; eluent 
petroleum ether (bp 40-60 °C):Et0Ac, 2:3 v/v, gave 83 as a pale yellow solid (227 mg, 
77%): mp 129.1-131.8 °C; 1H NMR (400 MHz, CDCb) cS 8.78 (lH, d, J= 3.6 Hz), 8.50 
(lH, s), 8.17 (1H, d, J= 8.0 Hz), 8.10 (2H, dd, J= 7.0 Hz, J= 2.0 Hz), 7.82 (1H, td, J= 
7.8 Hz, J = 1.6 Hz), 7.03 (2H, dd, J = 6.8 Hz, J = 2.0 Hz), 4.30 (3H, s), 3.88 (3H, s); 13C 
NMR (100 MHz, CDCb) cS 161.3, 160.9, 156.0, 151.3, 150.1, 136.6, 129.0, 128.1, 
127.9, 125.7, 125.4, 124.1, 114.4, 55.5, 55.3; MS (ES+) mlz 294.2 ([M+Ht, 100%). 
Anal. Calcd. for C 17Ht 5N302: C, 69.61; H, 5.15; N, 14.33. Found: C, 69.46; H, 5.16; N, 
14.39%. Crystals for X-ray diffraction analysis were grown from EtOAc. 
3-Methoxy-6-( 4-methoxyphenyl)-4-(pyrimidin-5-yl)pyridazine (84) 
N Compound 77b (180 mg, 0.69 mmol), 5-~ 11 
~ N bromopyrimidine 62 (100 mg, 0.62 mmol), Pd2(dba)3 I~ 
N,N~ (5.8 mg, 0.0062 mmol), PCy3 (4.2 mg, 0.015 mmol), 1,4-
dioxane (5 mL) and K3P04 (1.27 M, 2 mL); microwave 
heating 120 °C, 1 h; eluent EtOAc, gave 84 as a white solid (87 mg, 43%): mp 191.4-
192.6 oc; 1H NMR (400 MHz, CDCb) cS 9.30 (1H, s), 9.07 (2H, s), 8.01 (2H, dd, J= 6.8 
Hz, J= 2Hz), 7.78 (lH, s), 7.04 (2H, dd, J= 6.8 Hz, J= 2Hz), 4.25 (3H, s), 3.88 (3H, 
s); 13C NMR (100 MHz, CDCb) cS 161.3, 160.8, 159.0, 156.8, 155.8, 128.34, 128.30, 
128.1, 125.1, 123.9, 114.7, 55.58, 55.56; MS (ES+) mlz 295.2 ([M+Ht, 100%). Anal. 
Calcd. for C16H14N40 2: C, 65.30; H, 4.79; N, 19.04. Found: C, 65.12; H, 4.88; N, 
18.66%. 
5-(3-Methoxy-6-( 4-methoxyphenyl)pyridazin-4-yl)-3-nitropyridin-2-amine (85) 
Compound 77b (284 mg, 0.83 mmol), 2-amino-5-
M eO bromo-3-nitropyridine 61 (164 mg, 0.75 mmol), 
1 
~ Pd2(dba)3 (6.9 mg, 0.0075 mmol), PCy3 (5.1 mg, 
N,N~ OMe 0.018mol), 1,4-dioxane (10 mL) and K3P04 (1.27 
M, 1.0 mL); reaction time 24 h; eluent petroleum ether (bp 40-60 °C):Et0Ac, 2:3 v/v, 
gave 85 as a yellow solid (120 mg, 46%): mp 222.9-225.8 °C; 1H NMR (400 MHz, 
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DMSO-d6) o 8.89 (2H, q, J = 6.4 Hz, J = 2.0 Hz), 8.29 (1H, s), 8.25 (2H, s), 8.14 (2H, 
d, J= 8.8 Hz), 7.09 (2H, d, J= 8.8 Hz), 4.14 (3H, s), 3.84 (3H, s); 13C NMR (100 MHz, 
DMSO-d6) o 160.54, 160.46, 156.5, 155.0, 153.6, 135.4, 128.4, 128.0, 125.0, 124.3, 
117.4, 114.2, 79.2, 55.3, 54.9: MS (ES+) m/z 354.2 ([M+Ht, 100%). Anal. Calcd. for 
C11HisNs04: C, 57.79; H, 4.28; N, 19.82. Found: C, 58.04; H, 4.25; N, 19.39%. 
3-Methoxy-6-(2-methoxypyridin-5-yl)-4-(pyridin-2-yl)pyridazine (86) 
MeO ?" 
N:--. I 
Compound 77c (378 mg, 1.1 mmol), 2-bromopyridine 78 
(0.095 mL, 1.0 mmol), Pd2(dba)3 (9.2 mg, 0.010 mmol), 
PCy3 (6.7 mg, 0.024 mmol), 1,4-dioxane (10 mL) and 
K3P04 (1.27 M, 1.33 mL); reaction time 24 h; eluent 
petroleum ether (bp 40-60 °C):Et0Ac 2:3 v/v, gave 86 as a white solid (170 mg, 58%): 
mp 156.0-157.7 °C; 1H NMR (400 MHz, CDCh) o 8.83 (IH, d, J = 2.4 Hz), 8.72 (IH, 
d, J= 4.4 Hz), 8.46 (1H, s), 8.32 (1H, dd, J= 9.8 Hz, J= 2.8 Hz), 8.13 (IH, d, J= 8.0 
Hz), 7.77 (IH, td, J= 7.6 Hz, J= 1.6 Hz), 7.30-7.34 (IH, m), 6.82 (IH, d, J= 8.0 Hz), 
4.26 (3H, s), 3.96 (3H, s); 13C NMR (100 MHz, CDCh) o 165.1, 161.6, 154.3, 151.0, 
150.2, 145.5, 137.0, 136.6, 128.1, 125.8, 125.5, 125.4, 124.3, 111.2, 55.4, 53.9; MS 
(ES+) mlz 295.2 ([M+Ht, 100%). Anal. Calcd. for C16H14N402: C, 65.30; H, 4.79; N, 
19.04. Found: C, 65.20; H, 4.83; N, 18.99%. 
Synthesis via the organozincate: Procedure followed as for the preparation of 79 via this 
protocol. n-Butyllithium (2.5M in hexane, 0.92 mL, 2.3 mmol), diisopropylamine (0.34 
mL, 2.4 mmol), 3-methoxy-6-(2-methoxypyridin-5-yl)pyridazine 75c (217 mg, 1.0 
mmol), ZnCh (272 mg, 2.0 mmol), Pd(PPh3)4 (4 mol%, 46.2 mg, 0.04 mmol), 2-
bromopyridine (0.11 mL, 1.2 mmol). Heated and sonicated for 4 h, until the reaction 
was complete (from TLC monitoring); eluent EtOAc: petroleum ether (bp 40-60 °C), 
2:3 v/v, gave 86 as an off-white solid (215 mg, 73%). Spectroscopically identical with 
the sample previously described. 
3-Methoxy-6-(2-methoxypyridin-5-yl)-4-(pyrimidin-5-yl)pyridazine (87) 
N~ Compound 77c (343 mg, 1.0 mmol), 5-bromopyrimidine 
y 11 
~ N 62 (145 mg, 0.91 mmol), Pd2(dba)3 (8.3 mg, 0.0091 
mmol), PCy3 (6.1 mg, 0.022 mmol), 1,4-dioxane (2.67 
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mL) and K3P04 (1.27 M, 1.33 mL); reaction time 24 h; eluent EtOAc, gave 87 as a 
white solid (102 mg, 37%): mp 192.0-194.3 °C; 1H NMR (400 MHz, CDCh) 8 9.29 
(1H, s), 9.06 (2H, s), 8.74 (1H, d, J = 2.8 Hz), 8.31 (lH, dd, J = 8.8 Hz, J = 2.4 Hz), 
7.76 (1H, s), 6.87 (1H, d, J = 8.8 Hz), 4.24 (3H, s), 3.99 (3H, s); Be NMR (100 MHz, 
CDCh) 8 165.1, 160.9, 158.9, 156.6, 153.8, 145.1, 136.8, 127.8, 125.0, 124.5, 124.0, 
111.4, 55.5, 53.8; MS (ES+) mlz 296.2 ([M+Ht, 100%). HRMS (ES+) calcd for 
CisH14Ns02 296.1142, found 296.1141. Anal. Calcd. for C1sHBN50 2: C, 61.01; H, 4.44; 
N, 23.72. Found: C, 60.39; H, 4.39; N, 23.25%. 
5-(3-Methoxy-6-(2-methoxypyridin-5-yl)-pyridazin-4-yl)-3-nitropyridin-2-amine 
(88) 
M eO 
Compound 77c (337 mg, 0.98 mmol), 2-amino-5-
bromo-3-nitropyridine 61 (195 mg, 0.89 mmol), 
Pd2(dba)3 (8.2 mg, 0.0089 mmol), PCy3 (6.0 mg, 
OMe 0.021 mmol), 1,4-dioxane (10 mL) and K3P04 (1.27 
M, 1.33 mL); reaction time 24 h; eluent petroleum ether (bp 40-60 °C):Et0Ac 1:1 v/v, 
final elution with EtOAc gave 88 as a yellow solid (134 mg, 42%): mp 249.5-252.3 °C; 
1H NMR (400 MHz, DMSO-d6) 8 8.97 (1H, d, J= 2.4 Hz), 8.91 (2H, s), 8.48 (1H, dd, J 
= 8.6 Hz, J = 2.4 Hz), 8.38 (1H, s), 8.26 (2H, s), 7.00 (1H, d, J = 8.8 Hz), 4.16 (3H, s), 
3.94 (3H, s); Be NMR (100 MHz, DMSO-d6) 8 164.3, 160.8, 156.5, 153.6, 153.3, 
145.5, 137.3, 135.4, 126.2, 125.5, 125.1, 124.4, 117.2, 110.7, 55.0, 53.5; MS (ES+) m/z 
355.2 ([M+Ht, 100%). Anal. Calcd. for C16H14N604: C, 54.24; H, 3.98; N, 23.72. 
Found: C, 54.62; H, 4.00; N, 23.43%. 
3-Methoxy-6-(2-fluoropyridin-5-yl)-4-(pyridin-2-yl)pyridazine (89) 
Compound 77d (310 mg, 0.94 mmol), 2-bromopyridine 78 
(0.081 mL, 0.85 mmol), Pd2(dba)3 (7.8 mg, 0.0085 mmol), 
PCy3 (5.5 mg, 0.020 mmol), 1,4-dioxane (2.5 mL) and 
K3P04 (1.27 M, 1.1 mL); reaction time 24 h; eluent 
petroleum ether (bp 40-60 °C):Et0Ac 1:1 v/v, gave 89 as an off-white solid (160 mg, 
67%): mp 190.3-191.7 °C; 1H NMR (400 MHz, CDCh) 8 8.89 (lH, d, J= 2.4 Hz), 8.75 
(1H, d, J = 4.8 Hz), 8.57 (1H, td, J = 7.8 Hz, J = 2.4 Hz), 8.55 (1H, s), 8.19 (1H, d, J = 
8.0 Hz), 7.81 (1H, td, J= 7.8 Hz, J=1.6 Hz), 7.35-7.39 (lH, m), 7.06 (lH, dd, J= 8.4 
Hz, J= 2.8 Hz), 4.31 (3H, s); Be NMR (100 MHz, CDCh) 8 164.4 (lC, d, J= 242Hz), 
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161.9, 153.0, 150.5, 150.2, 146.0 (IC, d, J = 15 Hz), 139.5 (1C, d, J = 8 Hz), 136.7, 
130.5 (1C, d, J= 4Hz), 128.1, 125.6, 125.4, 124.4, 109.9 (IC, d, J= 38Hz), 55.5; MS 
(ES+) m/z 336.9 ([M+MeOH+Nat, 100%). Anal. Calcd. for C15H11FN40: C, 63.83; H, 
3.93; N, 19.85. Found: C, 63.58; H, 3.89; N, 19.69%. 
3-Methoxy-6-(2-fluoropyridin-5-yl)-4-(pyrimidin-5-yl)pyridazine (90) 
N Compound 77d (364 mg, 1.1 mmol), 5-bromopyrimidine 62 ~ ll 
~ N (159 mg, 1.0 mmol), Pd2(dba)J (9.2 mg, 0.01 mmol), PCy3 
(6.7 mg, 0.024 mmol), 1,4-dioxane (3 mL) and K3P04 (1.27 
M, 1.3 mL); reaction time 24 h; eluent EtOAc, gave 90 as a 
white solid (82 mg, 29%): mp 256.1-257.9 °C; 1H NMR (400 MHz, CDCh) o 9.33 (IH, 
s), 9.09 (2H, s), 8.83 (1H, d, J= 2.5 Hz), 8.57 (1H, td, J= 8.1 Hz, J= 2.5 Hz), 7.83 (IH, 
s), 7.12 (1H, dd, J = 8.6 Hz, J = 3.0 Hz), 4.29 (3H, s); 13C NMR (125 MHz, CDCh) o 
164.6 (1C, d, J= 242Hz), 161.5, 159.2, 156.8, 152.9, 145.9 (IC, d, J= 16Hz), 139.7 
(1C, d, J= 9Hz), 129.9 (IC, d, J= 5Hz), 127.8, 125.0, 124.4, 110.3 (1C, d, J= 37Hz), 
55.9; MS (ES+) mlz 284.2 ([M+Ht, 100%). Anal. Calcd. for C14HIOFNsO: C, 59.36; H, 
3.56; N, 24.72. Found: C, 59.30; H, 3.56; N, 24.45%. 
5-(6-(2-Fluoropyridin-5-yl)-3-methoxypyridazin-4-yl)-3-nitropyridin-2-amine (91) 
N02 Compound 77d (189 mg, 0.57 mmol), 2-amino-5-
'7" 
1 
NHz bromo-3-nitropyridine 61 (1 09 mg, 0.5 mmol), 
I ~ ~ N Pd(OAc)2 (5.6 mg, 0.025 mmol), D-t-BPF (12 mg, 
N,N.--: 0.025 mmol), 1,4-dioxane (7 mL) and NazC03 (1 M, 2 
mL); reaction time 5 h; eluent hexane:EtOAc 1:1 v/v, recrystallization from 
EtOAc/hexane, gave 91 as a yellow solid (91 mg, 52%): mp 281.5 oc (decomp.); 1H 
NMR (400 MHz, DMSO-d6) o 9.01 (IH, s), 8.91 (2H, s), 8.74 (IH, t, J= 7.8 Hz), 8.45 
(1H, s), 8.28 (IH, br. s), 7.34 (1H, d, J = 8.1 Hz), 4.17 (3H, s); 13C NMR (125 MHz, 
DMSO-d6) o 163.6 (1C, d, J= 238Hz), 161.1, 156.4, 153.6, 152.3, 146.0 (1C, d, J= 15 
Hz), 140.2, (IC, d, J =9Hz), 135.4, 130.3 (1 C, d, J =4Hz), 126.2, 125.1, 124.7, 117.0, 
109.8 (1C, d, J = 38 Hz), 55.2; MS (ES+) mlz 343.2 ([M+Ht, 95%), 365.2 ([M+Nat, 
100%). HRMS (ES+) calcd for C1sH12N603F 343.0949, found 343.0950. 
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Potassium 3-methoxy-6-phenyl-4-pyridazinyltrifluoroborate salt (92) 
Ph'(XBF3- K+ 3-Methoxy-6-phenyl-4-pyridazinylboronic acid 76a (640 mg, 2.8 
N, I mmol) and potassium hydrogen fluoride (650 mg, 8.3 mmol) were 
'N OMe 
stirred in methanol (5 mL) at room temperature; on addition of 
water (3 mL) a white precipitate formed. The reaction mixture was stirred at room 
temperature for 1 h before standing in an ice bath for 1 h. The precipitate was filtered 
and recrystallized from hot MeCN to yield 92 as a white solid (792 mg, 97%): mp 
209.4-210.8 oc; 1H NMR (400 MHz, DMSO-d6) 8 7.96 (2H, dd, J = 8.4 Hz, J = 1.6 
Hz), 7.82 (1H, s), 7.52 -7.46 (2H, m), 7.43- 7.39 (1H, m), 3.97 (3H, s); 13C NMR (125 
MHz, DMSO-d6) 8 167.8, 153.7, 137.7, 129.6, 128.7, 128.3, 125.9, 53.4; 11B NMR (128 
MHz, DMSO-d6) 8 3.5; 19F NMR (376 MHz, DMSO-d6) 8 -136.5. 
Typical Procedure for the Suzuki-Miyaura Cross-Coupling Reactions of 92 in 
Scheme 2.6 
The trifluoroborate salt 92 (1.1 equiv.), 2-bromopyridine 78 (1.0 equiv.), 
Pd(dppf)Cb·DCM or Pd2(dba)3 (ea. 1 mol% 78), PCy3 (ea. 2.4 mol% 78) in certain 
cases, Et3N or K3P04 (s) were sequentially added to de gassed solvent (3 mL ). The 
reaction mixture was heated under argon at reflux for the time stated. In some cases 
several drops of deionized water were added in attempts to make the reaction mixture 
homogeneous. Solvent was removed in vacuo then EtOAc was added and the organic 
layer was washed with brine, separated, and dried over MgS04. The mixture was 
purified by chromatography on a silica gel column or analyzed by LCMS. 
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5.3 Experimental details for Chapter 3 
6-(6-Chloropyridin-3-yl)pyridazin-3(2H)-one (99) 
0 
Phosphorus oxychloride (1.86 mL, 20 mmol) was added 
dropwise to a stirred solution of 75c ( 434 mg, 2.0 mmol) in 
anhydrous DMF (40 mL) at 0 °C. Stirring was continued for 1 h 
then the mixture was heated at 11 0 oc for 19 h. The reaction was 
cooled to 0 oc and quenched with saturated NaOAc solution (60 mL). The mixture was 
transferred to a separating funnel with the addition of deionized water (25 mL). The 
mixture was extracted with EtOAc (3 x 200 mL) and washed with deionized water (3 x 
150 mL). The organic layer was dried over MgS04 and evaporated to dryness. The solid 
was recrystallized from EtOAc to give 99 as a beige solid (249 mg, 60% ): mp 262.4-
263.0 oc; 1H NMR (400 MHz, DMSO-d6) 13.40 (IH, s), 8.89 (IH, s), 8.29 (IH, dd, J= 
8.9 Hz, J= 1.3 Hz), 8.10 (IH, d, J= 10.4 Hz),7.64 (1H, d, J= 8.3 Hz), 7.05 (IH, d, J= 
9.9 Hz); 13C NMR (100 MHz, DMSO-d6) o 160.6, 151.1, 147.6, 141.2, 137.2, 131.8, 
130.8, 130.4, 124.9; MS (ES+) m/z 208.1 ([M+Ht, 100%). Anal. Calcd. for 
C9H6ClN30: C, 52.07; H, 2.91; N, 20.24. Found: C, 52.10; H, 2.95; N, 20.06%. 
6-Phenyl-4-(pyridin-2-yl)pyridazin-3(2H)-one (103) 
Boron tribromide (1 M in DCM, 3.6 mL, 3.6 mmol) was added 
dropwise to a solution of 79 (232 mg, 0.89 mmol) in anhydrous 
DCM (30 mL) at -78 °C. The reaction mixture was stirred at-
78 oc for 15 min before warming to room temperature. The 
reaction mixture was then heated at reflux for 4 h. The reaction was cooled and 
deionized water (40 mL) added. The mixture was neutralized with a saturated NaHC03 
solution to pH 7, before being extracted with DCM (2 x 50 mL). The combined organic 
phase was dried over Na2S04, evaporated to dryness and recrystallized from 
chloroform/petroleum ether (bp 40--60 °C) to give 103 as a yellow solid (186 mg, 84%): 
mp 247.6-248.5 oc; 1H NMR (400 MHz, DMSO-d6) o 13.57 (IH, s), 8.77- 8.68 (3H, 
m), 7.94-7.90 (3H, m), 7.54-7.47 (4H, m); 13C NMR (100 MHz, DMSO-d6) o 159.8, 
150.2, 149.7, 144.5, 136.7, 135.8, 134.8, 129.2, 129.0, 127.7, 125.6, 124.64, 124.57; 
MS (ES+) mlz 250.2 ([M+Ht, 100%). Anal. Calcd. for CtsHttNJO: C, 72.28; H, 4.45; 
N, 16.86. Found: C, 71.99; H, 4.38; N, 16.77%. 
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6-Phenyl-4-(pyrimidin-5-yl)pyridazin-3(2H)-one (1 04) 
N A mixture of 80 (100 mg, 0.38 mmol), HBr (5 mL, 48% aq. ~ ll 
~ N solution) and acetic acid glacial (1 mL) were stirred at 80 oc for 
3.5 h (TLC monitored). After cooling to room temperature 
deionized water (15 mL) was added and the reaction neutralized 
using NaHCO(s)· The mixture was extracted with DCM (2 x 100 mL) and washed with 
deionized water ( 1 x 1 00 mL ). The organic layer was dried over MgS04 and evaporated 
to dryness. After passing through a silica plug 104 was isolated as a cream colored solid 
(73 mg, 77%): mp 258.3-261.8 °C; 1H NMR (400 MHz, DMSO-d6) & 13.56 (1H, s), 
9.39 (2H, s), 9.25 (lH, s), 8.46 (1H, s), 8.02- 7.99 (2H, m), 7.52- 7.48 (3H, m); 13C 
NMR (100 MHz, DMSO-d6) & 159.2, 158.3, 156.4, 144.5, 134.6, 133.2, 129.3, 128.8, 
128.5, 127.8, 125.9; MS (El) mlz 250.3 (M+, 100%); HRMS (El) calcd for C14H10N40 
250.0855, found 250.0855. 
2-Benzyl-6-phenyl-4-(pyridin-2-yl)pyridazin-3(2H)-one (105) 
A mixture of 103 (46 mg, 0.18 mmol), benzyl bromide (0.02 
mL, 0.19 mmol), potassium carbonate (64 mg, 0.46 mmol) and 
tetrabutylammonium bromide (2.9 mg, 0.009 mmol) in 
acetonitrile (10 mL) was heated at reflux for 1 h. The solvent 
was then removed in vacuo before column chromatography on 
silica, eluent EtOAc to yield 105 as yellow needles after recrystallization from hexane 
(58 mg, 93%): mp 157.1-159.4 oc; 1H NMR (400 MHz, CDCh) & 8.77-8.71 (3H, m), 
7.95 (2H, d, J= 6.8 Hz), 7.81 (1H, t, J= 8.8 Hz), 7.55 (2H, d, J= 6.8 Hz), 7.51 -7.42 
(3H, m), 7.37-7.27 (4H, m), 5.54 (2H, s); 13C NMR (100 MHz, CDCh) & 159.4, 151.2, 
149.7, 145.0, 136.8, 136.7, 136.6, 135.3, 129.5, 129.01, 128.97, 128.7, 128.2, 128.0, 
126.3, 125.5, 124.3, 56.5; MS (ES+) mlz 340.2 ([M+Ht, 100%). Anal. Calcd. for 
C22H17N30: C, 77.86; H, 5.05; N, 12.38. Found: C, 77.42; H, 4.98; N, 12.29%. Crystals 
for X-ray structure determination were grown from hexane. 
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Pyridinium salt (1 06) 
To a methanol solution of compound 103 (30 mg), HBF4 
BF
4
- solution in EhO (Fluka, 54%) was added slowly until 
precipitation was complete. The solids were redissolved 
by heating the mixture. Slow evaporation of the cooled 
solution gave orange crystals of 106 suitable for X-ray structural analysis. 
Typical Procedure for the N-(Hetero)arylation of 103 in Table 3.1 
Compound 103 (1.05 equiv.), aryl halide (1.0 equiv.), Cui (ea. 5 mol%), 8-
hydroxyquinoline (ea. 10 mol%), Cs2C03 (1.5 equiv.) and poly(ethyleneglycol) methyl 
ether (average Mn 2000, 85 m g) were sequentially added to de gassed 1 ,4-dioxane ( 4 
mL). The reaction mixture was heated under argon at reflux for the time stated. The 
reaction mixture was cooled slightly and then paseed through a celite pad which was 
rinsed with EtOAc. The organic solvent was removed in vacuo. The mixture was 
purified by chromatography on a silica gel column followed if needed by 
recrystallization. 
2-( 4-Methoxyphenyl)-6-phenyl-4-(pyridin-2-yl)pyridazin-3(2H)-one (112) 
Compound 103 (90 mg, 0.36 mmol), 4-bromoanisole 109 (0.03 
mL, 0.24 mmol), 8-hydroxyquinoline copper (II) salt 107 (4.2 
mg, 0.012 mmol), K2C03 (50 mg, 0.36 mmol) and DMF (4 mL); 
reaction time 24 h; eluent acetone:hexane 1:4 v/v, gave 112 as a 
yellow solid (35 mg, 41%): mp 178.4-180.5 ac; 1H NMR (500 
MHz, CDCh) () 8.82 (lH, s), 8.76- 8.74 (2H, m), 7.97 (2H, d, J 
= 7.2 Hz), 7.81 (lH, td, J= 7.8 Hz, J= 1.8 Hz), 7.65 (2H, d, J= 8.9 Hz), 7.51 -7.43 
(3H, m), 7.38 - 7.34 (lH, m), 7.05 (2H, d, J = 8.9 Hz), 3.89 (3H, s); 13C NMR (125 
MHz, CDCh) () 159.6, 159.4, 151.1, 149.7, 145.3, 137.4, 136.7, 135.4, 135.1, 129.6, 
129.0, 128.3, 127.2, 126.4, 125.5, 124.5, 114.1, 55.7; MS (ES+) mlz 356.3 ([M+Ht, 
100%). HRMS (ES+) calcd for C22H1sN302 356.1393, found 356.1394. 
158 
Chapter 5 - Experimental Procedures 
2-( 6-Methoxypyridin-3-yl)-6-phenyl-4-(pyridin-2-yl)pyridazin-3(2H)-one (113) 
Conditions C: Compound 103 (102 mg, 0.41 mmol), 5-bromo-2-
l ~ methoxypyridine 110 (0.05 mL, 0.39 mmol), Cui (3.7 mg, 0.020 
N,N mmol), 8-hydroxyquinoline (5.7 mg, 0.040 mmol), Cs2C03 (191 A mg, 0.59 mmol), PEG (85 mg) and 1,4-dioxane (4 mL); reaction Ny time 51 h; eluent EtOAc, gave 113 as a white solid (111 mg, 
OMe 80%): mp 179.0-182.3 oc; 1H NMR (500 MHz, CDCh) 8 8.82 
(lH, s), 8.75-8.70 (2H, m), 8.56 (lH, d, J= 2.6 Hz), 7.98 (lH, dd, J= 8.8 Hz, J= 2.7 
Hz), 7.95 (2H, dd, J= 5.2 Hz, J= 3.2 Hz), 7.80 (lH, td, J= 7.9 Hz, J= 1.8 Hz), 7.51-
7.42 (3H, m), 7.35 (lH, ddd, J = 7.5 Hz, J = 4.7 Hz, J = 1.0 Hz), 6.87 (lH, d, J = 8.8 
Hz), 4.01 (3H, s); 13C NMR (125 MHz, CDCh) 8 163.4, 159.5, 150.8, 149.7, 145.8, 
144.2, 137.5, 136.7, 136.3, 134.8, 133.2, 129.8, 129.1, 128.6, 126.3, 125.4, 124.6, 
110.5, 54.0; MS (ES+) mlz 357.3 ([M+Ht, 60%), 379.2 ([M+Nat, 100%). Anal. Calcd. 
for C21 H16N402: C, 70.77; H, 4.53; N, 15.72. Found: C, 70.42; H, 4.53; N, 15.42%. 
Conditions A: Compound 103 (100 mg, 0.40 mmol), 5-bromo-2-methoxypyridine 110 
(0.05 mL, 0.38 mmol), 8-hydroxyquinoline copper (11) salt 107 (6.7 mg, 0.020 mmol), 
Cs2C03 (186 mg, 0.57 mmol) and DMF (4 mL); 140 oc reaction time 48 h; eluent 
hexane + 5% acetone to hexane:acetone 1:1 v/v, gave 113 as a yellow solid (29 mg, 
21% ). Spectroscopically identical to the sample previously described. Compound 117 
was obtained as the major product, as a cream coloured solid (54 mg, 54%). 
2-Methyl-6-phenyl-4-(pyridin-2-yl)pyridazin-3(2H)-one (117) 
Isolated from the above reaction as a cream coloured solid (54 
mg, 54%): mp 136.4-138.3 oc; 1H NMR (400 MHz, CDCh) 8 
8.77 (lH, dt, J = 8.0, 0.9 Hz), 8.73 (1H, s), 8.71 (lH, ddd, J = 
4.7 Hz, J= 1.8 Hz, J= 0.9 Hz), 7.94-7.87 (2H, m), 7.83-7.77 
(1H, m), 7.51 -7.39 (3H, m), 7.33 (1H, ddd, J= 7.5 Hz, J= 4.7 Hz, J= 1.1 Hz), 3.99 
(3H, s); 13C NMR (100 MHz, CDCh) 8 159.8, 151.1, 149.6, 144.9, 136.6, 136.1, 135.2, 
129.4, 129.0, 128.2, 126.2, 125.4, 124.3, 41.4; MS (ES+) mlz 264.2 ([M+Ht, 100%), 
286.1 ([M+Nat, 40%). Anal. Calcd. for C16H13N30: C, 72.99; H, 4.98; N, 15.96. 
Found: C, 72.72; H, 5.09; N, 15.73%. 
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2-(5-(Trifluoromethyl)pyridin-2-yl)-6-phenyl-4-(pyridin-2-yl)pyridazin-3(2H)-one 
(114) 
Compound 103 (102 mg, 0.41 mmol), 2-bromo-5-
I~ (trifluoromethyl)pyridine 111 (88 mg, 0.39 mmol), Cui (3.7 mg, 
N,N 0.020 mmol), &-hydroxyquinoline (5.7 mg, 0.040 mmol), 
t;-1~ CszC03 (191 mg, 0.59 mmol), PEG (85 mg) and 1,4-dioxane (4 y mL); reaction time 41.5 h; eluent petroleum ether (bp 40-60 
CF3 °C):Et0Ac 1:3 v/v, followed by recrystallzation from 
toluene!hexane gave 114 as white needles (125 mg, 81%): mp 206.7-208.2 °C; 1H NMR 
(400 MHz, CDCh) o 8.99 (dd, 1H, J = 1.5 Hz, J = 0.7 Hz), 8.88 (1H, s), 8.76- 8.73 
(1H, m), 8.72 (1H, d, J= 8.0 Hz), 8.17 (lH, dd, J= 8.3 Hz, J= 2.1 Hz), 7.97-7.93 
(2H, m), 7.89 (lH, d, J= 8.4 Hz), 7.81 (lH, td, J= 7.8 Hz, J= 1.9 Hz), 7.51 -7.44 (3H, 
m), 7.37 (lH, ddd, J= 7.6 Hz, J= 4.7 Hz, J= 1.1 Hz); 13C NMR (100 MHz, CDCh) o 
159.5, 156.8 (lC, q, J = 1 Hz), 150.4, 149.8, 146.7 (lC, q, J = 4 Hz), 146.5, 138.1, 
136.8, 135.7 (1C, q, J =4Hz), 134.7, 130.0, 129.4, 129.1, 126.8 (1C, q, J = 33 Hz), 
126.6, 125.5, 124.8, 123.2 (1C, q, J= 271Hz), 121.7; MS (ES+) mlz 394.9 (M+, 100%), 
395.9 ([M+Ht, 20%), 416.9 ([M+Nat, 30%). Anal. Calcd. for C21HnF3N40: C, 63.96; 
H, 3.32; N, 14.21. Found: C, 63.75; H, 3.35; N, 14.30%. 
6-Pheny l-4-(pyridin-2-yl)-2-(pyrimidin-5-yl)pyridazin-3(2H)-one (115) 
Compound 103 (1 02 mg, 0.41 mmol), 5-bromopyrimidine 62 
I~ (62 mg, 0.39 mmol), Cui (3.7 mg, 0.020 mmol), 8-
N,N hydroxyquinoline (5.7 mg, 0.040 mmol), Cs2C03 (191 mg, 0.59 A mmol), PEG (85 mg) and 1,4-dioxane (4 mL); reaction time 
N~N 41.5 h; eluent petroleum ether (bp 40-60 °C):Et0Ac 1:3 v/v, 
followed by recrystallzation from hexane/toluene gave 115 as a white solid ( 45 mg, 
35%): mp 259.4-261.7 °C; 1H NMR (400 MHz, CDCh) o 9.32 (2H, s), 9.24 (lH, s), 
8.86 (1H, s), 8.76 (lH, d, J = 4.6 Hz), 8.68 (1H, d, J = 8.0 Hz), 7.98- 7.95 (2H, m), 
7.84 (1H, td, J= 7.8 Hz, J= 1.8 Hz), 7.54-7.50 (3H, m), 7.40 (1H, ddd, J= 7.5 Hz, J= 
4.7 Hz, J = 0.8 Hz); 13C NMR (125 MHz, CDCh) o 159.3, 157.2, 153.2, 150.3, 149.9, 
147.0, 138.1, 137.4, 136.9, 134.3, 130.3, 129.2, 126.4, 125.5, 124.9; MS (ES) mlz 
328.2 ([M+Ht, 100%). HRMS (ES+) calcd for Ct9Ht4Ns0 328.1193, found 328.1194. 
Anal. Calcd. for C19H13N50: C, 69.71; H, 4.00; N, 21.39. Found: C, 68.83; H, 4.15; N, 
20.67%. 
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2-(5-Nitrothiophen-2-yl)-6-phenyl-4-(pyridin-2-yl)pyridazin-3(211)-one (116) 
Compound 103 (102 mg, 0.41 mmol), 2-bromo-5-nitrothiophene 
65 (81 mg, 0.39 mmol), Cui (3.7 mg, 0.020 mmol), 8-
hydroxyquinoline (5.7 mg, 0.040 mmol), Cs2C03 (191 mg, 0.59 
mmol), PEG (85 mg) and 1,4-dioxane (4 mL); reaction time 42 
h; eluent DCM:EtzO 1:1 v/v, followed by recrystallzation from 
chloroformlhexane gave 116 as an orange crystalline solid (98 
mg, 67%): mp 248.2-250.1 °C; 1H NMR (400 MHz, CDCh) 8 8.86 (lH, s), 8.78-8.75 
(1H, m), 8.73 (lH, d, J= 8.1 Hz), 8.06-8.00 (2H, m), 7.96 (1H, d, J= 4.8 Hz), 7.91-
7.83 (2H, m), 7.59 - 7.52 (3H, m), 7.42 (1 H, ddd, J = 7.5 Hz, J = 4. 7 Hz, J = 1.0 Hz); 
Be NMR (125 MHz, CDCh) 8 157.6, 150.0, 149.7, 147.8, 147.2, 146.6, 137.6, 137.0, 
134.0, 130.7, 129.3, 128.3, 127.2, 126.8, 125.7, 125.2, 116.7; MS (ES+) m/z 377.2 
([M+Ht, 60%), 774.7 ([Dimer+Nat, 100%). HRMS (ES+) calcd for C19HBN403S 
377.0703, found 377.0702. Anal. Calcd. for C19H12N403S: C, 60.63; H, 3.21; N, 14.89. 
Found: C, 60.14; H, 3.21; N, 14.85%. 
2-Benzyl-6-(6-chloropyridin-3-yl)pyridazin-3(211)-one (118) 
Cl 
0 
A mixture of 99 (70 mg, 0.34 mmol), benzyl bromide (0.04 mL, 
0.35 mmol), potassium carbonate (116 mg, 0.84 mmol) and 
tetrabutylammonium bromide (6.0 mg, 0.02 mmol) in 
acetonitrile ( 1 0 mL) was heated at reflux for 1 h. The solvent 
was then removed in vacuo before column chromatography on 
silica, eluent EtOAc to yield 118 as a cream coloured solid (76 mg, 75%): mp 156.3-
157.9 °C; 1H NMR (400 MHz, CDCh) 8 8.77 (lH, d, J= 2.5 Hz), 8.07 (1H, dd, J= 8.4 
Hz, J= 2.6 Hz), 7.63 (lH, d, J= 9.7 Hz), 7.50-7.47 (2H, m), 7.43 (1H, d, J= 8.4 Hz), 
7.38 - 7.28 (3H, m), 7.07 (1H, d, J = 9.7 Hz), 5.41 (2H, s); Be NMR (100 MHz, 
CDCh) 8 159.4, 152.5, 147.1, 140.9, 136.0, 136.0, 131.1, 129.7, 129.3, 129.1, 128.8, 
128.3, 124.6, 55.8; MS (ES+) mlz 320.0 ([M+Nat, 100%), 298.0 ([M+Ht, 40%). Anal. 
Calcd. for C16H12ClN30: C, 64.54; H, 4.06; N, 14.11. Found: C, 64.34; H, 4.13; N, 
14.04%. 
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2-Benzyl-6-(6-(2-methoxypyridin-3-yl)pyridin-3-yl)pyridazin-3(2H)-one (119) 
0 
Compound 118 (68 mg, 0.23 mmol), 2-methoxy-3-
pyridylboronic acid (38 mg, 0.25 mmol), Pd(PPh3)4 (13 mg, 
0.012 mmol) were charged to flask, purged with argon, 10 
mL degassed 1,4-dioxane was added. Degassed Na2C03 (1 
mL, 1 M) was added and the reaction mixture heated at 
reflux for 3 h. The solvent was then removed in vacuo, 50 
mL EtOAc and 50 mL brine added, before separating the 
organic phase. The organic phase was dried over Na2S04, filtered and evaporated to 
dryness and purified before column chromatography on silica, eluent EtOAc. 
Recrystallization from hexane/toluene gave 119 as a white solid (63 mg, 74%): mp 
129.7-130.0 oc; 1H NMR (400 MHz, CDCh) 8 9.09 (lH, t, J= 1.6 Hz), 8.32 (lH, dd, J 
= 7.5 Hz, J = 2.0 Hz), 8.25 (lH, dd, J = 4.9 Hz, J = 2.0 Hz), 8.13 (2H, d, J = 1.6 Hz), 
7.70 (1H, d, J= 9.7 Hz), 7.53 -7.50 (2H, m), 7.38-7.28 (3H, m), 7.09-7.05 (2H, m), 
5.43 (2H, s), 4.06 (3H, s); 13C NMR (100 MHz, CDCh) 8 161.3, 159.6, 154.9, 147.6, 
147.0, 142.0, 139.6, 136.2, 133.3, 130.9, 129.6, 129.1, 128.9, 128.8, 128.2, 124.6, 
122.3, 117.6, 55.8, 53.8; MS (ES+) mlz 371.2 ([M+Ht, 100%). Anal. Calcd. for 
C22H1sN402: C, 71.34; H, 4.90; N, 15.13. Found: C, 71.16; H, 4.86; N, 14.89%. 
6-( 6-(2-Methoxypyridin-3-yl)pyridin-3-yl)pyridazin-3(2H)-one (120) 
0 
Compound 99 (75 mg, 0.36 mmol), 2-methoxy-3-
pyridylboronic acid (61 mg, 0.40 mmol), Pd(PPh3)2Ch (13 
mg, 0.018 mmol) were charged to flask, purged with argon, 6 
mL degassed 1,4-dioxane was added. Degassed Na2C03 (1 
mL, 1 M) was added and the reaction mixture heated at 
reflux for 21 h. The solvent was then removed in vacuo, 50 mL EtOAc and 50 mL brine 
added, before separating the organic phase. The organic phase was dried over Na2S04, 
filtered and evaporated to dryness and purified before column chromatography on silica, 
eluent EtOAc to yield 120 as a yellow solid following recrystallization from toluene ( 45 
mg, 44%): mp 256.6 oc (decomp.); 1H NMR (400 MHz, DMSO-d6) 8 13.36 (lH, s), 
9.16 (lH, d, J= 1.7 Hz), 8.35-8.25 (3H, m), 8.13 (2H, t, J= 9.1 Hz), 7.18 (1H, dd, J= 
7.4 Hz, J = 4.9 Hz), 7.06 (1H, d, J = 9.9 Hz), 3.99 (3H, s); 13C NMR (100 MHz, 
DMSO-d6) 8 160.5, 160.1, 153.3, 147.4, 146.6, 141.6, 139.2, 133.3, 131.3, 130.3, 128.9, 
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124.0, 121.5, 117.6, 53.5; MS (ES+) m/z 281.3 ([M+Ht, 100%), 303.3 ([M+Na], 65%). 
HRMS (ES+) calcd for C1sH1302N4 281.1033, foUfld 281.1033. 
2-(6-Methoxypyridin-3-yl)-6-(6-(2-methoxypyridin-3-yl)pyridin-3-yl)pyridazin-
3(2H)-one (121) 
I~ 
~ 
OMe 
0 
Compound 120 (45 mg, 0.16 mmol), 5-bromo-2-
methoxypyridine 110 (0.02 mL, 0.15 mmol), Cui (1.4 mg, 
0.0075 mmol), 8-hydroxyquinoline (2.2 mg, 0.015 mmol), 
Cs2C03 (75 mg, 0.23 mmol), PEG (50 mg) and 1,4-dioxane 
(5 mL) were charged to a reaction flask and heated at reflux 
for 45 h. The reaction mixture was then cooled slightly 
before being passed through a silica!celite pad, rinsing the 
EtOAc. The organic solvent was evaporated in vacuo and the crude product purified by 
silica column chromatography, eluent EtOAc to yield 121 as a yellow solid (15 mg, 
26%): mp 162.7 °C (decomp.); 1H NMR (500 MHz, CDCh) o 9.11 (IH, s), 8.54 (1H, s), 
8.32 (1H, d, J= 6.9 Hz), 8.24 (1H, d, J= 4.3 Hz), 8.17 (2H, m), 7.95 (1H, dd, J= 8.9 
Hz, J= 2.7 Hz), 7.80 (1H, d, J= 9.7 Hz), 7.18 (1H, d, J= 9.7 Hz), 7.06 (IH, dd, J= 7.2 
Hz, J = 4.9 Hz), 6.86 (1H, d, J = 8.9 Hz), 4.05 (3H, s), 3.99 (3H, s; 13C NMR (125 
MHz, CDCh) o 163.4, 161.3, 159.4, 155.3, 147.7, 143.7, 142.9, 139.6, 135.7, 133.5, 
132.5, 131.8, 129.9, 117.6, 110.7, 54.1, 53.8. (Due to line-broadening not all of the 
carbon signals could be identified); HRMS (ES+) calcd for C21 H17N50 3 388.1404, found 
388.1405. Elemental analysis was incorrect, Uflfortunately there was insufficient sample 
remaining for recrystallization to improve purity. 
For 1H COSY, HSQC and HMBC spectra which aided confirmation of the structure see 
Appendix A2. 
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5.4 Experimental detains for Chapter 4 
6-(Trifluoromethyl)-3-pyridylboronic acid (136) 
(HOhB ~ n-Butyllithium (2.5 M in hexane, 19.5 mL, 49 mmol) was added U to a mixture of 5-bromo-2-(trifluoromethyl)pyridine 134 (1 0.0 g, 
N CF3 44 mmol) and triisopropylborate (12.3 mL, 53 mmol) in 
anhydrous THF (80 mL) at -78 oc under argon. The reaction was stirred at -78 oc for 3 
h before warming gradually to -10 °C when the reaction was quenched with deionised 
water (100 mL). The organic solvent was removed in vacuo. The resulting aqueous 
phase was treated with solid NaOH to obtain pH 10, then washed with EhO (50 mL) 
and acidified to pH 5 using acetic acid. The solution was extracted with EtOAc (200 
mL) and evaporated to dryness in vacuo to yield 136 as a white solid (8.04 g, 95%): mp 
255 oc (decomp.); 1H NMR (400 MHz, DMSO-d6, DCl) 8 8.98 (1H, s), 8.35 (1H, d, J= 
7.8 Hz), 7.82 (1H, d, J= 7.8 Hz); 13C NMR (125 MHz, DMSO-d6, DCl) 8 155.3, 144.6, 
120.5 (1C, q, J= 3Hz); 11B NMR (128 MHz, DMSO-d6, DCl) 8 29.2; 19F NMR (188 
MHz, DMSO-d6, DCl) 8-66.2. 
Crystals of 136 suitable for X-ray structure determination were grown on slow 
recrystallization from EtOAc. 
5-(Trifluoromethyl)-3-pyridylboronic acid (137) 
(HO) 8 CF n-Butyllithium (2.5 M in hexane, 19.5 mL, 49 mmol) was added 2yy 3 
~- .) to a mixture of 3-bromo-5-(trifluoromethyl)pyridine 135 (10.0 g, 
N 44 mmol) and triisopropylborate (12.3 mL, 53 mmol) in 
anhydrous THF (80 mL) at -78 oc under argon. The reaction was stirred at -78 oc for 
3.5 h before warming gradually to -10 °C when the reaction was quenched with 
deionised water (80 mL). The organic solvent was removed in vacuo. The resulting 
aqueous phase was treated with NaOH(s) to obtain pH 10, then washed with EtzO (1 x 80 
mL) and acidified to pH 5 using acetic acid. The solution was extracted with EtOAc (1 
x 250 mL) and evaporated to dryness in vacuo to yield 137 as an off-white solid (7.91 g, 
94%): mp 300.8 oc (decomp.); 1H NMR (400 MHz, DMSO-d6, DCl) 8 9.43 (lH, s), 
9.23 (1H, s), 9.11 (1H, s); 13C NMR (100 MHz, DMSO-d6, DCl) 8 151.6, 145.7 (1C, q, 
J= 3Hz), 142.2 (1C, q, J= 4Hz), 126.9 (lC, q, J= 35Hz), 122.7 (lC, q, J= 273Hz); 
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11 B NMR (128 MHz, DMSO-d6, DCl) 8 27.8; 19F NMR (188 MHz, DMSO-d6, DCl) 8-
61.0. 
Typical Procedure for the Suzuki-Miyaura Cross-Coupling Reactions in Table 4.1 
The boronic acid 136 or 137 (1.0-2.1 equiv.) the aryl halide (1.0 equiv.) and 
Pd(PPh3)2Ch (ea 5 mol% Ar-X), (for conditions b; t-Bu3P (ea. 5 mol% Ar-X)) were 
sequentially added to de gassed 1 ,4-dioxane (7 mL) and the mixture was stirred at 20 oc 
for 30 min. Degassed aqueous Na2C03 solution (1 M, 2 equiv.) was added and the 
reaction mixture was heated under argon at reflux for the time stated. The mixture was 
transferred to a separating funnel, EtOAc was added and the organic layer was washed 
with brine, separated, and dried over MgS04. The mixture was purified by 
chromatography on a silica gel column followed on some occasions by recrystallization 
or Ktigelrohr distillation. 
3-[ 6-(Trifluoromethyl)pyridin-3-yl] quinoline (143) 
CF3 
Compound 136 (216 mg, 1.13 mmol), 3-bromoquinoline 66 
(0.14 mL, 1.0 mmol), Pd(PPh3)2Ch (35.0 mg, 0.050 mmol), 
1,4-dioxane (7 mL) and Na2C03 (1 M, 3 mL); reaction time 
22 h reflux; eluent petroleum ether (bp 40-60 °C): EtOAc 1:1 
v/v and subsequent recrystallization from cyclohexane gave 143 as a white crystalline 
solid (259 mg, 94%): mp 173.0-174.7 °C; 1H NMR (500 MHz, CDCh) 8 9.16 (IH, d, J 
= 2.5 Hz), 9.07 (IH, d, J= 2.0 Hz), 8.37 (1H, d, J= 2.1 Hz), 8.18-8.16 (2H, m), 7.93 
(IH, d, J= 8.0 Hz), 7.85 (1H, d, J= 8.0 Hz), 7.84-7.80 (1H, m), 7.66-7.64 (IH, m); 
13C NMR (125 MHz, CDCh) 8 149.0, 148.7, 148.1, 147.7 (1C, q, J = 35 Hz), 136.6, 
136.0, 134.4, 130.7, 129.6, 129.3, 128.3, 127.8, 127.7, 121.6 (1C, q, J =274Hz), 120.9 
(1C, q, J = 3 Hz); 19F NMR (188 MHz, CDCh) 8 -68.3; MS (ES+) m/z 275.0 ([M+Ht, 
100%). Anal. Calcd. for C15H9F3N2: C, 65.69; H, 3.31; N, 10.21. Found: C, 65.62; H, 
3.31; N, 10.18%. 
5-[ 6-(Trifluoromethy l)pyridin-3-yl]-2-amino-3-nitropyridine (144) 
Compound 136 (216 mg, 1.13 mmol), 2-amino-5-bromo-3-
nitro-pyridine 61 (218 mg, 1.0 mmol), Pd(PPh3)2Cl2 (35.0 
mg, 0.050 mmol), 1,4-dioxane (7 mL) and Na2C03 (1 M, 3 
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mL); reaction time 17 h reflux; eluent EtOAc and subsequent recrystallization from 
toluene gave 144 as a yellow solid (214 mg, 75%): mp 124.2-126.5 oc; 1H NMR (500 
MHz, DMSO-d6) o 9.24 (1H, d, J = 1.7 Hz), 9.00 (1H, d, J = 2.3 Hz), 8.89 (lH, d, J = 
2.2 Hz), 8.53 (lH, dd, J= 8.2 Hz, J= 2.2 Hz), 8.29 (2H, br s, NH2), 8.06 (lH, d, J= 8.2 
Hz); Be NMR (125 MHz, DMSO-d6) o 154.8, 153.5, 147.6, 144.9 (1C, q, J= 34Hz), 
135.3, 134.8, 133.1, 126.8, 121.8 (lC, q, J= 273Hz), 120.8 (lC, q, J= 3Hz), 120.1; 
19F NMR (188 MHz, CDCh) o -68.3; MS (El) mlz 284.0 (M+, 100%). Anal. Calcd. for 
C11H7F3N402: C, 46.49; H, 2.48; N, 19.71. Found: C, 46.57; H, 2.47; N, 19.73%. 
3-Chloro-5-( trifluorom ethyl)-2-[ 6-( trifluoromethyl)pyridin-3-yl] pyridine (145) 
CF3 
Compound 136 (383 mg, 2.0 mmol), 2,3-dichloro-5-
(trifluoromethyl)pyridine 138 (0.14 mL, 1.0 mmol), 
Pd(PPh3)2Ch (35.0 mg, 0.050 mmol), 1,4-dioxane (7 mL) and 
Na2C03 (1 M, 3 mL); reaction time 4 h reflux; eluent 
DCM:EhO 95:5 v/v, gave a yellow oil which after Kiigelrohr distillation, gave 145 as a 
white crystalline solid (298 mg, 92%): mp 90.9-93.2 °C; 1H NMR (400 MHz, CDCh) o 
9.14 (lH, d, J= 1.4 Hz), 8.90 (lH, s), 8.31 (lH, dd, J= 8.1 Hz, J= 2.0 Hz), 8.11 (lH, d, 
J = 1.8 Hz), 7.83 (1H, d, J = 8.1 Hz); Be NMR (125 MHz, CDCh) o 155.7, 150.6, 
148.7 (1C, q, J= 35Hz), 145.0 (1C, q, J= 4Hz), 138.5, 135.8 (lC, q, J= 4Hz), 135.6, 
130.9, 127.6 (1C, q, J= 34Hz), 122.5 (lC, q, J= 272Hz), 121.5 (lC, q, J= 273Hz), 
120.0 (1C, q, J = 3 Hz); 19F NMR (188 MHz, CDCh) o -62.9, -68.5; MS (ES+) mlz 
327.1 ([M+Ht, 100%). Anal. Calcd. for C12H5ClF6N2: C, 44.13; H, 1.54; N, 8.58. 
Found: C, 44.26; H, 1.49; N, 8.71 %. 
4,6-Bis[6-(trifluoromethyl)pyridin-3-yl]pyrimidine (146) 
CF3 
Compound 136 (601 mg, 3.2 mrnol), 4,6-
dichloropyrimidine 139 (224 mg, 1.5 mrnol), 
Pd(PPh3)2Cb (53.0 mg, 0.075 mrnol), t-Bu3P (0.02 
mL, 0.075 mmol), 1,4-dioxane (7 mL) and Na2C03 (1 
M, 6 mL); reaction time 21 h reflux; eluent hexane:EtOAc 1:1 v/v, and subsequent 
recrystallization from cyclohexane gave a crystalline yellow solid 146 (456 mg, 81%): 
mp 156.9-158.6 °C; 1H NMR (400 MHz, CDCh) o 9.47 (1H, d, J = 1.3 Hz), 9.45 (2H, 
d, J= 1.9 Hz), 8.68 (2H, dd, J= 8.3 Hz, J= 1.5 Hz), 8.23 (lH, d, J= 1.3 Hz), 7.89 (2H, 
d, J= 8.0 Hz); 13C NMR (100 MHz, CDCh) o 161.9, 160.1, 150.4 (1C, q, J= 35Hz), 
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148.8, 136.5, 134.9, 121.4 (1C, q, J = 274 Hz), 120.9, 113.6; 19F NMR (376 MHz, 
CDCh) & -68.5; MS (ES+) m/z 371.2 ([M+Ht, 35%). Anal. Calcd. for C16HsF6N4: C, 
51.90; H, 2.18; N, 15.13. Found: C, 51.86; H, 2.16; N, 15.18%. 
2-(Trifluoromethyl)-5-{4-[6-(trifluoromethyl)pyridin-3-yl]-2,5-
dimethoxyphenyl}pyridine (147) 
,~ 
.....:; 
N 
OMe 
CF3 Compound 136 ( 400 mg, 2.1 mmol), 1 ,4-dibromo-
2,5-dimethoxybenzene 140 (296 mg, 1.0 mmol), 
Pd(PPh3)2Ch (35.0 mg, 0.05 mmol), 1,4-dioxane (7 
mL) and Na2C03 (1 M, 3 mL); reaction time 1 h 
reflux; recrystallization from toluene gave a white 
crystalline solid 147 (331 mg, 77%): mp 224.7-226.9 oc; 1H NMR (400 MHz, CDCh) & 
8.92 (2H, s), 8.09 (2H, dd, J= 8.1 Hz, J= 1.8 Hz), 7.76 (2H, d, J= 8.1 Hz), 7.01 (2H, 
s), 3.84 (6H, s); 13C NMR (100 MHz, CDCh) & 151.2, 150.5, 146.9 (2C, q, J =35Hz), 
138.1, 136.7, 127.1, 121.8 (2C, q, J= 274Hz), 120.0 (2C, q, J= 3Hz), 114.4, 56.5; 19F 
NMR (188 MHz, CDCh) & -68.3; MS (ES+) m/z 429.2 ([M+Ht, 100%), Anal. Calcd. 
for C2oH14F6N202: C, 56.08; H, 3.29; N, 6.54. Found: C, 56.21; H, 3.28; N, 6.56%. 
2-(Trifluoromethyl)-5-( thiophen-2-yl)pyridine (148) (Jl ~ Compound 136 (216 mg, 1.13 mmol), 2-bromothiophene 141 (0.1 
" l . .:L mL, 1.0 mmol), Pd(PPh3)2Ch (35.0 mg, 0.05 mmol), 1,4-dioxane (7 
N...-:; cF3 mL) and Na2C03 (1 M, 3 mL); reaction time 3 h reflux; eluent 
EhO:DCM 1:9 v/v, gave a beige crystalline solid 148 (221 mg, 93%): mp 65.2-66.5 ac; 
1H NMR (400 MHz, CDCh) & 8.97 (IH, d, J= 2.0 Hz), 8.02 (IH, dd, J= 8.1 Hz, J= 
2.3 Hz), 7.69 (lH, d, J = 8.1 Hz), 7.46- 7.44 (2H, m), 7.18- 7.16 (1H, m); 13C NMR 
(175 MHz, CDCh) & 147.1, 146.6 (1C, q, J =35Hz), 138.8, 133.9, 133.3, 128.8, 127.6, 
125.8, 121.7 (1C, q, J= 273Hz), 120.7 (lC, q, J= 3Hz); 19F NMR (188 MHz, CDCh) 
& -68.2; MS (ES+) m/z 230.4 ([M+Ht, 100%). Anal. Calcd. for CwH6F3NS: C, 52.40; 
H, 2.64; N, 6.11. Found: C, 52.66; H, 2.65; N, 6.09%. 
3-[5-(Trifluoromethyl)pyridin-3-yl]quinoline (149) 
Compound 137 (216 mg, 1.13 mmol), 3-bromoquinoline 66 
(0.14 mL, 1.0 mmol), Pd(PPh3)2Ch (35.0 mg, 0.050 mmol), CF3 
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1,4-dioxane (7 mL) and Na2C03 (1 M, 3 mL); reaction time 22 h reflux; eluent EtOAc 
and subsequent recrystallization from cyclohexane gave 149 as a white crystalline solid 
(268 mg, 98%): mp 164.9-166.3 oc; 1H NMR (500 MHz, CDCh) () 9.170 (1H, s), 9.166 
(1H, s), 8.97 (lH, s), 8.38 (lH, d, J= 2.1 Hz), 8.24 (lH, s), 8.19 (lH, d, J= 8.5 Hz), 
7.94 (1H, d, J = 8.1Hz), 7.83- 7.78 (lH, m), 7.65 (lH, t, J = 7.1 Hz); 13C NMR (125 
MHz, CDCh) 8 151.7, 148.9, 148.1, 146.1 (lC, q, J= 4Hz), 134.4, 134.0, 131.7 (lC, q, 
J= 4Hz), 130.7, 129.6, 129.2, 128.3, 127.84, 127.76 (1C, q, J= 33Hz), 127.2 (lC, q, J 
=33Hz), 123.5 (lC, q, J= 271Hz); 19F NMR (188 MHz, CDCh) 8 -62.9; MS (ES+) 
mlz 275.0 ([M+Ht, 100%). Anal. Calcd. for C15H9F3N2: C, 65.69; H, 3.31; N, 10.21. 
Found: C, 65.57; H, 3.28; N, 10.16%. 
5-[5-(Trifluoromethyl)pyridin-3-yl]-2-amino-3-nitropyridine (150) 
Compound 137 (216 mg, 1.13 mrnol), 2-amino-5-bromo-3-
nitro-pyridine 61 (218 mg, 1.0 mmol), Pd(PPh3)2Ch (35.0 
~ CF3 mg, 0.050 mrnol), 1,4-dioxane (7 mL) and Na2C03 (1 M, 3 
I N/- mL); reaction time 17 h reflux; eluent EtOAc gave 150 as a 
yellow solid (220 mg, 78%): mp 247.2-250.0 °C; 1H NMR (500 MHz, DMSO-d6) () 
9.26 (lH, d, J= 2.0 Hz), 8.94 (lH, s), 8.93 (lH, d, J= 2.2 Hz), 8.85 (lH, d, J= 2.2 Hz), 
8.6 (lH, s). 8.18 (2H, br s, NH2); 13C NMR (125 MHz, DMSO-d6) 8 154.8, 153.5, 
151.0, 144.7 (lC, q, J= 4Hz), 133.2, 131.8, 130.8 (lC, q, J= 3Hz), 126.8, 125.4 (lC, 
q, J= 32Hz), 123.7 (lC, q, J= 271Hz), 120.0; 19F NMR (188 MHz, CDCb) 8 -62.8; 
MS (El) mlz 284.0 (M+, 100%). Anal. Calcd. for C11H7F3N402: C, 46.49; H, 2.48; N, 
19.71. Found: C, 46.43; H, 2.49; N, 19.50%. 
3-(Trifluoromethyl)-5-( thiazol-2-yl)pyridine (151) 
c~ Compound 137 (324 mg, 1.7 mrnol), 2-bromothiazole 142 (0.14 
s~CF3 mL, 1.5 mrnol), Pd(PPh3)2Ch (52.0 mg, 0.075 mrnol), 1,4-dioxane 
lNJ (7 mL) and Na2C03 (1 M, 3 mL); reaction time 20.5 h reflux; 
eluent Et20:DCM 1:9 v/v, gave a white crystalline solid 151 (175 mg, 51%): mp 69.2-
71.9 °C; 1H NMR (400 MHz, CDCh) 8 9.32 (lH, d, J = 2.0 Hz), 8.90 (lH, d, J = 1.3 
Hz), 8.50- 8.49 (lH, m), 7.96 (1H, d, J= 3.3 Hz), 7.48 (lH, d, J= 3.3 Hz); 13C NMR 
(125 MHz, CDCh) 8 163.0, 150.7 (lC, q, J =2Hz), 147.3 (lC, q, J =4Hz), 144.6, 
130.7 (1C, q, J = 3 Hz), 129.7, 127.2 (1C, q, J =34Hz), 123.3 (lC, q, J = 273 Hz), 
120.7; 19F NMR (188 MHz, CDCh) 8 -63.0; MS (ES+) mlz 231.4 ([M+Ht, 100%). 
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Anal. Calcd. for C9HsF3N2S: C, 46.96; H, 2.19; N, 12.17. Found: C, 47.16; H, 2.25; N, 
12.08%. 
3-Chloro-5-(trifluoromethyl)-2-[5-(trifluoromethyl)pyridin-3-yl]pyridine (152) 
Compound 137 (192 mg, 1.0 mmol), 2,3-dichloro-5-
CF3 (trifluoromethyl)pyridine 138 (0.14 mL, 1.0 mmol), 
Pd(PPh3)2Ch (35.0 mg, 0.050 mmol), 1,4-dioxane (7 mL) and 
Na2C03 (1 M, 3 mL); reaction time 3 h reflux; eluent gradient 
DCM:EtOAc, 1 :0 to 0:1 v/v, gave a yellow oil which with subsequent distillation of the 
crude fraction, using Ki.igelrohr apparatus, gave 152 as a white crystalline solid (244 
mg, 75%): mp 47.5-48.7 °C; 1H NMR (400 MHz, CDCh) () 9.26 (lH, d, J = 2.0 Hz), 
9.00 (lH, d, J 1.3 Hz), 8.91 (1H, s), 8.39- 8.38 (lH, m), 8.12 (lH, d, J = 2.0 Hz); 13C 
NMR (125 MHz, CDCh) () 155.5, 153.4, 147.4 (1C, q, J =4Hz), 145.0 (lC, q, J = 4 
Hz), 135.9 (1C, q, J= 3Hz), 134.2 (lC, q, J= 4Hz), 132.9, 130.9, 127.6 (1C, q, J= 33 
Hz), 126.6 (1C, q, J= 33Hz), 124.0 (1C, q, J= 271Hz), 121.9 (lC, q, J= 271Hz); 19F 
NMR (188 MHz, CDCh) () -62.8, -62.9; MS (ES+) m/z 327.1 ([M+Ht, 100%). Anal. 
Calcd. for C12HsClF6N2: C, 44.13; H, 1.54; N, 8.58. Found: C, 44.06; H, 1.51; N, 
8.62%. 
Compound 137 (383 mg, 2.0 mmol), 2,3-dichloro-5-(trifluoromethyl)pyridine 138 (0.14 
mL, 1.0 mmol), Pd(PPh3)2Ch (35.0 mg, 0.050 mmol), 1,4-dioxane (7 mL) and Na2C03 
(1 M, 3 mL); reaction time 28.5 h reflux; eluent hexane:EtOAc, 1:1 v/v, gave a yellow 
oil which with subsequent distillation using Ki.igelrohr apparatus, gave 152 as a white 
crystalline solid (270 mg, 83%) spectroscopically identical with the sample previously 
prepared. A minor product was also isolated after column chromatography and distilled 
using a Ki.igelrohr apparatus to give a colourless oil which was identified as 153 from 
1H NMR, COSY and 19F NMR spectra. 
5-(Trifluoromethyl)-2,3-bis[5-(trifluoromethyl)pyridin-3-yl]pyridine (153) 
Compound 137 (401 mg, 2.1 mmol), 2,3-dichloro-5-
(trifluoromethyl)pyridine 138 (0.14 mL, 1.0 mmol), 
Pd(PPh3)2Ch (35.0 mg, 0.050 mmol), t-Bu3P (0.02 mL, 0.050 
CF3 mmol), 1,4-dioxane (7 mL) and Na2C03 (1 M, 3 mL); TLC 
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monitored, after 28 h reflux a second amount of Pd(PPh3)2Ch (35.0 mg, 0.050 mmol) 
was added, and left at reflux for a further 27 h; total reaction time 55 h reflux; eluent 
gradient hexane:EtOAc, 1:1 v/v, recrystallization from petroleum ether (bp 40-60 °C) 
gave 153 a white crystalline solid (255 mg, 58%): mp 73.7-75.8 °C; 1H NMR (500 
MHz, CDCh) 8 9.11 (IH, s), 8.92 (IH, s), 8.86 (IH, s), 8.66 (IH, d, J = 1.7 Hz), 8.64 
(1H, d, J = 1.8 Hz), 8.08 (IH, d, J = 1.9 Hz), 8.04 (IH, s), 7.81 (1H, s); Be NMR (125 
MHz, CDCh) 8 156.2, 153.6, 153.0, 147.2 (1C, q, J =4Hz), 147.0 (IC, q, J =4Hz), 
146.8 (IC, q, J= 4Hz), 136.2 (1C, q, J= 3Hz), 134.7 (IC, q, J= 3Hz), 133.7 (IC, q, J 
=4Hz), 133.7, 133.4, 131.8, 127.2 (IC, q, J= 34Hz), 127.0 (IC, q, J= 34Hz), 126.8 
(1C, q, J= 34Hz), 123.1 (2C, q, J= 273Hz), 122.9 (IC, q, J= 273Hz); 19F NMR (188 
MHz, CDCh) 8 -62.7, -63.1, -63.2; MS (ES+) mlz 437.9 (M+, 100%). Anal. Calcd. for 
CtsHsF9N3: C, 49.44; H, 1.84; N, 9.61. Found: C, 49.56; H, 1.82; N, 9.56%. 
A second product was identified as 152 (117 mg, 36%) spectroscopically identical to 
the sample previously prepared. 
5-(Trifluoromethyl)-2-[ 5-( trifluoromethyl)pyridin-3-yl] -3-( 6-methoxypyridin-3-
yl)pyridine (155) 
OMe 2-Methoxy-5-pyridylboronic acid 154 (53 mg, 0.35 mmol), 
F3C 152 (100 mg, 0.31 mmol), Pd(PPh3)2Ch (11 mg, 0.016 
cF
3 
mmol), t-Bu3P (0.004 mL, 0.016 mmol), 1,4-dioxane (5 mL) 
and Na2C03 (1 M, 1 mL); reaction time 2.5 h reflux; eluent 
hexane:EtOAc, 1:1 v/v, and subsequent Kiigelrohr 
distillation gave 155 a colourless oil (93 mg, 75%): 1H NMR (400 MHz, CDCh) 8 8.98 
(IH, d, J= 1.3 Hz), 8.81 (1H, d, J= 1.0 Hz), 8.70 (IH, d, J= 1.8 Hz), 8.10 (1H, s), 8.02 
(IH, d, J= 2.5 Hz), 7.98 (1H, d, J= 2.0 Hz), 7.34 (IH, dd, J= 8.7 Hz, J= 2.5 Hz), 6.73 
(1H, d, J = 8.6 Hz), 3.92 (3H, s); Be NMR (100 MHz, CDCh) 8 164.4, 156.0, 153.7, 
147.3, 146.4, (1C, q, J= 4Hz), 146.0 (IC, q, J= 4Hz), 139.2, 136.0 (1C, q, J= 4Hz), 
134.6, 134.5 (1C, q, J= 4Hz), 133.6, 126.8 (1C, q, J= 3Hz), 126.5 (1C, q, J= 4Hz), 
126.1, 123.3 (1C, q, J= 273Hz), 121.9 (1C, q, J= 273Hz), 111.6, 53.8; 19F NMR (376 
MHz, CDCh) 8 -62.7, -63.1; MS (ES+) m/z 400.2 ([M+Ht, 100%). Anal. Calcd. for 
C18H11 F6N30: C, 54.14; H, 2.78; N, 10.52. Found: C, 53.90; H, 2.92; N, 10.41%. 
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2-Chloro-5-(trifluoromethyl)-3-pyridylboronic acid (157) and 2-chloro-5-
( trifluoromethyl)-4-pyridylboronic acid (158) 
F3C~B(OH)z 
~ .. A N Cl 
157 
A solution consisting of diisopropylamine (2.1 
mL, 15 mmol), and anhydrous THF (15 mL) 
was cooled to -10 oc and n-butyllithium (2.5 
M in hexanes, 6.0 mL, 15 mmol) was added 
dropwise, and then stirred at 0 °C for 30 min. The lithium diisopropylamine solution 
was cooled to -78 oc and a solution of 2-chloro-5-(trifluoromethyl)pyridine 156 (1.82 
g, 10 mmol) in anhydrous THF (10 mL) was added dropwise over 15 min. The reaction 
mixture was stirred for a further 2 h at -78 °C, before adding triisopropylborate (3.5 
mL, 15 mmol) dropwise. After stirring at -78 °C for 0.5 h the reaction mixture was 
warmed to -1 0 °C and quenched with deionised water (20 mL ). Et20 (20 mL) was 
added and the aqueous phase separated and taken to pH 10 with NaOH(s)· The aqueous 
phase was then acidified with glacial acetic acid, at pH 6 the solution turned opaque, the 
aqueous solution was further acidified to pH 5 then extracted with EtOAc (100 mL). In 
attempts to decolourize, the organic phase was treated with carbon and filtered through 
a celite pad. The organic solvent was removed in vacuo resulting in an orange solid. The 
crude product was then purified by column chromatography, eluent EtOAc to 
EtOAc:MeOH 1:1 v/v to yield 158 as a cream solid (0.94 g, 42%), followed by 157, an 
off-white solid, (0.58 g, 25%). 
157: mp 138.9-141.1 oc; 1H NMR (400 MHz, DMSO-d6, DCl) & 8.68 (1H. s), 8.12 (lH, 
d, J = 2.2 Hz); 13C NMR (175 MHz, DMSO-~, DCl) & 156.6, 146.8 (1 C, q, J = 5 Hz) 
140.4 (lC, q, J= 4Hz), 124.0 (1C, q, J= 33Hz), 123.8 (1C, q, J= 269Hz); 11B NMR 
(128 MHz, DMSO-d6, DCl) & 28.3; 19F NMR (376 MHz, DMSO-d6, DCI) & -61.2; Anal. 
Calcd. for C6~BClF3NOz: C, 31.98; H, 1.79; N, 6.22. Found: C, 30.95; H, 1.93; N, 
5.95%. 
158: mp 147.9-149.2 °C; 1H NMR (400 MHz, DMSO-d6, DCl) & 8.61 (lH, s), 7.54 (1H, 
s); 13C NMR (100 MHz, DMSO-d6, DCl) & 153.6 (lC, q, J= 2Hz), 146.8 (1C, q, J= 5 
Hz), 127.4, 126.6 (1C, q, J= 31 Hz), 124.1 (1C, q, J= 272Hz); 11 B NMR (128 MHz, 
DMSO-d6, DCl) & 27.2; 19F NMR (376 MHz, DMSO-d6, DCl) & -59.0. Anal. Calcd. for 
C6H4BC1F3N02: C, 31.98; H, 1.79; N, 6.22. Found: C, 32.39; H, 1.88; N, 6.10%. 
Crystals for X-ray diffraction analysis were grown from EtOAc. 
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Typical Procedure for the preparation of 159a-c 
A flame-dried round-bottomed flask, purged with argon was charged with Cu20 (5 
mol%), salicylaldoxime (20 mol%), 3-(trifluoromethyl)pyrazole 129 (1.0 equiv.), 
anhydrous CszC03 (2.0 equiv.) and iodo(hetero)aryl (1.5 equiv.). To the reaction flask 
de gassed acetonitrile (20 mL) was added, the reaction mixture was stirred at reflux for 
18 h. The reaction mixture was cooled to room temperature, diluted with DCM and 
filtered through a celite pad and further washed with DCM ( ~ 1 00 mL ). The filtrate was 
concentrated in vacuo, the residue was further purified by column chromatography on 
silica gel. 
3-(Trifluoromethyl)-1-phenyl-1H-pyrazole (159a)483 
cF
3 
3-(Trifluoromethyl)pyrazole 129 (2.0 g, 14.7 mmol), iodobenzene (2.5 mL, eN 22.0 mmol), CuzO (106 mg, 0.74 mmol), salicylaldoxime (398 mg, 2.9 
N mmol), anhydrous CszC03 (9.6 g, 29.4 mmol) and acetonitrile (20 mL); b reaction time 18 h reflux; eluent petroleum ether (bp 40-60 °C):DCM, 100:0 to 1:1 v/v. The crude product a yellow oil was further distilled using 
Kligelrohr apparatus (69-75 oc/0.6-0.75 mbar) to give 159a as a pale yellow oil (2.92 
g, 94%); 1H NMR (500 MHz, CDCh) 3 7.95 (IH, d, J = 2.0 Hz), 7.70 (2H, d, J = 8.5 
Hz), 7.49 (2H, t, J = 7.7 Hz), 7.37 (1H, t, J = 7.4 Hz), 6.72 (1H, d, J = 2.6 Hz); 13C 
NMR (175 MHz, CDCh) 3 144.1 (1C, q, J= 38Hz), 139.6, 129.7, 128.4, 127.9, 121.4 
(1C, q, J =268Hz), 120.1, 106.1; 19F NMR (188 MHz, CDCh) 3 -62.5; MS (El) m/z 
212.0 (M+, 100%). HRMS (El) calcd for CIOH7F3Nz212.0561, found 212.0561. 
3-(Trifluoromethyl)-1-( 4-methoxyphenyl)-1H-pyrazole (159b) 
3-(Trifluoromethyl)pyrazole 129 (2.0 g, 14.7 mmol), 4-iodoanisole (5.15 
g, 22.0 mmol), Cu20 (106 mg, 0.74 mmol), salicylaldoxime (398 mg, 2.9 
mmol), anhydrous Cs2C03 (9.6 g, 29.4 mmol) and acetonitrile (20 mL); 
reaction 19.5 h reflux; eluent DCM:petroleum ether (bp 40-60 °C) 1:9 v/v 
to give 159b as a pale yellow oil (3.48 g, 98%); 1H NMR (400 MHz, 
acetone-d6) 3 8.37 (1H, dd, J = 2.5 Hz, J = 1.0 Hz), 7.76 (2H, d, J = 9.2 
Hz), 7.07 (2H, d, J = 9.2 Hz), 6.85 (1H, dd, J = 2.5 Hz, J = 0.4 Hz), 3.84 (3H, s); 13C 
NMR (100 MHz, acetone-d6) 3 160.3, 143.7 (1C, q, J = 38 Hz), 134.0, 130.3, 122.7 
(1C, q, J= 267Hz), 122.1, 115.6, 106.0 (1C, q, J= 2Hz), 56.0; 19F NMR (188 MHz, 
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CDCh) 8 -62.4; MS (El) mlz 242.0 (~, 100%), 226.9 ([M-CH3t, 80%). Anal. Calcd. 
for C11H9F3N20: C, 54.55; H, 3.75; N, 11.57. Found: C, 54.90; H, 3.80; N, 11.96%. 
3-(Trifluoromethyl)-1-(pyridin-2-yl)-1H-pyrazole (159c) 
3-(Trifluoromethyl)pyrazole 129 (2.0 g, 14.7 mmol), 2-iodopyridine (2.3 mL, 
22.0 mmol), Cu20 (106 mg, 0.74 mmol), salicylaldoxime (398 mg, 2.9 
mmol), anhydrous Cs2C03 (9.6 g, 29.4 mmol) and acetonitrile (20 mL); 
reaction 22 h reflux; eluent EtOAc:petroleum ether (bp 40-60 °C) 1 :9 v/v to 
give 159c as a white crystalline solid (2.95 g, 94%); mp 81.2-82.6 °C. 1H 
NMR (400 MHz, acetone-d6) 8 8.79- 8.77 (lH, m), 8.52 (lH, ddd, J= 4.9 Hz, J= 1.7 
Hz, J = 1.0 Hz), 8.09 - 8.01 (2H, m), 7.45 ( 1 H, ddd, J = 8.0 Hz, J = 3.6 Hz, J = 1.6 Hz), 
6.93 (IH, dd, J = 2.7 Hz, J = 0.4 Hz); 13C NMR (100 MHz, CDCh) 8 150.9, 148.3, 
144.9 (1C, q, J= 38Hz), 139.1, 128.5, 122.7, 121.2 (1C, q, J= 267Hz), 113.1, 106.0 
(IC, q, J= 2Hz); 19F NMR (188 MHz, CDCh) 8 -63.0; MS (El) m/z 212.9 (M+, 100%). 
Anal. Calcd. for C9H6F3N3: C, 50.71; H, 2.84; N, 19.71. Found: C, 50.60; H, 2.88; N, 
19.75%. 
3-(Trifluoromethyl)-5-( 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-phenyl-1H-
pyrazole (160a) 
n-Butyllithium (2.5 M in hexane, 1.4 mL, 3.5 mmol) was added 
drop wise to a solution of 3-(trifluoromethyl)-1-phenyl-1 H-pyrazole 
159a (617 mg, 2.9 mmol) in 20 mL anhydrous THF at -78 oc 
under argon. The reaction mixture was stirred for 45 min at -78 °C. 
2-lsopropoxy-4,4,5,5-tetramethyl-1 ,3,2-dioxaborolane (0.62 mL, 
3.1 mmol) was added dropwise to the reaction mixture at -78 °C, and the mixture was 
stirred for 1. 5 h. The mixture was warmed to room temperature over 1 h and glacial 
acetic acid (0.18 mL, 3.2 mmol) was added. The mixture was filtered through a celite 
pad which was washed with EtOAc (1 x 100 mL). The organic solvent was removed in 
vacuo and the crude product distilled to remove any unreacted starting material and 
boron-containing species, the remaining pale-brown solid was confirmed to be 160a 
(906 mg, 92%); mp 77.7-79.3 °C. 1H NMR (400 MHz, acetone-d6) 8 7.65- 7.62 (2H, 
m), 7.54- 7.48 (3H, m), 7.19 (1H, s), 1.29 (12H, s); 13C NMR (100 MHz, acetone-d6) 8 
143.8 (1C, q, J= 38Hz), 141.6, 129.54, 129.53, 125.9, 122.8 (1C, q, J= 266Hz), 115.8 
(lC, q, J =2Hz), 85.7, 25.0; 11 B NMR (128 MHz, acetone-d6) 8 27.9; 19F NMR (188 
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MHz, acetone-d6) o -62.5; MS (El) mlz 337.8 ([M(160a)t, 80%), 211.9 ([M(159a)t, 
60%). Anal. Calcd. for C16H1sBF3N202: C, 56.83; H, 5.37; N, 8.28. Found: C, 56.72; H, 
5.37; N, 8.07%. 
3-(Trifluoromethyl)-1-( 4-methoxyphenyl)-5-( 4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-1H-pyrazole (160b) 
CF3 n-Butyllithium (2.5 M in hexane, 4.0 mL, 10.0 mmol) was added £N dropwise to a solution of 3-(trifluorornethyl)-1-( 4-
~0~8 N' methoxyphenyl)-1H-pyrazole 159b (2.0 g, 8.3 mmol) in 20 mL 
· ~6 0 anhydrous THF at -78 °C under argon. The reaction mixture was ~ stirred for 30 min at -78 °C. 2-lsopropoxy-4,4,5,5-tetramethyl-
OMe 
1,3,2-dioxaborolane (1.9 mL, 9.1 mmol) was added dropwise to 
the reaction mixture at -78 °C, and the mixture was stirred for 1.5 h. The mixture was 
warmed to room temperature over 1 hand glacial acetic acid (0.52 mL, 9.1 mmol) was 
added. The mixture was filtered through a celite pad which was washed with EtOAc (I 
x 1 00 mL ). The organic solvent was removed in vacuo, recrystallization of the crude 
product from hexane with external cooling precipitated 160b as an off-white crystalline 
solid (2.99 g, 98%): mp 97.8-99.7 °C. 1H NMR (400 MHz, acetone-d6) o 7.52 (2H, d, J 
= 9.1 Hz), 7.11 (1H, s), 7.06 (2H, d, J = 9.1 Hz), 3.88 (3H, s), 1.28 (12H, s); 13C NMR 
(100 MHz, acetone-d6) o 160.9, 143.3 (lC, q, J= 36Hz), 135.0, 127.2, 122.8 (1C, q, J= 
266 Hz), 115.4, 114.6, 85.7, 56.0, 25.0; 11 B NMR (128 MHz, acetone-d6) o 27.9; 19F 
NMR (188 MHz, acetone-d6) o -62.5; MS (El) m/z 368.0 (M+, 100%). Anal. Calcd. for 
C11H2oBF3N203: C, 55.46; H, 5.48; N, 7.61. Found: C, 55.27; H, 5.44; N, 7.46%. 
Crystals suitable for X-ray diffraction analysis were grown on slow recrystallization 
from hexane. 
3-(Trifluoromethyl)-1-(pyridin-2-yl)-5-( 4,4,5,5-tetramethyl-1 ,3,2-dioxa borolan-2-
yl)-1H-pyrazole (160c) 
n-Butyllithium (2.5 M in hexane, 3.3 mL, 8.4 mmol) was added 
dropwise to a solution of 3-(trifluoromethyl)-1-(pyridin-2yl)-1H-
pyrazole 159c (1.5 g, 7.0 mmol) in 50 mL anhydrous THF at -78 
°C under argon. The reaction mixture was stirred for 45 min at -78 
°C. 2-lsopropoxy-4,4,5,5-tetramethyl-1 ,3,2-dioxaborolane (1.6 mL, 
7.7 mmol) was added dropwise to the reaction mixture at -78 °C, and the mixture was 
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stirred for 1.5 h. The mixture was warmed to room temperature over 1 h and glacial 
acetic acid (0.44 mL, 7.7 mmol) was added. The mixture was filtered through a celite 
pad which was washed with EtOAc (1 x 100 mL). The organic solvent was removed in 
vacuo and the crude product distilled to remove any unreacted starting material and 
boron-containing species, the remaining colorless opaque oil was confirmed to be 160c 
(1.98 g, 84%). 1H NMR (400 MHz, CDCh) & 8.35 (1H, ddd, J= 4.9 Hz, J= 1.8 Hz, J= 
0.9 Hz), 8.00 (IH, dt, J = 8.2, 0.9 Hz), 7.85 (IH, ddd, J = 8.3 Hz, J = 7.4 Hz, J = 1.8 
Hz), 7.26 (IH, ddd, J= 7.5 Hz, J= 5.0 Hz, J= 1.0 Hz), 6.83 (1H, s), 1.42 (12H, s); 13C 
NMR (100 MHz, CDCh) & 150.8, 146.7, 145.1 (IC, q, J= 38Hz), 139.3, 122.5, 121.1 
(1C, q, J= 267Hz), 113.2, 111.5 (IC, q, J =2Hz), 84.6, 24.8; 11 B NMR (128 MHz, 
CDCh) & 28.1; 19F NMR (188 MHz, CDCh) & -62.6; MS (El) mlz 323.9 ([M-CH3t, 
100%). Anal. Calcd. for C1 5H 17BF3N302: C, 53.13; H, 5.05; N, 12.39. Found: C, 53.40; 
H, 5.09; N, 12.29%. 
Typical Procedure for the Suzuki-Miyaura Cross-Coupling Reactions of 160a-c in 
Table 4.3. 
The boronic esters 160a-c (1.1 equiv.) the aryl halide (1.0 equiv.), Pd(dppf)Ch·DCM 
(ea 10 mol%), K3P04 (3.0 equiv.) and HCOOK (46 mol% with respect to the boronic 
ester) were sequentially added to degassed 1,4-dioxane (7 mL) and the mixture was 
heated under argon at 80 °C for the time stated. The mixture was filtered through a 
celite pad, which was rinsed with EtOAc. The organic solvent was removed in vacuo 
and the resulting mixture was purified by chromatography on a silica gel column 
followed on some occasions by recrystallization. 
2-[3-(Trifluoromethyl)-1-phenyl-1H-pyrazol-5-yl]pyridine (162) 
Compound 160a (279 mg, 0.83 mmol), 2-bromopyridine 78 (0.07 
mL, 0.75 mmol), Pd(dppf)Ch·DCM (61 mg, 0.075 mmol), 1,4-
dioxane (7mL), K3P04 (477 mg, 2.3 mmol) and HCOOK (32 mg, 
0.38 mmol); reaction time 4.5 h at 80 oc; eluent gradient petroleum 
ether (bp 40-60 °C) to EtOAc:petroleum ether (bp 40-60 °C) 1 :3 v/v 
gave 162 as a light yellow oil (167 mg, 77%). 1H NMR (400 MHz, CDCh) & 8.58 (IH, 
d, J= 4.1 Hz), 7.61 (1H, td, J= 7.8 Hz, J= 1.8 Hz), 7.40-7.30 (5H, m), 7.24 (1H, ddd, 
J= 7.6 Hz, J= 4.9 Hz, J= 1.1 Hz), 7.15 (1H, dt, J= 7.9, 1.0), 7.03 (IH, s); 13C NMR 
(100 MHz, CDCh) & 150.1, 148.4, 144.0, 143.3 (1C, q, J= 39Hz), 139.7, 136.6, 129.2, 
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128.8, 125.7, 123.7, 123.5, 121.3 (1C, q, J= 269Hz), 106.8 (lC, q, J= 2Hz); 19F NMR 
(188 MHz, CDCh) 8 -62.7; MS (El) mlz 288.0 ([M-Ht, 100%), 289.1 (M+, 40%). 
Anal. Calcd. for C1sH10F3N3: C, 62.28; H, 3.48; N, 14.53. Found: C, 62.30; H, 3.68; N, 
14.37%. 
5-[3-(Trifluoromethyl)-1-phenyi-1H-pyrazol-5-yl]-3-nitropyridin-2-amine (163) 
CF3 Compound 160a (279 mg, 0.83 mmol), 2-amino-5-bromo-3-
nitropyridine 61 (164 mg, 0.75 mmol), Pd(dppf)Ch·DCM (61 
mg, 0.075 mmol), 1,4-dioxane (7 mL), K3P04 (477 mg, 2.3 
mmol) and HCOOK (32 mg, 0.38 mmol); reaction time 4 hat 80 
°C; eluent gradient petroleum ether (bp 40-60 °C) to 
EtOAc:petroleum ether (bp 40-60 °C) 1 :3 v/v gave 163 as a yellow solid (215 mg, 
82%): mp 166.6-168.1 °C. 1H NMR (400 MHz, CDCh) 8 8.27 (1H, d, J= 2.2 Hz), 8.18 
(1H, d, J = 2.2 Hz), 7.47- 7.42 (3H, m), 7.37- 7.32 (2H, m), 6.81 (1H, s); De NMR 
(100 MHz, CDCh) 8 154.7, 152.8, 143.6 (1C, q, J= 38Hz), 139.7, 138.5, 134.5, 129.7, 
129.3, 127.4, 125.7, 121.0 (1C, q, J= 260Hz), 115.6, 105.5 (1C, q, J= 2Hz); 19F NMR 
(188 MHz, CDCh) 8 -62.8; MS (El) m/z 348.8 (M+, 100%). Anal. Calcd. for 
C15H10F3Ns02: C, 51.58; H, 2.89; N, 20.05. Found: C, 51.47; H, 2.91; N, 20.15%. 
Crystals suitable for X-ray diffraction analysis were grown from EtOAc/hexane. 
3-[3-(Trifluoromethy l)-1-phenyi-1H-pyrazol-5-yl]-5-methoxypyridine (164) 
Compound 160a (279 mg, 0.83 mmol), 3-bromo-5-methoxypyridine 
161 (141 mg, 0.75 mmol), Pd(dppf)Ch·DCM (61 mg, 0.075 mmol), 
1,4-dioxane (7mL), K3P04 (477 mg, 2.3 mmol) and HCOOK (32 mg, 
0.38 mmol); reaction time 4 h at 80 °C; eluent gradient petroleum 
ether (bp 40-60 °C) to EtOAc:petroleum ether (bp 40-60 °C) 1:3 v/v 
gave 164 as a pale pink oil (192 mg, 80%). 1H NMR (400 MHz, CDCh) 8 8.27 (lH, d, J 
= 2.8 Hz), 8.12 (1H, d, J = 1.7 Hz), 7.41 -7.37 (3H, m), 7.33- 7.29 (2H, m), 6.92 (lH, 
dd, J = 2.8 Hz, J = 1.8 Hz), 6.83 (1H, s), 3.69 (3H, s); De NMR (100 MHz, CDCh) 8 
155.3, 143.5 (lC, q, J= 39Hz), 141.5, 141.3, 138.9, 138.4, 129.6, 129.1, 125.8, 121.1 
(lC, q, J= 267Hz), 120.1, 106.2, 55.7; 19F NMR (188 MHz, CDCh) 8 -62.7; MS (El) 
mlz 319.0 (M+, 80%), 317.9 ([M-Ht, 100%). Anal. Calcd. for C16H12F3N30: C, 60.19; 
H, 3.79; N, 13.16. Found: C, 59.89; H, 3.94; N, 13.53%. 
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5-[3-(Trifluoromethyl)-1-phenyl-1H-pyrazol-5-yl]pyrimidine (165) 
Compound 160a (279 mg, 0.83 mmol), 5-bromopyrimidine 62 (119 
mg, 0.75 mmol), Pd(dppt)Ch·DCM (61 mg, 0.075 mmol), 1,4-
dioxane (7mL), K3P04 (477 mg, 2.3 mmol) and HCOOK (32 mg, 
0.38 mmol); reaction time 3 h at 80 oc; eluent gradient petroleum 
ether (bp 40-60 °C) to EtOAc:petroleum ether (bp 40-60 °C) 1 :3 v/v 
gave 165 as a pale orange crystalline solid (161 mg, 74%): mp 117.3-118.8 °C. 1H 
NMR (400 MHz, CDCh) o 9.17 (IH, s), 8.60 (2H, s), 7.46-7.42 (3H, m), 7.33-7.28 
(2H,m),6.91 (1H,s); 13CNMR(lOOMHz,CDCh)o 158.6, 156.0,144.1 (1C,q,J=39 
Hz), 138.4, 138.2, 129.9, 129.7, 125.8, 124.1, 121.1 (IC, q, J= 267Hz), 106.6 (1C, q, J 
= 2 Hz); 19F NMR (188 MHz, CDCh) o -62.8; MS (El) mlz 290.0 (M+, 90%), 289.0 
([M-Ht, 100%). Anal. Calcd. for C14H9F3N4: C, 57.93; H, 3.13; N, 19.30. Found: C, 
57.93; H, 3.24; N, 19.42%. 
5-[3-(Trifluoromethyl)-1-phenyl-1H-pyrazol-5-yl] pyrimidin-2-amine (166) 
CF3 Compound 160a (279 mg, 0.83 mmol), 2-amino-5-~N bromopyrimidine 63 (131 mg, 0.75 mmol), Pd(dppt)Ch·DCM 
N
1
YbJ (61 mg, 0.075 mmol), 1,4-dioxane (7mL), K3P04 (477 mg, 2.3 
H N)__N_-:; ~ ~ mmol) and HCOOK (32 mg, 0.38 mmol); reaction time 5 hat 80 
2 ::--
oc; eluent gradient petroleum ether (bp 40--60 °C) to 
EtOAc:petroleurn ether (bp 40--60 °C) 1:1 v/v gave 166 as a white solid (153 mg, 67%): 
mp 172.3-174.3 °C. 1H NMR (400 MHz, CDCh) 8 8.14 (2H, s), 7.46- 7.40 (3H, m), 
7.37- 7.32 (2H, m), 6.74 (1H, s), 5.28 (2H, s); 13C NMR (100 MHz, CDCh) 8 162.5, 
157.9, 143.7 (1C, q, J= 38Hz), 139.5, 138.9, 129.7, 129.2, 125.8, 121.2 (1C, q, J= 264 
Hz), 114.2, 105.2 (1C, q, J= 2Hz); 19F NMR (188 MHz, CDCh) 8 -62.8; MS (El) mlz 
305.0 (M+, 100%). HRMS (El) calcd for C14HwF3N5 305.0994, found 305.0994. 
3-(Trifluoromethyl)-1-phenyl-5-(thiophen-2-yl)-1H-pyrazole (167) 
CF3 Compound 160a (279 mg, 0.83 mmol), 2-bromothiophene 143 (0.07 ~N mL, 0.75 mmol), Pd(dppt)Ch·DCM (61 mg, 0.075 mmol), 1,4-Q) dioxane (7mL), K3P04 (477 mg, 2.3 mmol) and HCOOK (32 mg, 0.38 
" 
8 b mmol); reaction time 5 hat 80 "C; eluent gradient petroleum ether (bp 
40--60 °C) to petroleum ether (bp 40-60 °C):DCM 1:1 v/v gave 167 as 
a pale yellow solid (178 mg, 81%): mp 78.7-80.4 °C. 1H NMR (400 MHz, CDCh) 8 
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7.47-7.39 (5H, m), 7.32 (1H, dd, J= 5.1 Hz, J= 1.2 Hz), 6.96 (lH, dd, J= 5.1 Hz, J= 
3.7 Hz), 6.86 (1H, dd, J = 3.7 Hz, J = 1.2 Hz), 6.80 (1H, s); 13C NMR (100 MHz, 
CDCh) o 143.1 (IC, q, J = 38 Hz), 138.9, 138.7, 129.7, 129.3, 129.2, 128.1, 127.50, 
127.45, 126.3, 121.3 (1C, q, J= 267Hz), 105.3 (1C, q, J= 2Hz); 19F NMR (188 MHz, 
CDCh) o -62.8; MS (El) m/z 293.9 (M+, 100%). Anal. Calcd. for C14H9F3NzS: C, 57.14; 
H, 3.08; N, 9.52. Found: C, 57.01; H, 3.11; N, 9.67%. 
2-[3-(Trifluoromethyl)-1-( 4-methoxyphenyl)-1H-pyrazol-5-yl] pyridine (168) 
cF3 Compound 160b (304 mg, 0.83 mmol), 2-bromopyridine 78 (0.07 
I '\N mL, 0.75 mmol), Pd(dppf)Clz·DCM (61 mg, 0.075 mmol), 1,4-
OMe 
dioxane (7mL), K3P04 (477 mg, 2.3 mmol) and HCOOK (32 mg, 
0.38 mmol); reaction time 5.5 h at 80 °C; eluent EtOAc:petroleum 
ether (bp 40-60 °C) 1:4 v/v gave 168 as an off-white crystalline 
solid (150 mg, 63%): mp 107.6-109.4 °C. 1H NMR (400 MHz, 
CDCh) o 8.59 (1H, ddd, J= 4.9 Hz, J= 1.7 Hz, J= 1.0 Hz), 7.60 (lH, td, J= 7.8 Hz, J 
= 1.8 Hz), 7.27- 7.20 (m, 3H), 7.12 (lH, dt, J = 8.0 Hz, J = 1.0 Hz), 7.03 (lH, s), 6.88 
(2H, d, J = 9.0 Hz), 3.82 (3H, s); 13C NMR (100 MHz, CDCh) o 159.7, 149.9, 148.3, 
143.9, 142.9 (lC, q, J= 38Hz), 136.4, 132.7, 126.9, 123.4, 123.3, 121.2 (lC, q, J= 267 
Hz), 114.3, 106.3 (lC, q, J =2Hz), 55.50.; 19F NMR (188 MHz, CDCh) o -62.7; MS 
(El) mlz 318.0 ([M-Ht, 100%), 319.1 (M+, 40%). Anal. Calcd. for C,6H12F3N30: C, 
60.19; H, 3.79; N, 13.16. Found: C, 59.89; H, 3.78; N, 13.12%. 
5-[3-(Trifluoromethyl)-1-( 4-methoxyphenyl)-1H-pyrazol-5-yl] -3-nitropyridin-2-
amine (169) 
Compound 160b (304 mg, 0.83 mmol), 2-amino-5-bromo-3-
nitropyridine 61 (164 mg, 0.75 mmol), Pd(dppf)Clz·DCM (61 
mg, 0.075 mmol), 1,4-dioxane (7mL), K3P04 (477 mg, 2.3 
mmol) and HCOOK (32 mg, 0.38 mmol); reaction time 5 h at 
80 °C; eluent EtOAc:petroleum ether (bp 40-60 °C) 1 :3 v/v 
gave 169 as a yellow solid (225 mg, 79%): mp 190.9-193.1 
°C. 1H NMR (400 MHz, CDCh) o 8.29 (1H, d, J= 2.2 Hz), 8.18 (lH, d, J= 2.2 Hz), 
7.26 (~H, d, J=: 9.0 Hz), 6.93 qH, d, J= 9.0 Hz), 6.79 (1H, s), 3.84 (3H, s); 13C NMR 
(100 MHz, CDCh) o 160.3, 154.9, 152.9, 143.3 (1C, q, J =39Hz), 139.9, 134.7, 131.6, 
127.6, 127.2, 121.2 (lC, q, J= 267Hz), 115.9, 114.9, 105.3 (1C, q, J= 2Hz), 55.7; 19F 
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NMR (188 MHz, CDCh) D -62.8; MS (El) mlz 378.9 (M+, 100%). Anal. Calcd. for 
C16H12F3Ns03: C, 50.67; H, 3.19; N, 18.46. Found: C, 50.38; H, 3.20; N, 18.51%. 
3-[3-(Trifluoro methyl)-1-( 4-methoxyphenyl)-1H-pyrazol-5-yl] -5-methoxypyridine 
(170) 
Compound 160b (304 mg, 0.83 mmol), 3-bromo-5-
methoxypyridine 161 (141 mg, 0.75 mmol), Pd(dppf)Ch·DCM (61 
mg, 0.075 mmol), 1,4-dioxane (7mL), K3P04 (477 mg, 2.3 mmol) 
and HCOOK (32 mg, 0.38 mmol); reaction time 5 h at 80 oc; 
eluent gradient petroleum ether (bp 40-60 °C) to EtOAc:petroleum 
ether (bp 40-60 °C) 1 :3 v/v gave 170 as a pink oil, which 
solidified and was recrystallized from hexane (214 mg, 82%): mp 88.2-90.2 °C 1H 
NMR (400 MHz, CDCb) D 8.25 (1H, d, J= 2.8 Hz), 8.10 (1H, d, J= 1.7 Hz), 7.21 (2H, 
d, J= 9.1 Hz), 6.95 (IH, dd, J= 2.8 Hz, J= 1.8 Hz), 6.87 (2H, d, J= 9.0 Hz), 6.79 (IH, 
s), 3.79 (3H, s), 3.72 (3H, s); Be NMR (100 MHz, CDCb) D 159.9, 155.2, 143.1 (1C, q, 
J= 28Hz), 141.3, 141.1, 137.9, 131.8, 127.0, 125.8, 121.1 (IC, q, J= 267Hz), 120.1, 
114.5, 105.7 (IC, q, J= 2Hz), 55.53, 55.52; 19F NMR (188 MHz, CDCb) D -62.6; MS 
(El) mlz 349.0 (M+, 100%), 348.0 ([M-Ht, 90%). Anal. Calcd. for C17H14F3N302: C, 
58.45; H, 4.04; N, 12.03. Found: C, 58.40; H, 4.08; N, 12.06%. 
5-[3-(Trifluoromethyl)-1-( 4-methoxyphenyl)-1H-pyrazol-5-yl] pyrimidine (171) 
cF3 Compound 160b (304 mg, 0.83 mmol), 5-bromopyrimidine 62 
I \:N (119 mg, 0.75 mmol), Pd(dppf)Ch·DCM (61 mg, 0.075 mmol), 
OMe 
1,4-dioxane (7mL), K3P04 (477 mg, 2.3 mmol) and HCOOK (32 
mg, 0.38 mmol); reaction time 3 h at 80 °C; eluent gradient 
petroleum ether (bp 40-60 °C) to EtOAc:petroleum ether (bp 40-
60 °C) 1:3 v/v gave 171 as a pale orange solid (143 mg, 60%): mp 
94.4-95.9 °C. 1H NMR (400 MHz, CDCb) D 9.14 (IH, s), 8.58 (2H, s), 7.20 (2H, d, J= 
9.1 Hz), 6.90 (2H, d, J = 9.0 Hz), 6.87 (1H, s), 3.80 (3H, s); Be NMR (100 MHz, 
CDCb) D 160.4, 158.4, 155.9, 143.6 (IC, q, J = 39 Hz), 138.2, 131.3, 127.2, 124.1, 
121.0 (1C, q, J =268Hz), 115.0, 106.1 (1C, q, J =2Hz), 55.7; 19F NMR (188 MHz, 
CDCh) D -62.7; MS (El) mlz 319.9 (M+, 100%). Anal. Calcd. for CisH11F3N40: C, 
56.25; H, 3.46; N, 17.49. Found: C, 56.33; H, 3.59; N, 17.09%. 
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5-[3-(Trifluoromethyl)-1-( 4-methoxyphenyl)-1H-pyrazol-5-yl] pyrimidin-2-amine 
(172) 
CF3 Compound 160b (304 mg, 0.83 mmol), 2-amino-5-
1 "N bromopyrimidine 63 (131 mg, 0.75 mmol), Pd(dppf)Ch·DCM 
(61 mg, 0.075 mmol), 1,4-dioxane (7mL), K3P04 (477 mg, 
2.3 mmol) and HCOOK (32 mg, 0.38 mmol); reaction time 5 
h at 80 oc; eluent gradient petroleum ether (bp 40-60 °C) to 
OMe 
EtOAc:petroleum ether (bp 40-60 °C) 1:1 v/v gave 172 as a 
white solid (180 mg, 72%): mp 171.3-173.3 °C. 1H NMR (400 MHz, CDCh) () 8.11 
(2H, s), 7.23 (2H, d, J = 9.0 Hz), 6.89 (2H, d, J = 9.0 Hz), 6.70 (IH, s), 5.61 (2H, s), 
3.80 (3H, s); 13C NMR (100 MHz, CDCh) () 162.5, 160.0, 157.8, 143.2 (1C, q, J= 38 
Hz), 139.6, 131.8, 127.2, 121.2 (1C, q, J= 268Hz), 114.8, 114.0, 104.7 (1C, q, J= 2 
Hz), 55.6; 19F NMR (188 MHz, CDCh) () -62.7; MS (El) m/z 334.8 (M+, 100%). HRMS 
(El) calcd for CisH12F3NsO 335.0994, found 335.0994. Anal. Calcd. for C 15H12F3N50: 
C, 53.73; H, 3.61; N, 20.89. Found: C, 53.48; H, 3.77; N, 20.32%. 
3-(Trifluoromethyl)-1-( 4-methoxyphenyl)-5-( thiophen-2-yl)-1H-pyrazole (173) 
CF3 Compound 160b (304 mg, 0.83 mmol), 2-bromothiophene 143 
1 "N (0.07 mL, 0.75 mmol), Pd(dppf)Ciz·DCM (61 mg, 0.075 mmol), 
OMe 
1,4-dioxane (7mL), K3P04 (477 mg, 2.3 mmol) and HCOOK (32 
mg, 0.38 mmol); reaction time 5 h at 80 oc; eluent gradient 
petroleum ether (bp 40-60 °C) to petroleum ether (bp 40-60 
°C):DCM 1:1 v/v gave 173 as a pale yellow solid (206 mg, 85% ): 
mp 107.5-109.1 °C; 1H NMR (400 MHz, CDCh) () 7.34- 7.29 (3H, m), 6.97- 6.93 
(3H, m), 6.88 (1H, dd, J = 3.6 Hz, J = 1.0 Hz), 6.79 (IH, s), 3.86 (3H, s); 13C NMR 
(100 MHz, CDCh) () 160.4, 143.0 (1C, q, J= 38Hz), 139.1, 132.0, 130.0, 128.0, 128.0, 
127.6, 127.5, 121.3 (IC, q, J= 268Hz), 114.5, 104.8 (1C, q, J= 2Hz), 55.7; 19F NMR 
(188 MHz, CDCh) () -62.8; MS (El) mlz 323.9 (M+, 100%). Anal. Calcd. for 
C 15H 11 F3N20S: C, 55.55; H, 3.42; N, 8.64. Found: C, 55.33; H, 3.43; N, 8.55%. 
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2-[3-(Trifluoromethyl)-1-(pyridin-2-yl)-1H-pyrazol-5-yl]pyridine (17 4) 
CF3 Compound 160c (280 mg, 0.83 mmol), 2-bromopyridine 78 (0.07 mL, 
,N 0.75 mmol), Pd(dppf)Ch·DCM (61 mg, 0.075 mmol), 1,4-dioxane 
b (7mL), K3P04 (477 mg, 2.3 mmol) and HCOOK (32 mg, 0.38 mmol); N :._ ~ reaction time 4.5 h at 80 °C; eluent EtOAc:petroleum ether (bp 40-60 
°C) 1:1 v/v gave 174 as a yellow oil (35 mg, 16%): 1H NMR (400 
MHz, CDCh) 8 8.48 (1H, ddd, J = 4.8 Hz, J = 1.6 Hz, J = 0.9 Hz), 8.26 (1H, ddd, J = 
4.8 Hz, J= 1.7 Hz, J= 0.7 Hz), 7.89-7.82 (1H, td, J= 8.0 Hz, J= 2.0 Hz), 7.75-7.67 
(2H, m), 7.41 (1H, dt, J = 7.9 Hz, J = 1.0 Hz), 7.28 - 7.24 (2H, m), 6.96 (1H, s); 13C 
NMR (100 MHz, CDCb) 8 152.2, 149.5, 149.1, 148.2, 144.4, 143.7 (1C, q, J= 39Hz), 
138.8, 136.5, 123.7, 123.6, 123.4, 121.2 (1C, q, J= 268Hz), 119.1, 107.2 (IC, q, J= 2 
Hz); 19F NMR (188 MHz, CDCb) 8 -62.9; MS (El) mlz 220.7 ([M-CF3t, 90%), 289.0 
([M-Ht, 50%), 290.1 (M+, 30%). HRMS (ES+) calcd for C14H10F3N4 291.0852, found 
291.0852. Anal. Calcd. for C14H9F3N4: C, 57.93; H, 3.13; N, 19.30. Found: C, 57.03; H, 
3.35; N, 18.39%. 
5-[3-(Trifluoromethyl)-1-(pyridin-2-yl)-1H-pyrazol-5-yl]pyrimidine (175) 
CF3 Compound 160c (280 mg, 0.83 mmol), 5-bromopyrimidine 62 (119 
N mg, 0.75 mmol), Pd(dppf)Ch·DCM (61 mg, 0.075 mmol), 1,4-
N dioxane (7mL), K3P04 (477 mg, 2.3 mmol) and HCOOK (32 mg, 
\lr{ Nb 0.38 mmol); reaction time 4.5 hat 80 °C; eluent EtOAc:petroleum 
ether (bp 40-60 °C) 1:1 v/v gave 175 as an white solid (65 mg, 
30%): mp 116.5-117.2 oc; 1H NMR (400 MHz, CDCh) 8 9.21 (IH, s), 8.76 (2H, s), 
8.21 (IH, ddd, J= 4.8 Hz, J= 1.7 Hz, J= 0.9 Hz), 7.95-7.87 (m, 2H), 7.29 (1H, ddd, J 
= 6.9 Hz, J = 4.9 Hz, J = 1.5 Hz), 6.85 (IH, s); 13C NMR (100 MHz, CDCh) 8 158.4, 
156.6, 151.6, 147.9, 144.23 (1C, q, J= 38Hz), 139.4, 138.9, 125.7, 123.7, 120.9 (IC, q, 
J= 267Hz), 117.4, 108.6 (IC, q, J= 2Hz); 19F NMR (188 MHz, CDCh) 8 -63.1; MS 
(El) mlz 290.0 ([M-Ht, 100%). Anal. Calcd. for C13HsF3N5: C, 53.61; H, 2.77; N, 
24.05. Found: C, 53.44; H, 2.83; N, 23.91%. 
4-Bromo-3-(trifluoromethyl)-1-phenyi-1H-pyrazole (177) 
Bromine (0.4 mL, 7.4 mmol) was added to a solution of compound 159a 
(1.05 g, 5.0 mmol) in 10 mL glacial acetic acid. The mixture was heated 
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to 1 00 °C for 17 h. The reaction mixture was allowed to cool slightly before quenching 
with deionised water (10 mL), the mixture was then neutralised with NaOH solution 
(1M). A saturated solution of Na2S20 3 (50 mL) was added and the product then 
extracted with EtOAc (2 x 100 mL). The organic phase was dried over Na2S04, filtered 
and evaporated to dryness in vacuo. Following column chromatography, eluent 
DCM:petroleum ether (bp 40-60 °C) 1:4 v/v, 177 was isolated as a colourless oil (1.33 
g, 92%): 1H NMR (400 MHz, CDCh) () 7.94 (lH, d, J= 0.9 Hz), 7.66-7.59 (2H, m), 
7.50-7.44 (2H, m), 7.41-7.35 (1H, m); 13C NMR (100 MHz, CDCh) () 141.8 (1C, q, 
J= 38Hz), 138.9, 129.78, 129.75, 128.3, 120.7 (lC, q, J= 268Hz), 93.6 (lC, q, J= 
1Hz); 19F NMR (188 MHz, CDCh) () -62.5; MS (El) mlz 289.8 (M+C9Br], 100%). Anal. 
Calcd. for C10H6BrF3N2: C, 41.26; H, 2.08; N, 9.62. Found: C 41.61; H, 2.15; N, 9.78%. 
4-Bromo-1-( 4-bromophenyl)-3-(trifluoromethyl)-1H-pyrazole (179) 
Br~F3 
lL.~;N 
N q 
Br 
Bromine (0.65 mL, 12.7 mmol) and iron powder (140 mg, 2.5 mmol) 
were added to compound 159a (1.0 g, 4.7 mmol). The mixture was 
heated to 100 oc for 1 h. Na2S20 3 (2.5 g, 16.0 mmol) in 10 mL water 
was added to the mixture. The product was then extracted with Et20 (3 x 
50 mL). The organic phase was combined and washed with brine (2 x 25 
mL) and water (1 x 50 mL). The organic phase was dried over Na2S04, 
filtered and evaporated to dryness in vacuo. Following column chromatography, eluent 
petroleum ether (bp 40-60 °C) + 5% DCM, 179 was isolated as a white solid (1.28 g, 
73%): mp 51.5-53.2 °C; 1H NMR (400 MHz, CDCh) () 7.90 (lH, s), 7.54 (2H, d, J= 8.7 
Hz), 7.46 (2H, d, J= 8.7 Hz); 13C NMR (100 MHz, CDCh) () 1412.0 (lC, q, J= 37Hz), 
137.7, 132.8, 129.5, 124.8, 120.8, 120.5 (1C, q, J= 268Hz), 94.0 (lC, q, J= 2Hz); 19F 
NMR (188 MHz, CDCh) () -62.8; MS (El) m/z 369.7 (M+C9Br], 100%). Anal. Calcd. 
for C10HsBrzF3N2: C, 32.46; H, 1.36; N, 7.57. Found: C, 32.72; H, 1.42; N, 7.50%. 
2-[4-Bromo-3-(trifluoromethyl)-1-phenyl-1H-pyrazol-5-yl]pyridine (181) 
Br 
Bromine (0.02 mL, 0.48 mmol) was added to a solution of compound 
162 (92 mg, 0.32 mmol) in 5 mL glacial acetic acid. The mixture was 
heated to 100 oc for 17 h. The reaction mixture was allowed to cool 
slightly before quenching with deionised water (10 mL), the mixture 
was then neutralised with NaOH solution (lM). A saturated solution 
ofNa2Sz03 (40 mL) was added and the product then extracted with EtOAc (2 x 75 mL). 
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The organic phase was dried over Na2S04, filtered and evaporated to dryness in vacuo. 
Following column chromatography, eluent DCM, 181 was isolated as a white solid (78 
mg, 66%): mp 106.4-108.2 oc; 1H NMR (400 MHz, CDCh) o 8.61 (lH, d, J= 4.2 Hz), 
7.77 (1H, td, J= 7.7 Hz, J= 1.6 Hz), 7.47 (lH, d, J= 7.8 Hz), 7.32-7.30 (4H, m), 7.26 
-7.23 (2H, m); 13C NMR (100 MHz, CDCh) o 150.3, 147.2, 142.3, 141.4 (lC, q, J= 
37Hz), 139.4, 136.7, 129.2, 128.8, 125.9, 125.0, 124.1, 120.8 (1C, q, J= 269Hz), 94.1 
(lC, q, J= 1.4 Hz); 19F NMR (188 MHz, CDCh) o -62.9; MS (El) mlz 367.8 (M+C9Br], 
100%). HRMS (El) calcd for C1 5H9BrF3N3 366.9932, found 366.9932. Anal. Calcd. for 
C15H9BrF3N3: C, 48.94; H, 2.46; N, 11.41. Found: C, 48.22; H, 2.49; N, 11.20%. 
5-[ 4-Bromo-3-( trifluoromethyl)-1-phenyl-1H-pyrazol-5-yl] -3-nitropyridin-2-amine 
(182) 
N 
I 
H2N 
Br 
~ 
,0 
N02 
Bromine (0.012 mL, 0.24 mmol) was added to a solution of 
compound 163 (55 mg, 0.16 mmol) in 5 mL glacial acetic acid. 
The mixture was heated to 1 00 oc for 18 h. The reaction mixture 
was allowed to cool slightly before quenching with deionised 
water (25 mL ), the mixture was then neutralised with a saturated 
solution of NaHC03. A saturated solution of Na2S20 3 (50 mL) was added and the 
product then extracted with DCM (3 x 50 mL ). The organic phase was dried over 
Na2S04, filtered and evaporated to dryness in vacuo. The crude product was passed 
through a silica pad and then recrystallized from cyclohexane to yield 182 as a yellow 
crystalline solid (58 mg, 86%): mp 183.9-185.6 oc; 1H NMR (400 MHz, CDCh) o 8.41 
(1H, d, J= 2.2 Hz), 8.20 (1H, d, J= 2.2 Hz), 7.44-7.40 (3H, m), 7.31 -7.27 (2H, m); 
13C NMR (100 MHz, CDCh) o 155.9, 153.2, 141.8 (lC, q, J =37Hz), 138.7, 138.5, 
136.4, 129.8, 129.6, 127.6, 125.5, 120.6 (IC, q, J =267Hz), 113.8, 94.3 (1C, q, J = 1 
Hz); 19F NMR (188 MHz, CDCh) o -63.0; MS (El) m/z 426.8 (M+C9Br], 100%). Anal. 
Calcd. for C15H9BrF3N50 2: C, 42.08; H, 2.12; N, 16.36. Found: C, 41.96; H, 2.14; N, 
15.97%. 
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2-[3-(Trifluoromethyl)-4-( 6-methoxypyridin-3-yl)-1-phenyl-1H-pyrazo 1-5-
yl]pyridine (183) 
M eO Compound 181 (120 mg, 0.33 mmol), 2-methoxy-5-
pyridylboronic acid (55 mg, 0.36 mmol), Pd(PPh3)4 (5 mol%, 19 
mg, 0.016 mmol) and degassed1,4-dioxane (4 mL) were added 
sequentially to a reaction flask, under an argon atmosphere, the 
mixture was placed stirred at room temperature for 20 min. 
Degassed Na2C03 (1M, 1.0 mL, 1.0 mmol) was added and the reaction mixture heated 
to reflux. After 6 h at reflux the reaction was complete, the mixture was cooled slightly 
before adding EtOAc (50 mL) and brine (50 mL). The organic phase was extracted and 
dried over Na2S04, filtered and evaporated to dryness in vacuo. The crude product was 
purified by column chromatography, eluent EtOAc, followed by recrystallization from 
hexane/DCM to yield 183 as light yellow/orange, rectangular crystals (104 mg, 80%): 
mp 127.8-130.1 °C; 1H NMR (400 MHz, CDCh) 8 8.53 (lH, ddd, J = 4.9 Hz, J = 1.8 
Hz, J= 1.0 Hz), 8.06 (1H, d, J= 2.2 Hz), 7.59-7.51 (2H, m), 7.34-7.28 (5H, m, 5H), 
7.20 (1H, ddd, J = 7.7 Hz, J = 4.9 Hz, J = 1.2 Hz), 7.06 (1H, dt, J = 7.8, 1.1 Hz), 6.71 
(lH, dd, J = 8.6 Hz, J = 0.8 Hz), 3.92 (3H, s); 13C NMR (100 MHz, CDCh) 8 163.8, 
150.2, 148.3, 147.9, 141.2, 141.6 (lC, q, J =36Hz), 140.5 (1C, q, J = 1 Hz), 139.4, 
136.6, 129.1, 128.5, 126.0, 125.3, 123.7, 121.6 (1C, q, J= 268Hz), 119.2, 118.6, 110.6, 
53.6; 19F NMR (188 MHz, CDCh) 8 -60.1; MS (El) mlz 395.0 ([M-Ht, 100%), 396.1 
(M+, 25%). Anal. Calcd. for C21H1sF3N40: C, 63.63; H, 3.81; N, 14.14. Found: C, 
63.60; H, 3.86; N, 14.33%. Crystals, obtained as described above, were suitable for X-
ray diffraction analysis. 
5-[3-(Trifluoromethyl)-4-( 6-( trifluoromethyl)pyridin-3-yl)-1-phenyl-1H-pyrazol-5-
yl]-3-nitropyridin-2-amine (184) 
F3C Compound 182 (43 mg, 0.10 mmol), 6-(trifluoromethyl)-3-
N02 
pyridylboronic acid 136 (21 mg, 0.11 mmol), Pd(PPh3)4 (5 
mol%, 5.8 mg, 0.005 mmol) and degassed1,4-dioxane (10 mL) 
were added sequentially to a reaction flask, under an argon 
atmosphere, the mixture was placed stirred at room temperature 
for 10 min. Degassed Na2C03 (1M, 0.30 mL, 0.30 mmol) was 
added and the reaction mixture heated to reflux. After 3.5 h at reflux the reaction was 
complete, the reaction solvent was removed in vacuo before EtOAc (50 mL) and brine 
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(50 mL) were added to the reaction mixture. The organic phase was extracted and 
solvent removed in vacuo, the crude product was filtered through a silica pad, washing 
with EtOAc. The combined organic solvent was removed in vacuo and the crude 
product was purified by column chromatography, eluent DCM to yield 184 as a yellow 
solid (15 mg, 30%): mp 164.9 °C darkens, >200 °C decamp.; 1H NMR (400 MHz, 
CDCh) D 8.56 (IH, d, J = 1.8 Hz), 8.04 (IH, d, J = 2.2 Hz), 7.97 (IH, d, J = 2.2 Hz), 
7.88 (IH, dd, J = 8.0 Hz, J = 1.7 Hz), 7.75 (IH, d, J = 8.0 Hz), 7.48- 7.43 (3H, m), 
7.37- 7.31 (2H, m), 6.01 (2H, br. s); 13C NMR (175 MHz, CDCh) D 155.8, 153.1, 
150.8, 147.9 (IC, q, J = 33 Hz), 141.5 (1C, q, J =37Hz), 139.1, 138.7, 138.1, 136.3, 
129.9, 129.7, 129.2, 127.5, 125.8, 121.4 (1C, q, J= 271Hz), 121.1 (1C, q, J= 270Hz), 
120.5 (1C, q, J =2Hz), 116.9, 113.6; 19F NMR (188 MHz, CDCh) D -60.0, 68.4; MS 
(ES+) mlz 495.1 ([M+Ht, 100%). HRMS (ES+) calcd for C21H13F6N602 495.09987, 
found 495.09995. 
4-Bromo-1-(3-bromo-4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole (185) 
srJF3 
lL.~;N 
N Q-sr 
OMe 
Bromine (0.31 mL, 6.0 mmol) was added to a solution of compound 
159b (971 mg, 4.0 mmol) in 10 mL glacial acetic acid. The mixture 
was heated to 100 oc for 17 h. The reaction mixture was allowed to 
cool slightly before quenching with deionised water (25 mL ), the 
mixture was then neutralised with a saturated solution ofNaHC03. A 
saturated solution of Na2S20 3 (50 mL) was added and the product 
then extracted with DCM (3 x 50 mL). The organic phase was dried over Na2S04, 
filtered and evaporated to dryness in vacuo. The crude product was purified by silica 
column chromatography eluent petroleum ether (bp 40-60 °C):DCM 1:1 v/v, to yield 
185 as a cream coloured solid (695 mg, 43%): mp 84.1-86.6 oc; 1H NMR (400 MHz, 
CDCh) D 7.90 (1H, d, J= 0.9 Hz), 7.87 (IH, d, J= 2.7 Hz), 7.56 (1H, dd, J= 8.9 Hz, J 
= 2.7 Hz), 6.97 (IH, d, J= 8.9 Hz), 3.94 (3H, s); 13C NMR (100 MHz, CDCh) D 156.1, 
141.9 (1C, q, J= 37Hz), 132.9, 129.8, 125.3, 120.6 (IC, q, J= 268Hz), 120.1, 112.6, 
112.2, 93.7 (IC, q, J= 2Hz), 56.8; 19F NMR (188 MHz, CDCh) D -62.6; MS (El) mlz 
397.7 (M+(9Br], 50%). Anal. Calcd. for C11 H7Br2F3N20: C, 33.03; H, 1.76; N, 7.00. 
Found: C, 32.99; H, 1.95; N, 6.81%. 
Also isolated from the reaction mixture were minor products: isomers 186 and 187 as a 
mixture (142 mg, 11% yield) confirmed by 1H NMR. 188 observed by 1H NMR, as a 
mixture with another species, GCMS (El) mlz 383.8 (M+(9Br], 100%). 189 
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recrystallized from hexane to yield an off-white solid (53 mg, 3%). For the 1H NMR 
spectra of the 186 and 187 mixture and 188 see Appendix 2. 
2,6-Dibromo-4-( 4-bromo-3-( trifluoromethyl)-lH-pyrazol-1-yl)phenol (189) 
Br~F3 
lL.~,"N 
N Q-sr 
Br OH 
Isolated from the above reaction, following recrystallization from 
hexane after column chromatography (53 mg, 3%): mp 159.3-161.6 
ac; 1H NMR (400 MHz, CDCh) 8 7.91 (1H, d, J= 0.9 Hz), 7.81 (2H, 
s), 6.02 (lH, s); 13C NMR (100 MHz, CDCh) 8 149.8, 142.3 (1C, q, 
J= 37Hz), 133.1, 129.8, 123.6, 120.4 (1C, q, J= 269Hz), 110.5, 
94.2 (1 C, q, J = 1 Hz); 19F NMR (188 MHz, CDCh) 8 -62.6; MS (El) 
mlz 463.6 (M+C9Br], 100%. Anal. Calcd. for CwH4Br3F3N20: C, 25.84; H, 0.87; N, 
6.03. Found: C, 25.86; H, 0.87; N, 5.97%. 
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APPENDIX 1 - 2-AMIN0-5-PYRIMIDYLBORONIC ACID 
Al.ll Introduction 
Pyrimidylboronic acids are important reagents in the preparation of functionalized 
pyrimidine derivatives, 1-3 however there are far fewer reports of substituted 
pyrimidylboronic acids than pyridylboronic acid derivatives, as discussed previously. 
Our group were interested in the Suzuki-Miyaura cross-coupling reactions of 
(hetero)aryl halides in the presence of an unprotected primary amine substituent.4• 5 
Previous to our work, it was generally regarded that compounds bearing labile protons 
were unsuitable as coupling partners6 and that reactions would occur only when the 
amine was protected. However, a systematic study into the Suzuki-Miyaura reactivity of 
a variety of amine-substituted halogenated-benzenes, -pyridines, -pyrazines and -
pyrimidines with a number of pyridylboronic acids and aryldiboronic acids showed the 
suitability of these substrates without need for protection/deprotection of the amine, 
yielding highly functionalized bi(hetero)aryls in moderate to good yields, 35-84%.5 At 
this time other groups were also reporting the synthesis of biheteroaryl compounds 
containing an unprotected amine group, in good yields, via the Suzuki-Miyaura 
reaction.7• 8 Our research was extended to the preparation of 2-amino-5-
pyrimidylboronic acid A2; there are several reports of aniline boronic acids9- 11 and 
amino-pyridylboronic acids, 12• 13 both of which are commercially available, however, 
the aminopyrimidine derivative had not been reported. 
In this appendix the background work regarding the synthesis and reactions of 2-amino-
5-pyrimidylboronic acid A2 is outlined. Optimization of the Suzuki-Miyaura reaction 
conditions, gave synthetically viable yields for the cross-coupling of A2 with a variety 
of (hetero )aryl bromides. 
Al.l.l Synthesis of A2 and initial Suzuki-Miyaura cross-couplings 
The commercially available 2-amino-5-bromopyrimidine Al was treated with n-BuLi in 
the presence of triisopropylborate in THF at -78 oc to yield boronic acid A2 in typically 
25% yield (a yield of 40% was obtained on one occasion)4 (Scheme A 1.1 ). Competitive 
deprotonation of the amine substituent was thought to account for the low isolated 
yields of boronic acid A2; optimum yields were obtained when at least 3 equivalents of 
Al.l 
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n-BuLi was used. Lithium-halogen exchange in the presence of the free 2-amino group, 
combined with the in situ boronic acid preparation, 14 was successful for the pyrimidine 
derivative. However, analogous lithiationlborylation procedures on 2-amino-5-
bromopyridine and 1-amino-4-bromobenzene gave complex product mixtures; the 
corresponding boronic acid/ester derivatives could not be isolated. One may anticipate 
that for Al the negative charge resulting from deprotonation of the amine group will be 
delocalized over the two nitrogen atoms, and therefore will significantly influence the 
lithium-halogen exchange. However, for the pyridine and benzene derivatives there 
would be less stabilization of the negative charge, which may possibly have prevented 
the lithium-halogen exchange from occurring efficiently. We have found that a more 
reliable route to A2 is via the pinacol ester derivative A3 which was generated by 
reaction of Al with HxLi in THF at -78 °C, in the presence 2-isopropoxy-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane, then intermediate A3 was hydrolyzed in situ to A2 
( 46% optimized yield from Al ). 15 
(i), (ii) 
N~~~ 
H2N).__NJ 
A3 
Scheme Al.l (i) n-BuLi, B(Oi-Pr)3, THF , -78 °C. (ii) H20, 48% aq. HBr. (iii) HxLi, 2-
isopropoxy-4,4,5,5-tetramethyl-I,3,2-dioxaborolane, THF, -78 oc. (iv) H20, AcOH.4• 15 
Suzuki-Miyaura reactions of A2 with (hetero)aryl halides 66, 78, A4-A9 were carried 
out under a variety of conditions to yield (hetero)arylpyrimidine derivatives A10-A16. 
The results are collated in Table Al.1. 16 Initially reactions of A2 with heteroaryl 
bromides yielded coupling products in low yields (entries 1 and 2) with 
iodoheterocycles generally giving higher coupling yields, typically 27-60% (entries 3-
8). Reaction conditions [Pd(PPh3)2Ch (5 mol% A2)/t-Bu3P (5 mol% A2), 1,4-dioxane, 
Na2C03 (1 M), reflux, 24 h] were found to give reliably moderate to good yields; 
however, protodeboronation of A2 to give 2-aminopyrimidine was a competing side-
reaction. The overall yield of cross-coupled product could be further improved by a 
A1.2 
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second addition of A2 (1.1 equiv.) to the reaction mixture after 24 h reflux (entries 3 
and 5, conditions D) to overcome the loss of A2 by protodeboronation, and maintain a 
viable amount of A2 in the reaction mixture. However, for practical purposes the 
advantage of higher product yield is offset by the use of more of compound A2. 
N~B(OHh 
11 ~ ----------H2N~N Conditions A-D 
Ar-X 
A2 
Entry Ar-X Product Conditions Isolated yield(%) 
"'~ "Xb H2N-{ ~ lj \ A 45 1 - ~ N- - ~ c 45 (39)* 
66 A10 
2 
x-Q A (from 78) 6 H2N-f:)--Q A (from A4) 47 
3 78 X= Br B (from A4) 56 
A4X= I A11 D (from A4) 96 
1-{) N)---(N H2N-{N_~ ~~ A 33 4 
AS A12 B 60 
--0 N)-{J B 49 5 I S H2N-\,_ ~ ~ I 
A6 A13 
D 76 
6 
sX) 1-<'N I ~ H2N-{N~S=o N- N ~ B 40 
A7 A14 
7 1--{)---sr N- H2N-fN)----(J-sr N- N B 27 
AS A15 
8 IVNo2 H2N-{)--O-N02 A 42 
A9 A16 
Table Al.l Conditions: A: Pd(PPh3) 2Cb (5 mol% A2), I ,4-dioxane, Na2C03 (I M), reflux, 24 h. 
B: Pd(PPh3) 2Cb (5 mol% A2)/t-Bu3P (5 mol% A2), I ,4-dioxane, Na2C03 (I M), reflux, 24 h. C: 
Pd(OAc)2 (5 mol% A2)/D-t-BPF (5 mol% A2), I,4-dioxane, Na2C03 (I M), reflux, 65 h. D: 
Conditions B, with a second addition ofboronic acid A2 (1.1 equiv.) after 24 h reflux. *K3P04(s) 
used (2 equiv.). 16 
Al.3 
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A1.1.2 Boronic ester synthesis and in situ cross-coupling reactions 
In attempts to improve the cross-coupling yields we looked to stabilize the boronic 
species. From literature precedents there is no general rule as to whether the boronic 
acid or an ester derivative is more suitable for cross-coupling. One must evaluate each 
system on a case-by-case basis; for example, Rault et al. showed that a-
cyanopyridylboronic esters are more suitable than the acids, 17 however, as shown in 
Chapter 2 the improvement in the cross-coupling yields may not be significant when 
employing boronic ester derivatives (compared to the analogous boronic acid). Instead 
of isolating the boronic ester A3 from the lithium-halogen exchange/boronation 
protocol outlined in Scheme A 1.1, one could alternatively prepare A3 through the 
palladium catalyzed reaction of 2-amino-5-bromopyrimidine Al with 
bis(pinacolato )diboron (B2pin2). Miyaura et al. have worked extensively on the 
palladium-catalyzed borylation of(hetero)aryl halides18• 19 as discussed in Chapter 1. 
Scheme A1.2 (i) B2pin2, Pd(OAc)2 (5 mol% Al), KOAc, DMF, 90 °C, 17 h.20 
On treating Al with B2pinz, Pd(OAc)z and KOAc in DMF, boronic ester A3 was readily 
synthesized (Scheme Al.2); to achieve optimum yields 2.5 equivalents of B2pin2 were 
required, using fewer equivalents resulted in a significant proportion of unreacted Al 
being recovered.20 Purification of the boronic ester was particularly problematic, after 
silica column chromatography, A3 was isolated along with a second boron-containing 
species. We assume this species to be 'pinacol acetate' resulting from transmetalation 
during the catalytic cycle. Further column chromatography using a more polar eluent 
resulted in the isolation of A3 in very low yields (ea. 2% ). The polar nature of the amine 
and pyrimidine functionality of A3 presumably makes column chromatography more 
difficult. Recrystallization was also unsuccessful in purifying A3. As isolation of 
boronic ester A3 proved difficult, in situ Suzuki-Miyaura cross-coupling reactions were 
performed. 21 The boronic ester A3 was prepared as before, and the reaction mixture was 
cooled prior to addition of the Suzuki-Miyaura cross-coupling reagents. Unfortunately, 
when using the Suzuki-Miyaura conditions previously used for the cross-coupling of 
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boronic acid A2, [Pd(PPh3)2Ch (5 mol% Ar-X)/t-Bu3P (5 mol% Ar-X), 1,4-dioxane, 
Na2C03 (1 M), reflux, 65 h], isolated yields of coupling products All and Al2 (with 
respect to Al) were poor, even when using heteroaryl iodides as coupling partners 
(Table A1.2).20 
N~8r (i) 9~ (ii) N~Ar )!__/- N~8'0 H2N)__N-'-
H2N N )!__/-
H2N N 
A1 A3 A11, A12 
Entry Ar-X Product Conditions Isolated yield(%) 
1 x-Q H2N-{)-O A (from 78) 13 2 78 X= 8r 8 (from A4) 29 
A4X= I A11 
3 1-{) N)----(N H2N\-~ ~J> 8 9 
AS A12 
Table Al.2 (i) B2pin2, Pd(OAc )2 (5 mol% AI), KOAc, 1 ,4-dioxane, 80 °C, 17 h. (ii) Ar-X, 
Conditions A: Pd(PPh3) 2Ch (5 mol% Ar-X), Na2C03 (1 M), reflux, 65 h. Conditions B: 
Pd(PPh3) 2Ch (5 mol% Ar-X)/t-Bu3P (5 mol% Ar-X), Na2C03 ( 1 M), reflux, 65 h?0 
Alongside coupling products All and Al2, 2-aminopyrimidine was isolated indicating 
that the boronic ester A3 was unstable towards protodeboronation under the reaction 
conditions; this may occur during the boronic ester preparation or the subsequent 
Suzuki-Miyaura cross-coupling. The isolated yields for cross-coupling products (with 
respect to Al) were slightly improved when using the boronic ester/in situ Suzuki-
Miyaura protocol, compared to the overall yields when using the boronic acid; yield of 
All, from 2-iodopyridine A4, via boronic ester/in situ route 29%, via boronic acid 26%. 
Nonetheless, as in situ Suzuki-Miyaura reactions ofboronic ester A3 were ineffective in 
improving the preparation, stability and cross-coupling yields (compared to the boronic 
acid A2) we re-investigated alternative Suzuki-Miyaura reaction conditions. 
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A1.2 Improved Suzuki-Miyaura cross-coupling reactions 
The reactions of less expensive (hetero )aryl bromides or chlorides with A2 were 
attractive. However, as previously the reactivity of A2 with (hetero)aryl iodides was 
shown to be fairly poor, we anticipated that cross-coupling with bromo- and chloro-
coupling partners would be difficult. We found that for the electron-deficient coupling 
partners using bromo derivatives and conditions [Pd2(dba)3 (1 mol% Ar-X)/PCy3 (2.4 
mol% Ar-X), 1 ,4-dioxane, K 3P04 (1.27 M), reflux]22 resulted in similar or improved 
yields of AlO, All, A15 and A16 compared to previous reactions with the comparable 
iodo coupling partners (Table Al.3, entries 1, 2, 9 and 10). Chloropyrazine gave A12 in 
a synthetically useful yield of 51% (entry 4 ), compared to the 72% yield of A12 from 
iodopyrazine (entry 3). 
The overall improved reactivity of boronic acid A2 when using Pd2( dba)3/PCy3 as the 
catalyst system applies when utilizing (hetero )aryl bromides, which are far more 
appealing reagents than (hetero )aryl iodides, mainly due to their lower cost. This system 
is far more efficient than the boronic ester/in situ Suzuki-Miyaura protocol in terms of 
general cost of reagents and ease of isolation of final cross-coupling products. 
A1.3 Conclusions 
2-Amino-5-pyrimidylboronic acid can be prepared on a relatively large-scale (70 g) in 
good yield, considering the competitive deprotonation of the amine substituent which 
can occur. Boronic acid A2 is stable to storage under ambient conditions and should 
prove to be a valuable reagent in pyrimidine chemistry. Preparation of the boronic acid 
from cheap commercial reagents and superior reactivity in Suzuki-Miyaura cross-
coupling reactions renders the boronic ester derivative obsolete. 
Protection/deprotection steps ofthe primary amine are not required at any stage in order 
to prepare novel 5-heteroarylpyrimidine scaffolds in synthetically viable yields. A 
selection of heterocycles (quinoline, pyridine, pyrimidine, pyrazine, thiophene, 
benzothiazole) with primary amine, bromo and nitro functional groups were shown to 
be applicable and compatible with the reaction conditions. 
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Entry 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Ar-X 
sr---{'Nh 
~ 
66 
Br-o 
78 
x-{) 
AS X= I 
A17X=CI 
-0 X S 
A6 X= I 
141 X= Br 
x--<~X) 
A7 X= I 
A18 X= Br 
1-o--~ Br 
N-
AB 
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Product 
H2N~XJ 
A11 
Isolated yield 
(%) 
72 
75 
72 (from AS) 
61 (from A17) 
37 (from A6) 
26 (from 141) 
N~sX) 45 (from A7) H2N---{ ~ ~ I 
N- N ~ 33 (from A18) 
A14 
49 
43 
Table A1.3 Conditions: (i) Pd2(dba)3 (I mol% Ar-X)/PCy3 (2.4 mol% Ar-X), 1,4-dioxane, 
K3P04 (1.27 M), reflux, 1-30 h. 
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A1.4 Experimental details for Appendix 1 
Several compounds reported in Appendix 1 were prepared prior to this work; synthesis 
of A2,4• 15 initial Suzuki-Miyaura cross-couplings of A2 (Section Al.l.1),16 synthesis of 
A3 and in situ Suzuki-Miyaura cross-couplings.2° For general considerations refer to 
Chapter 5. 
2-Amino-5-pyrimidylboronic acid (A2) 
N~B(OHh To a solution of2-amino-5-bromopyrimidine Al (69.6 g, 0.4 mol) 
)l_ .J and 2-isopropoxy-4,4,5,5-tetrarnethyl-1 ,3,2-dioxaborolane (223 g, 
H2N N 
1.2 mol) in THF (2 L) at -78 °C, HxLi (2.5 M in hexane, 640 mL, 
1.6 mol) was added dropwise over 1 h. The reaction was stirred for 2.5 h at -78 °C, then 
allowed to warm to room temperature overnight. The reaction mixture was quenched 
with water (1.5 L) and stirred for 30 min. The aqueous phase was separated and washed 
with EtOAc (2 x 1 L) then carbon treated and stirred for 30 min at room temperature 
before filtration through celite. The resulting aqueous filtrate was acidified slowly to pH 
6 using glacial acetic acid (maintaining the temperature below 30 °C) and stirred for a 
further 30 min before filtering the white precipitate which formed. The white solid was 
oven dried at 50 oc and identified as boronic acid A2 (25.6 g, 46%); mp > 300 oc; 1H 
NMR (400 MHz, DMSO-d6) 8 8.49 (2H, s), 7.96 (2H, br. s); 13C NMR (100 MHz, 
DMSO-d6) 8 164.1, 163.9. 
Alternative route: To a solution of 2-amino-5-bromopyrimidine Al (1.74 g, 10 rnrnol) 
and triisopropylborate (2.9 mL, 12 mmol) in anhydrous THF (50 mL) at -78 °C, n-BuLi 
(2.5 M in hexane, 10 mL, 25 rnrnol) was added dropwise over 1 h. The reaction was 
stirred for 3.5 hat -78 °C, then allowed to warm to -20 °C and quenched with water (50 
mL) before being stirred for 30 min. The organic solvent was evaporated in vacuo and 
the remaining aqueous layer filtered to remove inorganic salts. The filtrate was washed 
with diethyl ether (3 x 50 mL) to remove unreacted starting material and the aqueous 
layer filtered to remove inorganic salts. The filtrate was then acidified to pH 6 (with 
48% aq. HBr) to precipitate A2 as a white solid (347 mg, 25%), spectroscopically 
identical to the sample previously described. 
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Typical Procedure for the Suzuki-Miyaura Cross-Coupling Reactions in Table 
Al.l 
The boronic acid (1.1 equiv.) the arylhalide (1.0 equiv.) and catalyst (ea. 5 mol%) were 
sequentially added to degassed 1,4-dioxane (10 mL) and the mixture stirred at 20 °C for 
30 min. Degassed aqueous Na2C03 (1 M, 3.0 equiv.) was added and the reaction 
mixture was heated under argon at reflux (typically for 24 h). The solvent was removed 
in vacuo then EtOAc was added and the organic layer was washed with brine, separated, 
and dried over MgS04. The mixture was purified by chromatography on a silica gel 
column. On some occasions an additional recrystallization was necessary. 
Conditions A: Pd(PPh3)2Ch (5 mol% A2), 1 ,4-dioxane, Na2C03 (1 M), reflux, 24 h. 
Conditions B: Pd(PPh3)2Ch (5 mol% A2)/t-Bu3P (5 mol% A2), 1,4-dioxane, Na2C03 (1 
M), reflux, 24 h. 
Conditions C: Pd(OAc)2 (5 mol% A2)/D-t-BPF (5 mol% A2), 1,4-dioxane, Na2C03 (1 
M), reflux, 65 h. 
Conditions D: Conditions B, with a second addition of boronic acid A2 (1.1 equiv.) 
after 24 h reflux. 
Typical Procedure for the Suzuki-Miyaura Cross-Coupling Reactions in Table 
A1.3 
The boronic acid A2 (1.1 equiv.) the arylhalide (1.0 equiv.) Pd2(dba)3 (ea. 1 mol%) and 
PCy3 (ea. 2.4 mol%) were sequentially added to degassed 1,4-dioxane (2.7 mL) and the 
mixture stirred at 20 °C for 30 min. Degassed aqueous K3P04 solution (1.27 M, 1.7 
equiv.) was added and the reaction mixture was heated under argon at reflux (typically 
between 1-30 h). The solvent was removed in vacuo then EtOAc was added and the 
organic layer was washed with brine, separated, and dried over MgS04. The mixture 
was purified by chromatography on a silica gel column or by recrystallization. 
3-(2-Aminopyrimidin-5-yl)-quinoline (Al 0) 
HN 'I \ '\ 
N:Kblj N Table Al.3: Boronic acid A2 (153 mg, 1.1 mmol), 3-
2 ~N- - -~ bromoquinoline 66 (0.14 mL, 1.0 mmol), Pd2(dba)3 (9.2 
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mg, 0.01 mmol), PCy3 (6.7 mg, 0.024 mmol), 1,4-dioxane (2.7 mL) and K3P04 (1.3 
mL ); reflux 24 h; eluent MeOH:EtOAc 1 :4 v/v gave Al 0 as a cream solid (160 mg, 
72%); mp 267.5-269.0 °C. 1H NMR (400 MHz, CDCh) o 9.08 (IH, d, J= 2.4 Hz), 8.67 
(2H, s), 8.24 (lH, d, J= 2.3 Hz), 8.16 (lH, d, J= 8.4 Hz), 7.89 (lH, d, J= 8.2 Hz), 7.75 
(lH, t, J= 7.7 Hz), 7.61 (lH, t, J= 7.6 Hz), 5.22 (2H, s); 13C NMR (100 MHz, DMSO-
d6) 0 163.2, 156.4, 154.8, 153.8, 148.5, 146.5, 130.7, 129.2, 128.7, 128.4, 128.1, 127.0, 
119.2. MS (ES+) mlz 223.5 ([M+ It). Anal. Calcd. for C13H10N4: C, 70.26; H, 4.54; N, 
25.21. Found: C, 70.00; H, 4.40; N, 24.86%. 
Conditions C: Boronic acid A2 (236 mg, 1. 7 mmol), 3-bromoquinoline 66 (0.2 mL, 1.5 
mmol), Pd(OAc)2 (19 mg, 0.085 mmol), D-t-BPF (38 mg, 0.080 mmol), 1,4-dioxane 
(10 mL) and Na2C03 (4 mL); reflux 65 h; eluent EtOAc gave impure AlO as a 
red/brown solid. To remove the colouration (thought to be caused by D-t-BPF) the 
product was columned again to give AlO as a white solid (149 mg, 45%), 
spectroscopically identical with the sample previously described. 
Conditions A: Boronic acid A2 (236 mg, 1.7 mmol), 3-bromoquinoline 66 (0.2 mL, 1.5 
mmol), Pd(PPh3)2Ch (59.6 mg, 0.085 mmol), 1,4-dioxane (10 mL) and Na2C03 (4 mL); 
reaction time 65 h; eluent methanol:EtOAc (1 :9 v/v) and recrystallization from 
toluenelhexane gave AlO as a white solid (72 mg, 22%), spectroscopically identical 
with the sample previously described. 
2-(2-Aminopyrimidin-5-yl)-pyridine (All) 
N)----Ofj '\:; Conditions D: Boronic acid A2 (236 mg, 1. 7 mmol), 2-
H2N---{ . . . 
N- N- wdopyndme A4 (0.16 mL, 1.5 mmol), Pd(PPh3)2Ch (59.6 mg, 
0.085 mmol), t-Bu3P (0.02 mL, 0.080 mmol), 1,4-dioxane (10 mL) and Na2C03 (4 mL); 
reflux 24 h then addition of boronic acid A2 (236 mg, 1. 7 mmol), further reflux for 48 
h; eluent methanol:EtOAc (1 :9 v/v) and recrystallization from toluene gave All as a 
pale yellow crystalline solid (249 mg, 96%); mp 192.5-194.5 °C. 1H NMR (400 MHz, 
CDCh) o 8.93 (2H, s), 8.65 (IH, d, J = 4.1 Hz), 7.74 (lH, t, J = 8.0 Hz), 7.60 (lH, d, J 
= 8.0 Hz), 7.22 (lH, t, J= 6.1 Hz), 5.41 (2H, s); 13C NMR (100 MHz, CDCh) o 163.2, 
157.1, 153.3, 150.1, 137.1, 123.5, 122.3, 119.0. MS (ES+) mlz 173.1 ([M+lt). Anal. 
Calcd. for C9H8N4: C, 62.78; H, 4.68; N, 32.54. Found: C, 62.64; H, 4.66; N, 32.79%. 
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Conditions B: Boronic acid A2 (236 mg, 1.7 mmol), 2-iodopyridine A4 (0.16 mL, 1.5 
mmol), Pd(PPh3)2Ch (59.6 mg, 0.085 mmol), t-Bu3P (30 mg, 0.15 mmol), 1 ,4-dioxane 
(10 mL) and Na2C03 (4 mL); reaction time 65 h; eluent MeOH:EtOAc 1:9 v/v gave 
All as an off-white solid (145 mg, 56%), spectroscopically identical with the sample 
previously described. 
Table A1.3: Boronic acid A2 (160 mg, 1.15 mmol), 2-bromopyridine 78 (0.10 mL, 1.05 
mmol), Pd2(dba)3 (9.6 mg, 0.011 mmol), PCy3 (7.0 mg, 0.025 mmol), 1,4-dioxane (2.7 
mL) and K3P04 (1.3 mL); reflux 3 h; recrystallization from toluene gave All as a white 
crystalline solid (135 mg, 75%), spectroscopically identical with the sample previously 
described. 
2-Amino-5-pyrazinylpyrimidine (A12) 
N:x::lj N Table A1.3: Boronic acid A2 (153 mg, 1.1 mmol), iodopyrazine H2N~ ~ 
N- Nd A5 (0.1 mL, 1.0 mmol), Pd2(dba)3 (9.2 mg, 0.01 mmol), PCy3 
(6.7 mg, 0.024 mmol), 1,4-dioxane (2.7 mL) and K3P04 (1.3 mL); reflux 2.5 h; 
recrystallization from toluene gave A12 as a white solid (126 mg, 72%); mp 213.0-
215.5 °C, lit. mp23 213-216°C. 1H NMR (500 MHz, DMSO-d6) () 9.16 (1H, d, J = 1.5 
Hz), 8.97 (2H, s), 8.62 (IH, m), 8.52 (IH, d, J = 2.4 Hz), 7.16 (2H, s); 13C NMR (125 
MHz, DMSO-d6) <> 163.9, 156.7, 144.8, 144.1, 142.6, 140.5, 118.2. MS (El) m/z 173.0 
(M+). Anal. Calc. for C8H7N5: C, 55.48; H, 4.07; N, 40.44. Found: C, 55.24; H, 4.02; N, 
40.77%. 
Conditions B: Boronic acid A2 (236 mg, 1. 7 mmol), iodopyrazine A5 (0.15 mL, 1.5 
mmol), Pd(PPh3)2Ch (59.6 mg, 0.085 mmol), t-Bu3P (0.02 mL, 0.080 mmol), 1,4-
dioxane (10 mL) and Na2C03 (4 mL); reflux 65 h; eluent EtOAc gave A12 as a white 
solid (155 mg, 60%), spectroscopically identical with the sample previously described. 
Table A1.3: Boronic acid A2 (236 mg, 1.7 mmol), chloropyrazine A17 (0.13 mL, 1.5 
mmol), Pd2(dba)3 (13.7 mg, 0.015 mmol), PCy3 (10.1 mg, 0.036 mmol), 1,4-dioxane 
(2.7 mL) and K3P04 (1.3 mL); reflux 2.5 h; recrystallization from toluene gave A12 as 
an off-white solid (158 mg, 61 %), spectroscopically identical with the sample 
previously described. 
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2-(2-Aminopyrimidin-5-yl)-thiophene (Al3) 
NXJS Conditions D: Boronic acid A2 (236 mg, 1.7 rnrnol), 2-
H N-f \ ~ I 2 N- iodothiophene A6 (0.17 mL, 1.5 rnrnol), Pd(PPh3)2Ch (59.6 mg, 
0.085 rnrnol), t-Bu3P (0.02 mL, 0.080 mmol), 1,4-dioxane (10 mL) and Na2C03 (4 mL); 
reflux 24 h then addition of boronic acid A2 (236 mg, 1. 7 rnrnol), further reflux for 48 
h; eluent methanol:EOAc (1 :9 v/v) and recrystallization from toluene gave Al3 as a 
pale yellow solid (203 mg, 76%); mp 171.2-172.9 °C. 1H NMR (400 MHz, CDCh) 8 
8.53 (2H, s), 7.30 (1H, dd, J = 5.1, 1.2 Hz), 7.18 (lH, dd, J = 3.6, 1.2 Hz), 7.09 (1H, dd, 
J = 5.2, 3.6 Hz), 5.14 (2H, s); 13C NMR (100 MHz, CDCh) 8 162.3, 155.7, 137.9, 
128.3, 124.8, 122.9, 119.6. MS (El) mlz 177.0 (M+). Anal. Calc. for C8H7N3S: C, 54.22; 
H, 3.98; N, 23.71. Found C, 54.05; H, 3.93; N, 23.60%. 
Conditions B: Boronic acid A2 (236 mg, 1.7 rnrno1), 2-iodothiophene A6 (0.17 mL, 1.5 
mmol), Pd(PPh3)2Ch (59.6 mg, 0.085 rnrnol), t-Bu3P (0.02 mL, 0.080 mmol), 1,4-
dioxane (10 mL) and Na2C03 (4 mL); reflux 65 h; eluent methanol:EtOAc (1:9 v/v), 
recrystallization from toluene/hexane to give A13 as a pale yellow solid (131 mg, 49%), 
spectroscopically identical with the sample previously described. 
Table Al.3: Boronic acid A2 (153 mg, 1.1 rnrnol), 2-iodothiophene A6 (0.11 mL, 1.0 
rnrnol), Pd2(dba)3 (9.2 mg, 0.01 mmol), PCy3 (6.7 mg, 0.024 mmol), 1,4-dioxane (2.7 
mL) and K3P04 (1.3 mL); reflux 3 h; recrystallization from toluene gave A13 as a beige 
solid (66 mg, 37%), spectroscopically identical with the sample previously described. 
Table Al.3: Boronic acid A2 (153 mg, 1.1 rnrnol), 2-bromothiophene 141 (0.1 mL, 1.0 
mmol), Pd2(dba)3 (9.2 mg, 0.01 rnrnol), PCy3 (6.7 mg, 0.024 mmol), 1,4-dioxane (2.7 
mL) and K3P04 (1.3 rnL); reflux 24 h; eluent EtOAc gave A13 as a yellow solid (46 
mg, 26%), spectroscopically identical with the sample previously described. 
2-Amino-5-benzothiazol-2-ylpyrimidine (A14) 
N~SJ) Conditions B: Boronic acid A2 (236 mg, 1. 7 rnrnol), 2-
HzN-f ~ I . . N- N .o todobenzothtazole A 7 (342 mg, 1.5 mmol), Pd(PPh3)2Ch 
(59.6 mg, 0.085 mmol), t-:e\.13P (0.02 mL, 0:080 rnrnol), 1,4-dioxane (10 mL) and 
Na2C03 ( 4 mL); reflux 65 h; eluent EtOAc followed by recrystallization from 
toluene/hexane gave A14 as an orange solid (136 mg, 40%); mp 267.0-269.5 °C. 1H 
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NMR (400 MHz, DMSO-d6) 8 8.89 (2H, s), 8.11 (lH, d, J = 7.8 Hz), 7.98 (lH, d, J = 
8.1 Hz), 7.51 (1H, t, J= 7.9 Hz), 7.44 (2H, s), 7.42 (1H, t, J= 7.4 Hz); ne NMR (125 
MHz, DMSO-d6) 8 164.3, 163.5, 157.1, 153.3, 133.6, 126.6, 125.1, 122.2, 122.2, 116.4. 
MS (El) mlz 227.9 (M+). HRMS (El) calcd. for e1 1HsN4S 228.0470, found 228.0473. 
Table Al.J: Boronic acid A2 (153 mg, 1.1 mmol), 2-iodobenzothiazole A7 (628 mg, 1.0 
mmol), Pd2(dba)3 (9.2 mg, 0.01 mmol), Pey3 (6.7 mg, 0.024 mmol), 1,4-dioxane (2.7 
mL) and K3P04 (1.3 mL); reflux 24 h; recrystallization from toluene gave A14 as an 
orange-brown solid (102 mg, 45%), spectroscopically identical with the sample 
previously described. 
Table Al.J: Boronic acid A2 (153 mg, 1.1 mmol), 2-bromobenzothiazole AlS (214 mg, 
1.0 mmol), Pd2(dba)3 (9.2 mg, 0.01 mmol), Pey3 (6.7 mg, 0.024 mmol), 1,4-dioxane 
(2.7 mL) and K3P04 (1.3 mL); reflux 30 h; eluent EtOAc gave A14 as a light brown 
solid (76 mg, 33%), spectroscopically identical with the sample previously described. 
3-Bromo-6-(2-aminopyrimidin-5-yl)-pyridine (A15) 
N~ Table Al.J: Boronic acid A2 (96 mg, 0.69 mmol), 5-
H2N---{' :-.. /; · Br 
N- N bromo-2-iodopyridine AS (179 mg, 0.63 mmol), Pd2( dba)3 
(5.8 mg, 0.007 mmol), Pey3 (4.2 mg, 0.015 mmol), 1,4-dioxane (2.7 mL) and K3P04 
(1.3 mL); reflux 2 h; recrystallization from toluene gave A15 as a white solid (77 mg, 
49%); mp 237.0-239.5 oe. 1H NMR (500 MHz, DMSO-d6) 8 8.91 (2H, s), 8.68 (lH, d, 
J = 2.3 Hz), 8.05 (1H, dd, J = 8.6, 2.5 Hz), 7.85 (1H, d, J = 8.6 Hz), 7.07 (2H, s); ne 
NMR (125 MHz, DMSO-d6) 8 163.7, 156.5, 151.8, 150.1, 139.6, 120.2, 119.8, 118,0. 
MS (ES+) mlz 251.2, 253.2 ([M+1t). Anal. ealc. for e 9H7BrN4: e, 43.05; H, 2.81; N, 
22.31. Found: e, 43.21; H, 2.78; N, 21.89%. 
Conditions B: Boronic acid A2 (236 mg, 1. 7 mmol), 5-bromo-2-iodopyridine AS ( 426 
mg, 1.5 mmol), Pd(PPh3)2eh (59.6 mg, 0.085 mmol), t-Bu3P (0.02 mL, 0.080 mmol), 
1,4-dioxane (10 mL) and Na2e03 (4 mL); reflux 65 h; eluent EtOAc and 
recrystallization from toluene gave A15 as an off-white solid (103 mg, 27%), 
spectroscopically identical with the sample previously described. 
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4-(2-Aminopyrimidin-5-yl)-nitrobenzene (A16) 
N)-0--- Conditions A: Boronic acid A2 (196 mg, 1.4 mmol), 1-
H2N---{ ' /; N02 N- '' iodo-4-nitrobenzene A9 (311 mg, 1.25 mmol), 
Pd(PPh3)2Ch (50 mg, 0.071 mmol), 1,4-dioxane (10 mL) and Na2C03 (4 mL); reflux 65 
h; eluent methanol:EtOAc 1:9 v/v, gave A16 as an orange solid (113 mg, 42%); mp 
279.5-281.0 °C. 1H NMR (500 MHz, DMSO-d6) 8 8.74 (2H, s), 8.25 (2H, d, J = 9.2 
Hz), 7.94 (2H, d, J = 9.2 Hz), 7.09 (2H, s); 13C NMR (125 MHz, DMSO-d6) 8 163.5, 
156.8, 146.0, 142.2, 125.8, 124.2, 119.6. MS (El) mlz 216.00 (M+). Anal. Calc. for 
C10HsN402: C, 55.55; H, 3.73; N, 25.91. Found: C, 55.81; H, 3.74; N, 25.95%. 
Table A1.3: Boronic acid A2 (153 mg, 1.1 mmol), 1-bromo-4-nitrobenzene A18 (202 
mg, 1.0 mmo1), Pd2(dba)3 (9.2 mg, 0.01 mmol), PCy3 (6.7 mg, 0.024 mmol), 1,4-
dioxane (2.7 mL) and K3P04 (1.3 mL); reflux 1 h; recrystallization from toluene gave 
A16 as a brown crystalline solid (93 mg, 43%), spectroscopically identical with the 
sample previously described. 
Representative procedure for the synthesis of 5-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)pyrimidin-2-amine (A3) 
Y 2-Amino-5-bromopyrimidine Al (0.50 g, 2.87 mmol), 
~ -~ bis(pinacolato)diboron (1.80 g, 7.18 mmol), KOAc (2.3 g, 23 
N~ '0 JL .. .J mmol), Pd(OAc)2 (15 mg, 0.14 mmol) and degassed anhydrous 
H2N N DMF (10 mL) was heated to 90 oc for 17 hours. The reaction 
was allowed to cool and the DMF was removed in vacuo. EtOAc was added (25 mL) 
and the organic layer was washed with brine (25 mL), and extracted with EtOAc (2 x 25 
mL), the organic phase was dried over MgS04. The organic solvents were removed in 
vacuo and the resulting yellow solid appeared to be compound A3, from 1H, 11 B and 13C 
NMR evidence, alongside a second boron-containing species. Recrystallization from 
hexane did not improve the purity. Column chromatography with eluent EtOAc also had 
little effect on isolating the boronic ester A3 with increased purity. Therefore in further 
work compound A3 was reacted in situ. 
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Typical Procedure for the Suzuki-Miyaura Cross-Coupling Reactions in Table 
A1.2 
2-Amino-5-bromopyrimidine Al (1.0 equiv.), bis(pinacolato)diboron (2.5 equiv.), 
Pd(OAc)2 (5 mol% Al) and degassed 1,4-dioxane were stirred at room temperature for 
30 min under argon. KOAc (12 equiv.) was added and the reaction was stirred at 80 °C 
for 17 h. The reaction mixture was allowed to cool to room temperature before addition 
of the heteroaryl halide (1.0 equiv.), Pd(PPh3)2Ch (ea. 5 mol% Ar-X), t-Bu3P (ea. 5 
mol% Ar-X), and degassed Na2C03 (IM, 3 equiv.), and the reaction was stirred at 
reflux for 65 h. The reaction mixture was cooled and filtered to remove any palladium 
salts; the solvent was then removed in vacuo, EtOAc was added and the organic layer 
was washed with brine, separated, and dried over MgS04. The mixture was purified by 
chromatography on a silica gel column. On some occasions an additional 
recrystallization of the product was necessary to obtain a pure compound. 
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